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Abstract: A Population Perspective on Physical Activity and Health 
Oliver Tristan Mytton 
Regular physical activity reduces the risk of many chronic diseases. Consequently, the promotion of it 
and particular types (e.g. walking and cycling for travel), have become a priority for governments 
seeking to improve health and constrain rising demand on health services. Despite this many 
uncertainties persist. The aim of this thesis is to address two particular areas of uncertainty: a) the 
association of walking and cycling for travel with indices of health and well-being; b) and the extent 
to which increases in physical activity will reduce need for health and social care. 
 
The first part of my thesis consists of three studies that describe the health benefits associated with 
walking and cycling to work among working age adults. The first is a longitudinal study of the 
associations between maintenance of active commuting with sickness absence and well-being using 
the Commuting and Health in Cambridge dataset. The second, using the same dataset, describes the 
longitudinal associations between maintenance of active commuting and self-reported body mass 
index. Building on this, the third study using a large cohort study (the Fenland Study) with detailed 
characterisation of diet and physical activity (including objective measurement) describes the 
baseline associations between active commuting and objective measures of adiposity. 
 
The second part of my thesis describes the development of a combined microsimulation multi-state 
life table model that is used to characterise the effects of a population ‘shift’ in physical activity on 
the burden of six major diseases at the population-level. Specifically, it seeks to better describe the 
effect of increases in physical activity on healthcare need considering not just the effect of physical 
activity on disease incidence but also the effect on healthcare need arising from consequent survival 
to an older age (at which disease incidence is higher), and contrasts this with a method that does not 
make allowance for increased survival. 
 
The findings of this thesis provide evidence of the importance of walking or cycling to work in 
maintaining or improving the health and well-being of working age adults. It suggests that increases 
in physical activity, even after allowance for increased survival, are likely to reduce need for 
healthcare, although the reductions in need are less than might be assumed when allowance is not 
made for increased survival. Taken together this work provides a stronger empirical basis to inform 
public health practice. A stronger ‘health case’ for active travel can be made. The benefits of which 
should be communicated to individuals choosing how to travel as well as policy makers and others 
who can influence the determinants of active travel. It also provides a more realistic and nuanced 
understanding of how increases in physical activity may affect future healthcare need. 
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For Ella 
 
Why would you lie when you can sit? 
Why would you sit when you can stand? 
Why would you stand when you can climb? 
You were born to move. 
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1 Introduction 
 
“Public health is the science and art of preventing disease, 
prolonging life and promoting health through the organized 
efforts of society” 
Donald Acheson 
 
“Lack of activity destroys the good condition of every human 
being, whilst movement and methodical physical exercise save 
it and preserve it” 
Plato 
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1.1 Public health 
 
“What do you do?” It is a common question. And in recent years it is not one that I have found easy to 
answer. The words ‘public health’ are usually met with a confused look. Further explanation is always 
possible, but never quite does it justice. Invoking ‘the science and the art’ can come across as remote. 
Focusing on the activities of a public health professional answers the question but doesn’t convey the 
richness or the importance of the work. Occasionally my reply is met with an excited response. But 
invariably I am left disappointed as that person’s view of public health does not accord with my own. 
Public health is about more than preventing disease by encouraging individuals to live healthily.  
 
In the UK, the Faculty of Public Health defines public health “as the science and art of promoting and 
protecting health and well-being, preventing ill-health and prolonging life through the organised 
efforts of society.”1 The Faculty also stresses other key elements of public health, that it is population 
based; depends on collective responsibility; requires working in partnership; and recognises an 
important role for the state. Similar themes are echoed by definitions offered by others.2–5 For me 
one of the most important aspects, particularly as I moved from medicine into public health, is a 
focus on populations instead of individuals. This notion is explicit or implicit in all these definitions,1–5 
although none of these definitions fully explains the richness of a ‘population approach’ to health.  
 
1.1.1 The population approach to preventive medicine 
Rose distinguished between a population approach and an individual approach to medicine.6,7 He 
was primarily concerned with the prevention of cardiovascular disease. His argument was predicated 
on two simple assumptions. First, the risk of disease (normally) increases as exposure to a risk factor 
increases, in a linear or curvilinear fashioni. Second, there will be a distribution of risk within the 
population and for many risk factors this will tend towards a normal or bell-shaped distribution.  
 
Given these two assumptions, Rose observed that the majority of incident cases are not likely to 
occur amongst those individuals at highest risk. The number of individuals at highest risk is relatively 
small. In contrast the number of individuals at low or moderate risk is relatively large. He argued that 
the majority of cases would occur amongst this population, as the size of that population was so 
                                                          
i Rose outlined four relationships between exposure to a risk factor and disease risk. For one of these relationships (a U-
shaped relationship), within certain limits increasing exposure to a risk factor was associated with decreasing risk. Rose 
gave two examples, the relationship between blood pressure with symptoms and body mass index with mortality.  
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much larger than the size of the high-risk population. A large number of people at moderate risk will 
give rise to more incident cases than a few people at high riskii. 
 
He further observed that medical practice tends to focus on those who are at high risk. Whilst these 
individuals have the most to gain from treatment aimed at reducing their risk, this approach is 
inherently limited because it will only prevent a relatively small proportion of all incident cases within 
a population. To prevent more cases requires shifting the thresholds for treatment, so that more 
people who are at ‘moderate’ risk are offered treatment. Whilst theoretically this approach may 
work, in practice it creates problems. Symptoms, illness and even disease may be created as side-
effects from treatment.8 It may not be financially sustainable. Furthermore, ‘medicalising’ risk factors 
in otherwise healthy people is rejected by some doctors and some patients.9 
 
An alternative approach is a population approach. Instead of focusing just on those at highest risk 
Rose advocated an approach targeted at the whole population with the aim of ‘shifting’ the 
distribution of risk towards lower risk. He observed that there were marked differences in the 
distribution of risk in different geographic settings (e.g. the mean blood pressure of Kenyan nomads 
is noticeably lower than that of London civil servants).7 He suggested that such differences were 
unlikely to be explained by genetics, and that environmental differences might explain most or all of 
the observed differences between populations. As many environmental differences are modifiable, 
the identification and modification of important environmental differences may offer a means to 
shift the population distribution of risk towards a more favourable (lower) distribution of risk. 
Moreover, that approach offers much greater opportunity to prevent disease as it reduces the risk of 
disease for those at moderate and low risk, in whom the majority of incident cases will arise. 
 
Rose further argued that the population-approach should be “radical”, by which he meant it should 
address the root or fundamental causes of health behaviours. Health education, whilst often 
politically acceptable, was described as “superficial” because it does not address the underlying 
(social, environmental and economic) determinants of behaviour and so has limited ability to shift 
the distribution of risk. This radical approach to improving health shares much in common with socio-
ecological models of health that emphasise a role for social, culture, economic and other 
environmental factors in determining health behaviours and health.10,11 
 
                                                          
ii The extent to which the ‘normal’ majority will give rise to more cases than the high-risk minority is variable. It will, for 
example, depends on the shape of the dose-response relationship, distribution of risk within the population and the 
definition of high-risk. 
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1.1.2 Practice of public health in England 
Alongside these theoretical concepts of public health, one also needs to consider public health 
practice in England today, which delivers both services for the public (e.g. preventive programmes, 
health education) as well as providing a broad set of functions which are equally important but less 
visible to the public (e.g. surveillance, evaluation, advocacy, guidance, research). The delivery of 
these services and functions is widely distributed, although there are several bodies with key roles.  
 
Public Health England has a wide ranging remit “to protect and improve the nation’s health and 
address inequalities”. It undertakes a number of public health functions: e.g. surveillance, 
development of standards or guidelines, management of infectious diseases outbreaks, offering 
expertise, analysis and publication of health data, and running health education campaigns. 
However, it does not directly deliver, or even commission, most preventive services. Such preventive 
programmes (e.g. vaccination, screening) and health improvement programmes (e.g. weight loss 
clinics, smoking cessation clinics) are typically commissioned by local government or NHS England, 
with services being delivered by the NHS and other providers. Other organisations also provide 
important functions (e.g. Department of Health sets health and health policy, National Institute for 
Health and Care Excellence sets guidelines and standards).   
 
The Health and Social Care Act 2012 was responsible for instituting the changes that led to the 
present arrangement.12,13 One of the key changes was the movement of local public health 
departments out of the NHS and into local government. This potentially gives the discipline a greater 
ability to focus on prevention and health improvement, in part because local government has 
responsibility for many of the local determinants of health (e.g. planning, education and leisure 
services) and in part because public health specialists may be freed from dealing with immediate 
needs of the health service. However, it also poses challenges for the discipline (e.g. local public 
health officials may be politically restrained from advocating for health). The act also led to the 
establishment of local Health & Well-being boards, chaired by local government and bringing 
together the NHS, local government and other local stakeholders.  
 
Public health practice in England is increasingly organised into three domains or sub-specialties: 
health protection, health services public health and health improvement.1,14 Health protection is 
primarily concerned with prevention and control of infectious diseases and other environmental 
hazards. Health services public health is concerned with the commissioning of appropriate services 
for the needs of the local population and assuring the quality of those services. Health improvement 
21 
 
aims to improve the health and well-being of individuals or communities by enabling and 
encouraging healthy behaviours.  
 
There are different arrangements in the devolved nations of Wales, Scotland and Northern Ireland. 
 
1.1.3 My perspective 
 
1.1.3.1 Medicine and public health 
My interest in public health predates medical school. I first began reading about epidemiology (John 
Snow on Cholera and Richard Doll on smoking) when I was at school. At various points, prior to 
starting formal public health training in 2010, I’ve had an opportunity to express or develop my 
interests in population health and quantitative methods. 
 
There were two particularly formative experiences that led me to academic public health. The first 
experience was working at the Shoklo Malaria Research Unit on the Thai-Burmese border (2004 and 
2006). The experience showed me the importance of population-level thinking. The introduction of 
good systems of care (e.g. surveillance, anti-malarial stewardship, quality controlled laboratory 
diagnostics) had dramatically improved health.15,16 It was also an excellent model of clinical research, 
where the clinical problems framed the research questions, and led to evolution of practice. The 
second experience was undertaking a two-year placement in the Department of Health working with 
Sir Liam Donaldson, the Chief Medical Officer for England and the country’s most senior public health 
doctor.17 I saw that scientific evidence could shape policy. I also saw and learnt how it failed to have 
an impact on policy. 
 
Equally I am very conscious that my background is in medicine. This has given me a broad experience 
of health and healthcare. I have practised both general medicine and psychiatry. I’ve worked in 
different healthcare settings (e.g. community settings, small hospitals, larger hospitals) in different 
countries (New Zealand, Thailand, as well as England) and partly through my public health training 
I’ve worked in different parts of the public health system (locally, nationally and internationally as 
well as working for government bodies and non-governmental organisations). Whilst data and 
studies give me one perspective, the clinical experience gives me a different perspective around what 
health and disease means for families and individuals. The health services and policy experience gives 
me another perspective on how things do (or do not) change: what studies or statistics might be a 
motivator for action; and what the practical implications of any research findings are across a 
complicated and diverse system. 
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1.1.3.2 Diet and physical activity 
Whilst I have explored different topics within public health, one interest that has persisted is 
population approaches to prevent obesity, which first began as a medical student. Studying in 
Oxford, I was very cognisant of Richard Doll’s work on smoking and health. I thought, perhaps 
naïvely, that the ‘tobacco epidemic’ was drawing to a close. I reasoned that other risk factors, 
notably obesity which was becoming a concern,18 would pose a bigger threat to the public’s health. I 
also thought the era of chronic disease epidemiology was drawing to a close as epidemiologists had 
identified most of the important risk factors for health. I thought that public health research needed 
to move beyond describing associations between obesity and health, and instead should research 
solutions. It was also around this time that I first learnt of Rose’s work and the concept of shifting the 
population distribution. Influenced by the success of tobacco taxation and using some of Rose’s 
arguments, I wrote my finals dissertation on the potential for taxes on unhealthy foods to reduce 
obesity. With colleagues at Oxford I have developed that line of work,19,20 and more recently I have 
focussed on taxes on sugar sweetened beverages.21,22 I have also undertaken work concerned with 
physical activity. My Masters in Public Health dissertation described the associations between 
greenspace near the home and physical activity in England.23 
 
Some of this work has been influential and some has been highly cited. However, neither topic was 
quite right for my PhD. Both topics were relatively narrow, and not in keeping with a broader 
appreciation of public health. I was also unsure how to advance the work. Empirical evidence from 
real world taxes, rather than more modelling studies, appeared necessary to address many residual 
uncertainties and to persuade governments to tax sugar sweetened beverages. The greenspace work 
was hindered by poor measurement, and I was unsure what the practical intervention might be as it 
did not seem feasible to increase greenspace in urban environments to the extent that my research 
appeared to suggest it was necessary. 
 
1.1.3.3 Approach to PhD 
All of these experiences have influenced my PhD. There were several strands that I have wanted to 
bring together. First, I wanted to take a population approach. Second, I wanted to combine and 
develop quantitative methods I have used before (epidemiology and public health modelling). Third, I 
was very conscious of my background in medicine, and I wanted to find ways both to make use of 
that knowledge and to consider the implications of my work for healthcare. Fourth, being grounded 
in public health practice and having experience of policy, I wanted to ask relevant or critical 
questions with the potential to influence public health practice or policy.  
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1.2 Physical activity and health 
 
1.2.1 Physical activity 
Physical activity can be defined as any bodily movement produced by skeletal muscles that requires 
energy expenditure.24 It is a broad set of behaviours that can take place in a variety of contexts. It is, 
and always has been, an intrinsic part of human life. The ability of humans to be active was essential 
for survival in the pre-historic period, and for the subsequent development of civilisation. The main 
parts of human life focusing around work or home, until comparatively recently, required physical 
activity. Cultural and social life has always celebrated a physical dimension to life, from the ritualised 
dance undertaken by early primitive societies to modern global sporting events.25,26 
 
Its importance for health has been recognised for a long time. Organised exercise as a form of health 
promotion took place in China in 2500 BC.25 The ancient Greek physician Hippocrates (c.460 BC to 
370 BC) and other Greek scholars (Plato and Galen) wrote about the benefits of physical activity for 
health and well-being.25–28  
 
1.2.2 Early studies of physical activity and health 
Whilst the notion that physical activity is beneficial for health and well-being may be very old, 
scientific evidence of its effect on health is comparatively new.28 One of the earliest reports 
describing associations between physical activity and disease was produced by Ramazzini in 1700. He 
compared the diseases experienced by different occupational groups and reported that professional 
messengers, who walked or ran, avoided some of the diseases experienced by those who undertook 
relatively sedentary occupations (e.g. tailors and cobblers).29,30 In 1843, Guy reported that mortality 
rates were higher amongst sedentary workers compared to those undertaking more active work.31 
Foreshadowing a shift in focus towards recreational activity, Hartley and Llewellyn in 1939, reported 
increased longevity amongst those who rowed for either Cambridge or Oxford University, in 
comparison with the general population.32 
 
The findings from these early reports may have been suggestive, but were far from conclusive. 
Confounding, for example by age or socio-economic status, and selection bias, for example self-
selection into less active occupations amongst those with pre-existing illness, might explain the 
findings.  
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1.2.3 Modern studies of physical activity and health 
Beginning in the 1950s Morris and co-workers undertook a series of studies that described the 
associations between physical activity and cardiovascular disease. Their initial study reported a lower 
incidence of fatal coronary heart disease among bus conductors who, by walking up and down the 
stairs on the bus throughout their working day, were relatively active compared to bus drivers.33 
Although based on observational data, a strength of this study was that the two groups of busmen 
were relatively comparable in many other habits and behaviours. Morris’s subsequent work drew on 
a range of emerging epidemiological techniques to provide a much stronger basis for causal 
inference.34,35  
 
Morris and colleagues established cohort studies in bus workers and civil servants to test the 
association of physical activity (both occupational and recreational) with coronary heart disease.36–39 
They explicitly measured and adjusted for other potential confounding factors, such as hypertension 
and diet,36 as well as testing the extent to which other factors, principally job stress, might account 
for the differences in observed incidence between occupations.33 They also documented differences 
in extent of ischaemic heart disease at post-mortem between those who had been employed in 
sedentary and in active occupations,40 and a dose-response relationship between physical activity 
and disease risk.38,39 
 
Others have built on this work. Today there is a large body of scientific evidence, mostly although not 
exclusively from cohort studies, demonstrating the importance of physical activity for health.  The 
focus of much of this work is moderate-to-vigorous physical activity (MVPA), i.e. physical activity that 
requires an energy expenditure three times basal metabolic rate. The evidence is summarised below. 
 
1.2.3.1 All-cause mortality 
Many cohort studies have reported that regular physical activity is associated with reduced all-cause 
mortality. A recent meta-analysis of cohort studies (70 studies, 1,525,377 participants, with an 
average follow-up of 11.1 years and 111,125 deaths) reported a 31% lower risk of all-cause mortality 
in the most active individuals.41 A clear dose-response relationship was observed, with the greatest 
reduction in risk associated with the change from being inactive to undertaking some activity. Risk 
reduction was similar for males and females. In a separate meta-analysis of cohort studies (80 
studies, 1,338,143 participants, 10.7 years follow-up, 118,121 deaths) a reduction in risk was 
associated with increased activity in all three ‘domains’ of physical activity (leisure-time, activities of 
daily living and occupational).42 Risk reduction was reported to be greater for females than males.42 
In another meta-analysis of cohort studies focusing on non-vigorous physical activity (22 studies, 
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977,925 participants, follow-up from 4.1 to 17 years) non-vigorous physical activity (light or 
moderate physical activity) was also associated with reduced risk of mortality.43 The authors 
estimated that 2.5 hours of non-vigorous physical activity (compared to no activity) was associated 
with a 19% reduction in mortality compared to no physical activity. 
 
1.2.3.2 Cardiovascular disease 
A recent dose-response meta-analysis of cohort studies (33 studies, 1,683,693 participants, 12.8 
years average follow-up, 89,493 events) of the association between physical activity and 
cardiovascular disease (including the outcomes of CVD incidence, CVD mortality, stroke incidence, 
coronary heart disease incidence, coronary heart disease mortality, heart failure incidence and 
myocardial infarction incidence), reported that adherence to guidelines was associated with a 23% 
reduction in CVD morality and 17% reduction in CVD incidence.44 As with mortality a dose-response 
(inverse) relationship was reported with the greatest reductions in risk associated with increases in 
physical activity amongst the least active. 
 
A previous meta-analysis of cohort studies (59 studies, 726,474 participants, average follow-up 14.1 
years, 34,815 events) estimated a 33% reduction in incident disease comparing the most active with 
the least active.41 The association between physical fitness (an objective assessment of ability to 
undertake work without fatigue, and which is associated with physical activity) and cardiovascular 
disease is stronger. The authors also suggested that the association between physical activity and 
cardiovascular disease may have been under estimated because of over-adjustment by multivariate 
control and a failure to adequately account for within person variation in physical activity.41,45 
 
The epidemiological evidence, from which a causal relationship between physical activity and 
cardiovascular disease cannot be proven,35 is supported by evidence from trials and laboratory 
studies. For example, randomised controlled trials have shown that exercise can lead to beneficial 
changes in cardio-metabolic risk factors, such as a reduction in blood pressure,46,47 weight loss and 
changes in fat distribution.48,49. Laboratory studies have shown how physical activity leads to short-
term differences in metabolism that may explain the changes in risk factors or disease risk, for 
example acute exercise and endurance training are linked to beneficial changes in post-prandial 
lipoprotein metabolism.50–52  
Moreover, randomised trials of physical activity, more usually referred to as ‘exercise’ or ‘exercise 
based cardiac rehabilitation’, in patients with diagnosed cardiovascular disease have been shown to 
reduce cardiovascular mortality and measures of disease severity (e.g. hospital admission). A meta-
analysis of 47 studies randomising 10,794 patients to exercise-based cardiac rehabilitation or usual 
care reported a 13% reduction in all-cause and a 26% reduction in cardiovascular mortality in the 
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medium to long term (i.e. after 12 months or more of follow-up).53 Taking all the evidence together 
provides a strong basis for inferring a causal relationship between physical activity and cardiovascular 
disease. 
 
1.2.3.3 Type 2 diabetes 
A recent meta-analysis (28 studies, 261,991 participants, 5 to 23 years follow-up, 84,134 incident 
cases) estimated that compliance with physical activity guidelines was associated with a 26% 
reduction in risk of type 2 diabetes.54 Whilst the studies in this review related primarily to leisure-
time physical activity and overall physical activity, associations have been observed between 
occupational physical activity and travel-related physical activity with incident diabetes.55 Similar to 
other clinical conditions, the dose-response relationship observed suggests that small increases in 
physical activity amongst the least active are associated with marked reductions in the risk for type 2 
diabetes, although considerable benefits (in terms of type 2 diabetes risk reduction) can be realised 
at levels of physical activity considerably higher than recommended by present guidelines.56 
 
1.2.3.4 Obesity and overweight 
In contrast to some of the other outcomes reported here, some of the evidence of the importance of 
physical activity for weight loss or prevention of weight gain comes from randomised controlled 
trials. For example, one recent meta-analysis of 25 small randomised controlled studies reported that 
walking interventions of greater than four weeks duration were associated with a reduction in body 
weight (1.37kg), reduction in percentage body fat (1.22%) and reduction in BMI (0.53kg/m2).57 
However, there is also a body of observational data (from cohort studies), suggesting that physical 
activity (principally leisure-time physical activity) is associated with reduced risk of obesity and 
reduced weight gain over time over a period of years.58–61 
 
It has been suggested that relatively high levels of physical activity are required to prevent weight 
gain (e.g. 150-250 minutes of physical activity per week), and particularly to cause weight loss (e.g. 
225-420 minutes of physical activity per week to cause 5-7.5kg weight loss),62 although it is 
acknowledged that there is uncertainty about the type intensity, frequency and duration of physical 
activity to prevent weight gain or enable weight loss.63 
 
1.2.3.5 Cancer 
Physical activity guidelines typically report that physical activity is protective for breast and colon 
cancer.41,63–65 Consistent with this meta-analyses of cohort studies (12 cohort studies using individual 
level data on 1,440,000 participants) have shown the physical activity is associated with reduced risk 
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of colon cancer and breast cancer. A recent meta-analysis estimated that the high levels of physical 
activity (relative to low levels) were associated with a 14% reduction in colon cancer incidence and a 
10% reduction in breast cancer incidence.66 As with cardiovascular disease there is evidence to 
suggest that physical activity reduces risk of incident disease and improves disease-specific survival 
after diagnosis.67,68  
 
One systematic review has highlighted evidence that physical activity, in cohort studies, was 
associated with risk of other cancers, notably lung cancer, prostate cancer, pancreatic cancer, 
ovarian cancer, endometrial cancer and non-Hodgkin’s lymphoma,69 and a recent meta-analysis of 
individual-level data from 12 cohorts reported that leisure-time physical activity was associated with 
reduced risk of 13 types of cancer (oesophageal adenocarcinoma, lung, kidney, gastric cardia, 
endometrial, myeloid leukaemia, myeloma, colon, head and neck, rectal, bladder and breast) and 
increased risk of two types of cancer (malignant melanoma and prostate cancer) out of 26 that were 
studied.66 
 
1.2.3.6 Mental Health 
A recent meta-analysis of randomised controlled trials in a non-clinical population found that 
physical activity was associated with a moderateiii reduction in symptoms of depression 
(standardised mean difference = 0.50; 92 studies, 4310 participants) and a smalliii reduction in 
anxiety symptoms (standardised mean difference = 0.38; 306 studies, 10,775 participants).70 Physical 
activity or exercise has also been shown, in randomised controlled trials, to be an effective treatment 
for depression (standardised mean difference = 0.62; 35 trials, 1356 participants).71.  
Cohort studies show that physical activity, particularly in mid-life, is associated with reduced risk of 
dementia in late life.72–74 One recent meta-analysis (26 cohorts, follow-up one to 26 years) suggested 
that higher levels of physical activity, compared to lower levels, were associated with a 14% 
reduction in dementia incidence. It has also been suggested based on some observational studies 
(both cross-sectional and prospective) that physical activity may be important for general mood or 
psychological well-being.75,76 
 
1.2.3.7 Musculoskeletal health 
In meta-analyses of randomised controlled trials physical activity (both aerobic and resistance 
training) have been shown to have a beneficial effect on bone mineral density, which is a predictor of 
                                                          
iii Cohen defined a small effect as a standardised mean different of 0.20 to <0.50, a medium effect as 0.50 to <0.80, and a 
large effect as >0.80.364 
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development of osteoporosis.77–79 One systematic review estimated exercise training programme 
prevented or reversed about 1% of bone loss per year in both pre- and post-menopausal women.77 
 There is also some evidence from randomised controlled trials that exercise training programmes in 
older persons, which typically focus on balance and strength, reduce the risk of falls.80,81 However 
relatively few studies have described the association between physical activity and osteoporosis.41 
One cohort study (n=8734 women) has described an inverse dose-response relationship between 
physical activity and osteoporosis prevalence.82  
 
1.2.4 Sedentary behaviour and its relationship to physical activity 
Recently evidence has also emerged that sedentary behaviour, independent of (moderate-to-
vigorous) physical activity, is also a risk factor for disease. Sedentary behaviour can be defined as any 
waking activity in a sitting or lying posture that requires an energy expenditure between one and 1.5 
times basal metabolic energy expenditure.83 Sedentary behaviour is not the same as lack of 
moderate-to-vigorous physical activity. Activity that is not moderate-to-vigorous includes both 
sedentary behaviour and other light intensity activity, such as standing activities with an energy 
expenditure less than three times basal metabolic rate.84 Thus, it is possible to be both highly 
sedentary and active (i.e. undertaking 150 minutes of MVPA per week with >8hrs of sedentary time 
per week), termed an ‘active couch potato’.84 Nonetheless sedentary behaviour may relate to MVPA. 
High levels of MVPA can offset the risk associated with being sedentary,85 and reducing sedentary 
behaviour may be associated with an increase in MVPA. 
 
Prospective cohort studies have shown that sedentary behaviour is associated with all-cause 
mortality, cardiovascular disease, type 2 diabetes, metabolic syndrome and development of 
cardiovascular risk factors, and some cancers (e.g. colon, ovarian and endometrial).84–87  
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1.3 Physical activity and public health 
 
1.3.1 Public health guidelines on physical activity 
Based on the scientific evidence outlined in the previous section many western countries have 
established recommendations or “public health guidelines” about the amount and types of physical 
activity that individuals should engage in to prevent disease.41,62–64,88,89 Public health guidelines first 
emerged, in the UK and the USA, in the 1990s.90,91 This was partly in response to the emerging 
evidence base and partly in response to a growing focus on the prevention of non-communicable 
diseases, including obesity.18,92,93  
 
The UK guidelines were last updated in 2011.63,88 There are now separate guidelines for children, 
adults (19-64 years) and older adults (aged 65 years and over). The recommendations for adults are 
as follows: 
 
1) Adults should aim to be active daily. Over a week, activity should add up to at least 150 
minutes (2½ hours) of moderate intensity activityiv in bouts of 10 minutes or more – one way 
to approach this is to do 30 minutes on at least 5 days a week.  
 
2) Alternatively, comparable benefits can be achieved through 75 minutes of vigorous 
intensity activity spread across the week or combinations of moderate and vigorous intensity 
activity.  
 
3) Adults should also undertake physical activity to improve muscle strength on at least two 
days a week.  
 
4) All adults should minimise the amount of time spent being sedentary (sitting) for extended 
periods.  
 
                                                          
iv Moderate intensity activity results in an energy expenditure between three and six times basal metabolic rate. Vigorous 
intensity activity results in an energy expenditure of more than six times basal metabolic rate. The guidelines state that 
“moderate intensity physical activities will cause adults to get warmer and breathe harder and their hearts to beat faster, 
but they should still be able to carry on a conversation”, and that “vigorous intensity physical activities will cause adults to 
get warmer and breathe much harder and their hearts to beat rapidly, making it more difficult to carry on a conversation”.  
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The recommendations for older adults are similar, but with additional recommendations (e.g. 
benefits of small increases in physical activity from a low baseline, recommendation to incorporate 
balance or co-ordination activities).  
 
Guidelines in other countries are similar, although some of these (e.g. in the USA and Australia) 
include explicit encouragement  to undertake higher levels of physical activity (300 minutes, i.e. 5 
hours, of moderate or 150 minutes of vigorous activity per week).64,94,95 
 
Alongside the public health guidelines, which are population based and focus on prevention, physical 
activity is increasingly recognised as a treatment for some conditions and explicitly included in the 
treatment pathways for some conditions, for example the management of depression and ischaemic 
heart disease.96,97  
 
1.3.2 Prevalence and trends in inactivity 
In the UK, and globally, a large proportion of the adult population is not meeting these guidelines. In 
England in 2012, it was estimated that around one third of men (33%) and just under half of women 
(45%) were not meeting the physical activity guidelines.v,98 Globally around one in three adults (31%) 
are classified as ‘inactive’,vi with women tending to be less active than men.99  
 
Whilst there is some evidence that levels of leisure-time physical activity have increased in the past 
20 years in the UK, any increases are relatively small.98,100 Moreover these comparisons should be 
treated with some caution as the measuring instruments have changed over time and increases in 
leisure-time activity may have been accompanied by decreases in occupational activity.99 Looking 
further back in time, it is likely that levels of physical activity were much higher 50 or 100 years ago. 
Although there are no long term measures of physical activity, population indices that do exist 
suggest large declines in physical activity, for example changes in travel patterns such as a shift away 
                                                          
v Reflecting the convention used by others, not meeting the guidelines refers only to parts 1 and 2 (i.e. not achieving 150 
minutes of moderate-to-vigorous physical activity or 75 minutes of vigorous physical activity per week). The equivalent 
figures in 2008 appeared much worse, 61% of men and 78% of women were classified as not meeting the guidelines.365 The 
difference in reported activity levels reflect a change in the UK physical activity guidelines in 2010. Before 2010 a minimum 
of 150 minutes of moderate-to-vigorous physical activity was recommended (rather than 150 minutes of moderate or 75 
minutes of vigorous) in bouts of at least 20 minutes (rather than 10 minutes).88 
vi Physical inactivity was defined as not meeting any of three criteria: 30 minutes of moderate-intensity physical activity on 
at least 5 days every week, 20 minutes of vigorous-intensity physical activity on at least 3 days every week, or an equivalent 
combination of moderate or vigorous activities achieving the equivalent of 10 MET-hours per week. MET-hours is a 
measure of energy expenditure (intensity multiplied by time) and is discussed in detail in Chapter 5 (section 5.3.6.1). 
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from bicycle use and walking towards car use.101,102 Comparisons between typical modern and 
traditional living show very large differences in daily physical activity energy expenditure, suggesting 
large declines in physical activity are likely to have occurred.102  
 
In England the proportion of the population that is meeting guidelines varies by age, ethnicity and 
socio-economic group.98,103,104 For example, for men it declines with age, from 83% of men aged 16-
24 years to 30% of men aged 75 years and over, whereas for women it rises during early adult life, 
from 57% of women aged 16-24 years to 66% for women aged 35-44 years of age, and then declines 
with age, to 13% among women aged 75 years and over.98 There are also differences in the types of 
physical activity undertaken by age (and between the sexes), with a shift in focus away from sport 
and exercise with increasing age.105 
 
Given this decreasing trend in physical activity with age and the increasing incidence of disease with 
age, the burden of disease attributable to lack of physical activity is likely to be particularly large 
amongst those in mid- and later-life. Consequently, strategies to engage those in mid and later-life 
may be particularly important (although engagement at younger ages may also be important, for 
example to establish lifelong habits). 
 
1.3.3 Burden of disease and costs attributed to lack of physical activity 
Lack of physical activity contributes to a substantial burden of diseases. In the UK it is estimated to 
account for 5% of disability-adjusted life-years in 2010, making it the fourth largest risk factorvii for 
burden of disease and responsible for a similar burden of disease as alcohol.106 Globally lack of 
physical activity accounts for 9% of premature mortality (5.3 million deaths per year) and it is the 
fourth leading risk factor for mortality and burden of disease (measured in DALYs).107  
 
Lack of physical activity has significant financial costs for health services and society more broadly. In 
England lack of physical activity costs society an estimated £7.4 billion annually.108 Globally it was 
estimated conservatively that lack of physical activity costs healthcare systems 53.8 billion 
international dollarviii (Intl.$) and a further Intl.$13·7 billion in productivity losses in 2013 and was 
responsible for 13·4 million DALYs worldwide.109 
                                                          
vii Whilst it is common to draw comparisons between risk factors, a degree of caution should be exercised. Others have pooled together all 
dietary risk factors and suggested that diet is the second largest risk factor, although this may involve double counting. Hypertension and 
overweight rank above physical inactivity, and it is unclear whether the contribution of physical activity to these risk factors has been 
considered within physical activity or within those risk factors.  
viii International dollar is a hypothetical unit of currency that has the same purchasing power parity that the US dollar had in the United 
States at the time of measurement. 
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All of these estimates are based on increasing the levels of physical activity of those who are not 
achieving recommended amount of moderate-to-vigorous physical activity up to the recommended 
levels (i.e. 150 minutes of moderate-to-vigorous physical activity per week). However further health 
gains are likely to occur from exceeding the recommended levels,42,43,110 so these estimates may 
understate the health gains and cost savings that could accrue from increases in physical activity. 
 
1.3.4 Approaches to promotion of physical activity 
This apparent failure of previous approaches to increase levels of physical activity has led to calls for 
different approaches to the promotion of physical activity.26,108 A ‘traditional approach’ to promoting 
physical activity might be characterised as offering advice to, educating and motivating people to 
adopt an active lifestyle. For example, offering ‘exercise on prescription’ to high-risk or less-active 
individuals.111 Using Rose’s language, exercise on prescription and similar interventions targeting 
individuals could be characterised as individual-level interventions. Mass education campaigns might 
be characterised as population level interventions, but, again using Rose’s language, would be 
‘superficial’ (rather than ‘radical’) in their approach. Accordingly, such approaches may have limited 
ability to reduce the burden of disease and are unlikely to be sustainable.  
 
There is recognition, at least from some organisations, that attention needs to shift from an 
individual approach to a population approach.26,108,112–114 The latter approach seeks to shift the 
distribution of physical activity by modifying the underlying social, economic and environmental 
determinants of physical activity.6,115 As physical inactivity is prevalent and the risk of most diseases, 
for which physical activity is protective, is widely distributed, there is a strong case for a population 
approach. 
 
Past approaches have also placed particular emphasis on leisure-time activities (sport, exercise and 
recreational activities). Leisure-time activity, particularly sport and exercise, may require relatively 
high levels of motivation and have associated economic and time costs. They may not appeal to 
many people, particularly the least active, who have the most to gain from increasing physical 
activity.  
 
Much less emphasis has been given to physical activity as an integral (or incidental) part of everyday 
life,26 although this is now being addressed.108,116 Conceptualising physical activity in this way 
(sometimes termed ‘active living’), the scope for increasing physical activity is much broader as it 
crosses four domains: travel, domestic, occupational, as well as sport and recreation.115 The 
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promotion of walking and cycling as forms of travel (active travel), instead of car-use, is an integral 
part of promoting active living.  
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1.4 Walking and cycling 
 
There are several reasons why promoting walking and cycling as forms of travel may be able to shift 
the distribution of physical activity. Such incidental physical activity may be more acceptable than 
more structured ‘exercise’. The high prevalence of walking for travel (e.g. London) and cycling for 
travel (e.g. Cambridge, the Netherlands) in some areas suggests that it can be acceptable to large 
number of adults.117,118 Changes in behaviour are hard to sustain, but changes that become habitual 
or embedded as partly of daily routines,119 as travel patterns can be, may have more likelihood of 
being sustained for many years, which is necessary to realise health improvements throughout life. 
Lack of time is a reported barrier to being physically active.120,121 The average journey to work in the 
UK is 29 minutes.122 Being active for only a portion of this journey (e.g. 10 minutes) would sum up to 
a large dose of physical activity across the week (e.g. 10 minutes times two commuters per day times 
five days, equates to 100 minutes per week).  
 
1.4.1 Co-benefits of walking and cycling 
The promotion of active travel, particularly in large urban areas, may be associated with many other 
co-benefits.123–125 These include other health benefits. Reduced car use, as a consequence of 
increased active travel, is likely to be associated with reduced air pollution and a reduction in road 
traffic accidents (involving motor vehicles). It may also be associated with improvements in well-
being and mental health, through reductions in severance (division of communities by major roads or 
other infrastructure routes) and by improving the attractiveness or liveability of the local 
environment. 
 
The promotion of walking and cycling, often alongside or facilitated by public transport, may help 
reduce congestion and carbon emissions. It is for this reason that some cities, such as London have 
invested significantly in cycling, walking and public transport infrastructure and successfully shifted 
travel patterns away from car-use towards walking and cycling.126 
 
1.4.2 Existing studies of active travel and health 
There is an extensive body of evidence describing the associations between physical activity and 
health (outlined in section 1.2.3).41,63 However most of this work has, following Morris’ lead,ix focused 
                                                          
ix Morris’ later work shifted attention away from occupational physical activity to leisure physical activity. This was a 
strategic decision, partly driven by a wish to study activities of different intensities (the range of intensity is greater for 
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on leisure-time physical activity (sport, exercise and recreation) and not on walking or cycling as 
forms of travel. This is necessary as there may be differences between travel-related physical activity 
and leisure-time physical activity in terms of the frequency, duration and intensity, as well as 
associated risks (e.g. injury or air pollution), that may influence the associations with health and may 
also be context dependent. 
 
1.4.2.1 Epidemiological studies 
Associations of active travel with all-cause mortality,127,128 cardio-vascular mortality, incident 
diabetes,129 incident hypertension and obesity have been reported.130,131 Relatively few studies have 
explored the associations of active travel with cancer, mental health and other indices, such as 
sickness absence or well-being.132 Subjective indices of health, like well-being, are increasingly 
recognised as being important outcomes in their own right and may contribute to engaging a 
broader set of actors in promoting active travel.133,134 Sickness absence is another indicator that is 
infrequently studied, but is of economic importance and of interest to those outside the health 
sector.135 While, some of the associations between active travel and health have been described in 
longitudinal studies, much of the evidence, particularly for obesity and other indices of health, is 
based on smaller and often cross-sectional studies. Cross-sectional studies provide a weak basis for 
inference because the exposure has not been shown to precede the outcome and reverse causation 
(e.g. obesity determining active travel) may sometimes explain the observed associations. 
 
Many studies of active travel have focused on active commuting,132 which may be considered a sub-
set of active travel. Active commuting is frequently studied because it is relatively easy to record, is 
captured in many standard physical activity questionnaires (e.g. the Recent Physical Activity 
Questionnaire) and is regularly undertaken (i.e. the ‘exposure’ is consistent and may continue for a 
period of time). However most of the studies of active commuting classify commuting based on 
‘usual mode of travel’ (reflecting limitations with the study questionnaire). Usual mode of travel does 
not reflect the reality of commuting for some people who may either combine modes of travel (e.g. 
walk to train station, train to work) or people who may use alternative modes on different days (e.g. 
cycle to work on some days and drive on other days).136,137 Individuals who adopt these travel 
patterns may be incorrectly classified as ‘passive’ commuters when they do undertake some 
commuting. Such classifications also result in comparisons being drawn between individuals who 
cycle or walk (the whole journey) to work with individuals who only use the car. Whilst such 
comparisons have a role, many journeys to work are too far to be undertaken solely by foot or 
                                                          
recreational activity than occupational activity) and partly a belief that a relatively sedentary society could only become 
‘active’ by undertaking recreational physical activity.28 
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bicycle (the average commute in the UK in 2014 was 8.7 miles).122 More meaningful comparisons that 
reflect actual travel options may be possible. 
 
1.4.2.2 Public health modelling studies 
The epidemiological evidence is also complemented by public health or health impact modelling 
studies. Whilst shifting the population distribution can realise large health gains, in practice these 
gains are either not directly observable or cannot be observed immediately. Public health modelling 
is one approach to estimate the gains (or harms) of such interventions. It effectively translates the 
findings of epidemiological studies (typically expressed as relative risk for individuals) into estimates 
of population-level health impact that are more relevant (e.g. number of incident cases) for policy 
makers and practitioners, and may be more salient for the public.138 For public health practice it is a 
valuable complement to epidemiological work. 
 
Several physical activity models have been developed, such as the Health Economic Assessment Tool 
(HEAT) for cycling and the Integrated Transport and Health Impact Modelling Tool (ITHIM). HEAT 
estimates the economic benefits from changes in health due to increases in physical activity from 
walking or cycling for travel. It has been used in several countries to inform the economic appraisal of 
transport planning, which had not previously accounted for such health benefits.139 ITHIM estimates 
the health impacts of changes in walking and cycling, considering physical activity, air pollution and 
road traffic accidents. It considers a range of health outcomes: depression, stroke, ischaemic heart 
disease, type 2 diabetes, colon cancer, breast cancer and all-cause mortality. It has been used to 
estimate the potential health benefits and consequent savings in NHS expenditure from a shift away 
from car-use to walking and cycling,125,140,141 as well as the health benefits associated with particular 
interventions, such as the London cycle hire scheme.142 
 
Both these models, like other public health models,143 are comparative risk assessment models. 
Comparative risk assessment models do not make allowance for changes in life expectancy, which 
may be important. Increases in physical activity reduce risk of disease, but also increase life 
expectancy resulting in an increase in the number of years lived at old age when disease incidence is 
higher. It is conceivable that disease events could be postponed rather than prevented, but 
comparative risk assessment models (by assuming all other factors, including life expectancy are 
unchanged) cannot model such effects. This may be particularly important for understanding the 
impact of shifts in the distribution of physical activity on demand or need for healthcare.  
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1.5 Overview of thesis 
 
This thesis aims to address the two areas of uncertainty highlighted in the previous section:  
a) the associations of active commuting with indices of health and well-being  
b) the extent to which increases in physical activity, when making allowance for changes in 
life expectancy, will reduce need for health and social care.  
 
My thesis, therefore, is divided into these two parts, which use different and complementary 
methods, observational epidemiology and public health modelling. 
 
1.5.1 Part I: Associations between active travel and health 
In this section, I will describe the associations between active travel and indices of health (sickness 
absence, well-being and adiposity). The unique contribution of this work will be, first to describe the 
little-explored associations of active travel with well-being and sickness absence, second to describe 
the longitudinal associations between active travel and body mass index, and third to describe the 
associations of active travel with objective measures of adiposity (visceral adipose tissue and 
percentage body fat) in a large dataset which has accurately characterised physical activity and 
dietary behaviour.  
 
I will use two datasets, Commuting and Health in Cambridge and the Fenland Study. I describe these 
datasets and the rationale for choosing them below.  
 
1.5.1.1 Commuting and Health in Cambridge 
The Commuting and Health in Cambridge study (2009-2012) was established to study the effect of 
changes to the environment (principally the development and opening of the Cambridge guided 
busway) on commuter behaviour, physical activity and health. A full description of this study has 
been published elsewhere.144,145 
 
The study had multiple elements and used both quantitative (e.g. repeat annual questionnaire, 
intercept survey of busway users, in-depth objective physical activity monitoring) and qualitative 
approaches (e.g. semi-structured interviews, photo-elicitation interviews). It has been described as a 
natural experimental study, although I only make use of one element of the study, the cohort of 
commuters who were followed for up to three years. I refer to this as the Commuting and Health in 
Cambridge dataset, and below I describe the key elements that are relevant to the analysis reported 
in my thesis. 
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Briefly, the study recruited adults who worked in Cambridge and did not reside at their work address. 
Participants (n=1434) were recruited over four waves (2009, 2010, 2011, 2012), with the majority 
recruited in 2009. Each year participants were invited to complete a questionnaire including 
information on socio-demographic characteristics, a validated seven-day retrospective travel record, 
the Recent Physical Activity Questionnaire (RPAQ), health (sickness absence, well-being assessed 
using the Short Form 8 Questionnaire, self-reported height and self-reported weight) as well as other 
factors related to travel to work. 
 
This dataset had several advantages. The prevalence of active commuting, principally cycling, was 
relatively high compared to the UK average (in Cambridge 29% of the population report cycling as 
their usual mode of travel compared to 3% in the UK) and many western settings.117,146 Unlike in 
other settings, cycling to work was not restricted to younger males, which might improve the 
generalizability of the findings. The detailed characterisation of commuting behaviour may facilitate 
a more nuanced representation of how people commute as well as reduce measurement error.147 
Whilst, small compared to some studies, this and the high prevalence of active commuting meant the 
study was relatively well powered compared to some larger studies.  
 
The study was also longitudinal. In contrast many studies of the association of active travel with 
sickness absence, well-being and body mass index are cross-sectional. Being focused on active 
commuting and health, the study had also captured other important factors, e.g. occupational and 
leisure-time physical activity and travel factors (e.g. distance from home to work). 
 
1.5.1.2 Fenland Study 
The Fenland Study (International Standard Randomised Controlled Trials Number 72077169) is an 
ongoing population-based cohort study of adults born between 1950 and 1975 and living in part of 
Cambridgeshire, UK. It was designed to investigate the interaction between environmental and 
genetic factors in determining obesity, type 2 diabetes, and related metabolic disorders. The level of 
detail it collects about the health and behaviours of its participants is unusual. 
 
Participants (n=12,434) were recruited from general practice lists between 2005 and 2015. They 
attended one of three clinical research facilities, where they completed a general questionnaire, a 
food frequency questionnaire (FFQ) and the Recent Physical Activity Questionnaire (RPAQ). In 
addition they underwent a number of tests, including assessment of body composition by dual-
energy X-ray absorptiometry and up to six days of objective physical activity monitoring (Actiheart®, 
combined heart rate and accelerometer sensing).148  
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Compared to other studies of active travel and adiposity this study had a number of advantages. It 
has measured adiposity objectively by DEXA (Dual-Energy X-ray Absorptiometry) scan. Thus rather 
than only measure body mass index (BMI), it includes different measures of regional (e.g. visceral 
adipose tissue, android to gynoid fat mass) and total adiposity (e.g. percentage body fat, total fat 
mass). Such measures are more strongly associated with cardio-metabolic disease than BMI.149–151 It 
has detailed characterisation of both diet and physical activity (both self-reported and objective), in 
contrast to most other studies of active travel and adiposity. 
 
It includes information on both mode and frequency of travel to work, so will facilitate a more 
appropriate appraisal of commuting patterns than usual mode of travel. Being in Cambridgeshire and 
being a cohort of working age adults the prevalence of active commuting is relatively high. 
 
It complements the Commuting and Health in Cambridge dataset. It is larger, is more socially diverse, 
has more appropriate and objective measurements of adiposity, and includes detailed measures of 
diet and physical activity. However, it is cross-sectional and does not characterise commuting in as 
much detail. 
 
1.5.2 Part II: Estimating the effect of shifting the distribution of physical 
activity on healthcare need 
The second part of this thesis aims to understand the effect of increases in physical activity on 
indicators of need for healthcare. The unique contribution of this work is to model the effect of 
changes in life expectancy and demonstrate the effect that this has on estimates of need for 
healthcare. In contrast to other work I do not seek an aggregate measure of healthcare need (e.g. 
disability adjusted life years), but I try to understand the changing patterns of need for each disease. 
To do this I developed a life table based model. The model was parameterised for the English 
population.  
 
Below I justify the choice of modelling (over observational studies), the choice of modelling 
techniques and briefly set out the data used to parameterise the model. 
 
1.5.2.1 Modelling approach 
Observational epidemiology has been used to describe the association between physical activity and 
healthcare usage.152,153 However, cross-sectional studies are problematic as an inverse association 
between physical activity and healthcare utilisation may be explained by reverse causation, e.g. 
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those who have high healthcare utilisation are not able to be physically active. Similar problems may 
occur with prospective studies. Observational studies also lack some of the flexibility of modelling 
studies, such as modelling several different scenarios. Nor can they readily observe the effects of a 
change in physical activity throughout the whole life, which is necessary to understand the extent to 
which disease may be postponed rather than prevented. 
 
Modelling studies that model ageing or time may be a more appropriate means to understand the 
effect of increasing longevity as long follow-up (throughout life) is possible. The two common health 
impact modelling techniques that would permit this are microsimulation and life table modelling. 
 
Microsimulation involves simulating many individuals. When these individuals are followed over 
time, this becomes computationally very demanding. This requires the use of more complicated 
software, more programming, often more data, and either larger computer servers or more 
computer time. It becomes particularly useful when granular outcomes (e.g. breakdown by socio-
economic group or activity status), granular scenarios or interaction between risk factors (e.g. anti-
hypertensive treatment and lipid lowering treatment) are important. In the absence of these 
demands, multistate life table modelling probably yields comparable answers to microsimulation 
modelling, although I am not aware of any direct comparisons. 
 
Given the constraints of the modelling project, within the scope of a broader PhD, I chose a 
compromise. The effect of changes in physical activity on disease risk was modelled using a 
microsimulation approach. The effect of changes in disease risk on disease and survival was modelled 
using a multistate life table approach. This combined approach used some of the flexibility of 
microsimulation (principally in terms of modelling scenarios), ensured the core health impact 
modelling explicitly modelled time, whilst limiting the computational demands and programming 
needs of the overall model. However, the core part of the model which describes the effects on 
health is a proportional multistate life table model and consequently I refer to the model as a “life 
table model” throughout this thesis. 
 
1.5.3 Datasets 
I used the Health Survey for England (2012) to describe physical activity levels of my simulated 
population.98 This is a representative sample of the English population, from which the published 
estimates of the prevalence of inactivity are derived. Whilst it is an annual survey, not every year 
includes detailed questions on physical activity. The last module that did include physical activity was 
2012, using a modified version of the validated Health Survey for England physical activity 
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questionnaire. This asks about the type, frequency and duration of activity across three areas: 
housework; manual/gardening/do-it-yourself activities; walking and sports and exercise.98 
 
I used routine data to estimate the incidence and case fatality from the diseases included in the 
model (e.g. mortality statistics, cancer registry data for incidence, primary care audit for prevalence 
of diabetes). Estimates of the effect of physical activity on relative risk of disease and mortality were 
taken from appropriate meta-analyses.  
 
1.5.3.1 Scope 
My focus is moderate-to-vigorous physical activity. Whilst the work may have implications for 
sedentary behaviour and other aspects of physical activity included in the guidelines (e.g. muscular 
strength and balance), I predominantly limit the work to consideration of its implications for 
moderate-to-vigorous physical activity (hereafter referred to as “physical activity”). Given the focus 
on physical activity, I do not consider other health effects of travel (e.g. air pollution, road traffic 
injuries). My focus includes adults, but does not include children. 
 
1.5.4 Thesis structure 
Chapter Two describes the longitudinal associations of active travel with sickness absence and well-
being in the Commuting and Health in Cambridge dataset. An abbreviated version of this work has 
been published as: Mytton OT, Panter J, Ogilvie D. Longitudinal associations of active commuting 
with well-being and sickness absence. Prev Med. 2016 Mar;84:19-26.154  
 
Chapter Three describes the longitudinal associations between active travel and body mass index in 
the Commuting and Health in Cambridge study. This work draws on similar methods to the work 
reported in Chapter Two, consequently the methods section is relatively brief and principally covers 
aspects of the method that are different. An abbreviated version of this work has been published as: 
Mytton OT, Panter J, Ogilvie D. Longitudinal associations of active commuting with body mass index. 
Prev Med. 2016 Sep;90:1-7.155  
 
Chapter Four addresses some of the limitations identified in Chapter Three. It describes the 
associations of active travel with visceral adipose tissue and body fat in the Fenland Study at 
baseline.  
 
Chapter Five begins with an introduction to Part II of this thesis. It discusses the different ways that 
physical activity may affect ‘need’ for healthcare. It introduces the concept of ‘need’ and how this 
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relates to burden of disease. It then sets out the modelling methods: describing the model structure, 
the health outcomes studied, the scenarios modelled, sensitivity and uncertainty analyses 
undertaken, and finally sources of data. 
 
Chapter Six sets out the results, including sensitivity analyses, from the modelling study. 
 
Chapter Seven includes a detailed discussion of the modelling work, which includes consideration of 
model validity.  
 
Chapter Eight presents a discussion of this thesis. It summarises the key findings, discusses over-
arching themes, sets out implications for practice and policy and offers suggestions for future 
research. 
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Part I 
 
Observational epidemiology: associations between 
active travel and indices of health  
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2 Longitudinal associations of active travel with sickness absence 
and well-being 
 
“I would say I’m much calmer now I drive and I don’t cycle. As I 
mentioned I was getting very stressed [when I cycled] because 
of the behaviour of others on the road.” 
 
“I’ve been cycling now for well over 35 years... [For] me it’s the 
only way to travel around Cambridge. It’s so easy. I choose to 
do it because I used to do a lot of sports years ago and as you 
get older you can’t do those sort of things ... so cycling now is 
my main exercise.” 
 
Participants in the Commuting and Health in Cambridge Study 
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2.1 Introduction 
 
This chapter describes the longitudinal associations of active travel with sickness absence and well-
being in the Commuting and Health in Cambridge dataset. An abbreviated version of this chapter has 
been published in Preventive Medicine.155 
 
2.1.1 Chapter outline 
This chapter describes in detail the Commuting and Health in Cambridge dataset (which is also used 
in the subsequent chapter). Data was collected over four years, and I explain why I have chosen to 
use data from only two time-points in this analysis, before then going on to describe the methods 
(exposure and outcome measurement and the analytic approach). I have chosen to use two 
complementary analyses and the rationale for these is set out in the methods, and interpretation of 
each is further discussed in the discussion section. Study results are presented separately for cycling 
and walking, as it was only for the former that significant associations were observed. The discussion 
includes the following: a summary of the findings; strengths and limitations; comparisons with other 
studies; interpretation and implications; unanswered questions and future research. The chapter 
finishes with a summary of the chapter.  
 
2.1.2 Background 
As discussed briefly in Chapter One relatively little work has explored the associations of active travel 
with sickness absence156 and well-being,157–160 although other work has described the association 
between leisure-time physical activity and these indices.156,161–166  
 
2.1.2.1 Well-being 
The Oxford English Dictionary defines well-being as “the state of being healthy, happy, or 
prosperous; physical, psychological, or moral welfare.” Within the scientific literature there is no 
agreed definition of well-being.133,167–169 Whilst it may loosely equate with happiness or satisfaction, 
most authors agree that “well-being” constitutes more than this, for example developing as a person, 
being fulfilled, and/or making a contribution to the community.170 
 
Well-being is increasingly recognised as an important driver for public policy. For example the past 
Government chose to systematically measure and publish estimates of national well-being.133 They 
also established Health & Well-being boards as a forum where key leaders, at a local level, from the 
health and social care system work together to improve the health and well-being of their local 
population and reduce health inequalities at the local level.[151]  
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Very limited work to date has described the associations between active travel and well-being (see 
Table 2.1). These studies have reported mixed findings, with some reporting positive associations, 
some null findings and some negative associations, although the studies have all used different 
measures of well-being. They have tended to either report associations for walking to work160 or 
have studied a population who predominantly walked.158,159 Three of the five studies were cross-
sectional in design. 
 
Table 2.1 Summary of studies describing the association of active travel with well-being 
and sickness absence 
Author, Year Settings and 
dataset (size) 
Analytic 
Approach 
Exposure Outcome Co-variates Significant Findings 
Martin, 
2014159 
British 
Household 
Panel Survey 
1991/2-2008/9 
(n=17,985) 
Longitudinal Active 
commuting 
Public transport 
Walking to work 
Psychological 
well-being 
assessed using 
a 12-item 
general health 
questionnaire 
Age, sex, SES, 
commute 
duration, work 
satisfaction, 
neighbourhood 
characteristics 
Active commuting, 
public transport and 
walking to work 
associated with 
better psychological 
well-being 
Humphrey, 
2013157 
Commuters in 
Cambridge 
(n=989) 
Cross-sectional Active 
commuting (i.e. 
walking or 
cycling) 
Well-being 
assessed using 
the Short Form 
8 questionnaire 
Age, sex, SES, 
home to work 
distance, BMI 
Active commuting 
associated with an 
increases in physical 
well-being (but not 
mental well-being) 
score  
Gomez, 
2013160 
Women living 
in low and 
middle income 
areas of Cali, 
Columbia 
(n=1,263) 
Cross-sectional Walking for 
transport 
Health related 
quality of life 
Age, SES, leisure 
time PA, 
neighbourhood 
level deprivation 
Walking for transport 
negatively associated 
with both physical 
and mental 
dimension of health 
related quality of life 
(leisure time PA 
positively associated) 
Hendrikssn, 
2010156 
Commuters in 
Netherlands 
(n=1236) 
Cross-sectional Cycling to work Sickness 
absence 
Age, sex, SES, 
home to work 
distance, physical 
fitness, BMI, 
subjective health, 
smoking 
Decreases sickness 
absence (1 day per 
year) amongst those 
who cycle to work 
compared to those 
who do not 
Mutrie, 
2002158 
Glasgow, 
Scotland 
(n=295) 
RCT of 
intervention to 
promote active 
commuting 
Walking or 
cycling to work  
Well-being 
assessed using 
the Short Form-
36 
questionnaire 
 Significant 
improvement in three 
of eight domains of 
well-being in the 
intervention group 
relative to control 
group (the 
intervention group 
significantly 
increased walking to 
work) 
PA=physical activity; BMI=body mass index; SES=socio-economic status. 
2.1.2.2 Sickness absence 
Sickness absence is typically measured as the number or days absent from work due to ill-health. It 
may cost employers as much as £15 billion per annum in the UK.172 In 2014 it was estimated that 131 
million working days were lost to sickness absence (an average of 4.4 days per employee).173 As well 
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as being of interest to employers,173 sickness absence is also associated with future disability or 
death, so may be a good proxy for ‘general health’.174–176 
 
To some extent sickness absence and well-being (at work) may be related. In the UK, there has been 
a focus on improving workplace well-being, not only because well-being is important in its own right 
but also because it may be associated with productivity and sickness absence.134,135 
 
Only one study, which was cross-sectional, has described the association between active travel 
(cycling to work) and sickness absence.156 However, several studies have described the associations 
between other domains of physical activity, principally leisure-time physical activity, and sickness 
absence or absenteeism. In prospective studies leisure-time physical activity at baseline or increases 
in leisure-time physical activity were associated with reduced sickness absence,161,163,177–180 although 
occupational physical activity has been reported to be inversely associated with sickness absence.178 
Physical activity appears to be important for sickness absence attributable to both musculo-skeletal 
problems and mental well-being, although its association with the former may be stronger.180 
 
2.1.2.3 Study rationale and aims 
Both sickness absence and well-being are important measures in their own right, but they are also of 
interest to employers and governments who can influence the social, economic and physical 
environmental determinants of active commuting. If either measure were shown to be associated 
with active travel, this might strengthen the case for employers investing in its promotion. These 
measures may also be more sensitive to change than disease outcomes in a relatively healthy 
population of working age, and therefore may represent a pragmatic health outcomes in studies of 
interventions designed to promote active travel. 
 
This chapter seeks to build on the limited existing literature describing the associations of active 
travel with sickness absence and well-being. In particular it will employ a longitudinal design and 
study separately both cycling to work and walking to work. It aims to describe the longitudinal 
associations of active commuting with physical well-being, mental well-being and sickness absence. 
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2.2 Methods  
 
As discussed in the first chapter (section 1.5.1), I chose to use the Commuting and Health in 
Cambridge dataset, which for the purposes of my work may be considered a cohort study of 
commuters who work in Cambridge.  
 
Below I describe the key elements of the study (under study settings and data collection) as they 
apply to the analyses reported in this chapter (on sickness absence and well-being) and the next 
chapter (on body mass index). Many parts of the method (e.g. classification of exposure, co-variates, 
analytic approach) are the same or similar, across the two chapters and are described fully in this 
chapter and only briefly in the next chapter. 
 
2.2.1 Study setting and data collection 
 
2.2.1.1 Study setting 
The city of Cambridge lies in the east of England. The surrounding area is largely rural with a number 
of towns (Ely, Royston, St Neots, New Market and Huntingdon) and smaller settlements. It lies 
approximately 80km northeast of London. 
 
In contrast to most of the UK, Cambridge has a strong cycling culture related to a combination of 
factors including its flat topography, its large student population and traffic congestion. The reported 
prevalence of cycling to work (amongst Cambridge residents) was 29% in the 2011 Census, compared 
with 3% as a national average (based on ‘usual mode’ of commuting).146 
 
Cambridge has good road transport links. The M11 motorway links it with London and the south east. 
The A14 trunk road provides a major east-west route, linking to the Midlands in the west and 
Norwich and East Anglia to the east. There are ‘Park and Ride’ facilities at a number of sites to the 
south (Trumpington and Brabham Road), east (Newmarket Road) and west (Maddingley Road) of the 
city, which allow car drivers to park at the edge of the city and continue the rest of the journey by 
bus, bicycle or foot. The city is also well served by frequent train services to London, and nearby 
towns (Royston) and cities (Norwich and Ely), as well as smaller towns and settlements in the 
immediate area. Public transport to other rural areas is relatively limited.  
 
The population of Cambridge was 124,000 in 2011 Census.181 Reflecting its status as a university city, 
the population is relatively young, with a population ‘bulge’ between the ages of 15 and 34 years. It 
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is also a relatively prosperous and educated city. Unemployment is relatively low (3.8% vs 5.1% for 
England).182 A relatively large proportion of the population are employed in professional occupations 
(40.2% vs 20.0% for England) with a relatively small proportion employed in service related roles 
(6.5% vs 16.7% for England) or machine operative roles and elementary occupations (10.6% vs 
17.1%).182,183 Nearly two-thirds (66.5%) of the population have a degree, compared to a third in 
England (36.8%). Median earnings are above the English average (£15.76 per hour compared to 
£13.41 in England). These patterns contrast with the surrounding county of Cambridgeshire 
(population of 621,000)x, which tends to be close to the English average. 
 
2.2.1.2 Participants 
The study population comprised adults aged 16 and over who worked in areas of Cambridge served 
by the Cambridgeshire Guided Busway and thus includes both residents of Cambridge and the 
surrounding areas (both inside and outside of Cambridgeshire). 
 
Participants were eligible for inclusion irrespective of their employer, workplace, type or grade of 
occupation, length of employment contract or working hours; whether they also worked at single or 
multiple locations; and whether they had any disability that may limit their mobility.  
 
Participants were ineligible if they were currently taking part in another research study that involved 
measuring their physical activity or if they lived in on-site (staff) accommodation and therefore did 
not routinely commute to their workplace. 
 
2.2.1.3 Recruitment 
Since the study was focused on travel to work, participants were recruited through workplaces rather 
than from the general population. They were approached using a combination of recruitment stands, 
newspaper and magazine advertisements, posters, fliers, and announcements distributed on the 
investigators' behalf by employers through corporate email distribution lists, intranets and staff 
newsletters. Participants who opted in to the study were entered into a prize draw to win one of 
eight £50 gift vouchers.  
 
Recruitment commenced in March 2009. During the first phase of recruitment, there were 2163 
expressions of interest to participate, with 1582 participants meeting the inclusion criteria, of which 
1164 completed the baseline questionnaire in 2009. New participants were recruited during each of 
                                                          
x Estimates for Cambridgeshire include the city of Cambridge. 
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the subsequent phases of the study (in year two, year three and year four), although the majority of 
participants were recruited in 2009 (81.2% 1164/1434). 
 
2.2.1.4 Core questionnaire 
The core questionnaire collected information related to the main outcomes (well-being and sickness 
absence), travel behaviour, usual physical activity, socio-demographic characteristics and other co-
variates. The core questionnaire was mailed to all participants.  
 
The core questionnaire included the Medical Outcomes Study Short Form 8 (SF-8) questionnaire, a 
series of eight questions used to assess general physical and mental well-being,184 and an item on 
self-reported sickness absence. It also asked participants to report their height and weight. It 
included a seven-day retrospective travel record focusing on the journey to and from work, which 
was based on an instrument used in other studies of active commuting and shown to have 
acceptable test-retest reliability.185 This instrument asked participants to list all modes of travel used 
to travel to or from work. Separately participants who reported cycling to or from work were asked 
to report the duration of the cycling part of the journey. The same questions were asked for walking 
to or from work. Usual physical activity was assessed using a validated questionnaire, the Recent 
Physical Activity Questionnaire (RPAQ), which assess usual physical activity in the past four weeks 
across four domains of physical activity (domestic, travel, occupational, leisure).186 
 
A copy of the questionnaire used during the first wave of recruitment in 2009 is shown in the 
Appendix. 
 
2.2.1.5 Ethics 
Ethical approval was granted by the Hertfordshire Research Ethics Committee for phases one 
(08/H0311/208), two (09/H0311/166) and three (10/H0311/65) of the cohort study 
(08/OH0311/208) and the Cambridge Psychology Research Ethics Committee for phase four 
(2012.14). All participants gave written informed consent. 
 
 
2.2.2 Choice of approach to longitudinal analysis 
Data was available, on both the exposure and the outcome, from four time points representing the 
four annual waves of data collection. In theory this could permit a number of different analytic 
approaches (e.g. interrupted time-series analyses, analysis of change).187,188  
 
51 
 
Whilst it might appear attractive to use data from all four-time points, only a small number of 
participants (24%, 347/1434) participated in all four waves. As travel patterns could change in 
multiple ways across four time pointsxi, the number of participants who adopted any particular 
trajectory across the four time points would be relatively small. Splitting the limited sample size into 
sub-groups risked loss of power. Missing data might further exacerbate the issue of small sample 
size, or alternatively require techniques to impute missing data. 
 
For reasons of parsimony and power, I chose to restrict my analysis to using data from two time-
points and I included participants who completed two consecutive questionnaires (i.e. took part in 
two consecutive phases of the study) rather than restrict the analysis to only the first two waves of 
data collection to increase the number of eligible participants and thus improve study power. 
 
A number of potential analytic approaches using data from two time-points were identified (see 
Figure 2.1). I chose to use two complementary approaches, a ‘predictor’ analysis and a change 
analyses, rather than use a single approach. More may be learnt from combining approaches than 
using either approach in isolation. 
 
Furthermore, I further chose to restrict the ‘predictor’ analysis to those who were confirmed at 
follow-up to have comparatively stable commuting behaviour (i.e. their classification of commuting 
behaviour was the same at follow-up). This ensured that estimates of association would not be 
influenced by the potential misclassification of those who changed their behaviour during the period 
of observation (e.g. if a participant switched from cycling to work to not cycling to work two weeks 
after baseline data collection). Misclassification of commuting behaviour in this way may be 
considered a form of measurement error, akin to regression dilution, that would tend to bias 
estimates to the null.189 Consequently, I termed the ‘predictor’ analysis the maintenance analysis. 
 
                                                          
xi In theory two different travel behaviours (e.g. active travel and non-active travel) could yield 16 different permutations or 
trajectories) 
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Figure 2.1 Approaches to longitudinal analysis with two time points 
 
 
In addition, I separately conditioned the maintenance analysis on the baseline measure of the 
outcome of interest (i.e. analysis of covariance or conditional analysis). This is similar to, but slightly 
different, from testing the association between maintenance of active commuting and change in the 
outcome at follow-up.188,190  Thus it may be considered a third type of longitudinal analysis (Figure 
2.2.).  
 
Figure 2.2 Summary of longitudinal analyses undertaken 
 
PCS-8=physical component score, scored using the short form eight questionnaire; =change.  
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2.2.3 Inclusion and exclusion criteria 
I restricted the analysis to those who completed two consecutive waves of the study (n=866) from 
the original sample who completed a questionnaire at baseline (n=1434). I excluded those with 
missing exposure (n=25), outcome (n=5) or covariate data (n=35), such that I undertook a complete 
case analysis (n=801).  
 
Some of these participants completed more than two consecutive phases of data (e.g. phase 1, phase 
2 and phase 3). I defined the baseline questionnaire for each participant as their first questionnaire 
with complete information on exposure. The follow-up questionnaire for each participant was the 
questionnaire completed one year after their baseline questionnaire.  
 
2.2.4 Exposure measures 
The primary exposures of interest were maintenance of cycling to work and maintenance of walking 
to work. The secondary exposures of interest were change in weekly time spent cycling to work and 
change in weekly time spent walking to work.  
 
I choose change in weekly time spent cycling (or walking) to work rather than comparing uptake (i.e. 
no cycling at baseline, cycling at follow-up) with continued abstinence (i.e. no cycling at baseline and 
no cycling at follow-up) and comparing stopping (i.e. cycling at baseline, no cycling at follow-up) with 
continuation (i.e. cycling at baseline and follow-up) as the number of changers was relatively small 
(n=110 for cycling, n=144 for walking) and the sample would have been effectively divided into two 
(one sample for uptake analyses, and one sample for the stopping analyses), potentially reducing 
power.  
 
2.2.4.1 Classification of cycling maintenance 
Weekly time spent cycling to work at each time point was estimated by summing the total number of 
trips to and from work involving any cycling that was reported in the seven day travel record (copy 
included in the Appendix, page 249), and multiplying this by the typical duration of cycling per trip 
(assessed in a separate question).191 Thus maintenance of cycling to work, included both cycling to 
work and cycling from work, but for simplicity I only refer to cycling to work. Maintenance of cycling 
to work was defined as weekly cycling time > 0 minutes at both baseline and follow-up. The 
reference group consisted of those who did not cycle to work at both baseline and follow-up (weekly 
cycling time = 0 minutes at both baseline and follow-up), i.e. this group maintained not cycling to 
work. 
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Consequently, participants who stopped cycling to work (weekly cycling time > 0 minutes at baseline 
and weekly cycling time = 0 minutes at follow-up) or took up cycling to work (weekly cycling time = 0 
minutes at baseline and weekly cycling time > 0 minutes at baseline) were not categorised, and were 
therefore excluded from the maintenance analyses that used this exposure measure. 
 
The same process was followed for walking to work. 
 
After excluding those who stopped or started cycling between the two time points (n=110), 691 
participants were included in the maintenance of cycling analyses. After excluding those who 
stopped or started walking between the two time points (n=144), 657 participants were included in 
the maintenance of walking analyses. 
 
2.2.4.2 Change in weekly time spent cycling to work 
Change in weekly time cycling to work between baseline and follow-up was categorised as either any 
increase, no change, or any decrease, based on the difference in the estimates of time cycling to 
work at baseline and follow-up.  
 
As small increases or decreases might reflect reporting errors rather than true changes, I also 
conducted a sensitivity analysis in which only large increases or decreases in cycle commuting time 
(≥50 mins/week) were categorised as ‘change’, and smaller changes were re-categorised as ‘no-
change’.192  
 
The same process was followed for walking to work. 
 
2.2.5 Outcome measures 
 
2.2.5.1 Well-being 
Physical Component Summary (PCS-8) score and Mental Component Summary (MCS-8) score were 
derived from responses to the Medical Outcomes Study Short Form eight (SF-8) questionnaire.184 The 
SF-8 questionnaire comprised eight ordinal response questions concerning participants’ well-being in 
the past four weeks (see Appendix, page 250), with different weights being applied to each question 
to derive the scores as described by Ware et al.184 The PCS-8 score had a theoretical score range of 
9.1 to 69.0, and had a mean of 50 in the US adult population. MCS-8 score had a theoretical score 
range of 9.1 to 69.0, with a mean of 50 in the US adult population.184 
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I treated the scores as continuous variables. I analysed each as separate outcomes, as one might 
expect each measure to have different associations with active travel.157,193  
 
2.2.5.2 Sickness absence 
Sickness absence was ascertained by asking the following: “In the past twelve months how many 
days were you off sick for health reasons?” It was thus measured in days. This simple question has 
been shown to have good agreement with employer certified sickness absence.162 Sickness absence 
was not normally distributed. The distribution had a right skew, with a large number of zero counts. 
 
2.2.6 Covariates 
 
2.2.6.1 Assessment and categorisation 
Date of birth, date of questionnaire completion, education, sex, height, weight, difficulty walking, 
limitation of physical activity, home postcode, home to work distance, and physical activity (Recent 
Physical Activity Questionnaire)186 were assessed by questionnaire. Dates of birth and questionnaire 
completion were used to calculate age. Weight status (low or healthy weight, overweight, obese) 
was assigned based on participant’s body mass calculated by dividing weight by height squared.194 
Education was the preferred measure of socio-economic status as it was measured at the individual-
level. An alternative measure was area-level deprivationxii but as this is geographic measure it may 
not reflect an individual’s socio-economic status. 
 
A physical limitation variable (yes/no) was created, with participants being assigned to ‘yes’ if they 
either (a) reported difficultly walking for a quarter of a mile on the level or (b) reported that physical 
health problems limited their ability to do usual physical activities. 
 
Physical activity level (inactive, moderately inactive, moderately active, active) was assigned based 
on occupation and time spent in recreational activity following the Cambridge Physical Activity 
Index.195 Individuals are assigned to one of four categories (inactive, moderately inactive, moderately 
active and active) based on reported physical activity at work and reported recreational physical 
activityxiii. The index has been shown to be associated with overall physical activity energy 
                                                          
xiiArea level deprivation is measured using the Index of Multiple Deprivation 2010 score (based on a series of indicators for 
income, employment, health, crime, education, housing and the environment) for small geographic units known as Lower 
Super Output Area. It can be linked to individuals based on the postcode of residence.202 
xiii Inactive = Sedentary job with no recreational activity; Moderately inactive = sedentary job with <0.5 hours per day of 
recreational activity or standing job with no recreational activity; Moderately active 
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expenditure and all-cause mortality.195,196 Whilst the original index incorporated walking and cycling 
to work, I discounted time spent in these activities when assigning participants.  
 
2.2.6.2 Choice of covariates 
A directed acyclic graph showing the hypothesised relationship between active commuting, indices 
of health (well-being and sickness absence) and confounders is shown in Figure 2.3. Confounders 
were identified based on empirical evidence from others studies (e.g. age is a determinant of active 
travel and is associated with PCS-8)137,184,197 or observation of univariate associations consistent with 
confounding that appeared biologically plausible (e.g. physical limitation may be a determinant of 
active travel and may be associated with PCS-8, which was supported by univariate analysis).  
 
Figure 2.3 Hypothesised relationship between active commuting and indices of well-being 
 
 
Home-work distance has been associated with active commuting in the same study.136,191,198 It was 
also associated with PCS-8, MCS-8 and sickness absence on univariate analysis. In other analyses 
commute duration has been shown to be associated with reduced well-being.168,199 Given that a long 
commute may also reduce time available for other health-promoting activities that have not been 
adjusted for (e.g. sleep), it seemed conceivable that distance to work was a confounding factor. 
Within the study population, home-work distance may be a marker of socio-economic status, for 
example the price of housing in Cambridge is high, resulting in some people living out of Cambridge 
and commuting into the city.  
 
Study year was also included as a covariate as participants were drawn from three different years of 
entry to the cohort.  
                                                          
Sedentary job with 0.5 to 1 hours recreational activity per day or standing job with < 0.5 hours recreational activity per day 
or physical job with no recreational activity; Active = sedentary job with 1 hour of recreational activity per day or standing 
job with > 0.5 hours recreational activity per day or Physical job with at least some recreational activity or heavy manual 
job. 
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2.2.7 Analysis 
I used two complementary approaches to test longitudinal associations. In the first set of analyses, I 
tested the associations between maintenance of cycling (or walking) to work and indices of well-
being at follow-up. These ‘maintenance analyses’ were intended to contribute to establishing 
evidence of a temporal relationship, because the exposure was ascertained before the outcome.35  
 
In the second set of analyses, I used linear regression to test the associations between change in 
cycling (or walking) to work and changes in indices of well-being. By focusing on individuals who 
changed their behaviour, these ‘change analyses’ were intended to provide a more direct estimate of 
the association attributable to increasing or decreasing a given behaviour. 
 
2.2.7.1 Maintenance analyses 
I used linear regression to test the associations of maintenance of cycling (or walking) to work with 
PCS-8 and MCS-8. Given the nature (discrete data) and distribution of sickness absence (positive 
skew with a large number of zero counts), following the approach described by Zhou et al,200 I fitted 
different models (e.g. linear, binomial, negative binomial, zero-inflated). I found the data were fitted 
best by a negative binomial distribution. Consequently, I used negative binomial regression to test 
the associations with sickness absence.  
 
Regression models were adjusted for all covariates (age, sex, education, physical activity, weight 
status, physical limitation, home-work distance and study year), which I will term Model A. 
 
I further conditioned each analysis on the baseline value of the outcome variable in question (i.e. 
analysis of covariance) (model B). In this context, analysis of covariance addresses whether there is a 
difference in the change in outcome between cyclists and non-cyclists who have the same initial 
value of the outcome? It is considered the most appropriate approach to test for differences in 
change between two groups, when there are baseline differences in the outcome of interest 
between groups.188,190 It is similar to, although different from testing the association between 
maintenance of cycling (or walking) to work with change scores (i.e. well-being at follow-up minus 
well-being at baseline). Thus it could be considered as another form of longitudinal analysis (see 
Figure 2.2). 
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I also undertook sensitivity analyses adjusting the ‘maintenance’ analyses for the reciprocal 
commuting behaviour (e.g. models using cycling to work as the exposure were additionally adjusted 
for walking to work). 
 
2.2.7.2 Change analyses 
I used linear regression to test the association between change in active commuting and change in 
outcome. I used the same approaches to adjustment for covariates described above (model A and 
model B). The conditional analysis addressed the following question: whether there was a difference 
in the change in outcome between those whose cycle commute time increased, decreased or stayed 
the same, after adjusting for covariates and assuming the same baseline measure of the outcome of 
interest. 
 
I considered adjusting for time varying covariates (i.e. other variables that may have changed and 
might confound the relationship), but such variables were either unavailable (e.g. change in diet or 
change in sleep), liable to be on the causal pathway (e.g. change in recreational physical activity is 
likely to be associated with a change in well-being, and the change in recreational physical activity 
might arise as a result of change in commuting), or of uncertain association with well-being (e.g. 
change in home location might be associated with a set of other changes e.g. sleep, time pressure or 
stress, and the direction of these effects would be uncertain). Adjustment for variables on the causal 
pathway (i.e. mediators) would be inappropriate.201 
 
Change in sickness absence had a positive kurtosis, and I truncated outliers (to +/- 30 days) so that 
residuals were normally distributed.  
 
2.2.7.3 Software 
Analyses were undertaken using Stata Statistical Software: Release 13 (College Station, TX: StataCorp 
LP) using the “regress” and “nbreg” commands for linear and negative binomial regression 
respectively. 
 
2.2.7.4 Analysis summary 
In summary, I used two analytic approaches (‘maintenance’ and ‘change’), each with two stages of 
adjustment for covariates (model A and model B), applied to two exposures (cycling and walking to 
work) and for three outcomes (PCS-8, MCS-8 and sickness absence). These analyses are summarised 
in Table 2.2, for the outcome of PCS-8. Across all three outcomes, this yielded a total of 24 different 
regression analyses.  
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Table 2.2 Summary of analyses and research questions for physical well-being (PCS-8) 
Exposure Categorisation Outcome Adjustment Research question 
Maintenance 
of cycling  
 
None vs some PCS-8 at one-
year follow-
up 
Model A What is the difference in physical well-being at one-year follow-
up between those who maintain commuting by bicycle during 
the year of follow-up and those who maintain not doing so, 
after adjustment for covariates? 
Maintenance 
of cycling  
 
None vs some PCS-8 at one-
year follow-
up 
Model B 
(conditional) 
What is the difference in change in physical well-being at one-
year follow-up between those who maintain commuting by 
bicycle during the year of follow-up and those who maintain not 
doing so, after adjustment for covariates assuming the same 
baseline physical well-being at baseline? 
Any change in 
weekly cycle 
time 
No change, 
increase, decrease 
Change in 
PCS-8 (follow-
up PCS-8 
minus 
baseline PCS-
8) 
Model A What is the difference in change in physical well-being between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates? 
Any change in 
weekly cycle 
time 
No change, 
increase, decrease 
Change in 
PCS-8 (follow-
up PCS-8 
minus 
baseline PCS-
8) 
Model B 
(conditional) 
What is the difference in change in physical well-being between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates assuming 
the same baseline PCS-8? 
Maintenance 
of walking  
 
None vs some PCS-8 at one-
year follow-
up 
Model A What is the difference in physical well-being at one-year follow-
up between those who maintain commuting by foot during the 
year of follow-up and those who maintain not doing so, after 
adjustment for covariates? 
Maintenance 
of walking  
None vs some PCS-8 at one-
year follow-
up 
Model B 
(conditional) 
What is the difference in change in physical well-being at one-
year follow-up between those who maintain commuting by foot 
during the year of follow-up and those who maintain not doing 
so, after adjustment for covariates assuming the same baseline 
physical well-being at baseline? 
Any change in 
weekly walk 
time 
No change, 
increase, decrease 
Change in 
PCS-8 (follow-
up PCS-8 
minus 
baseline PCS-
8) 
Model A What is the difference in change in physical well-being between 
those whose walk commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates? 
Any change in 
weekly walk 
time 
No change, 
increase, decrease 
Change in 
PCS-8 (follow-
up PCS-8 
minus 
baseline PCS-
8) 
Model B 
(conditional) 
What is the difference in change in physical well-being between 
those whose walk commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates assuming 
the same baseline PCS-8? 
PCS-8 = physical component score derived from the Short Form 8 questionnaire; Model A co-variates: age, sex, education, body mass 
index, other physical activity and home-work distance; Model B co-variates: age, sex, education, body mass index, other physical activity, 
home-work distance and baseline PCS-8; an analogous set of questions apply to the other outcomes (mental well-being and sickness 
absence). 
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2.3 Results  
 
2.3.1 Descriptive characteristics 
The participants included in analysis were predominantly women (69.7%), educated to degree level 
or higher (70.2%), of low or healthy bodyweight (65.4%), and slightly more than half reported cycling 
to work (54.3%) (Table 2.3). The average scores for physical well-being (median PCS-8 55.5, IQR 51.5 
to 58.0) and for mental well-being (median MCS-8 52.5, IQR 48.5 to 57.5) were higher than the 
specified population average (50). Sickness absence (mean = 3.6 days, median 1 day, IQR 0 to 4 days) 
was lower than the UK mean (4.4 days).173  
 
Baseline differences between those who cycled to work and those who did not (and the equivalent 
for walking) are shown in Table 2.3. Those who reported maintenance of some cycling to work, 
compared to maintenance of not cycling to work, were more likely to be male, be younger, live close 
to their workplace and have a degree. Their health status at baseline appeared to be better as 
indicated by fewer days of sickness absence and a lower prevalence of obesity, although differences 
in MCS-8 and PCS-8 were slight. Those who reported maintenance of some walking to work, 
compared to maintenance of not walking to work, were more likely to be female and there were few 
differences in other socio-demographic characteristics. Their health status (obesity prevalence, PCS-8 
and MCS-8) at baseline appeared similar to those who reported maintenance of not walking to work, 
although those who maintained walking to work reported more days of sickness absence at baseline. 
 
Differences between participants included in and excluded from the analysis are shown in Table 2.4. 
Those who were excluded tended to be younger, but there were no other notable differences 
between those included and excluded. 
 
2.3.2 Cycling maintenance and well-being  
In univariable analysis, those who maintained cycling to work were found to report higher PCS-8 and 
MCS-8 scores at follow-up relative to those who did not cycle to work (Table 2.5). For PCS-8 the 
association was not significant after adjustment for covariates (model A) or when additionally 
conditioning on baseline PCS-8 (model B), although the estimates of effect size were of similar 
magnitude to the unadjusted estimate. 
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Table 2.3 Characteristics of participants included in the analyses (n=801) 
 Cycling to work at baseline Walking to work at baseline 
 None (n=366) Some (n=435) None (n=597) Some (n=204) 
 N (%) N (%) N (%) N (%) 
Sex      
Female 283 (50.7) 275 (49.3) 404 (72.4) 154 (27.6) 
Male 83 (34.2) 160 (65.8) 193 (79.4) 50 (20.6)  
Age      
Median 44.4 (34.7-52.9) 43.0 (33.1-51.6) 43.2 (34.0-52.0) 43.3 (33.7-52.2) 
16-29 years 42 (39.6) 64 (60.4) 73 (68.9) 33 (31.1) 
30-39 years 103 (46.8) 117 (53.2) 169(76.8) 51 (23.2) 
40-49 years 93 (44.3) 117 (55.7) 160 (76.2) 50 (23.8) 
50-59 years 92 (46.2) 107 (53.8) 148 (74.4) 51 (25.6) 
≥60 years 36 (54.6) 30 (45.5) 47 (71.1) 19 (28.8) 
Highest educational 
qualification 
    
Less than degree 140 (58.6) 99 (41.4) 177 (74.1) 62 (25.9) 
degree or higher 226 (40.2) 336 (59.8) 420 (74.5) 142 (25.3) 
Deprivation quintile     
1 (= least deprived) 181 (49.7) 183 (50.3) 269 (73.9) 95 (26.1) 
2 110 (46.8) 125 (53.2) 180 (76.6) 55 (23.4) 
3 50 (48.1) 54 (51.9) 71 (68.3) 33 (31.8) 
4 22 (23.9) 70 (76.1) 73 (79.3) 19 (20.7) 
5 (= most deprived) 3 (50.0) 3 (50.0) 4 (66.7) 2 (33.3) 
Weight status     
low or healthy weight 213 (40.6) 311 (59.4) 395 (75.4) 129 (24.6) 
Overweight 102 (49.8) 103 (50.2) 148 (72.2) 57 (27.8) 
Obese 51 (70.8) 21 (29.2) 54 (75.0) 18 (25.0) 
PCS-8 score     
Median (IQR) 55.2 (51.1-58.0) 55.7 (52.2-58.0) 55.5 (51.7-58.0) 55.4 (51.6-58.0) 
MCS-8 score     
Median (IQR) 52.3 (47.1-57.5) 52.6 (49.4-57.5) 52.5 (49.2-57.5) 52.3 (47.3-57.5) 
Sickness Absence (days per 
year) 
    
Median (IQR) 2 (0-4) 1 (0-3) 1 (0-3) 2 (0-5) 
Physical limitation     
Yes 350 (45.4) 421 (54.6) 575 (74.6) 196 (25.4) 
No 16 (53.3) 14 (46.7) 22 (73.3) 8 (26.7) 
Home to work distance     
Median (IQR) 19.3 (8.0-27.4) 4.8 (3.2-8.1) 8.0 (4.8-19.3) 8.0 (3.2-24.1) 
0-9.99 km 117 (24.8) 354 (75.2) 361 (76.7) 110 (23.4) 
10-19.99 km 71 (60.7) 46 (39.3) 89 (76.1) 28 (23.9) 
≥20 km 178 (83.6) 35 (16.4) 147 (69.0) 66 (31.0) 
Physical activity index     
Inactive 9 (37.5) 15 (62.5) 19 (79.2) 5 (20.8) 
Moderately inactive 111 (50.5) 109 (49.5) 162 (73.6) 58 (26.4) 
Moderately active 113 (46.1) 132 (53.9) 180 (73.5) 65 (26.5) 
Active 133 (42.6) 179 (57.4) 236 (75.6) 76 (24.4) 
Weekly time cycling to work 
(minutes) 
    
Median (IQR) 0 (0-0) 150 (90-200) 100 (0-180) 0 (0-45) 
Weekly time walking to work 
(minutes) 
    
Median (IQR) 0 (0-90) 0 (0-0) 0 (0-0) 100 (60-180) 
Changed behaviour     
Started walking/cycling to 
work 
42 (9.7) 0 (0) 75 (36.7) 0 (0) 
Stopped walking/cycling to 
work 
0 (0) 68 (18.6) 0 (0) 67 (11.2) 
Time frame     
2009-10 (reference) 305 (47.0) 344 (53.0) 477 (73.5) 172 (26.5) 
2010-11 16 (39.0) 25 (61.0) 25 (61.0) 16 (39.0) 
2011-2 45 (40.5) 66 (59.5) 95 (85.6) 16 (14.4) 
IQR=Interquartile range; PCS-8 = Physical Component Summary score derived from the Short Form 8 Questionnaire, deprivation quintile is 
based on national quintiles of deprivation ranked using the Index of Multiple Deprivation 2010 score for the Lower Super Output Area 
(assigned based on postcode or residence)202; unless otherwise stated characteristics are measured at baseline; changed behaviour 
describes the number of individuals who started or stopped active travel between baseline and follow-up (e.g. cycle to work at baseline 
and not cycling to work at follow-up). 
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Table 2.4 Characteristics of participants included and excluded from the analyses (n=1434) 
 Included (n=801) Excluded (n=633) 
 N (%) N (%) 
Sex    
Female 558 (69.7) 414 (69.0) 
Male 243 (30.3) 186 (31.0) 
Age    
Median (IQR) 43.3 (33.7-52.2) 38.5 (31.0-48.1) [n=607] 
16-29 years 106 (13.2) 133 (21.9) 
30-39 years 220 (27.5) 196 (32.3) 
40-49 years 210 (26.2) 153 (25.2) 
50-59 years 199 (24.8) 90 (14.8) 
≥60 years 66 (8.2) 35 (5.7) 
Highest educational 
qualification 
  
Less than degree 239 (39.8) 188 (31.6) 
Bachelor or higher 562 (70.2) 406 (68.4) 
Deprivation quintile   
1 (= least deprived) 364 (45.4) 266 (41.3) 
2 235 (29.3) 187 (31.1) 
3 104 (13.0) 91 (15.1) 
4 92 (11.5) 55 (9.2) 
5 (= most deprived) 6 (0.7) 2 (0.3) 
Weight status   
Normal or underweight 524 (65.4) 351 (60.0) 
Overweight 205 (25.6) 168 (28.7) 
Obese 72 (9.0) 66 (11.2) 
PCS-8 score   
Median (IQR) 55.5 (51.6-58.0) 55.0 (51.5-57.7) [n=602] 
MCS-8 score   
Median (IQR) 52.5 (48.5-57.5) 52.1 (45.8-56.4) [n=602] 
Sickness Absence (days per 
year) 
  
Median (IQR) 1 (0-4) 2 (0-4) [n=584] 
Disability   
Yes 30 (3.7) 21 (3.4) 
No 771 (96.3) 589 (96.6) 
Home to work distance   
Median (IQR) 8.0 (4.8-22.5) 8.0 (3.2-20.9) [n=608] 
0-9.99 km 471 (58.8) 348 (57.2) 
10-19.99 km 117 (14.6) 104 (17.1) 
≥20 km 213 (26.6) 156 (25.7) 
Physical activity index   
Inactive 24 (3.0) 20 (3.3) 
Moderately inactive 220 (27.5) 165 (27.2) 
Moderately active 245 (30.6) 200 (33.0) 
Active 312 (39.0 221 (36.4) 
Weekly time cycling to work 
(minutes) 
  
Median (IQR) 56 (0-150) 40 (0-150) [n=610] 
Weekly time walking to work 
(minutes) 
  
Median (IQR) 0 (0-10) 0 (0-30) [n=605] 
IQR=Interquartile range; PCS-8 = Physical Component Summary score derived from the Short Form 8 Questionnaire; MCS-8 = Mental 
Component Summary score derived from the Short Form 8 Questionnaire; deprivation quintile is based on national quintiles of deprivation 
ranked using the Index of Multiple Deprivation 2010 score for the Lower Super Output Area (assigned based on postcode or residence). 
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Table 2.5 Associations between maintenance of cycling to work and well-being (n=691) 
 Physical Well-being (PCS-8) Mental Well-being (MCS-8) 
 Unadjusted Model A Model B Unadjusted Model A Model B 
 Coefficient 
(95% CI) 
Coefficient  
(95% CI) 
Coefficient  
(95% CI) 
Coefficient  
(95% CI) 
Coefficient 
(95% CI) 
Coefficient 
(95% CI) 
Cycling       
None (reference)       
Some 1.05 (0.13, 1.96) 1.08 (-0.06, 2.23) 0.87 (-0.17, 1.93) 1.33 (0.19, 2.48) 1.50 (0.10, 2.90) 0.82 (-0.42, 2.08)  
Sex       
Male (reference)       
Female 0.24 (-0.76, 1.25) 0.31 (-0.72, 1.24) 0.14 (-0.81, 1.09) -1.81 (-3.06, -0.56) -1.14 (-2.41, 0.12) -0.95 (-2.09, 0.17) 
Age       
16-29 years 
(reference) 
      
30-39 years -0.37 (-1.97, 1.21) -0.24 (-1.85, 1.36) -0.12 (-1.59, 1.35) 2.43 (0.47, 4.39) 2.64 (0.68, 4.61) 1.83 (0.07, 3.58) 
40-49 years -0.33 (-1.92, 1.26) -0.26 (-1.86, 1.35) -0.07 (-1.54, 1.41) 3.92 (1.96, 5.88) 3.88 (1.91, 5.85) 3.06 (1.30, 4.82) 
50-59 years -1.25 (-2.84, 0.35) -1.09 (-2.72, 0.54) -0.73 (-2.23, 0.75) 3.74 (1.77, 5.71) 3.67 (1.68, 5.66) 2.69 (0.91, 4.48) 
≥60 years -1.30 (-3.33, 0.74) -0.91 (-2.98, 1.17) -0.68 (-2.58, 1.21) 5.49 (2.98, 7.99) 5.87 (3.33, 8.40) 3.72 (1.44, 6.05) 
Degree       
No (reference)       
Yes 0.14 (-0.85, 1.15) -0.38 (-1.46, 0.70) -0.73 (-1.73, 0.25) 0.03 (-1.22, 1.29) -0.27 (-1.59, 1.05) -0.23 (-1.40, 0.94) 
Home to work 
distance 
      
0-9.99 km 
(reference) 
      
10-19.99 km -0.10 (-1.43, 1.22) 0.54 (-0.88, 1.98) 0.47 (-0.84, 1.77) 0.07 (-1.59, 1.72) 0.04 (-1.71, 1.78) 0.35 (-1.20, 1.54) 
≥20 km -0.60 (-1.66, 0.46) 0.13 (-1.18, 1.44) -0.01 (-1.21, 1.19) -0.46 (-1.79, 0.86) 0.23 (-1.37, 1.82) 0.54 (-0.88, 1.97) 
Physical limitation       
No (reference)       
Yes -4.10 (-6.55, -1.66) -3.84 (-6.33, -1.35) 4.03 (1.39, 6.68) -4.30 (-7.36, -1.23) -3.81 (-6.86, -0.77) -3.16 (-5.88, -0.45) 
Physical Activity       
Inactive (reference)       
Moderately inactive 0.73 (-2.10, 3.57) 0.41 (-2.47, 3.29) -1.14 (-3.79, 1.49) 4.33 (0.81, 7.86) 4.96 (1.45, 8.48) 2.68 (-0.47, 5.83) 
Moderately active 1.57 (-1.26, 4.40) 1.14 (-1.76, 4.03) -0.81 (-3.49, 1.85) 4.37 (0.86, 7.88) 5.09 (1.54, 8.06) 2.58 (-0.58, 5.76) 
Active 1.53 (-1.26, 4.34) 1.02 (-1.84, 3.89) -0.77 (-3.41, 1.87) 5.58 (2.10, 9.06) 6.00 (2.49, 9.50) 2.88 (-0.28, 6.03) 
Weight status       
Low or healthy 
(reference) 
      
Overweight -0.68 (-1.75, 0.39) 0.56 (-1.39, 0.82) -0.30 (-1.32, 0.71) -0.25 (-1.60, 1.09) -0.37 (-1.72, 0.98) -0.39 (-1.60, 0.81) 
Obese -1.72 (-3.35, 0.09) -1.11 (-2.82, 0.59) -0.51 (-2.08, 1.05) 0.29 (-1.76, 2.33) 0.80 (-1.29, 2.89) 0.47 (-1.39, 2.34) 
Study Year       
2009-10 (reference)       
2010-11 0.05 (-2.09, 2.19) -0.29 (-2.44, 1.85) -0.11 (-2.08, 1.84) 1.14 (-1.52, 3.81) 1.14 (1.47, 3.76) 0.13 (-2.20, 2..47) 
2011-2 -0.74 (-2.10, 0.60) -1.08 (-2.47, 0.32) -0.86 (-2.14, 0.41) -0.06 (-1.74, 1.62) -0.06 (-1.76, 1.65) -0.42 (-1.94, 1.10) 
Baseline well-being 0.42 (0.36, 0.50)  0.48 (0.40, 0.56)   0.46 (0.39, 0.53) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; physical activity is categorised 
using the Cambridge Physical Activity Index; weight status is categorised using body mass index; study year refers to the time period when 
data were collected; Model A is adjusted for sex, age, degree, home to work distance, physical limitation, physical activity, weight status 
and study year; Model B is adjusted for sex, age, degree, home to work distance, physical limitation, physical activity, weight status, study 
year and baseline well-being (baseline PCS-8 for PCS-8 model or baseline MCS-8 for MCS-8 model); bold indicates significant results 
(p<0.05). 
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The association between maintenance of cycling to work and MCS-8 remained significant after 
adjustment for covariates (model A), but not after additional adjustment for baseline MCS-8 (model 
B). Sensitivity analysis, adjusting for walking to work, resulted in a similar pattern and magnitude of 
findings, although the only significant finding was for PCS-8 (model A: 1.45, 95% CI 0.06 to 2.84; 
n=573). 
 
2.3.3 Cycling maintenance and sickness absence  
Maintenance of cycling to work was associated with reduced sickness absence in univariable analysis 
(Table 2.6). The association remained significant after adjustment for covariates (model A) and 
additionally adjusting for baseline sickness absence (model B). The estimate of effect size 
(approximately 0.5) was equivalent to just over one day of sickness absence per year, and was 
similar in univariable and adjusted analyses. 
 
2.3.4 Association of changes in weekly cycling time with changes in well-
being and sickness absence 
There were no significant associations between change in weekly cycling time and changes in PCS-8, 
MCS-8 or sickness absence (Table 2.7). However, I note that the adjusted estimate of the effect size 
from the change analysis for well-being (both PCS-8 and MCS-8) is of similar magnitude to the 
estimated effect size for the maintenance analyses, when conditioning on baseline well-being 
(Model B: PCS-8, 1.01 in change analyses vs 0.87 in maintenance analyses; MCS-8, 0.69 vs 0.82 
respectively).  
 
Using the alternative definition of change (i.e. large changes or changes > 50 minutes per week), the 
pattern of results was similar (Table 2.8). There were no significant associations. 
 
2.3.5 Walking 
There were no significant associations between maintenance of walking and PCS-8, MCS-8 or 
sickness absence (Table 2.9 and Table 2.10). The associations for MCS-8 were borderline significant 
and the direction of the association was negative, i.e. those who reported maintaining walking to 
work tended to report lower MCS-8 scores. These associations remained non-significant after 
adjusting for cycling to work (data not shown). 
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There were no significant associations between either any change or a large change in walking and 
change in any of the outcomes (PCS-8, MCS-8 or sickness absence). Results for any change in walking 
are shown in Table 2.11, and for large changes (>50 minutes per week) in Table 2.12. 
 
Table 2.6 Association between maintenance of cycling to work and sickness absence 
(n=691) 
  Unadjusted Model A Unadjusted 
  Co-efficient (95% CI) Co-efficient (95% CI) Co-efficient (95% CI) 
Cycling None (reference)    
 Some -0.51 (-0.76, -0.26) -0.47 (-0.80, -0.14) -0.46 (-0.77, -0.14) 
Sex Male (reference)    
 Female 0.18 (-0.10, 0.46) 0.12 (-0.14, 0.40) 0.17 (-0.10, 0.43) 
Age 16-29 years (reference)    
 30-39 years -0.42 (-0.85, 0.02) -0.50 (-0.93, -0.06) -0.43 (-0.84, -0.01) 
 40-49 years -0.79 (-1.22, -0.35) -0.88 (-1.31, -0.44) -0.80 (-1.21, -0.37) 
 50-59 years -0.27 (-0.70, 0.14) -0.44 (-0.89, 0.00) -0.42 (-0.85, 0.01) 
 ≥60 years -0.56 (-1.11, -0.02) -0.79 (-1.35, -0.22) -0.56 (-1.10, -0.02) 
Degree No (reference)    
 Yes -0.34 (-0.62, -0.07) -.10 (-0.39, 0.19) -0.01 (-0.29, 0.27) 
Home to work 
distance 
0-9.99 km (reference)    
 10-19.99 km 0.14 (-0.21, 0.50) -0.10 (-0.50, 0.29) -0.09 (-0.47, 0.28) 
 ≥20 km 0.38 (0.09, 0.66) -0.07 (-0.44, 0.29) -0.12 (-0.47, 0.22) 
Physical limitation No (reference)    
 Yes 1.22 (0.59, 1.86) 0.97 (0.34, 1.61) 0.51 (-0.11, 1.13) 
Physical Activity Inactive (reference)    
 Moderately inactive -0.19 (-0.96, 0.57) -0.02 (-0.78, 0.74) 0.70 (-0.08, 1.48) 
 Moderately active -0.11 (-0.88, 0.65) -0.04 (-0.81, 0.73) 0.72 (-0.07, 1.51) 
 Active -0.33 (-1.09, 0.43) -0.08 (-0.86, 0.68) 0.54 (-0.25, 1.33) 
Weight status Low or healthy (reference)    
 Overweight 0.13 (-0.16, 0.42) 0.17 (-0.12, 0.47) 0.18 (-0.10, 0.47) 
 Obese 0.59 (0.15, 1.02) 0.31 (-0.14, 0.76) 0.28 (-0.15, 0.72) 
Study Year 2009-10 (reference)    
 2010-11 0.11 (-0.47, 0.70) 0.23 (-0.34, 0.80) 0.17 (-0.37, 0.72) 
 2011-2 0.30 (-0.06, 0.67) 0.13 (-0.24, 0.51) 0.30 (-0.05, 0.67) 
Baseline sickness 
absence 
 0.09 (0.06, 0.11)  0.07 (0.05, 0.09) 
Negative binomial coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; physical activity is categorised 
using the Cambridge Physical Activity Index; weight status is categorised using body mass index; study year refers to the time period when 
data were collected; Model A is adjusted for sex, age, degree, home to work distance, physical limitation, physical activity, weight status 
and study year; Model B is adjusted for sex, age, degree, home to work distance, physical limitation, physical activity, weight status, study 
year and baseline sickness absence; bold indicates significant results (p<0.05). 
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Table 2.7 Associations of change in weekly cycle commuting time with change in PCS-8, 
MCS-8 and sickness absence (n=801) 
  Unadjusted Model A Model B 
  Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Physical Well-
being (PCS-8) 
No change 
(reference) 
   
 Increase (n=183) 0.62 (-0.54, 1.79) 0.94 (-0.22, 2.11) 1.01 (-0.05, 2.07) 
 Decrease (n=223) -0.49 (-1.58, 0.60) -0.47 (-1.59, 0.64) -0.31 (-1.33, 0.69) 
     
Mental Well-
being (MCS-8) 
No change 
(reference) 
   
 Increase (n=183) -0.31 (-1.68, 1.06) 0.20 (-1.26, 1.65) 0.69 (-0.59, 1.97) 
 Decrease (n=223) -0.51 (-1.79, 0.77) -0.11 (-1.51, 1.29) -0.18 (-1.41, 1.05) 
     
Sickness 
Absence (days) 
No change 
(reference) 
   
 Increase (n=183) -0.14 (-1.20, 0.90) -0.40 (-1.51, 0.72) -0.37 (-1.33, 0.59) 
 Decrease (n=223) 0.23 (-0.75, 1.21) 0.03 (-1.03, 1.10) -0.14 (-1.06, 0.79) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; Model A is adjusted for sex, 
age, degree, home to work distance, physical limitation, physical activity, weight status and study year; Model B is adjusted for sex, age, 
degree, home to work distance, physical limitation, physical activity, weight status, study year and appropriate baseline health index 
(baseline PCS-8 for PCS-8 model, baseline MCS-8 for MCS-8 model or baseline sickness absence for sickness absence model). 
 
Table 2.8 Associations of large changes in weekly walk commuting time (≥ 50 minutes per 
week) with change in PCS-8, MCS-8 and sickness absence (n=801) 
  Unadjusted Model A Model B 
  Co-efficient (95% CI) Co-efficient (95% CI) Co-efficient (95% CI) 
Physical Well-being 
(PCS-8) 
No change or change less than 50 
minutes 
(reference) 
   
 Large increase (n=114) 0.70 (-0.65, 2.05) 0.80 (-0.50, 2.10) 1.10 (-0.08, 2.28) 
 Large decrease (n=158) -0.03 (-1.21, 1.15) -0.37 (-1.52, 0.79) -0.13 (-1.18, 0.91) 
     
Mental Well-being 
(MCS-8) 
No change or change less than 50 
minutes 
(reference) 
   
 Large increase (n=114) -0.28 (-1.86, 1.30) 0.17 (-1.44, 1.79) 0.60 (-0.82, 2.02) 
 Large decrease (n=158) -0.61 (-2.00, 0.78) -0.25 (-1.69, 1.18) -0.47 (-1.73, 0.79) 
     
Sickness Absence 
(days) 
No change or change less than 50 
minutes 
(reference) 
   
 Large Increase (n=114) 0.21 (-0.99, 1.42) 0.19 (-1.05, 1.43) -0.34 (-1.41, 0.73) 
 Large decrease (n=158) 0.96 (-0.10, 2.02) 0.93 (-0.17, 2.03) 0.46 (-0.49, 1.41) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; Model A is adjusted for gender, 
age, degree, home to work distance, physical limitation, physical activity, weight status and study year; Model B is adjusted for gender, 
age, degree, home to work distance, physical limitation, physical activity, weight status, study year and appropriate baseline health index 
(baseline PCS-8 for PCS-8 model, baseline MCS-8 for MCS-8 model or baseline sickness absence for sickness absence model); Large 
increase defined as increase of more than 50 minutes per week and a large decrease defined as a decrease of more than 50 minutes per 
week; Total sample size: n=801; Study undertaken in Cambridge, UK (2009-12). 
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Table 2.9 Associations between maintenance of walking to work and well-being (n=659) 
 Physical Well-being Mental Well-being 
 Unadjusted Model A Model B Unadjusted Model A Model B 
 Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Walking       
None (reference)       
Some -0.18 (-1.39, 1.02) -0.18 (-1.39, 1.03) -0.15 (-1.27, 0.97) -1.50 (-3.01, 0.02) -1.36 (-2.86, 0.14) -0.65 (-1.99, 0.68) 
Sex       
Male (reference)       
Female -0.34 (-1.40, 0.71) -0.46 (-1.53, 0.61) -0.46 (-1.46, 0.52) -1.78 (-3.11, 0.45) -1.13 (-1.25, 1.57) -0.86 (-2.03, 0.32) 
Age       
16-29 years 
(reference) 
      
30-39 years 0.64 (-1.01, 2.31) 0.72 (-0.94, 2.40) 1.13 (-0.41, 2.68) 3.36 (1.31, 5.42) 3.29 (1.22, 5.36) 1.99 (0.15, 3.84) 
40-49 years -0.24 (-1.91, 1.42) -0.24 (-1.93, 1.44) 0.14 (-1.42, 1.71) 4.64 (2.59, 6.71) 4.64 (2.55, 6.73) 3.45 (1.59, 5.32) 
50-59 years -0.87 (-2.55, 0.81) -0.81 (-2.53, 0.91) -0.50 (-2.10, 1.10) 5.31 (3.22, 7.39) 5.30 (3.17, 7.44) 3.81 (1.90, 5.72) 
≥60 years -1.62 (-3.83, 0.59) -1.47 (-3.72, 0.77) -0.97 (-3.05, 1.11) 6.33 (3.58, 9.07) 6.67 (3.89, 9.45) 4.26 (1.75, 6.75) 
Higher Degree       
No (reference)       
Yes -0.36 (-1.44, 0.72) -0.89 (-2.04, 0.25) -1.24 (-2.30, -0.18) 0.16 (-1.21, 1.52) 0.16 (-1.26, 1.58) -0.11 (-1.37, 1.15) 
Home to work 
distance 
      
0-9.99 km 
(reference) 
      
10-19.99 km 0.34 (-1.05, 1.74) 0.62(-0.78, 2.31) 0.62 (-0.68, 1.92) 1.25 (-0.51, 3.02) 0.54 (-1.20, 2.29) 0.67 (-0.87, 2.23) 
≥20 km -0.58 (-1.73, 0.58) -0.59 (-1.79, 0.61) -0.70 (-1.81, 0.41) 0.58 (-0.88, 2.03) 0.55 (-0.93, 2.04) 0.90 (-0.42, 2.22) 
Disability       
No (reference)       
Yes -5.38 (-7.81, -2.95) -5.22 (-7.69, -2.77) 2.59 (-0.13, 5.31) -4.42 (-7.52, -1.33) -3.93 (-6.99, -0.89) -3.31 (-6.03, -0.61) 
Physical Activity       
Inactive (reference)       
Moderately inactive 1.88 (-1.29, 5.06) 1.15 (-2.06, 4.36) -0.12 (-3.11, 2.86) 6.46 (2.47, 10.5) 6.61 (2.63, 10.6) 3.91 (0.35, 7.47) 
Moderately active 2.90 (-0.26,6.05) 1.94 (-1.28,5.18) 0.37 (-2.63, 3.39) 6.76 (2.80, 10.7) 6.99 (2.99, 11.0) 3.90 (0.32, 7.50) 
Active 2.89 (-0.23, 6.02) 1.87 (-1.33, 5.07) 0.61 (-2.35, 3.59) 7.25 (3.32, 11.2) 7.42 (3.45, 11.4) 3.79 (0.23, 7.36) 
Weight status       
Low or healthy 
(reference) 
      
Overweight -0.71 (-1.84, 0.43) -0.25 (-1.42, 0.93) -0.28 (-1.37, 0.86) -0.55 (-1.99, 0.90) -1.18 (-2.63, 0.28) -0.94 (-2.24, 0.36) 
Obese -1.92 (-3.62, -0.22) -1.65 (-3.42, -0.13) -0.68 (-2.34, 0.97) 0.03 (-2.11, 2.19) -0.02 (-2.20, 2.27) 0.10 (-1.85, 2.04) 
Study Year       
2009-10 (reference)       
2010-11 0.05 (-2.09, 2.19) -1.11 (-3.34, 1.12) -1.02 (-3.09, 1.05) 1.09 (-1.75, 3.94) 1.16 (-1.59, 3.93) 0.42 (2.04, 2.88) 
2011-2 -0.74 (-2.10, 0.60) -0.94 (-2.41, 0.52) -1.04 (-2.40, 0.33) -0.58 (-2.38, 1.21) -0.79 (-2.11, 1.02) -0.68 (-2.30, 0.94) 
Baseline health 0.42 (0.36, 0.50)  0.47 (0.38, 0.55) 0.52 (0.45, 0.59)  0.48 (0.41, 0.55) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; physical activity is categorised 
using the Cambridge Physical Activity Index; weight status is categorised using body mass index; study year refers to the time period when 
data were collected; baseline well-being refers to the appropriate well-being measure for each outcome (e.g. for the outcome of physical 
well-being it refers to baseline physical well-being); bold indicates significant results (p<0.05). 
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Table 2.10 Associations between maintenance of walking to work and sickness absence 
(n=659) 
  Unadjusted Model A Model B 
  Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Walking None (reference)    
 Some -0.02 (-0.35, 0.31) 0.20 (-0.13, 0.53) 0.12 (-0.19, 0.43) 
Sex Male (reference)    
 Female 0.45 (0.16, 0.75) 0.23 (-0.06, 0.53)  0.27 (-0.01, 0.54) 
Age 16-29 years (reference)    
 30-39 years -1.05 (-1.49, 0.62) -0.84 (-1.28, -0.40) -0.79 (-1.20, -0.37) 
 40-49 years -1.09 (-1.53, 0.65) -0.97 (-1.42, -0.53) -0.87 (-1.29, -0.44) 
 50-59 years -0.89 (-1.33, -0.44) -0.81 (-1.27, -0.35) -0.73 (1.18, -0.29) 
 ≥60 years -1.10 (-1.68, -0.51) -0.98 (-1.57, -0.38) -0.66 (-1.23, -0.09) 
Higher Degree No (reference)    
 Yes -0.10 (-0.40, 0.19) -0.04 (-0.34, 0.27) 0.08 (-0.21, 0.36) 
Home to work 
distance 
0-9.99 km (reference)    
 10-19.99 km -0.15 (-0.53, 0.24) 0.12 (-0.25, 0.51) 0.07 (-0.30, 0.44) 
 ≥20 km 0.03 (-0.29, 0.34) 0.11 (-0.21, 0.43) 0.07 (-0.24, 0.37) 
Disability No (reference)    
 Yes 1.06 (0.41, 1.72) 1.01 (0.39, 1.63) 0.45 (-0.16, 1.06) 
Physical Activity Inactive (reference)    
 Moderately inactive -1.82 (-2.64, -1.01) -0.82 (-1.69, 0.04) 0.35 (-0.53, 1.22) 
 Moderately active -1.77 (-2.58, -0.96) -1.02 (-1.87, -0.16) 0.23 (-0.65, 1.10) 
 Active -1.73 (-2.53, -0.93) -0.82 (-1.68, 0.02) 0.27 (-0.60, 1.13) 
Weight status Normal (reference)    
 Overweight -0.02 (-0.33, 0.29) 0.11 (-0.20, 0.42) 0.12 (-0.18, 0.42) 
 Obese 0.99 (0.54, 1.43) 0.34 (-0.14, 0.82) 0.22 (-0.24, 0.69) 
Study Year 1 (reference)    
 2 0.09 (-0.52, 0.69) 0.19 (-0.40, 0.77) 0.13 (-0.43, 0.70) 
 3 0.93 (0.56, 1.30) 0.63 (0.24, 1.03) 0.77 (0.40, 1.14) 
Baseline sickness 
absence 
 0.09 (0.07, 1.22)  0.07 (0.05, 0.10) 
Negative binomial coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; physical activity is categorised 
using the Cambridge Physical Activity Index; weight status is categorised using body mass index; study year refers to the time period when 
data were collected; bold indicates significant results (p<0.05). 
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Table 2.11 Associations of changes in weekly walk commuting time with change in PCS-8, 
MCS-8 and sickness absence (n=801) 
  Unadjusted Model A Model B 
  Co-efficient (95% CI) Co-efficient (95% CI) Co-efficient (95% CI) 
Physical Well-being 
(PCS-8) 
No change 
(reference) 
   
 Increase (n=139) -0.36 (-1.61, 0.88) -0.07 (-1.26, 1.13) -0.21 (-1.29, 0.88) 
 Decrease (n=126) 0.02 ((-1.29, 1.31) -0.07 (-1.31, 1.15) -0.22 (-1.34, 0.90) 
     
Mental Well-being 
(MCS-8) 
No change 
(reference) 
   
 Increase (n=139) 0.94 (-0.52, 2.39) 0.93 (-0.56, 2.42) 0.38 (-0.93, 1.69) 
 Decrease (n=126) -0.25 (-1.78, 1.26) -0.14 (-1.68, 1.39) -0.44 (-1.78, 0.91) 
     
Sickness Absence 
(days) 
No change 
(reference) 
   
 Increase (n=139) -0.87 (-1.98, 0.25) -0.65 (-1.79, 0.48) -0.33 (-1.31, 0.66) 
 Decrease (n=126) -0.50 (-1.66, 0.66) -0.41 (-1.58, 0.76)  0.20 (-0.81, 1.22) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; Model A is adjusted for sex, 
age, degree, home to work distance, physical limitation, physical activity, weight status and study year; Model B is adjusted for sex, age, 
degree, home to work distance, physical limitation, physical activity, weight status, study year and appropriate baseline health index 
(baseline PCS-8 for PCS-8 model, baseline MCS-8 for MCS-8 model or baseline sickness absence for sickness absence model). 
 
Table 2.12 Associations of large changes in weekly walk commuting time (≥ 50 minutes 
per week) with change in PCS-8, MCS-8 and sickness absence (n=801) 
  Unadjusted Model A Model B 
  Co-efficient (95% CI) Co-efficient (95% CI) Co-efficient (95% CI) 
Physical 
Well-being 
(PCS-8) 
No change or change less than 50 
minutes 
(reference)  
   
 Large Increase (n=114) -0.23 (-1.76, 1.30) -0.02 (-1.48, 1.45) -0.06 (-1.39, 1.27) 
 Large Decrease (n=158) -0.35 (-1.84, 1.15) -0.33 (-1.76, 1.10) -0.53 (-1.82, 0.77) 
     
Mental 
Well-being 
(MCS-8) 
No change or change less than 50 
minutes 
(reference) 
   
 Increase (n=82) 1.63 (-0.16, 3.43) 1.74 (-0.07, 3.57) 1.15 (-0.45, 2.74) 
 Decrease (n=87) -0.24 (-1.99, 1.51) 0.07 (-1.69, 1.85) -0.34 (-1.90, 1.22) 
     
Sickness 
Absence 
(days) 
No change or change less than 50 
minutes 
(reference) 
   
 Increase (n=82) -0.75 (-2.12, 0.63) -0.60 (-1.99, 0.80) -0.53 (-1.73, 0.68) 
 Decrease (n=87) -0.97 (-2.31, 0.37) -0.96 (-2.33, 0.40)  0.22 (-1.40, 0.96) 
Linear regression coefficients shown; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the Short Form 8 
Questionnaire; MCS-8 = Mental Component Summary score derived from the Short Form 8 Questionnaire; Model A is adjusted for sex, 
age, degree, home to work distance, physical limitation, physical activity, weight status and study year; Model B is adjusted for sex, age, 
degree, home to work distance, physical limitation, physical activity, weight status, study year and appropriate baseline health index 
(baseline PCS-8 for PCS-8 model, baseline MCS-8 for MCS-8 model or baseline sickness absence for sickness absence model); Large 
increase defined as increase of more than 50 minutes per week and a large decrease defined as a decrease of more than 50 minutes per 
week; Total sample size: n=801. 
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2.4 Discussion  
 
2.4.1 Summary of findings 
Cycling to work was associated with sickness absence. Maintenance of cycling to work was 
associated with reduced sickness absence during the year of follow-up after adjustment for 
covariates and baseline sickness absence. In the studied cohort, the effect size was equivalent to 
about one day less of sickness absence per year. Changes in cycling to work were not significantly 
associated with changes in sickness absence, although increases in cycling tended to be associated 
with reductions in sickness absence (around one day per year). 
 
There was also some evidence that cycling to work was associated with well-being. Maintenance of 
cycling to work was associated with a reduced MCS-8 score at follow-up, although the effect size was 
attenuated and no longer significant after conditioning on baseline MCS-8. Whilst there were no 
significant associations between cycling to work and PCS-8 after adjustment for co-variates, the 
pattern of results was consistent with an association and many of the observed associations were 
close to significance. Taken together, then the results are consistent with cycling to work being 
important for both mental and physical well-being.  
 
I did not find any significant associations between walking to work and either well-being or sickness 
absence. Whilst some indices were in the expected direction (i.e. indicating that walking to work was 
associated with better health), some indices were also in the opposite direction or close to null, 
notably the association between maintenance of walking and MCS-8 was negative, whereas the 
association between increase in walking and change in MCS-8 was positive and the association 
between a decrease in walking and change in MCS-8 was close to zero. 
 
2.4.2 Strengths and limitations 
 
2.4.2.1 Longitudinal analyses 
The primary strength of this study lies in the use of complementary longitudinal analyses to test the 
little-studied associations of active commuting with sickness absence and well-being. Considering 
the maintenance analyses, the outcomes were measured after the exposure (active commuting), 
which is important for building a case for causal association.35 However the findings, particularly 
when not adjusting for the baseline outcome, might be explained by reverse causation, for example 
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well-being prior to baseline being causally associated with both active travel at baseline and well-
being at follow-up. Such a scenario is shown in Figure 2.4, where both active commuting at baseline 
(t1) and well-being at follow-up (t2) share a common cause or ‘ancestor’, well-being before baseline 
(t0). Under these circumstances a crude association between the two variables would be 
expected.203 The change analyses provided an alternative test of causation, although should be 
interpreted with caution as it is possible for the change in well-being or sickness absence (or an 
associated underlying change in health status) to have caused the change in active commuting. 
 
Figure 2.4 Diagram outlining possible relationship between active commuting and well-
being 
 
t=timepoint, with numbers indicated successive points in time, such that t0 is prior to baseline, t1 is baseline and t2 is follow-up; single 
headed arrows represent direct links from causes to effects 
The principle of the maintenance analysis was to reduce misclassification error from individuals that 
would tend to bias estimates towards the null.189 Consistent with this I observed that restricting the 
analyses in this way tended to result in stronger associations (data not shown). However, it is also 
possible that this restriction may have introduced bias that led to an overestimate of the association. 
For example, if a participant’s cycling to work resulted in an accident and he or she no longer cycled 
to work, he or she would have been excluded from the analysis. It is likely that such an event would 
be associated with consequent sick leave and/or decline in well-being, which would not be captured 
in my estimates. Furthermore, there is a risk that other medical events that are independent of 
commuting behaviour (e.g. development of multiple sclerosis) could prevent cycling to work but not 
prevent car commuting, which would bias the estimates of the control group in a negative direction, 
although the likelihood of such major events in a young and relatively healthy population is small. 
The estimates for maintenance should not be interpreted as estimate of the association for cycling 
(or walking) to work, but may be better interpreted as an estimate for cycling to work if that 
behaviour is maintained.  
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2.4.2.2 Study power 
This study may appear comparatively small and thereby lack power compared to some cohort 
studies. However, it is larger than some other studies focusing on active travel and health158,204  and 
has also accurately characterised the exposure by asking about active travel on any part of the 
journey over a seven-day period. The exposure might be considered as being more accurately 
measured. All other things being equal reducing measurement error should improve study power.147 
 
2.4.2.3 Self-reported measures 
The study relies on self-reported measures of exposure and outcome, this is entirely appropriate for 
well-being (which depends on self-report) and appears unlikely to have resulted in important biases 
for the other measures (sickness absence and active commuting). It has previously shown good 
agreement between self-reported and objective estimates of time spent in active commuting using 
this dataset, although a bias to overestimating may exist205–207 and the measure of self-reported 
sickness absence has been shown to have good agreement with employer records of sickness 
absence in another UK cohort.162 Nonetheless, because I used data from a study designed to 
investigate the relationships between commuting and health, it is possible that responses might 
have been influenced by social desirability bias. Whilst such a bias could account for differences in 
well-being between those who did and did not use active modes of travel, it is unclear why this 
might have occurred only for cycling and not for walking.  
 
2.4.2.4 Socio-demographic characteristics of sample 
The study population was relatively educated compared to the English population (70% had a degree 
compared to 37% for England).182 Others have also described the study sample as being relatively 
affluent and white-collar.136,157 The prevalence of cycling to work was high relative to the English 
average, although the measurement methods are different (47% reported some cycling to work at 
baseline in the sample, compared to 3% who report cycling as their usual mode of travel to work in 
the Census).208  
 
Some of these differences will be explained by the population from which the study sample was 
drawn. As I set out in the methods (under study setting, 2.2.1.1) the socio-demographics of the City 
of Cambridge, although not the surrounding county, are not typical of the English population. A 
focus on commuters and thus working age adults, necessarily focuses on a younger population, 
which will also be different from the English average (e.g. older adults are less likely to have a 
degree). It is unclear to what extent the sample is not representative of the population from which it 
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is drawn, as the characteristics of this population, the working population who live within or outside 
Cambridge, are poorly characterised. 
 
The socio-demographic characteristics of the sample and the nature of Cambridge (it is by UK 
standards relatively cycle friendly) may suggest the findings are not generalizable to other 
populations, such as the UK population. Whilst the Cambridge setting may affect the likelihood of 
cycling to work compared to other settings, it doesn’t seem likely that it (or socio-cultural 
differences) will influence the physiological effects of cycling to work, where these benefits are 
attributed to energy expenditure, cardio-metabolic stress or musculoskeletal work. However, it 
seems plausible that the Cambridge setting may influence perceptions, social acceptability and ease 
of cycling, which could affect enjoyment associated with cycling to work. This may influence the 
association between cycling to work and mental well-being, and so these findings may be less 
generalizable. The findings for sickness absence and physical well-being may be relatively 
generalizable, although it is likely that mental health or well-being will contribute to both these 
indices. 
 
2.4.3 Comparison with other studies 
 
2.4.3.1 Mental Well-being 
My finding is in keeping with some previous research, but differs from other findings.157–160 First in a 
study that shared some similarities to the one described here (a longitudinal study of adult 
commuters in the UK), Martin et al reported positive associations between active travel and 
psychological well-being as assessed using the General Health Questionnaire (GHQ-12).159 
Specifically they reported that active commuting (either walking or cycling) or public transport was 
associated with increased psychological well-being (0.19 unitsxiv) relative to car commuting. 
Comparable analyses in my work, association between maintenance of cycling to work and MCS-8 at 
follow-up, were also significant. They also reported that switching to active commuting from car 
commuting or public transport was associated with an increase in psychological well-being (0.53 
units) relative to maintaining car commuting. Comparable analyses in my work (the change 
analyses), was not significant. Martin et al’s study had a larger sample (n=17,895) so is likely to have 
had more power. 
                                                          
xiv The GHQ scale is not directly comparable with the SF-8 scale. By way of context being in a relationship was associated 
with increased psychological well-being (0.43 units) as was living in a neighbourhood that participants reported liking (0.43 
units). 
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In a randomised controlled trial of an intervention to increase walking to work (and in which walking 
increased in the intervention group), Mutrie et al. found improvements in three of eight sub-scales 
of well-being assessed using the SF-36 amongst the intervention group compared to the control 
group. As this study did not compute MCS and PCS scores, direct comparisons with my findings are 
not possible, but I note that mental health was one of the three domains in which they observed 
significant improvements, paralleling the increase in MCS-8 that I observed for cycling.158 As this 
study was a randomised controlled trial it is possible that the observed differences in well-being 
might relate to the intervention rather than the change in physical activityxv. Elements of the 
intervention (e.g. advice on route choice, maintaining safety) might conceivably influence mental 
well-being. The intervention was not placebo controlled raising the possibility that the psychological 
benefits might relate to a placebo effect. 
 
However, my findings also contrast with those of Martin et al. and Mutrie et al.158,159 In both these 
studies the primary form of active commuting was walking. In addition, Martin et al reported an 
association between each additional 10 minutes of walk commuting and psychological well-being,159 
whereas I found mixed and non-significant associations for walk commuting.  
 
In contrast to the other two UK studies, a study of women living in low and middle income 
neighbourhoods in the urban area of Cali, Colombia observed negative associations of walking for 
transport with MCS-8.160 This might give more credence to a possible negative association between 
maintenance of walk commuting and MCS-8. However, there are also different contextual factors. 
For example, walking for transport may be more associated with activities perceived as burdensome, 
or concerns about personal safety, in Cali compared to Cambridge. Some commuters in Cambridge, 
in part because of their financial resources, can exert choice over their mode of travel to work, and if 
travel mode is chosen rather than constrained, then active travel may be experienced as being more 
pleasant.136 
 
I also note my findings may appear to contrast with baseline (cross-sectional) associations observed 
in the same dataset. An earlier study, using the Commuting and Health in Cambridge study, did not 
report a significant association between active commuting (either walking or cycling) and MCS-8.157 
However the exposure was categorised differently considering weekly minutes of active commuting 
(grouped into four categories), and so may have had reduced power to detect an association. The 
reported associations in that analysis (0.29, 0.27 and 0.71 for 30-149 min/week, 150-224 min/week 
                                                          
xv No analysis was undertaken between change (or increase in) walking and well-being 
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and ≥225 min/week respectively compared ≤30 min/week) are in keeping with the positive 
association observed between cycling to work and MCS-8 that I observed. 
 
The positive associations between active commuting and well-being are also consistent with a much 
broader evidence base showing positive associations between physical activity (typically leisure-time 
physical activity) and mental well-being among healthy adults.166 My own analysis is also showed a 
strong association between physical activity index and MCS-8 (see ‘physical activity index’ in Table 
2.9).  
 
2.4.3.2 Physical well-being 
The associations between active commuting and physical well-being have been described less 
frequently. The Colombian study reported a negative association between walking for transport and 
physical well-being.160 Contextual differences between Cali and Cambridge may account for the 
differences, for example the nature of walking for transport may be more hazardous in Cali than in 
Cambridge. It is also possible that walking for transport is an indicator of low socio-economic status 
and that this may contribute to the observed associations.  
 
The baseline analysis of the Commuting and Health in Cambridge dataset, reported positive 
associations between active commuting and PCS-8. Whilst I did not observe a significant association 
for PCS-8 after adjustment for co-variates the association was marginally non-significant and of 
magnitude consistent with previous observations (0.48, 0.79 and 1.21 for 30-149 min/week, 150-224 
min/week and ≥225 min/week respectively compared ≤30 min/week).  
 
2.4.3.3 Sickness absence 
Concerning sickness absence, my findings are very similar to those of Hendriksen et al., who found 
that cycling to work was associated with just over one fewer day of employer-recorded sickness 
absence per year in a sample of Dutch workers.156 Their analysis was in a population with a higher 
level of sickness absence (mean of 8 days) than the one I studied (3.6 days). It was also cross-
sectional and consequently was not adjusted for baseline sickness absence, although it was adjusted 
for self-reported health and measures of chronic disease. My findings are also consistent with a 
broader literature suggesting positive associations between physical activity (predominantly 
recreational physical activity) or physical fitness and sickness absence.161,163 
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2.4.4 Interpretation  
Taken together my findings provide some evidence that cycling to work may contribute to improved 
well-being and reduced sickness absence. 
 
2.4.4.1 Observed effect size 
The effect sizes observed for PCS-8 and MCS-8 fall below the thresholds that some have posited for 
clinical significance, typically three units,157 although those who developed the score only gave 
examples of the differences in scores observed between a healthy population and population with 
disease (a variety of disease states were offered for comparison) and refrained from using the term 
“clinical significance”.184 Whilst the observed differences may appear small relative to the changes 
associated with onset of disease, small shifts in the population average can be important for 
population health and well-being (see section 1.1.1. on population approaches). Moreover, generally 
it is hard for shifts in the population average to match individual treatment effects, particularly when 
those treatments are targeted at individuals at high risk (e.g. reduction of population salt intake by 
1-2g in the UK may have lowered mean blood pressure by 2-3mmHg, whereas a single anti-
hypertensive might lower blood pressure by around 9mmHg).209,210 
 
For well-being, more appropriate comparisons may be made by comparing between population 
groups. For example, a one-unit difference in PCS-8 score is similar to the differences observed in 
the study cohort between the young (16-29 years) and old (>50 years), or between those with 
obesity and those of low or healthy bodyweight. The effect size for MCS-8 is similar to that which I 
observed between men and women in the study cohort.  
 
The observed effect size for sickness absence was equivalent to one day per annum. In the context 
of relatively low levels of sickness absence this is likely to be important, and consequently could 
represent a modest proportion of total days of sickness absence across an organisation. The financial 
burden of sickness absence is an important cost to employers (£15 billion per annum in the UK), 
including the NHS.134,135,172 
 
My findings also provide an indicative estimates of effect sizes that might be observed in future 
studies of the health benefits of interventions to promote active travel. This may form the basis for 
power calculations. 
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2.4.4.2 Conditional analysis 
For both the ‘maintenance’ and the ‘change’ analyses I estimated two sets of models, one adjusting 
for covariates, and a second additionally conditioning on the baseline value of the outcome in 
question. The pattern of results for MCS-8 (significant after adjustment for covariates, not significant 
after additionally conditioning on baseline MCS-8) suggests that the differences observed between 
those who cycled to work and those who did not are, at least partly, explained by differences in 
MCS-8 between the two groups at baseline. In contrast, the equivalent models for sickness absence 
produced effect size estimates that were both statistically significant and similar in magnitude to 
each other. This suggests that even after allowing for differences in sickness absence between those 
who cycled to work at baseline and those who did not, those who maintained cycling to work were 
still likely to report less sickness absence at follow-up.188  
 
2.4.4.3 Null findings for walking 
In light of the positive findings for cycling to work, the null findings for walking to work may appear 
unexpected. It seems unlikely that they can be explained simply by many non-walkers cycling to 
work, as additional adjustment for cycling to work did not reveal any significant associations. Among 
those who reported walking to work in this analysis, the average weekly duration of time walking 
(median 20 minutes per day) was relatively low compared to other studies and to estimates of 
walking undertaken by the average office worker at work (3700 steps per day, equivalent to about 2 
miles of walking).211  
 
This partly reflects how I chose to categorise the walking exposure. Any walking on the commute 
included both short walking journeys as part of a longer journey (e.g. by public transport) as well as 
trips made entirely by foot. Whilst the same problem might occur for cycling, the duration of cycling 
time tended to be higher212 and it may be less common to use cycling to bridge parts of a longer 
commute. 
 
I also note that walking is undertaken at a lower intensity than cycling 212,213 and that intensity of 
physical activity may be important for some health outcomes, such as sickness absence.214 This may 
be true for sickness absence, for which only vigorous but not moderate physical activity has been 
associated with reduced absence.161.  
 
It is possible then that the average ‘dose’ of walking to work (duration, intensity or both) in the 
exposed group in the study was too low for an association with well-being or sickness absence to be 
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observed. Other differences between cycling and walking in Cambridge for example in relation to 
motivations or perceptions of the activity may contribute to the differences.215,216 There may also be 
unmeasured socio-economic differences between those who walk to work and those who cycle to 
work and the measures of socio-economic status used (presence or absence of a degree) may not 
have captured such differences. 
 
2.4.5 Unanswered questions and future research 
Considerable uncertainty remains concerning the dose, frequency and intensity of active commuting 
(or active travel) necessary to reduce sickness absence and improve well-being. There are also 
unresolved questions about the relative value of walking to work compared to cycling to work, as 
well as the value of other commuting practices (e.g. using public transport or multi-modal 
commuting) relative to car-use alone. 
 
Future research should seek to reduce this uncertainty and test more thoroughly whether changes in 
travel behaviour are associated with changes in well-being or sickness absence. It should also seek to 
replicate my findings in different populations, particularly in more deprived communities in which 
commuting choices may be more constrained and active travel perceived differently. Exploring the 
differential benefits of active travel among those who are obese or sedentary would also be of value 
as they may have more to gain.196 Some large cohort studies (e.g. Fenland, UK Biobank) have not 
enquired about sickness absence, whilst others that do (e.g. Whitehall II) have not recorded active 
travel. Given it can be ascertained by a single simple question and its importance, it should be 
considered for inclusion in future studies or rounds of data collection in existing studies. 
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2.5 Chapter summary 
 
This chapter has described the longitudinal associations of active commuting with mental well-being 
(MCS-8), physical well-being (PCS-8) and sickness absence in the Commuting and Health in 
Cambridge dataset. Two complementary approaches to testing longitudinal associations 
(maintenance analyses and change analyses) were used, adjusting first for co-variates and the 
additionally conditioning on the baseline outcome of interest. 
 
Maintenance of cycling to work, compared to maintenance of not cycling to work, was associated 
with increased MCS-8 scores and reduced sickness absence. Whilst the observed associations for 
PCS-8 were not significant, the pattern of findings was suggestive that cycling to work was likely to 
be associated with PCS-8. No significant findings were observed for walking to work.  
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3 Longitudinal associations of active commuting with body mass 
index 
 
“I wanted to lose weight and get fitter…so I went to the gym 
for three months at the beginning of the year but… I'm not 
someone who will exercise for the sake of exercising, I don't 
enjoy it and don't tend to stick to it. The commute to work, it 
means that I'm doing exercise consistently for a reason and I'll 
stick to it.” 
 
“I’ve put on a stone in the past two years since I started 
working here and I don’t think it’s due to a change in my diet… 
Before I came here I would walk [to work which was] 25 
minutes in the morning and… [again] in the evening. I don’t 
have that anymore and I think I miss that. So over the past two 
years my weight has crept up and up.” 
Participants in the Commuting and Health in Cambridge Study, reflecting on active 
commuting and body weight. 
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3.1 Introduction 
 
This chapter describes the longitudinal associations between active commuting and body mass index 
in the Commuting and Health in Cambridge dataset. An abbreviated version of this chapter has been 
published in Preventive Medicine.155 
 
3.1.1 Chapter outline 
This chapter briefly discusses the importance of active travel and obesity from a public health 
perspective. It then describes limitations with existing studies reporting associations between active 
travel and adiposity. In this chapter, I make use of the same dataset and analytic approach 
(maintenance and change analyses), that was described in the previous chapters. Consequently, the 
methods section is relatively brief and primarily describes parts of the methods that are different. I 
present results. The discussion includes the following: a summary of the findings; strengths and 
limitations; comparisons with other studies; interpretation and implications; unanswered questions 
and future research. The chapter finishes with a summary.  
 
3.1.2 Active travel and obesity 
Overweight and obesity are major public health concerns. Obesity is a risk factor for cardio-metabolic 
diseases, some cancers, as well as some other conditions (e.g. osteoarthritis, infertility and liver 
disease).217–223 In England, 26% of adults are classified as obese.224 In the UK, it is estimated that 
obesity costs the National Health Service £5.1 billion per year, and society as a whole £27 billion per 
year.225  
 
Obesity also appears to be a driver for policy changes in the UK, as reflected in the recent desire to 
tackle childhood obesity.226,227 In contrast lack of physical activity or poor dietary consumption may 
contribute to a similar or greater burden of disease,106,196 but neither issue alone seems as able to 
capture public and political concern. 
 
The promotion of walking and cycling for transport has been proposed as one means to reduce the 
prevalence of obesity.108,228 Ecological evidence, either from comparisons between countries or 
cities117,229 or temporal trends of obesity and active travel,101 suggest that shifts in travel patterns 
might have potential to reduce the prevalence of obesity by relatively large amounts. For example, a 
higher proportion of trips undertaken by foot or bicycle, 20% compared to 10%, is associated with a 
lower prevalence of obesity, 20% to 25%.229 
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Ecological studies are a weak form of evidence for making causal inference or estimating effect sizes. 
Other evidence of an association between active travel and obesity comes from cross-sectional 
studies (with measurement at the individual level) and prospective observational studies. These 
studies are summarised in Table 3.1.  
 
A number of criticisms of the studies can be made. Many studies are cross-sectional,130,230–240 rather 
than longitudinal. Many studies have identified active travel based on usual mode of travel, which 
forces individuals to identify only one mode of travel. This may not capture the true complexity of 
travel behaviour that can involve multiple modes (e.g. walk to bus-stop, bus journey, walk from bus-
stop to workplace) or alternating modes on different days (e.g. cycling to work twice a week, driving 
to work on the other days). Use of such a question may also result in some multi-modal commuters 
who regularly cycle or walk being (inappropriately) classified as not undertaking active travel.  
 
The outcome of all studies is body mass index (BMI),130,131,230–240 and for many studies this is based on 
self-reported131,231,233,236,237,240 rather than objectively measured height and weight. BMI can be a poor 
indicator of total body fat, because it is also affected by muscle mass.241,242  More biologically 
relevant measures, in terms of their association with metabolic disease, are indicators of visceral 
adiposity (e.g. waist circumference, or waist-to-hip ratio),149–151,243  but the association between 
active travel and these other measures of adiposity has seldom been studied.  
 
Non-travel physical activity and diet may be important confounders, but very few studies have 
adjusted for both behaviours.130,234–236,238 Moreover those studies that have adjusted for both, may 
not have adequately adjusted for these behaviours. Studies that have adjusted for diet have either 
used measures that may be less appropriate (e.g. energy intake)xvi,130 or used measures that only 
characterise part of the diet (e.g. fruit and vegetable intake).232,234–236,238 Whilst several studies have 
adjusted for leisure-time physical activity130,155,230,234–236,238,239 only three have explicitly adjusted for 
occupational physical activity.155,234,239 No study has adjusted for objectively measured physical 
activity. 
 
Finally, few studies have demonstrated a dose-response relationship between active travel and body 
mass index. Demonstration of a dose-response relationship is one suggested ‘test’ of causation.35  
 
                                                          
xvi Dietary energy intake tends to be poorly measured and much of the intra-participant variation may be accounted for by 
differences in physical activity.366 
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Table 3.1 Summary of observational studies describing the associations between active 
travel and adiposity 
Author, 
Year 
Settings and 
dataset (size) 
Analytic 
Approach 
Exposure Outcome Co-variates Significant Findings 
Larouche, 
2016230 
Canada using 
the Canadian 
Health 
Measures 
Survey 
(n=7,160) 
Cross-sectional Time spent in 
utilitarian (travel to 
work and doing 
errands) walking 
and cycling 
BMI 
(objective) 
Waist 
circumference 
Age, sex, SES, 
Leisure time 
PA 
Cycling more than one 
hour per week 
associated with 
reduced BMI (1.9 
kg/m2) 
Berglund, 
2016231 
Sweden using 
a postal 
questionnaire 
(random 
sample) 
(n=1,786) 
Cross-sectional Usual mode of 
travel to work and 
for other activities: 
inactive and active 
(walking and 
cycling) 
BMI (self-
report) 
Age, sex, SES, 
smoking, food 
choice based 
on health 
Inactive travel 
associated with higher 
odds of being obese 
(OR=1.42). 
Flint, 
2016130 
UK using UK 
Biobank 
(n=156,666) 
Cross-sectional Frequency and 
mode of travel 
used to assign 
participants to: car-
only, car and public 
transport, mixed 
public/active 
travel, walking and 
cycling 
BMI 
(objective) 
Body fat 
Age, SES, 
health status, 
occupational 
and leisure-
time physical 
activity, diet 
(energy intake) 
Relative to car-only, for 
women mixed 
public/active travel (0.7 
kg/m2), cycling (1.7 
kg/m2), for men mixed 
public/active travel (1.0 
kg/m2), cycling (1.8 
kg/m2) 
Laverty, 
2015232 
Six middle 
income 
countries 
(China, India, 
Mexico, 
Ghana, Russia 
and South 
Africa) using 
WHO Study on 
Global Aging 
and Adult 
Health 
(n=40,477) 
Cross-sectional Time and 
frequency spent 
travelling by foot 
or bicycle 
(extracted from 
general physical 
activity 
questionnaire) 
BMI 
Waist-to-hip 
ratio 
(all likely 
measured 
objective but 
not stated in 
the 
manuscript) 
 
 
Age, sex, SES, 
smoking, 
alcohol use, 
diet quality 
(fruit and 
vegetable 
consumption), 
urban-rural 
status.  
High-use of active travel 
associated lower risk of 
overweight (RR=0.71), 
high waist-to-hip ration 
(RR=0.71) and lower 
BMI (-0.54 kg/m2) 
Martin, 
2015131 
UK using 
British 
Household 
Panel Survey 
(n=4056) 
Longitudinal 
(one and two 
years) 
Usual mode of 
travel to work: 
private motor 
transport, public 
transport, active 
travel. Active travel 
predominantly 
walking (switched 
too, 83/109; 
switched from, 
121/156)  
BMI (self-
reported) 
Age, sex, SES, 
car ownership, 
major life 
event   
Switching from private 
motor transport to AT 
associated with 
decrease in BMI (0.45 
kg/m2), and switching 
from AT to private 
motor or public 
transport was 
associated with an 
increase in BMI (0.34 
kg/m2) 
Wojan, 
2015233 
USA using 
American Time 
Use Survey 
(n=13,206) 
Cross-sectional 
(using an 
“endogenous 
treatment 
model”) 
Active commuting, 
passive 
commuting. Multi-
modal commuting 
that included an 
active component 
as classified as 
active commuting. 
BMI (self-
reported) 
Murder rate, 
adverse 
weather and 
bicycle friendly 
community 
Active commuting 
associated with 
reduced BMI 
McKay, 
2015234 
India (Goa and 
Chennai) and 
Bangladesh 
(Matlab) using 
the Chronic 
Disease Risk 
Factor Study 
(n=2,122) 
Cross-sectional Duration of active 
travel (walking and 
cycling) extracted 
from general 
physical activity 
questionnaire 
BMI 
(objective) 
Age, sex, SES, 
smoking, diet 
(oil/butter 
consumption), 
additional PA, 
study site 
≥150 minutes of active 
travel per week 
associated with lower 
BMI (0.39 kg/m2) 
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Table 3.1 cont’d 
Flint, 
2014235 
UK using UK 
Household 
Longitudinal 
study 
(n=7534) 
Cross-sectional Primary mode of 
travel to work: 
Private transport, 
public transport, 
active travel. Active 
travel 
predominantly 
walking (11% 
modal share, vs 3% 
for cycling). 
BMI 
(objective) 
Body fat (%) 
Age, SES, PA in 
workplace, 
sporting 
activity, diet 
quality 
(vegetables 
consumption), 
urban-rural 
status 
-0.97 and -1.10 for men 
for active and public 
relative to private 
modes; -0.87 and -0.72 
for women  
Rissel, 
2014236 
New South 
Wales, 
Australia using 
the New South 
Wales Health 
Survey 
(n=66,101) 
Cross-sectional Usual mode of 
travel to work: 
walking, cycling, 
other 
BMI (self-
reported) 
Age, SES, diet 
(fruit, fast 
food, 
vegetables, 
meat), other 
PA, urban-rural 
status 
Decreased BMI for both 
men who commute 
actively (cycling: 2.15 
kg/m2, walking 2.47 
kg/m2) and women 
(cycling 1.22 kg/m2, 
walking 2.95 kg/m2) 
relative to other modes 
of travel 
Laverty, 
2013237 
UK using 
Understanding 
Society 
(n=19,380) 
Cross-sectional Usual mode of 
travel to work: 
private transport, 
public transport, 
cycling, walking. 
BMI (self-
reported) 
Age, sex, SES, 
ethnicity, 
region. 
Walking and cycling to 
work associated with 
reduced odds of being 
obese (OR= 0.80 for 
walking; 0.63 for 
cycling). For walking 
only those who 
reported walking ≥2 
miles to work (and not 
those walking <2 miles) 
had a significantly lower 
BMI relative to users of 
private transport. 
Millett, 
2013238 
India using 
Indian 
Migration 
Study 
(n=3,902) 
Cross-sectional Usual mode of 
travel to work: 
private transport, 
public transport, 
walking or cycling 
BMI 
(objective) 
Age, sex, caste, 
SES, region, 
leisure time 
PA, diet (fat 
intake), 
smoking status 
and alcohol) 
Reduced risk of obesity 
among those walking to 
work (RR=0.72) or 
cycling to work 
(RR=0.66) relative to 
private transport. 
Gordon-
Larsen, 
2009239 
USA using the 
CARDIA study 
(n=2,364) 
Cross-sectional Active commuting, 
defined as any 
walking or cycling 
on the journey to 
work 
BMI 
(objective) 
Age, SES, race, 
region, 
smoking, 
alcohol 
consumption, 
physical 
activity (leisure 
and 
occupational) 
Active commuting 
associated with 
reduced odds of being 
obese for men 
(OR=0.51), but not for 
women (OR=0.91) 
Lindstrom, 
2008240 
Skane, Sweden 
using the 2004 
public health 
survey in 
Skane 
Cross-sectional Means of 
transportation: car, 
walking/bicycling, 
public transport or 
other (use of more 
than one mode) 
BMI (self-
reported) 
Age, country of 
origin, SES, 
time to travel 
to work.  
Walking/bicycling 
associated with 
reduced odds of obesity 
(RR=0.79). 
PA=physical activity; AT=active travel; SES=socio-economic status; BMI=body mass index; study size refers to the analytic sample; studies 
identified by using the search terms: active travel, active commuting, adiposity, obesity, BMI. 
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3.2 Methods  
 
3.2.1 Study setting and data collection 
The analysis used the Commuting and Health in Cambridge dataset. This was described in the 
previous chapter. 
 
3.2.2 Inclusion and exclusion criteria 
I used the same inclusion and exclusion criteria that were described in the previous chapter. Applying 
these criteria gave an analytic sample of 809xvii. 
 
3.2.3 Exposure measures 
I used the same exposure measures that were described in the previous chapter: i.e. maintenance of 
cycling (and the equivalent for walking); change in weekly time cycling (and the equivalent for 
walking).  
 
In addition I created a second (categorical) measure of maintenance of cycling (0 minutes, 1-149 
minutes, >150 minutes). Participants who reported 0 minutes of cycling to work at both baseline and 
follow-up were categorised as maintaining 0 minutes of cycling. Similarly participants who reported 
1-149 minutes of cycling to work at both baseline and follow-up were categorised as maintaining 1-
149 minutes of cycling, and those who reported >150 minutes at both baseline and follow-up as 
maintain >150 minutes of cycling to work. The same approach was followed for walking. Participants 
who moved between categories between baseline and follow-up were not categorised and thus 
excluded from analyses using this variable. 
 
Thus again I undertook two complementary approaches to longitudinal analysis (maintenance 
analyses and change analyses) 
 
3.2.4 Outcome measures: body mass index  
I estimated body mass index (BMI) by dividing self-reported weight by the square of self-reported 
height.194 Change in BMI was estimating by subtracting baseline from follow-up values. Extreme 
values for BMI and change in BMI were identified. Height and weight measures were checked against 
                                                          
xvii This is different from the 801 for the sickness absence and well-being analyses, due to the different outcomes and co-
variates. 
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measurements at other time points, and then either modified if I was confident of the true value 
(n=8) or deleted if the true value was unclear (n=2). 
 
3.2.5 Covariates 
I hypothesised that the following factors may confound the relationship between active commuting 
and BMI: age; sex; education; physical well-being; distance from home to work; and other physical 
activity. Study year was also included as a co-variate. The included co-variates are different from 
those in the well-being and sickness absence analyses. 
 
The rationale for the inclusion of the co-variates for the BMI analyses is set out below. The 
description of how these covariates were measured is set out in the previous chapter. 
 
3.2.5.1 Rationale for inclusion of co-variates 
The assumed relationship between active commuting and BMI is shown in Figure 3.1. 
 
Figure 3.1 Directed acyclic graph showing the hypothesised relationship between active 
commuting and body mass index 
 
 
Age and sex: BMI varies with age and sex.244. Both are also determinants of active travel.136,137,191,215  
 
Socio-economic status: Obesity is patterned by socio-economic status (SES).244 In previous analyses of 
the Commuting and Health in Cambridge dataset, SES was shown to be associated with active 
travel.136,137,191 There were two measures of SES in the Commuting and Health in Cambridge study 
(area-level deprivation and education status). I chose education status because it is an individual 
measure (rather than an area-level measure) and in the data, it was strongly associated with BMI for 
both men and women. The further addition of an area-level measure of deprivation (quintile of index 
of multiple deprivation) did not materially alter the findings. 
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Physical well-being: I hypothesised that poor physical health could restrict ability to walk or cycle to 
work. Univariable analysis in the dataset supported this hypothesis. I also hypothesised that poor 
physical health would restrict ability to be active in other areas of life (beyond that captured by 
recreational physical activity). Reduced physical activity in other areas of life could also affect 
BMI.41,62 
 
Other physical activity: Physical activity is associated with BMI.41,62 It is commonly suggested that 
individuals who travel actively may also undertake more recreational physical activity,130 and thus it 
is important to adjust for it and other forms of physical activity. 
 
Home-work distance: Home-work distance was associated with active commuting in the study 
sample 136,191,198 and may be associated with other factors such as SES (the price of housing in 
Cambridge is high, resulting in some people living out of Cambridge and commuting into the city). 
Commute duration is associated with reduced well-being.168,199 A long commute duration may also 
reduce time available for other health-promoting activities (e.g. sleep, healthy eating, leisure-time 
physical activity) and so might conceivably be associated with obesity. Home-work distance was also 
strongly associated with BMI in the study dataset.  
 
3.2.5.2 Application of co-variates in change analyses 
I applied the same set of covariates to the two approaches to longitudinal analysis (maintenance 
analyses and change analyses). For the second approach (change analyses), I considered adjusting for 
time varying covariates (i.e. other variables that may have changed and might confound the 
relationship), but such variables were either unavailable (e.g. change in diet or change in sleep), 
liable to be on the causal pathway (e.g. change in recreational physical activity, which might arise, at 
least in part, as a result of change in commuting physical activity leading to a change in well-being 
and change in other non-commuting physical activity), or of uncertain association with BMI (e.g. 
change in home location, which might be associated with a set of other changes in e.g. sleep, time 
pressure or stress that might influence BMI in either direction).  
 
Adjustment for variables on the causal pathway (i.e. mediators) would be inappropriate.201 
Adjustment for variables whose association with BMI is uncertain or mixed (i.e. could be a positive or 
negative confounder) is unlikely to aid comprehension. A change in home (or work) location may be 
one such variable. Whether it acts as a positive or negative confounder may depend on other 
contextual factors. If it is acting in both ways, then including participants who have changed home or 
work location may inappropriately bias the results and/or increase the width of the confidence 
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interval. Consequently, I chose to undertake a sensitivity analysis in which the change analyses were 
restricted to those who had not moved home or work.  
 
3.2.6 Analysis 
As before, I used two complementary approaches to test longitudinal associations. 
 
I included both maintenance of cycling to work and maintenance of walking to work as explanatory 
variables in a single model so that the estimates were mutually adjusted, because the two 
behaviours contribute separately to physical activity energy expenditure. For the same reason I also 
include change in weekly cycling time and change in weekly walking time in a single ‘change’ model. 
 
To explore the dose-response relationship I repeated the maintenance analysis using a three-way 
categorical measure for both cycling and walking (0 minutes, 1-149 minutes, >150 minutes). To 
maintain sample size the maintenance of cycling (using the 3-way categorical variable) was adjusted 
for the dichotomous measure of maintenance of walking to work. The same approach was followed 
for maintenance of walking to work, using the 3-way categorical variable. 
 
I also tested for effect modification by sex and home-work distance, following the findings of 
previous research131,235 and by weight status (BMI ≤25 kg/m2 vs BMI>25 kg/m2), as I hypothesised  
that the association between physical activity and BMI may vary by weight status.245,246  
 
A summary of all analyses for cycling and the research questions that each analysis addresses is given 
in Table 3.2. An analogous set of questions exists for walking. 
 
3.2.6.1 Software 
Analyses were undertaken using Stata Statistical Software: Release 13 (College Station, TX: StataCorp 
LP) using the “regress” command for linear regression. 
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Table 3.2 Summary of analyses and research questions considering cycle commuting 
Exposure Categorisation Outcome Adjustment Research question 
Maintenance 
of cycling  
 
None vs some BMI at one-
year follow-
up 
Model A What is the difference in body mass index at one-year follow-up 
between those who maintain commuting by bicycle during the 
year of follow-up and those who maintain not doing so, after 
adjustment for covariates? 
Maintenance 
of cycling  
 
None vs some BMI at one-
year follow-
up 
Model B 
(conditional) 
What is the difference in change in body mass index at one-year 
follow-up between those who maintain commuting by bicycle 
during the year of follow-up and those who maintain not doing 
so, after adjustment for covariates assuming the same baseline 
body mass index? 
Maintenance 
of cycling  
 
0 minutes per week; 
1-149 minutes per 
week; >150 minutes 
per week 
BMI at one-
year follow-
up 
Model A What is the difference in body mass index at one-year follow-up 
between those who maintain commuting: a) by bicycle for at 
least 150 minutes per week; b) by bicycle for 1-149 minutes per 
week; and c) not commuting by bicycle, after adjustment for 
covariates? 
 
This serves as a test for a dose-response relationship. 
Maintenance 
of cycling  
 
0 minutes per week; 
1-149 minutes per 
week; >150 minutes 
per week 
BMI at one-
year follow-
up 
Model B What is the difference in body mass index at one-year follow-up 
between those who maintain commuting: a) by bicycle for at 
least 150 minutes per week; b) by bicycle for 1-149 minutes per 
week; and c) not commuting by bicycle, after adjustment for 
covariates assuming the same baseline body mass index? 
 
This serves as a test for a dose-response relationship. 
Change in time 
per week 
No change, 
increase, decrease 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model A What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates? 
Change in time 
per week 
No change, 
increase, decrease 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model B 
(conditional) 
What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates assuming 
the same baseline BMI? 
Change in 
cycling time 
per week 
No or small change, 
large increase (> 50 
minutes per week), 
large decrease (>50 
minutes per week) 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model A What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased by 50 minutes 
or more per week; b) decreased by 50 minutes or more per 
week; and c) did not change or changed by less than 50 minutes 
per week, after adjusting for co-variates? 
Change in 
cycling time 
per week 
No or small change, 
large increase (> 50 
minutes per week), 
large decrease (>50 
minutes per week) 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model B 
(conditional) 
What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased by 50 minutes 
or more per week; b) decreased by 50 minutes or more per 
week; and c) did not change or changed by less than 50 minutes 
per week, after adjusting for co-variates assuming the same 
baseline BMI? 
Change in time 
per week 
(excluding 
movers) 
No change, 
increase, decrease 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model A What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates among 
those whose active commuting time changed for reasons other 
than changing work or home location? 
This may be a better test of the effect of a change in active 
commuting on BMI as it only considers those whose activity 
pattern changed whilst continuing to commute between the 
same home and work locations.  
Change in time 
per week 
(excluding 
movers) 
No change, 
increase, decrease 
Change in 
BMI (follow-
up BMI minus 
baseline BMI) 
Model B 
(conditional) 
What is the difference in change in body mass index between 
those whose cycle commuting time: a) increased; b) decreased; 
and c) did not change, after adjusting for co-variates and 
assuming the same baseline BMI, among those whose active 
commuting time changed for reasons other than changing work 
or home location? 
This may be a better test of the effect of a change in active 
commuting on BMI as it only considers those whose activity 
pattern changed whilst continuing to commute between the 
same home and work locations. 
Model A co-variates: age, sex, education, physical well-being, other physical activity, walking (maintenance or change in weekly time 
walking to work) and home-work distance; Model B co-variates: age, sex, education, physical well-being, other physical activity, walking 
(maintenance or change in weekly time walking to work) home-work distance and baseline BMI; an analogous set of questions apply to 
walking. 
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3.3 Results  
 
3.3.1 Descriptive characteristics 
The included participants were predominantly women (69.6%) and educated to at least degree level 
(69.8%), and slightly more than half reported cycling to work (53.9%). Many of those who walked to 
work (48.5%) also reported some car commuting (compared to 27.3% amongst those who cycled to 
work) (Table 3.3). The prevalence of obesity and overweight (men: 37.8%; women: 33.2%) was lower 
than the national average for England (67.1% and 57.2% respectively).247 There were no major 
differences between participants included in and excluded from the analysis (Table 3.4). 
 
3.3.2 BMI and maintenance of cycling to work 
Those who maintained cycling to work had a significantly lower BMI at follow-up, after adjustment 
for covariates (Table 3.5, Model A; change in BMI -1.14 kg/m2, 95% CI -2.00 to -0.32), than those who 
did not cycle to work. Adjustment for maintenance of walking strengthened the observed 
association, and adjustment for home-work distance attenuated it (Model A, without adjustment for 
maintenance of walking: -0.86 kg/m2, 95% CI -1.64 to -0.08; Model A, without adjustment for home-
work distance:  -1.45 kg/m2, 95% CI -2.14 to -0.75). Adjusting the analysis for baseline BMI markedly 
attenuated the association such that it was no longer significant (Table 3.5, Model B). The effect size 
of maintaining 1-149 minutes of cycling to work per week was similar to that of maintaining 150 
minutes or more of cycling per week (-1.28 kg/m2, 95% CI -2.32 to -0.23 vs. -1.26 kg/m2, 95% CI -2.26 
to -0.27; n=493).  
 
Under Model A significant interactions were observed between maintenance of cycling to work and 
home-work distance (p=0.001) and weight status at baseline (p=0.02), but not sex (p=0.23). 
Stratifying by home-work distance, a stronger association with BMI was observed amongst those 
living further from work (0-9.99 km:  0.04 kg/m2, 95% CI -0.83 to 0.93, n=395; 10-19.99km: -1.27 
kg/m2, 95% CI -3.03 to 0.49, n=105; ≥20km: -2.77 kg/m2, 95% CI -4.35 to -1.19, n=199). Stratifying by 
weight status, a stronger association was observed among those who were overweight or obese at 
baseline (-1.02 kg/m2, 95% CI -2.08 to 0.02, n=375; vs. 0.05 kg/m2, 95% CI -0.41 to 0.52, n=204, for 
those with a BMI ≤25 kg/m2).  
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Table 3.3 Baseline characteristics of participants included in the analyses (n=809) 
 Cycling to work Walking to work 
 None (n=373) Some (n=436) None (n=597) Some (n=204) 
 N (%) N (%) N (%) N (%) 
Sex      
Female 289 (51.3) 274 (48.7) 197 (80.1) 49 (19.9) 
Male 84 (34.2) 162 (65.9) 408 (72.5) 155 (27.5) 
Age      
Median (years) 44.1 (34.8-52.9) 42.9 (33.1-51.5) 43.3 (34.0-52.0) 43.4 (42.7-52.8) 
16-29 years 42 (39.6) 64 (60.4) 73 (68.9) 33 (31.1) 
30-39 years 106 (47.5) 117 (52.5) 170 (76.2) 53 (23.8) 
40-49 years 95 (44.6) 118 (55.4) 165 (77.5) 48 (22.5) 
50-59 years 94 (46.5) 108 (53.5) 151 (74.8) 51 (25.2) 
≥60 years 36 (55.4) 29 (44.6) 46 (70.8) 19 (29.2) 
Highest educational 
qualification 
    
Less than degree 142 (58.2) 102 (41.8) 183 (75.0) 61 (25.0) 
Degree or higher 231 (40.9) 334 (59.1) 422 (74.7) 143 (25.3) 
Weight status     
Underweight/normal weight  217 (41.0) 312 (59.0) 400 (75.6) 129 (24.4) 
Overweight 105 (50.2) 104 (49.8) 152 (72.7) 57 (27.3) 
Obese 51 (71.8) 20 (28.2) 53 (74.7) 18 (25.4) 
Body Mass Index (kg/m2)     
Median (IQR) 24.4 (21.5-27.3) 23.3 (21.4-25.4) 23.7 (21.5-26.3) 23.6 (21.3-26.4) 
PCS-8 score     
Median (IQR) 55.2 (51.1-58.0) 55.7 (52.5-58.0) 55.4 (51.7-58.0) 55.4 (51.4-58.1) 
Home-work distance     
0.01-9.99 km 120 (25.3) 355 (74.7) 361 (76.8) 109 (23.2) 
10-19.99 km 71 (61.2) 45 (38.8) 89 (76.7) 27 (23.3) 
≥20 km 182 (83.5) 36 (16.5) 147 (68.4.0) 68 (31.6) 
Physical activity index     
Inactive 9 (37.5) 15 (62.5) 19 (79.2) 5 (20.8) 
Moderately inactive 115 (50.9) 109 (49.1) 168 (74.3) 58 (25.7) 
Moderately active 113 (46.5) 132 (53.5) 178 (73.3) 65 (26.7) 
Active 136 (43.0) 180 (57.0) 240 (76.9.0) 76 (24.1) 
Weekly time cycling to work      
Median (IQR) (min) 0 (0-0) 150 (90-200) 90 (0-180) 0 (0-30) 
Weekly time walking to work     
Median (IQR) (min) 0 (0-90) 0 (0-0) 0 (0-0) 100 (60-180) 
Use of other modes for 
commuting 
    
Car 245 (65.7) 119 (27.3) 265 (43.8) 99 (48.5) 
Public transport 115 (30.8) 43 (9.9) 64 (10.6) 94 (46.1) 
Changed behaviour     
Started walking/cycling to work 43 (11.5) 0 (0) 76 (12.6) 0 (0) 
Stopped walking/cycling to work 0 (0) 67 (15.4) 0 (0) 68 (33.3) 
Time frame     
2009-10 313 (47.5) 346 (52.5) 486 (73.8) 173 (26.3) 
2010-11 15 (39.5) 23 (60.5) 23 (60.5) 15 (39.5) 
2011-12 45 (40.2) 67 (59.8) 96 (85.7) 16 (14.3) 
IQR=Interquartile range; PCS-8 = Physical Component Summary score derived from the Short Form 8 Questionnaire, theoretical score range 
is 9.1 to 69.0, with a mean of 50 in the US adult population; unless otherwise stated characteristics are measured at baseline; changed 
behaviour describes the number of individuals who started or stopped active travel between baseline and follow-up (e.g. cycle to work at 
baseline and not cycling to work at follow-up); use of other modes, includes any use of the stated mode to commute to or from work, 
including for part of the journey, in the past seven days; car use includes the use of taxis. 
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Table 3.4 Characteristics of participants included and excluded from the analyses 
 Included (n=809) Excluded 
 N (%) N (%) 
Sex    
Female 563 (69.6) 409 (69.1) 
Male 246 (30.4) 183 (30.9) 
Age    
Median (IQR) 43.3 (33.7-52.2) 38.4 (31.0-48.1) [n=599] 
16-29 years 106 (13.1) 133 (22.2) 
30-39 years 223 (27.6) 193 (32.3) 
40-49 years 213 (26.3) 150 (25.0) 
50-59 years 202 (25.0) 87 (14.5) 
≥60 years 65 (8.0) 36 (6.0) 
Highest educational 
qualification 
  
Less than degree 244 (30.2) 183 (31.2) 
Bachelor or higher 565 (69.8) 403 (68.8) 
Weight status   
Normal or underweight 529 (65.4) 346 (60.0) 
Overweight 209 (25.8) 164 (28.4) 
Obese 71 (8.8) 67 (11.6) 
BMI (kg/m2)   
Median (IQR) 23.7 (21.5-26.3) 24.1 (21.8-27.1) 
PCS-8 score   
Median (IQR) 55.5 (51.5-58.0) 55.1 (51.5-57.7) [n=594] 
Home to work distance   
Median (IQR) 8.0 (4.8-22.5) 8.0 (3.2-20.9) [n=600] 
0-9.99 km 475 (58.7) 344 (57.3) 
10-19.99 km 116 (14.3) 105 (17.5) 
≥20 km 218 (27.0) 151 (25.2) 
Physical activity index   
Inactive 24 (3.0) 20 (3.3) 
Moderately inactive 226 (27.9) 159 (26.6) 
Moderately active 243 (30.0) 202 (33.8) 
Active 316 (39.1) 217 (36.3) 
Weekly time cycling to work 
(minutes) 
  
Median (IQR) 50 (0-150) 0 (0-150) [n=602] 
Weekly time walking to work 
(minutes) 
  
Median (IQR) 0 (0-10) 0 (0-50) [n=597] 
IQR=Interquartile range; PCS-8 = Physical Component Summary score derived from the Short Form 8 Questionnaire; MCS-8 = Mental 
Component Summary score derived from the Short Form 8 Questionnaire; deprivation quintile is based on national quintiles of deprivation 
ranked using the Index of Multiple Deprivation 2010 score for the Lower Super Output Area (assigned based on postcode or residence).  
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Table 3.5 Associations of maintenance of cycling to work and maintenance of walking to 
work with BMI (n=579) 
  Unadjusted Model A Model B 
  Coefficient (95% CI) Coefficient (95% CI) Coefficient (95% CI) 
Cycling to work None 
(reference) 
   
 Some -1.25 (-1.83, -0.67) -1.14 (-1.98, -0.30) -0.12 (-0.42, 0.17) 
Walking to work None 
(reference) 
   
 Some -0.19 (-0.99, 0.62) -0.80 (-1.63, 0.04) -0.18 (-0.48, 0.11) 
Sex Male 
(reference) 
   
 Female -0.71 (-1.41, -0.00) -0.80 (-1.49, -0.11)  -0.02 (-0.26, 0.22) 
Age 16-29 years 
(reference) 
   
 30-39 years 1.62 (0.49, 2.77) 1.28 (0.17, 2.39) -0.17 (-0.56, 0.22) 
 40-49 years 2.23 (1.09, 3.37) 1.77 (0.66, 2.88) 0.06 (-0.32, 0.45) 
 50-59 years 2.65 (1.51, 3.80) 2.29 (1.17, 3.40) -0.16 (-0.56, 0.22) 
 ≥60 years 2.94 (1.48, 4.41) 2.09 (0.64, 3.53) 0.07 (-0.44, 0.57) 
Degree No (reference)    
 Yes -1.03 (-1.75, -0.31) -0.78 (-1.51, -.04) 0.01 (-0.24, 0.27) 
Home-work 
distance 
0.01-9.99 km 
(reference) 
   
 10-19.99 km 0.73 (-0.19, 1.65) 0.06 (-0.90, 1.03) -0.14 (-0.48, 0.19) 
 ≥20 km 1.41 (0.65, 2.16) 0.64 (-0.26, 1.53) -0.08 (-0.40, 0.23) 
Physical well-
being (PCS-8) 
 -0.08 (-0.13, -0.02) -0.05 (-0.10, 0.00) -0.02 (-0.04, -0.00) 
Physical activity Inactive 
(reference) 
   
 Moderately 
inactive 
-3.67 (-5.82, -1.52) -3.44 (-5.54, -1.34) 0.19 (-0.55, 0.93) 
 Moderately 
active 
-4.72 (-6.86, -2.57) -4.33 (-6.44, -2.22) 0.22 (-0.53, 0.96) 
 Active -4.30 (-6.42, -2.17) -4.07 (-6.16, -1.99) 0.34 (-0.39, 1.08) 
Study year 2009-10 
(reference) 
   
 2010-11 -0.67 (-2.23, 0.88) -0.11 (-1.60, 1.37) -0.09 (-0.60, 0.43) 
 2011-2 -0.27 (-1.24, 0.69) -0.43 (-1.38, 0.52) -0.06 (-0.39, 0.27) 
Baseline BMI   0.94 (0.91, 0.96) - 0.94 (0.91, 0.97) 
Linear regression coefficients shown; - not included; CI=confidence interval; PCS-8 = Physical Component Summary score derived from the 
Short Form 8 questionnaire; physical activity is categorised using a modified form of the Cambridge Physical Activity Index; study year 
refers to the time period when data were collected; bold indicates significant results (p<0.05); Model A is adjusted for sex, age, education, 
home-to-work distance, physical well-being, physical activity and study year; Model B is adjusted for adjusted for sex, age, education, 
home-to-work distance, physical well-being, physical activity, study year and BMI at baseline.  
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3.3.3 BMI and maintenance of walking to work  
There was no significant association between maintenance of walking to work and BMI (Table 3.5), 
despite the observation that adjustment for maintenance of cycling to work strengthened the 
association (Model A, without adjustment for maintenance of cycling to work: -0.36 kg/m2, 95% CI -
1.13 to 0.43). All specified interactions were non-significant. There was some evidence of a possible 
dose-response relationship between walking to work and BMI (1-149 minutes: -0.51 kg/m2, 95% CI -
1.68 to 0.65; >150 minutes: -0.95 kg/m2, 95% CI -2.36 to 0.47; n=542), although the differences were 
not significant.   
 
3.3.4 Change in BMI and changes in weekly time spent cycling or walking to 
work 
There were no significant associations between either change in weekly cycle commute time or 
change in weekly walking commute time and change in BMI, in my primary analysis (Table 3.6). 
Interaction terms for sex, home-work distance and BMI were not significant. The associations 
between large increases/decreases and change in BMI were non-significant for both walking and 
cycling (Table 3.7). When restricting the change analysis to those who did not move home or work 
(n=651), a significant association between an increase in weekly time walking to work and decrease 
in BMI was observed (Table 3.8).  
 
Table 3.6 Associations of changes in weekly cycle commuting time and weekly walking 
commuting time with change in BMI (n=809) 
  Unadjusted Model A Model B 
  Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Cycling to 
work 
No change (reference)    
 Increase in weekly time 
(n=182) 
0.14 (-0.09, 0.37) 0.09 (-0.15, 0.34) 0.06 (-0.18, 0.31) 
 Decrease in weekly time 
(n=224) 
0.16 (-0.06, 0.38) 0.15 (-0.08, 0.39) 0.14 (-0.10, 0.37) 
Walking to 
work 
No change (reference)    
 Increase in weekly time 
(n=139) 
-0.20 (-0.45, 0.05) -0.20 (-0.45, 0.04) -0.23 (-0.48, 0.02) 
 Decrease in weekly time 
(n=126) 
0.25 (-0.01, 0.51) 0.24 (-0.02, 0.50) 0.25 (-0.01, 0.50) 
Linear regression coefficients shown; CI=confidence interval; Model A is adjusted for age, education, sex, study year, home-work distance, 
Physical Component Summary score derived from the Short Form 8 questionnaire, physical activity categorised using a modified form of 
the Cambridge Physical Activity Index; Model B is adjusted for age, education, sex, study year, home-work distance, Physical Component 
Summary score derived from the Short Form 8 questionnaire, physical activity categorised using a modified form of the Cambridge Physical 
Activity Index and baseline BMI. 
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Table 3.7 Associations of large changes (≥ 50 minutes per week) in weekly cycling and 
walking commuting time with change in BMI (n=809) 
  Unadjusted Model A Model B 
  Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Cycling to work No change 
(reference) 
   
 Increase in weekly 
time (n=106) 
0.16 (-0.12, 0.44) 0.12 (-0.16, 0.41) 0.12 (-0.17, 0.40) 
 Decrease in weekly 
time (n=149) 
0.21 (-0.03, 0.45) 0.20 (-0.05, 0.45) 0.20 (-0.05, 0.45) 
Walking to 
work 
No change 
(reference) 
   
 Increase in weekly 
time (n=76) 
-0.23 (-0.55, 0.08) -0.23 (-0.55, 0.09) -0.24 (-0.56, 0.07) 
 Decrease in weekly 
time (n=80) 
0.29 (-0.02, 0.59) 0.25 (-0.06, 0.57) 0.27 (-0.04, 0.58) 
Linear regression coefficients shown; CI=confidence interval; Model A is adjusted for age, education, sex, study year, home-work distance, 
Physical Component Summary score derived from the Short Form 8 questionnaire, physical activity categorised using a modified form of 
the Cambridge Physical Activity Index; Model B is adjusted for age, education, sex, study year, home-work distance, Physical Component 
Summary score derived from the Short Form 8 questionnaire, physical activity categorised using a modified form of the Cambridge Physical 
Activity Index and baseline BMI. 
 
Table 3.8 Associations of changes in weekly cycle commuting time and weekly walking 
commuting time with change in BMI, restricted to those who did not move home or work 
(n=651) 
  Unadjusted Model A Model B 
  Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Co-efficient  
(95% CI) 
Cycling to 
work 
No change (reference)    
 Increase in weekly time 
(n=141) 
0.21 (-0.06, 0.48) 0.19 (-0.09, 0.48) 0.15 (-0.13, 0.43) 
 Decrease in weekly time 
(n=169) 
0.21 (-0.04, 0.46) 0.25 (-0.02, 0.53) 0.23 (-0.05, 0.50) 
Walking to 
work 
No change (reference)    
 Increase in weekly time 
(n=105) 
-0.29 (-0.58, -0.00) -0.29 (-0.59, -0.00) -0.32 (-0.62,-0.03) 
 Decrease in weekly time 
(n=101) 
0.30 (0.01, 0.59) 0.29 (-0.01, 0.59) 0.29 (-0.01, 0.59) 
Linear regression coefficients shown; CI=confidence interval; bold indicates significant results (p<0.05); Model A is adjusted for age, 
education, sex, study year, home-work distance, Physical Component Summary score derived from the Short Form 8 questionnaire, 
physical activity categorised using a modified form of the Cambridge Physical Activity Index; Model B is adjusted for age, education, sex, 
study year, home-work distance, Physical Component Summary score derived from the Short Form 8 questionnaire, physical activity 
categorised using a modified form of the Cambridge Physical Activity Index and baseline BMI. 
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3.4 Discussion  
 
3.4.1 Summary of findings 
Maintenance of cycling to work was associated with a lower BMI at one-year follow-up, after 
adjustment for covariates. This association was stronger for those who had a longer commuting 
distance or who were overweight or obese at baseline, but there was no evidence of a ‘dose-
response’ between weekly time cycling to work and BMI. However, the conditional analysis 
(adjusting for baseline BMI) was not significant. Change in weekly time cycling to work was not 
associated with change in BMI. 
 
Increasing weekly time walking to work was associated with a reduction in BMI, but only when 
restricted to those who had not moved home or work. Whilst other associations for walking were 
non-significant, the pattern of results for walking was consistent with the findings of past research 
that has observed associations between walking to work and BMI. 
 
3.4.2 Strengths and limitations 
Many of the same strengths and limitations that were described in the previous chapter apply to this 
analysis (longitudinal analyses, study power, measurement of commuting behaviour) and are not 
described here. The strengths and limitations of this analysis that relate to body mass index are 
described below. 
 
3.4.2.1 Self-reported weight 
Body mass index was estimated based on self-reported weight and height. Weight is prone to 
systematic biases in reporting, in that heavier individuals tend to under-report their body 
weight.248,249 As heavier participants were less likely to report active commuting in the study, this 
reporting bias may have attenuated the observed associations. Conversely, because the study was 
designed to investigate the relationships between commuting and health, it is possible that some 
responses may have been affected by a social desirability bias whereby those who travelled by active 
or ‘healthy’ means were more likely to under-report their body weight. Such a bias would have 
strengthened the observed relationship. 
 
 
3.4.2.2 Unmeasured confounders 
Although the analyses were adjusted for the complementary commuting activity (walking or cycling) 
and other forms of physical activity, I have not adjusted for other aspects of behaviour, which were 
not measured but are associated with BMI, such as diet or sleep. Nor have I adjusted for car driving. 
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This was not well captured (neither time nor distance were recorded),250,251 although it is unclear to 
what extent the associations between car driving and BMI may be attributed to an absence of active 
travel or other factors, such as snacking whilst driving. 
 
3.4.3 Comparison with other studies 
The findings broadly corroborate and build on the existing literature, providing further evidence of 
inverse associations between active travel and BMI.130,131,230–240 
 
Taken together the findings for walking appear weaker than those for cycling, but are consistent with 
the literature. Most studies have reported stronger associations for cycling relative to 
walking,130,230,237,238 although one study found comparable (or larger) effect size estimates for walk 
commuting relative to cycle commuting.236 These studies also demonstrated significant associations 
for walking, whereas the associations I observed were not significant. Some of these studies defined 
walkers as those who used walking as the ‘main mode’ of travel,130,236–238 in contrast I defined walkers 
as those who undertook any walking on their commute and consequently included many people who 
used other travel modes. The relatively low average quantity of walking to work (median 90 
min/week), relatively high car use among walkers or limited number of walkers (low power), may all 
have contributed to the non-significant findings.  
 
My estimates of effect size are consistent with estimates from other studies. For example, my 
findings for change in walking are comparable to a previous effect size estimate of 0.3 kg/m2 for 
commuters changing from the car to active travel.131 My findings for maintenance of cycling appear 
slightly conservative relative to cross-sectional estimates from developed countries, e.g. 2.2 kg/m2 
and 1.2 kg/m2 (comparing men and women respectively in New South Wales who usually cycle to 
work, relative to men and women who usually use non-active means),236 1.8 kg/m2 and 1.7 kg/m2 (for 
men and women in the UK Biobank Study,130 relative to car-users), and 1.9 kg/m2 (for more than one 
hour of utilitarian cycling in the Canadian Health Survey, relative to those reporting less than one 
hour).230 This may reflect the relatively low prevalence of obesity in the sample compared to the UK 
average and in other study settings (e.g. mean BMI of 27.2 kg/m2 in the Canadian Health Survey).230 
Smaller effect size estimates from cross-sectional studies have been reported in other settings with a 
lower prevalence of obesity, although these are not specific to cycling (e.g. 0.4 kg/m2 comparing 
those who undertake 150 minutes or more of active travel a week with those who do not in India and 
Bangladesh, with an obesity prevalence of 3%).234  
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3.4.4 Interpretation 
 
3.4.4.1 Maintenance analyses 
I had hypothesised that the maintenance analyses might provide a test of a temporal relationship. 
However, although the exposure was ascertained prior to the outcome, the pattern of results (with a 
marked attenuation resulting in a near-null association after conditioning on baseline BMI) could be 
explained by baseline BMI (or BMI prior to baseline) determining the likelihood of cycling (i.e. acting 
as a confounder). Such an explanation would undermine an argument about the biological 
plausibility of a causal effect of active commuting on BMI.  
 
However, the findings are also consistent with the explanation that cycling to work prior to baseline 
contributed to differences in baseline BMI. From my analyses I cannot distinguish between these 
alternative explanations and consequently one should be cautious about drawing unequivocal causal 
inference from the findings.  
 
Bi-directional relationship, i.e. cycling to work determines BMI and BMI determines cycling to work, 
should also be considered. 
 
3.4.4.2 Change analyses 
Only one set of change analyses was significant, that for non-movers whose walking increased. 
Whilst the sample size for the change analyses was larger than for the maintenance analyses, they 
may have had less power to detect an association. First, the exposure of participants may have been 
misclassified if other factors (e.g. annual leave, weather or variable work commitments) produced an 
apparent change in travel behaviour between the two time points, biasing the association towards 
the null. My experience from the maintenance analyses suggested that removing misclassified 
participants produced stronger associations. Second, there is a lag between changes in physical 
activity and the full change in BMI.245 Given that the change in active commuting could have 
happened at any time between baseline and follow-up, the study design is unlikely to have permitted 
observation of the full effect of changes in active commuting on BMI. Third, other changes may have 
co-occurred with the change in active travel that might influence BMI in either direction and could 
not readily be accounted for. I note that excluding movers from the analysis (who might be subject to 
other life changes that could influence BMI) tended to strengthen the observed associations. One 
should therefore be cautious of over-interpreting the null results from the change analyses. 
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Whilst non-significant I note that the increases in cycling were associated with a small increase in 
BMI. In contrast the direction of the association for decrease in cycling and for walking (both increase 
and decrease) is in the expected direction. As exercise can be associated with increases in lean or 
muscle mass without decreases in body fat,252 it is possible that the small increase could be explained 
by gain in muscle mass, particularly as cycling engages large muscle groups in the legs. 
 
3.4.4.3 Interactions 
There was a significant interaction between maintenance of cycling and home-work distance, with a 
stronger association between maintenance of cycle commuting and BMI among those who lived 
20km or more from work, mirroring previous findings.131 This could be explained by those who lived 
further from work being at greater risk of obesity (those who lived 20km or more from work had a 
mean BMI of 25.2 kg/m2, compared to 23.7 kg/m2 for those who lived within 10km) perhaps because 
of reduced time for activities that prevent weight gain (e.g. healthy eating or sleep).253,254 Equally it 
may reflect residual confounding by age, SES (e.g. high living costs in Cambridge),136 or other 
covariates.250 In keeping with this finding, I also observed a stronger absolute effect size estimate 
among those who were overweight at baseline. Taken together these findings suggest a particular 
role for active commuting among populations who are more liable to be obese. 
 
3.4.5 Summary 
Whilst this study has demonstrated associations between active commuting and BMI, it has a 
number of short comings. These include: small size and limited power (with consequent inability to 
look at sub-groups); no adjustment for dietary confounding; use of self-reported BMI; use of an 
imprecise measure of adiposity and no testing of a dose-response relationship. These are areas that I 
plan to address in the next chapter using the Fenland Study, a larger dataset with detailed 
characterisation of physical activity, diet and adiposity.  
 
As the next chapter also describes the associations between active commuting and obesity, some 
elements of the discussion (implications and future directions) are not considered here. These issues 
are considered in the next chapter, reflecting the findings across both this and the next chapter. 
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3.5 Chapter summary 
 
This chapter has described the longitudinal associations between active commuting and body mass 
index in the Commuting and Health in Cambridge dataset. As before, I have used two complementary 
approaches, maintenance and change analyses, to test the associations. 
 
Those who maintained cycling to work reported a lower BMI at follow-up compared to those who 
maintained not cycling to work after adjustment for sociodemographic variables, other physical 
activity, physical well-being and maintenance of walking. The observed difference was markedly 
attenuated and no longer significant after adjusting for baseline BMI. After excluding those who 
reported a change in work or home address, an increase in walking time was associated with a 
reduction in BMI after adjustment for co-variates and baseline BMI. Whilst there were no other 
significant associations, the pattern of findings for both cycling and walking was generally in keeping 
with an inverse association between active travel and body mass index. There was a suggestion that 
the associations may be stronger in populations who are more liable to be obese.  
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4 Associations of active commuting with objectively measured 
adiposity 
 
“Physical activity does not promote weight loss” 
Aseem Malhotra and colleagues writing in the British Journal of Sports Medicine about the 
relative contributions of poor diet and lack of physical activity to obesity255 
 
“Physical activity is a minor distraction” 
Simon Capewell, professor of clinical epidemiology, commenting on the contribution of lack 
of physical activity to the epidemic of obesity on Inside Health on Radio 4 (13 September, 
2015) 
 
“Average recorded energy intake in Britain has declined 
substantially as obesity rates have escalated. The implication is 
that levels of physical activity, and hence energy needs, have 
declined even faster. Evidence suggests that modern inactive 
lifestyles are at least as important as diet in the aetiology of 
obesity and possibly represent the dominant factor.” 
Andrew Prentice and Susan Jebb discussing the contribution of lack of physical activity to the 
epidemic of obesity in the British Medical Journal101 
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4.1 Introduction 
 
This chapter describes the associations between active commuting and adiposity in the Fenland 
Study at baseline. This chapter builds on and complements the previous chapter. It addresses a 
different set of deficiencies identified in the existing literature to those addressed in Chapter Three.  
 
4.1.1 Chapter outline 
This chapter introduces two measures of adiposity (volume of visceral adipose tissue and percentage 
body fat) and explains why I chose to study these two measures. I describe aspects of the Fenland 
Study relevant to this analysis. A different approach to the categorisation of active commuting is 
used to that used in Chapter Two and Three. This approach (stratifying by distance and identifying 
‘patterns’ of commuting behaviour) has not been used by other authors. I explain why I chose it and 
how the categorisation has been operationalised. Results are presented separately for men and 
women and stratified by distance for the two outcomes (body fat and visceral adipose tissue).  
 
The discussion focuses on the results presented in this chapter, but interprets these in light of the 
findings presented in the previous chapter. It first summarises the key findings and presents the 
strengths and limitations specific to this analysis. I then compare the study results with past studies 
and the results presented in the previous chapter. I describe my interpretation of certain aspects of 
the results presented in this chapter, before giving an overall interpretation of the findings across the 
two studies relating to adiposity. I give some suggestions for future research, principally focused on 
using the Fenland dataset. Overarching comments in terms of implications and future research are 
discussed in the final chapter. The chapter finishes with a summary. 
 
4.1.2 Adiposity 
Body mass index is a common measure of adiposity. However, it is a poor indicator of total body 
adiposity as it is also affected by lean tissue mass.241,242 It is also thought that the cardio-metabolic 
outcomes associated with a raised BMI are primarily attributed to visceral adipose tissue. Other 
measures of adiposity that indirectly assess visceral adipose tissue such as waist-to-hip ratio are 
more strongly associated with cardio-metabolic disease than BMI.149–151,243 Total adiposity or body 
weight is still an important determinant of some other health outcomes, such as osteoarthritis, sleep 
apnoea.219,256 
 
The Fenland Study estimated eleven measures of adiposity using: simple measurement techniques 
(BMI, waist-to-hip ratio); Dual-energy x-ray absorptiometry (DEXA) scanning (total fat mass, trunk fat 
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mass, android fat mass, gynoid fat mass, visceral adipose tissue mass, peripheral fat mass); and 
ultrasound scanning (medial thickness, subcutaneous adipose tissue, liver fat).  
 
As my focus was on the public health implications of active travel, rather than understanding 
biological mechanisms, I chose two measures that reflected the way that adipose tissue may cause 
disease (i.e. one measure of visceral adipose tissue, which is important for cardio-metabolic diseases; 
and one measure of total body fat, which is important for some other health outcomes). These two 
measures were volume of visceral adipose tissue and percentage body fat. 
 
Studies describing the association between active travel and adiposity were summarised in Chapter 
Three (Table 3.1). No study has reported the association between active travel and visceral adipose 
tissue, although some studies have reported associations for waist-to-hip ratio232 or waist 
circumference.230 Two studies have described the association between active commuting and 
percentage body fat.130,235 
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4.2 Methods 
 
4.2.1 Study settings 
I used data from the Fenland Study, an ongoing population-based cohort study of adults born 
between 1950 and 1975 in Cambridgeshire, UK. Volunteers (n=12,434) were recruited from general 
practice lists between 2005 and 2015. There were 19 participating practices; five in Wisbech 
(including the town of Whittlesey); seven in Ely (including the nearby settlements in Sutton, 
Chatteris, Haddenham and Burwell); and seven in Cambridge (including the villages of Comberton 
and Cottenham). Thus participants were recruited from Cambridgeshire, predominantly from 
Cambridge and the north to north-eastern parts of the county. 
 
The socio-demographic characteristics of the populations of Cambridge and the (whole) county of 
Cambridgeshire were described in Chapter Two (section 2.2.1.1). The northern part of 
Cambridgeshire is relatively rural with a low population density. As this study included participants 
from both Cambridge and the north to north-eastern part of the county, the sample population from 
which the participants were recruited, was more socio-economically diverse than the sample 
population of the Commuting and Health in Cambridge study. 
 
A description of travel connections in the Cambridge area was also given in Chapter Two. The 
northern part of the county, compared to Cambridge, has fewer transport links. Ely is served by a 
train line connected to Cambridge, although Wisbech is not on the rail network. With the exception 
of the A1(M), which skirts the western part of the recruitment area there are no motorways serving 
that part of the county. Other towns in Cambridgeshire do not have ‘park and ride’ facilities. 
 
4.2.2 Data collection 
On entry to the study all participants were invited to attend one of three clinical research facilities 
(Princess of Wales Hospital, Ely, UK; the North Cambridgeshire Hospital, Wisbech, UK; or the Institute 
of Metabolic Science, Cambridge, UK), where they completed a general questionnaire, a food 
frequency questionnaire (FFQ) and the Recent Physical Activity Questionnaire (RPAQ).xviii,186 
Recruitment started in Cambridge in December 2004 and the first volunteer was measured in 
January 2005. The second site was opened at the North Cambridgeshire Hospital in Wisbech in 
February 2006 and a third was opened at the Princess of wales Hospital in Ely in March 2006. 
                                                          
xviii Copies of the questionnaire are available to view at the following website:  
http://epi-meta.medschl.cam.ac.uk/includes/fenland/fenland.html 
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On visiting one of the clinical research facilities, body composition was assessed by dual-energy X-ray 
absorptiometry (DEXA; Lunar Prodigy Advanced fan beam scanner; GE Healthcare). After their visit 
each participant completed six days of objective physical activity monitoring, wearing an Actiheart® 
device (combined heart rate and accelerometer).148 
 
Study exclusion criteria were pregnancy, diabetes, an inability to walk unaided, psychosis, or terminal 
illness. The study was approved by the Cambridge Local Research Ethics Committee (Ref 
04/Q0108/19). All participants gave written informed consent. 
 
4.2.3 Exposure measures: active commuting 
Commuting mode was assessed in the RPAQ, with the question “how did you normally travel to 
work?” (see Appendix, Fenland Recent Physical Activity Questionnaire Part B, page 252). Participants 
could indicate both travel mode (car/motor vehicle, works or public transport, bicycle, and walking) 
and frequency (always, usually, occasionally or never). This in theory yields 256 unique combinations 
of mode and frequency.  
 
4.2.3.1 Approach to categorisation 
My aim was to categorise participants in order to enable comparisons between real-world choices 
that commuters face, reflecting the constraints on travel choice imposed by distance to 
work.137,191,257. My approach was partly driven by theory and partly driven by data. I hypothesised 
that those living close to work had the following choices for travelling to work:  
 walking  
 cycling 
 car-use  
 public transport (likely combined with walking or cycling at the ends of the journey),  
 a combination of these options (most likely using different options on different days). 
Conversely beyond a certain distance from home to work, travelling only by foot or bicycle to work 
becomes impractical, and thus I hypothesised the options would become:  
 car-use,  
 public transport (likely combined with some walking or cycling) 
 car-use with active travelxix  
 
                                                          
xix Car-use with active travel may be an option principally for those working in Cambridge, as Cambridge is the only town in 
the region that is served by ‘park and ride’ facilities. 
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I decided an appropriate cut-point to segregate these two groups was five miles (from home to 
work). This cut-point was partly informed by the Commuting and Health in Cambridge study, which 
suggested that people who lived five miles or further from work were much less likely to only walk or 
cycle to work. It was also partly informed by a preliminary analysis of the data (40.9%, 1379/3368, of 
participants living within five miles of work reported regularly, i.e. usually or always, cycling or 
walking compared to 7.5%, 357/4726, of participants who lived five miles or further from work). 
 
I was also conscious from previous analyses that home-work distance had been an effect moderator 
(associations between cycling to work and BMI were greater amongst those living further from work, 
see section 3.3.2). The appropriate way to handle effect moderation is to stratify and present 
estimates for appropriate strata (although the chosen strata may only partially address this issue). 
 
4.2.3.2 Testing and modification of proposed categories 
 
Participants living within five miles of work: Of those participants who lived within five miles of work, 
approximately two-thirds could be categorised as car-only, walking only or cycling. The remaining 
participants could be categorised either as walking or cycling regularly with occasional car-use or 
regularly using the car with occasional walking or cycling.  
 
The prevalence of public transport use was low (1.9%, 65/3368 reported regularly using public 
transport). There was also limited evidence of ‘multi-modal’ commuting, i.e. commuters combining 
two or more modes of a travel to undertake a single journey to work (e.g. car journey to station; train 
to work; walk from train station to work) that involved active commuting.xx  
Consequently, I retained the car only group. I assumed that participants who regularly cycled or walk 
with occasional car-use would be more similar to those who reported only walking or cycling to work 
than those who reported only using the car. Thus I created two groups, ‘regular walking’ and ‘regular 
cycling’, which included participants who made use of other modes. 
 
Reflecting the different associations observed in the previous chapters for walking and cycling, I 
further divided those who reported regularly using the car with occasional walking or cycling, into 
those who reported occasional walking and those who reported occasional cycling. This yielded a 
total of five categories (Table 4.1). 
                                                          
xx In theory multi-modal commuting should be indicated by using two (or more) modes of travel at the same frequency (e.g. 
always using the car and always walking). Among those who lived within five miles of walk only a minority reported this 
pattern of commuting (5.1%; 172/3368 reported the same frequency of walking or cycling as public transport or car-use) 
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The ‘public transport group’ was dropped as a category and those participants reallocated to other 
groups. I assumed that public transport use involved some walking regardless of whether this was 
reported, and consequently users of public transport were assigned to the relevant walking group 
(either regular walking or regular car use with occasional walking). If participants reported cycling 
and walking they were assigned to the cycling group. 
 
Participants living five miles or further from work: Amongst those living five miles or further from 
work, a small number of participants reported regularly cycling with either occasional or no use of 
car/public transport (n=86), or regularly walking with either occasional or no use of car/public 
transport use (n=8). As the number of these participants was low and these commuting patterns 
were unlikely to be achievable for most commuters who live more than five miles from work, I 
excluded these participants. 
 
The remaining participants could be readily grouped into the three hypothesised categories (car only; 
82.0%, 3875/4726; public transport, 9.2%, 435/4726; car with some active travel, 8.8%, 416/4726). 
Consequently, I used this categorisation system, which is summarised in Table 4.1. 
 
4.2.3.3 Post-hoc classification of participants living five miles or further from work 
I re-classified participants who combined car or public transport use with active travel, reflecting the 
positive findings for cycling and null findings for walking amongst the sample who lived within five 
miles of work (as well as the similar pattern of results observed in the Commuting and Health in 
Cambridge study). Participants were categorised based on their active mode of travel (i.e. walking or 
cycling) rather than their ‘passive mode’ of travel (i.e. car or public transport). A full description of 
the categories is given in Table 4.1. 
 
4.2.4 Outcomes: body fat and visceral adipose tissue 
Whole and regional body fat was estimated from the DEXA scan using Encore software 
(v14.10.022).258 Percentage total body fat was estimated using a three-compartment model (fat 
mass, fat-free mass, and bone mineral mass). The software used an inbuilt algorithm to determine 
visceral adipose tissue (cm3) within the android region (the region outlined by iliac crest and with a 
superior height equivalent to 20% of the distance from the top of the iliac crest to the base of the 
skull).  
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Estimates of visceral adipose tissue (VAT) derived from DEXA scans have been shown to have good 
agreement with gold-standard estimates from Computed Tomography (CT) scan.259–261 The 
distribution of estimates of VAT was highly skewed and was transformed using a square root 
function. 
 
Table 4.1 Commuting categories 
Category Name Definition 
Participants living within five miles of work  
Car only Report regular (i.e. frequency is always or usual) car-use to travel to work. This 
group only includes those who use the car alone – there is no use of other 
modes. 
Regular walking 
Report walking to work regularly. Those who regularly used public transport in 
the absence of car-use were also assumed to walk regularly. This group includes 
those who use other modes, although those who report both regularly walking 
and regularly cycling were assigned to the ‘regular cycling’ group. 
Regular cycling 
Report cycling to work regularly. This group includes those who report both 
regularly walking and regularly cycling, as well as use of other modes. 
Car with occasional 
walking 
Report regular car-use to travel to work and additionally report either occasional 
walking or occasional public transport use. This group excludes those who 
regularly use active travel (walking, cycling or public transport) and who 
undertake any cycling to work.  
Car with occasional 
cycling 
Report regular car-use to travel to work and additionally report occasional 
cycling to work. This groups includes those who report both occasional cycling 
and occasional walking/public transport use. This group excludes those who 
regularly use active travel (walking, cycling or public transport). 
Participants living five miles or further from work 
Car only  
Report regular car-use to travel to work. This group only includes those who use 
the car alone – there is no use of other modes. 
Public Transport 
Report regular public transport use to travel to work. This group includes those 
who report other modes of travel.  
Car with active 
travel 
Report regular car-use to travel to work and additionally report some active 
travel (walking, cycling or public transport). Public transport use is occasional 
only, those using public transport regularly are assigned to the ‘public transport’ 
group. 
Participants living five miles or further from work (alternative classification) 
Car only  
Report regular car-use to travel to work. This group only includes those who use 
the car alone – there is no use of other modes. 
Public Transport 
only 
Report regular public transport use to travel to work. This group only includes 
those who report public transport and car-use. User who report walking or 
cycling in combination with public transport are assigned to one of the two 
groups below. 
Car or public 
transport with 
walking 
Report regular car-use or public transport to travel to work and additionally 
report some walking. Frequency of walking may be regular or occasional. 
Car or public 
transport with 
cycling 
Report regular car-use or public transport to travel to work and additionally 
report some cycling. Those who report some cycling and some walking are 
included in this group. Frequency of cycling may be regular or occasional. 
Regular implies a frequency of use that is ‘always or usually’ 
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4.2.5 Inclusion and exclusion criteria 
Only participants who were employed and reported regular travel to work (reported frequency 
either ‘always’ or ‘usually’) were included. Exclusion criteria were: any missing data, reported 
difficultly walking, not completing 48 hours of objective physical activity monitoring, living at work 
(home-work distance equals zero, or home postcode equals work post code), living more than 100 
miles from work. These are summarised in Figure 4.1.  
 
Figure 4.1 Flow chart illustrating inclusions and exclusions of study participants 
 
 
4.2.6 Co-variates 
Age, sex, education, difficultly walking, smoking status and alcohol consumption were assessed on 
the general questionnaire. Distance from home to work, home postcode, work postcode, 
occupational activity (sedentary, standing or manual occupation) and usual mode of travel (excluding 
travel to work) were assessed on the RPAQ.  
 
Dietary consumption was assessed using a 130-item food frequency questionnaire.262 I chose a 
measure of overall diet quality, the Mediterranean diet score, which has been associated with 
adiposity.263,264 The relative Mediterranean diet score (rMED) (range 0-18) was estimated by 
assigning a score to each of nine dietary components based on sex specific tertiles. Estimates of 
rMED and alcohol consumption (g per week) and were made using the FETA software program.265  
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Leisure-time physical activity was estimated by multiplying the energy expenditure (measure in 
metabolic equivalent of task)266 for each activity213 by the weekly duration of activity, reported in the 
RPAQ. Values for each reported activity were summed to give a total estimate. 
 
Estimates of objective physical activity energy expenditure (PAEE) were made using the branched 
equation framework.148,267 Estimates of PAEE were individually calibrated, based on a partial (n=475) 
or complete treadmill test (n=6942). If no adequate treadmill test was available estimates were 
calibrated based on age and sex averages (n=199). For participants with a poor heart rate trace, 
estimates were derived using accelerometer data only (n=64).  
 
4.2.7 Analysis 
I used linear regression to test the association of active commuting with body fat and VAT, stratified 
by home-work distance and by sex. 
 
4.2.7.1 Stratification by sex 
 I stratified by sex, as others have done,130,235 because of the different absolute levels and distribution 
of fat, differences in commuting patterns,136 and possible differences in activity intensity between 
the sexes.  
 
4.2.7.2 Adjustment of co-variates 
I adjusted for three sets of co-variates. Model A was adjusted for socio-demographic characteristics 
(age, education level), non-physical activity health behaviours (alcohol consumption, Mediterranean 
diet score and smoking status), test site and difficulty walking.  
 
I then adjusted for physical activity, using two complementary approaches (Model B and C). Model B 
was adjusted for Model A co-variates and other self-reported physical activity (leisure-time physical 
activity, usual method for getting about and occupational activity). Model C was adjusted for Model 
A co-variates and objectively measured PAEE. The former approach might be considered as treating 
physical activity as a confounder and the latter approach as a variable on the causal pathway. 
Consequently, Model B might provide the best estimate of the association between active 
commuting and adiposity after adjustment for confounders. 
 
4.2.7.3 Dose-response relationship 
Finally, I tested for a dose-response relationship between distance from home to work and measures 
of adiposity, for a) those who only cycle to work; and b) those who only walk to work, adjusting for 
111 
 
model B co-variates and sex. Demonstration of a dose-response relationship would strengthen causal 
inference.35 
 
4.2.7.4 Software 
Analyses were undertaken using Stata Statistical Software: Release 13 (College Station, TX: StataCorp 
LP) using the “regress” command for linear regression. 
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4.3 Results 
 
4.3.1 Descriptive characteristics 
Descriptive characteristics of the sample are shown in Table 4.2. Compared to the national average 
the sample was relatively educated (in the UK 36.9% of adults aged 16-64 years have a degree )182, 
healthy (in Great Britain 19% of adults smoked in 2014268; in England 23% of men and 16% of women 
exceed recommended intake of alcohol in 2012)269 and had a high prevalence of cycling to work (in 
the UK 3% of adults report cycling as their ‘usual’ means of travel to work in 2011).208 Compared to 
women, men had a lower percentage body fat and greater volume of VAT. Men were more likely to 
travel further to work, to have a manual job and to consume excess alcohol. Participants who lived 
further from work were more likely to be male, have a degree, and more likely to use the car rather 
than other modes of travel for non-commuting travel. Men who lived five mile or further from work 
tended to have higher body fat and more VAT, compared to men who lived within five miles of work.  
 
Frequency of travel mode by the different patterns of active commuting is shown in Table 4.3 and 
Table 4.4. People who lived within five miles of work and reported regularly walking or cycling also 
reported limited car and public transport use. People who used the car in combination with 
occasional walking or cycling used the car less frequently than those who only reported using the car. 
 
Amongst those who lived far from work and who undertook active travel, walking tended to be 
undertaken regularly and was combined with either public transport or car-use. In contrast cycling 
was undertaken occasionally and predominantly combined with car-use. 
 
Interaction terms for sex and adiposity were only significant for VAT amongst those living near to 
work (p=0.04, n=3171), but not for those living far from work or for percentage body fat among 
those living near to work. 
 
4.3.2 Body fat 
Associations between active commuting and body fat are shown in Table 4.5. Among those living 
within five miles of work, people who reported regularly cycling had a lower body fat, compared to 
those who only used the car (Model B: women, 1.74%, 95% CI: 0.76% to 2.27%; men, 1.30%, 95% CI:  
0.33% to 2.26%). People who reported regularly walking did not have reduced body fat. Women who 
reported regular car-use combined with occasional walking reported higher body fat compared to 
women who only used the car (Model B; 1.34%, 95% CI: 0.22% to 2.47%).  
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Table 4.2 Descriptive characteristics of sample (n=7,680) 
 People living within 5 miles of work People living 5 miles or further from work Total 
 Women 
(n=1,999) 
Men 
(n=1,268) 
Women 
(n=1,950) 
Men 
(n=2,463) 
 
Car only 845 (42.3) 489 (38.6) 1639 (84.1) 1958 (79.5) 4931 (64.2) 
Regular walking 339 (17.0) 122 (9.6) n/a n/a 461 (6.0) 
Regular cycling 480 (24.0) 460 (36.3) n/a n/a 940 (12.2) 
Car with occasional 
walking 
141 (7.1) 48 (3.8) n/a n/a 189 (2.5) 
Car with occasional 
cycling 
194 (9.7) 149 (11.8) n/a n/a 343 (4.5) 
Public Transport n/a n/a 154 (7.9) 265 (10.8) 419 (5.5) 
Car with active travel n/a n/a 157 (8.1) 240 (9.7) 397 (5.2) 
Age (years) 48.8 (43.4-54.1) 48.2 (42.2-54.5) 48.2 (42.5-53.8) 47.9 (42.2-53.8) 48.3 (42.6 to 54.0) 
Education      
Degree or equivalent  624 (31.2) 556 (43.9) 790 (40.5) 1052 (42.7) 3022 (39.4) 
A-Level or equivalent 910 (45.5) 463 (36.5) 858 (44.0) 1067 (43.3) 3298 (42.9) 
GCSE or equivalent 465 (23.3) 249 (19.6) 302 (15.5) 344 (14.0) 1360 (17.7) 
Smoking status      
Never 1116 (55.8) 671 (52.9) 1106(56.7) 1323 (53.7) 4293 
 (55.0) 
Ex-smoker 654 (32.7) 437 (34.5) 653 (33.5) 836 (33.9) 2616 (33.5) 
Current smoker 229 (11.5) 160 (12.6) 191 (9.8) 304 (12.3) 897 (11.5) 
Alcohol consumption      
None 422 (21.1) 141 (11.1) 339 (17.4) 221 (9.0) 1123 (14.6) 
Within guidelines 
(<16g per day) 
1420 (71.0) 840 (66.2) 1459 (74.8) 1711 (69.5) 5430 (70.7) 
Moderate (16-34.99g 
per day) 
132 (6.6) 182 (14.4) 129 (6.6) 346 (14.1) 789 (10.3) 
Heavy (>35g per day) 25 (1.3) 105 (8.2) 23 (1.2) 185 (7.5) 338 (4.4) 
Mediterranean Diet 
Score  
9 (7-11) 9 (7-11) 9 (7-11) 9 (7-11) 9 (7-11) 
Usual method of 
getting about 
     
Motor vehicle/car 1194 (59.7) 723 (57.0) 1497 (76.8) 1890 (76.7) 5304 (69.1) 
Public Transport 475 (23.8) 237 (18.7) 356 (18.3) 411 (16.7) 97 (1.2) 
Walking 21 (1.1) 10 (0.8) 33 (1.7) 33 (1.3) 1479 (19.3) 
Cycling 309 (15.5) 298 (23.5) 64 (3.3) 129 (5.2) 800 (10.4) 
Occupation      
Sedentary 986 (49.3) 629 (49.6) 1206 (61.9) 1391 (56.5) 4212 (54.8) 
Standing 832 (41.6) 219 (17.3) 616 (31.6) 337 (13.7) 2004 (26.1) 
Manual 181 (9.1) 420 (33.1) 128 (6.5) 735 (29.8) 1464 (19.1) 
Leisure time physical 
activity (MET-hours) 
2.63 (1.25-4.78) 3.99 (2.02-6.90) 2.75 (1.32-4.95) 4.11 (2.28-7.27) 3.3 (1.7-6.0) 
Physical Activity 
Energy Expenditure 
(kJ/day/kg) 
48.1 (36.1-61.8) 58.9 (44.0-75.7) 45.6 (35.1-58.4) 56.4 (42.1-73.2) 51.4 (38.5-66.9) 
Difficultly walking      
None 1385 (69.3) 933 (73.6) 1334 (68.4) 1757 (71.3) 5409 (70.4) 
Very Little 395 (19.8) 214 (16.9) 389 (20.0) 451 (18.3) 1449 (18.9) 
Somewhat 147 (7.4) 89 (7.0) 147 (7.1) 134 (5.4) 508 (6.6) 
Question not asked 72 (3.6) 32 (2.5) 72 (4.6) 121 (4.9) 314 (4.1) 
Home to work 
distance (miles) 
2.0 (1.0-3.0) 2.0 (2.0-3.0) 14.0 (9.0-20.0) 17.0 (11.0-30.0) 8.0 (3.0-17.0) 
Test Site      
Cambridge 818 (40.9) 660 (52.1) 591 (30.3) 735 (29.8) 2804 (36.5) 
Ely 613 (30.7) 246 (19.4) 976 (50.1) 1182(48.0) 3017 (39.3) 
Wisbech 568 (28.4) 362 (28.6) 383 (19.6) 546 (22.2) 1859 (24.2) 
Percentage Body Fat 
(%) 
37.5 (32.4-42.3) 28.8 (24.8-32.6) 37.4 (32.5-42.2) 29.3 (25.6-32.7) 32.7 (28.1-38.5) 
Visceral Adipose 
Tissue (cm3) 
514 (226-948) 1229 (700-1880) 492 (220-949) 1348 (798-1985) 848 (376-1520) 
BMI (kg/m2) 25.2 (22.7-29.1) 26.4 (24.1-28.9) 25.3 (22.8-28.9) 26.9 (24.7-29.6) 26.1 (23.6-29.2) 
Median and inter-quartile range shown for continuous variables; counts (n) and frequency (%) for categorical variables; ±for visceral adipose tissue, n=7,504; 
n/a = not applicable; BMI = body mass index and was measured objectively at one of three assessment centres. 
  
114 
 
Table 4.3 Description of the frequency of modes of travel undertaken by participants 
categorised by commuting patterns (n=7,680) 
 Reported frequency of mode use 
 Always  Usually Occasional Never 
Near (n=3267)     
Car only (n=1334)     
Car  1296 (97.2) 38 (2.9) 0 (0) 0 (0) 
Public Transport 0 (0.0) 0 (0.0) 0 (0.0) 1334 (100.0) 
Walking 0 (0.0) 0 (0.0) 0 (0.0) 1334 (100.0) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 1334 (100.0) 
Regular walking (n=461)     
Car-use 17 (3.7) 13 (2.8) 119 (25.8) 312 (67.8) 
Public Transport 30 (6.5) 22 (4.8) 15 (3.3) 394 (85.5) 
Walking 263 (57.1) 156 (33.8) 11 (2.4) 31 (6.7) 
Cycling 0 (0.0)  0 (0.0) 51 (11.1) 410 (88.9) 
Regular cycling (n=940)     
Car 3 (0.3) 21 (2.3) 215 (22.9) 701 (74.6) 
Public Transport 6 (0.6) 3 (0.3) 31 (3.3) 900 (95.7) 
Walking 7 (0.7) 24 (2.6) 166 (17.7) 743 (79.0) 
Cycling 594 (63.2) 346 (36.8) 0 (0.0) 0 (0.0) 
Car with occasional walking 
(n=189) 
    
Car 42 (22.2) 147 (77.8) 0 (0) 0 (0) 
Public Transport 0 (0.0) 0 (0.0) 31 (16.4) 158 (83.6) 
Walking 0 (0.0) 0 (0.0) 166 (87.8) 23 (12.2) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 189 (100.0) 
Car with occasional cycling 
(n=343) 
    
Car 51 (14.9) 292 (85.1) 0 (0) 0 (0) 
Public Transport 0 (0.0) 0 (0.0) 17 (5.0) 326 (95.0) 
Walking 0 (0.0) 0 (0.0) 108 (31.5) 235 (68.5) 
Cycling 0 (0.0) 0 (0.0) 343 (100.0) 0 (0.0) 
Far (n=4413)     
Car only (n=3597)     
Car 3574 (99.4) 23 (0.6) 0 (0) 0 (0) 
Public Transport 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Walking 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Public Transport (n=419)     
Car 82 (19.6) 23 (5.5) 79 (18.9) 235 (56.1) 
Public Transport 314 (74.9) 105 (25.1) 0 (0.0) 0 (0.0) 
Walking 114 (27.2) 33 (7.9) 23 (5.5) 249 (59.4) 
Cycling 60 (14.3) 33 (7.9) 18 (4.3) 308 (73.5) 
Car with active travel 
(n=397) 
    
Car 139 (35.0) 258 (65.0) 0 (0.0) 0 (0.0) 
Public Transport 0 (0.0) 0 (0.0) 173 (43.6) 224 (56.4) 
Walking 14 (3.5) 8 (2.0) 50 (12.6) 325 (81.9) 
Cycling 16 (4.0) 21 (5.3) 179 (45.1) 181 (45.6) 
Near = live within five miles of work; Far = live five miles or further from work; numbers and percentage shown in brackets. 
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Table 4.4 Description of the frequency of modes of travel undertaken by participants who 
live five or miles from home, using the four category classification of commuting behaviour 
(n=4,413) 
 Reported frequency of mode use 
 Always  Usually Occasional Never 
Car only (n=3597)     
Car  3574 (99.4) 23 (0.6) 0 (0) 0 (0) 
Public Transport 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Walking 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 3597 (100.0) 
Public Transport (n=322)     
Car-use 76 (23.6) 89 (27.6) 40 (12.4) 117 (36.3) 
Public Transport 146 (45.3) 47 (14.6) 129 (40.1) 0 (0.0) 
Walking 0 (0.0) 0 (0.0) 0 (0.0) 322 (100.0) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 322 (100.0) 
Walking (n=167)     
Car 80 (47.9) 27 (16.2) 17 (10.2) 43 (25.8) 
Public Transport 93 (55.7) 22 (13.2) 16 (9.6) 36 (21.6) 
Walking 99 (59.3) 25 (15.0) 43 (25.8) 0 (0.0) 
Cycling 0 (0.0) 0 (0.0) 0 (0.0) 167 (0.0) 
Cycling (n=327)     
Car 65 (19.8) 165 (50.5) 22 (6.7) 75 (22.9) 
Public Transport 75 (22.9) 36 (11.1) 28 (8.6) 188 (57.5) 
Walking 29 (8.9) 16 (4.9) 30 (9.2) 252 (77.1) 
Cycling 76 (23.2) 54 (16.5) 197 (60.2) 0 (0.0) 
Numbers and percentage shown in brackets. 
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Table 4.5 Associations between active commuting and percentage body fat stratified by 
distance from home to work and by sex (n=7,680) 
 Unadjusted Model A Model B Model C 
Participants living within five miles of work (n=3267)  
Women (n=1999)        
Car only (reference)        
Regular walking -0.59 (-1.44, 0.25) -0.14 (-0.95, 0.66) -0.05 (-0.94, 0.85) -0.21 (-0.96, 0.54) 
Regular cycling -3.01*** (-3.76, -2.26) -2.08*** (-2.85, -1.30) -1.74*** (-2.72, -0.76) -1.37*** (-2.10, -0.64) 
Car with occasional 
walking 1.73** (0.53, 2.93) 1.37* (0.24, 2.50) 1.34* (0.22,2.47) 0.93 (-0.12, 1.99) 
Car with occasional 
cycling -0.89 (-1.94, 0.16) -0.20 (-1.20, 0.80) -0.15 (-1.15,0.84) 0.26 (-0.67, 1.19) 
Men (n=1268)     
Car only (reference)     
Regular walking 0.37 (-0.77, 1.51) 0.82 (-0.34, 1.97) 0.91 (-0.32, 2.15) 0.26 (-0.85, 1.37) 
Regular cycling -2.31*** (-3.05, -1.58)         -1.59*** (-2.42, -0.77) -1.30** (-2.26, -0.33) -1.42*** (-2.20, -0.63) 
Car with occasional 
walking -0.26 (-1.96, 1.45)        -0.09 (-1.75, 1.57) -0.35 (-2.01, 1.31) -0.31 (-1.90, 1.27) 
Car with occasional 
cycling -1.39* (-2.44, -0.33)         0.99 (-2.04, 0.05) -0.88 (-1.92, 0.16) -0.81 (-1.81, 0.19) 
Participants living five miles or further from work (n=4413)  
Women (n=1950)        
Car only (reference)     
Public Transport -1.32* (-2.45, -0.19) -0.59 (-1.66, 0.49) -0.38 (-1.52, 0.76) -0.47 (-1.47, 0.54) 
Car with active travel -2.11*** (-3.23, -0.98) -1.55** (-2.62, -0.49) -1.18* (-2.23, -0.13) -1.30* (-2.30, -0.31) 
Men (n=2463)     
Car only (reference)     
Public Transport -0.64 (-1.37, 0.10) -0.13 (-0.86, 0.61) -0.17 (-0.95, 0.60) -0.02 (-0.72, 0.68) 
Car with active travel -1.63*** (-2.40, -0.87) -1.38*** (-2.13, -0.62) -1.19** (-1.93, -0.44) -1.20** (-1.92, -0.48) 
Model A adjusted for age, education, difficulty walking, alcohol consumption, Mediterranean diet score, smoking status and site; Model B 
adjusted for all co-variates in Model A and leisure time physical activity, usual method for getting about and work type; Model C adjusted 
for all co-variates in Model A and physical activity energy expenditure. Significance level: * p<0.05; ** p<0.01; *** p<0.001; adjusted co-
efficient shown that represent difference in percentage body fat (%) for given commuting pattern relative to reference. 
 
Among those who lived five miles or further from work, people who reported regular car-use with 
active travel had lower body fat relative compared to those who only used the car (Model B: women; 
1.18%, 95% CI: 0.13% to 2.23%; men, 1.19%, 95% CI: 0.44% to 1.93%). Using the alternative four-
category classification (Table 4.6), only those who reported combining cycling with either regular car-
use or public transport had lower body fat relative to those only using the car (Model B: women, 
2.58%, 95% CI: 1.20 to 3.92%; men, 1.71%, 95% CI: 0.92% to 2.50%).  
 
Adjustment for objective PAEE (Model C vs Model A) and self-reported physical activity (Model C vs 
Model A) tended to attenuate the reported associations but did not alter the statistical significance. 
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Table 4.6 Associations of commuting pattern with body fat and visceral adipose tissue for 
participants who live five miles or further from work (using the alternative categorisation 
of commuting behaviour) 
 Unadjusted Model A Model B Model C 
Percentage body fat (%) (n=4,413) 
Women (n=1,950) 
   
 
Car only (reference) 
   
 
Public transport 0.09 (-1.16,1.34) 0.57 (-0.61,1.75) 0.61 (-0.58,1.81) 0.43 (-0.68,1.54) 
Some walking -1.26 (-2.74,0.22) -0.71 (-2.10,0.68) -0.88 (-2.28,0.51) -0.85 (-2.15,0.45) 
Some cycling -4.29*** (-5.65,-2.92) -3.48*** (-4.79,-2.17) -2.58*** (-3.92,-1.24) -2.60*** (-3.83,-1.37) 
Men (n=2,463) 
   
 
Car only (reference) 
   
 
Public transport 0 (-0.83,0.83) 0.19 (-0.63,1.00) 0.01 (-0.82,0.83) 0.1 (-0.68,0.88) 
Some walking 0.21 (-1.05,1.47) 0.58 (-0.66,1.83) 0.37 (-0.88,1.61) 0.42 (-0.77,1.60) 
Some cycling -2.56*** (-3.35,-1.78) -2.06*** (-2.85,-1.27) -1.71*** (-2.50,-0.92) -1.60*** (-2.36,-0.85) 
Square root of visceral adipose tissue (cm3/2) (n=4,333) 
Women (n=1,875)     
Car only (reference) 
   
 
Public transport -0.53 (-2.60,1.53) 0.07 (-1.89,2.02) 0.28 (-1.72,2.28) -0.17 (-2.04,1.70) 
Some walking -2.92* (-5.30,-0.54) -1.87 (-4.12,0.37) -1.84 (-4.13,0.44) -2.04 (-4.20,0.11) 
Some cycling -5.89*** (-8.11,-3.66) -4.56*** (-6.70,-2.42) -3.82*** (-6.03,-1.62) -3.33** (-5.38,-1.27) 
Men (n=2,458) 
   
 
Car only (reference) 
   
 
Public transport -0.09 (-1.80,1.62) 0.90 (-0.73,2.52) 0.68 (-0.96,2.33) 0.79 (-0.79,2.36) 
Some walking -0.59 (-3.18,2.00) 0.83 (-1.64,3.30) 0.51 (-1.97,2.99) 0.56 (-1.84,2.96) 
Some cycling -5.00*** (-6.60,-3.39) -3.01*** (-4.57,-1.45) -2.25** (-3.83,-0.67) -2.29** (-3.81,-0.77) 
Model A adjusted for age, education, difficulty walking, alcohol consumption, Mediterranean diet score and smoking status; Model B 
additionally adjusted for leisure time physical activity, usual method for getting about and work type. Significance level: * p<0.05; ** 
p<0.01; *** p<0.001; adjusted co-efficient shown that represent difference in percentage body fat (%) or difference in square root of 
visceral adipose tissue (cm3/2) for given commuting pattern relative to reference. 
 
 
4.3.3 Visceral adipose tissue 
The pattern of associations for VAT (Table 4.6 and Table 4.7) was very similar to those observed for 
body fat, although the association for women living far from work who reported regular car-use was 
(marginally) not significant when adjusting for other self-reported physical activity (Model B: 
1.70cm3/2, 95% CI: -0.05 cm3/2 to 3.44cm3/2). It was significant when adjusted for objective physical 
activity (Model C: 1.73cm3/2, 95% CI:  0.06cm3/2 to 3.40cm3/2). 
 
4.3.4 Usual mode of travel 
The full regression model (i.e. showing the coefficients for all variables included in Model B, including 
usual mode of travel) are shown in the Tables 4.8-4.11. Usual mode of travel was associated with 
adiposity, particularly for those living far from work (e.g. walking, for women, and cycling were 
associated with reduced body fat relative to car as the usual mode of travel, Table 4.9). 
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Table 4.7 Associations between active commuting and visceral adipose tissue stratified by 
distance from home to work and by sex (n=7,504) 
 Unadjusted Model A Model B Model C 
Participants living within five miles of work (n=3171)  
Women (n=1904)        
Car only (reference)        
Regular walking -0.79 (-2.14, 0.57) -0.08 (-1.38, 1.21) 0.30 (-1.17, 1.76) -0.21 (-1.45, 1.03) 
Regular cycling -3.44*** (-4.66, -2.23) -1.81** (-3.08, -0.55) -1.92* (-3.51, -0.33) -0.93 (-2.14, 0.29) 
Car with occasional 
walking 3.19** (1.28, 5.10) 2.85** (1.04, 4.67) 2.89** (1.07, 4.71) 2.28* (0.54, 4.02) 
Car with occasional 
cycling -1.11 (-2.78, 0.56) -0.13 (-1.73, 1.47) -0.07 (-1.67, 1.53) 0.50 (-1.04, 2.04) 
Men (n=1267)     
Car only (reference)     
Regular walking -2.03 (-4.40, 0.35) -0.16 (-2.48, 2.15) -0.63 (-1.85, 3.11) -1.10 (-3.36, 1.15) 
Regular cycling -5.69*** (-7.21, -4.17) -2.79*** (-4.44, -1.15) -1.95* (-3.88, -0.02) -2.49** (-4.09, -0.90) 
Car with occasional 
walking -2.54 (-6.08, 1.00) -1.48 (-4.80, 1.84) -1.82 (-5.14, 1.49) -1.85 (-5.07, 1.37) 
Car with occasional 
cycling -2.95** (-5.14, -0.77) -1.19 (-3.28, 0.90) -1.04 (-3.12, 1.04) -0.88 (-2.91, 1.14) 
Participants living five miles or further from work (n=4333)  
Women (n=1875)        
Car only (reference)        
Public Transport -2.90** (-4.74, -1.06) -1.91* (-3.66, -0.16) -1.60 (-3.48, 0.27) -1.71* (-3.39, -0.03) 
Car with active travel -3.04** (-4.88, -1.21) -2.04* (-3.78, -0.29) -1.70 (-3.44, 0.05) -1.73* (-3.40, -0.06) 
Men (n=2458)     
Car only (reference)     
Public Transport -1.65* (-3.16, -0.15) 0.42 (-1.04, 1.88) 0.61 (-0.93, 2.16) 0.61 (-0.80, 2.03) 
Car with active travel -3.15*** (-4.71, -1.58) -2.14** (-3.63, -0.64) -1.79* (-3.27, -0.32) -1.86* (-3.31, -0.41) 
Model A adjusted for age, education, difficulty walking, alcohol consumption, Mediterranean diet score, smoking status and site; Model B 
adjusted for all co-variates in Model A and leisure time physical activity, usual method for getting about and work type; Model C adjusted 
for all co-variates in Model A and physical activity energy expenditure. Significance level: * p<0.05; ** p<0.01; *** p<0.001; adjusted co-
efficient shown that represent difference in visceral adipose tissue (cm3/2) for given commuting pattern relative to reference. 
 
 
4.3.5 Dose-response analysis 
There was an association between distance to work and body fat amongst those who reported only 
cycling to work and lived within five miles of work (-0.54 % per mile, 95% CI: -1.01 to -0.08, n=554), 
but the equivalent associations for VAT and for walking were not significant (cycling and VAT: -0.64 
cm3/2 per mile, 95% CI: -1.53 to 0.25, n=530; walking and body fat: -0.32 % per mile, 95% CI: -1.51 to 
0.88, n=243; walking and VAT: -1.24 cm3/2 per mile, 95% CI: -3.40 to 0.59, n=242).  
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Table 4.8 Linear regression (Model B) showing the correlates of body fat for men and 
women who live within five miles of work (n=3,267) 
 
Women (n=1999) Men (n=1268) 
Commuting (reference = car only)   
Regular walking -0.05 (-0.94,0.85) 0.91 (-0.32,2.15) 
Regular cycling -1.74*** (-2.72,-0.76) -1.30** (-2.26,-0.33) 
Car with occasional walking 1.34* (0.22,2.47) -0.35 (-2.01,1.31) 
Car with occasional cycling -0.15 (-1.15,0.84) -0.88 (-1.92,0.16) 
Age 0.16*** (0.12,0.20) 0.12*** (0.08,0.17) 
Education (reference = degree)   
A-level 1.80*** (1.08,2.51) 1.02* (0.17,1.86) 
GSCE 2.15*** (1.29,3.01) 0.93 (-0.07,1.93) 
Difficulty walking  
(reference = "not at all")   
Very little 2.80*** (2.09,3.51) 0.56 (-0.27,1.39) 
Somewhat 3.31*** (2.23,4.39) 1.83** (0.61,3.04) 
Not asked 1.95* (0.38,3.51) 1.95 (-0.14,4.05) 
Smoking status (reference = never)   
Ex-smoker 0.29 (-0.32,0.91) 0.54 (-0.15,1.22) 
Current smoker -1.42** (-2.34,-0.50) -1.15* (-2.15,-0.15) 
Alcohol consumption  
(reference = none)   
Within guidelines -1.08** (-1.78,-0.38) -0.01 (-1.01,0.99) 
Moderate (16-35 g/~) -1.29* (-2.55,-0.03) 0.35 (-0.92,1.61) 
Heavy (>35g/day) -1.07 (-3.62,1.48) 0.9 (-0.54,2.34) 
Mediterranean Diet Score -0.15** (-0.25,-0.05) -0.17** (-0.28,-0.05) 
Study site (reference=Cambridge)   
Ely -0.52 (-1.30,0.25) -0.68 (-1.64,0.28) 
Wisbech 0.82* (0.02,1.62) 1.12* (0.24,1.99) 
Usual method of travel  
(reference = car)   
Walking -0.23 (-0.99,0.53) -0.53 (-1.41,0.36) 
Public transport 0.11 (-2.67,2.89) -3.13 (-6.69,0.42) 
Cycling -0.51 (-1.61,0.60) -0.77 (-1.76,0.22) 
Occupation type  
(reference = sedentary)   
Standing -0.26 (-0.86,0.34) -0.46 (-1.38,0.45) 
Manual -0.84 (-1.88,0.19) -1.32** (-2.15,-0.49) 
Leisure physical activity -0.13*** (-0.19,-0.07) -0.05 (-0.10,0.00) 
Significance level: * p<0.05; ** p<0.01; *** p<0.001; co-efficient shown that represent difference in percentage body fat (%); all co-variates 
included in linear regression model are shown 
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Table 4.9 Linear regression (Model B) showing the correlates of percentage body fat for 
men and women who live five miles or further from work (n=4,413) 
 Women (n=1950) Men (n=2463) 
Commuting  
(reference = car only)   
Public Transport -0.38 (-1.52,0.76) -0.17 (-0.95,0.60) 
Car with active travel -1.18* (-2.23,-0.13) -1.19** (-1.93,-0.44) 
Age 0.18*** (0.14,0.22) 0.09*** (0.06,0.12) 
Education (reference = degree)   
A-level 1.51*** (0.87,2.15) 0.97*** (0.45,1.50) 
GSCE 1.86*** (0.96,2.75) 1.11** (0.37,1.85) 
Difficulty walking  
(reference = "not at all")   
Very little 2.94*** (2.22,3.65) 1.58*** (1.01,2.15) 
Somewhat 3.02*** (1.91,4.14) 3.09*** (2.13,4.05) 
Not asked 1.74* (0.33,3.15) 1.40** (0.34,2.45) 
Smoking status  
(reference = never)   
Ex-smoker 0.28 (-0.34,0.89) 1.00*** (0.52,1.48) 
Current smoker -1.74*** (-2.73,-0.75) -0.86* (-1.56,-0.16) 
Alcohol consumption  
(reference = none)   
Within guidelines -0.66 (-1.42,0.11) -0.4 (-1.18,0.37) 
Moderate (16-35 g/~) -0.77 (-2.07,0.53) -0.16 (-1.11,0.79) 
Heavy (>35g/day) 2.84* (0.17,5.50) 0.8 (-0.29,1.88) 
Mediterranean Diet Score -0.18*** (-0.29,-0.08) -0.05 (-0.13,0.03) 
Study site 
(reference=Cambridge)   
Ely -0.49 (-1.17,0.19) 0.12 (-0.42,0.66) 
Wisbech 0.33 (-0.53,1.19) 0.51 (-0.15,1.16) 
Usual method of travel  
(reference = car)   
Walking -0.90* (-1.64,-0.16) -0.52 (-1.11,0.07) 
Public transport -0.22 (-2.53,2.09) 0.44 (-1.54,2.43) 
Cycling -2.80*** (-4.43,-1.17) -2.46*** (-3.48,-1.45) 
Occupation type  
(reference = sedentary)   
Standing -0.73* (-1.35,-0.11) -0.17 (-0.83,0.49) 
Manual -0.45 (-1.61,0.71) -1.36*** (-1.91,-0.81) 
Leisure physical activity -0.24*** (-0.30,-0.17) -0.13*** (-0.17,-0.09) 
Significance level: * p<0.05; ** p<0.01; *** p<0.001; co-efficient shown that represent difference in square root of visceral adipose tissue  
(cm3/2); all co-variates included in linear regression model are shown. 
 
  
121 
 
Table 4.10 Linear regression (Model B) showing the correlates of visceral adipose tissue for 
men and women who live within five miles of work (n=3,171) 
 
Women (n=1904) Men (n=1267) 
Commuting (reference = car only)   
Regular walking 0.30 (-1.17,1.76) 0.63 (-1.85,3.11) 
Regular cycling -1.92* (-3.51,-0.33) -1.95* (-3.88,-0.02) 
Car with occasional walking 2.89** (1.07,4.71) -1.82 (-5.14,1.49) 
Car with occasional cycling -0.07 (-1.67,1.53) -1.04 (-3.12,1.04) 
Age 0.31*** (0.24,0.38) 0.45*** (0.37,0.54) 
Education (reference = degree)   
A-level 2.95*** (1.79,4.11) 2.03* (0.34,3.73) 
GSCE 3.68*** (2.27,5.08) 1.70 (-0.30,3.71) 
Difficulty walking  
(reference = "not at all")   
Very little 3.54*** (2.40,4.68) 1.12 (-0.55,2.79) 
Somewhat 4.11*** (2.36,5.86) 2.73* (0.30,5.17) 
Not asked 1.2 (-1.29,3.69) 2.61 (-1.59,6.80) 
Smoking status (reference = never)   
Ex-smoker 0.81 (-0.19,1.80) 1.71* (0.34,3.09) 
Current smoker 0.46 (-1.03,1.95) -0.95 (-2.95,1.05) 
Alcohol consumption  
(reference = none)   
Within guidelines -0.91 (-2.04,0.22) 0.92 (-1.08,2.92) 
Moderate (16-35 g/~) -0.82 (-2.85,1.20) 1.94 (-0.59,4.47) 
Heavy (>35g/day) 0.35 (-3.68,4.39) 4.49** (1.61,7.37) 
Mediterranean Diet Score -0.17* (-0.33,-0.00) -0.27* (-0.50,-0.04) 
Study site (reference=Cambridge)   
Ely -0.04 (-1.29,1.22) 1.37 (-0.55,3.30) 
Wisbech 0.98 (-0.31,2.28) 3.72*** (1.96,5.47) 
Usual method of travel  
(reference = car)   
Walking -0.72 (-1.96,0.51) -1.78* (-3.55,-0.00) 
Public transport -1.05 (-5.56,3.46) -8.46* (-15.57,-1.35) 
Cycling 0.24 (-1.55,2.03) -2.11* (-4.09,-0.12) 
Occupation type  
(reference = sedentary)   
Standing 0.10 (-0.87,1.08) -1.20 (-3.03,0.63) 
Manual -0.98 (-2.65,0.70) -2.33** (-3.99,-0.66) 
Leisure physical activity -0.12* (-0.22,-0.02) 0.00 (-0.10,0.10) 
Significance level: * p<0.05; ** p<0.01; *** p<0.001; co-efficient shown that represent difference in square root of visceral adipose tissue  
(cm3/2); all co-variates included in linear regression model are shown. 
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Table 4.11 Linear regression (Model B) showing the correlates of visceral adipose tissue for 
men and women who live five miles or further from work (n=4,333) 
 Women (n=1875) Men (n=2458) 
Commuting  
(reference = car only)   
Public Transport -1.60 (-3.48,0.27) 0.61 (-0.93,2.16) 
Car with active travel -1.70 (-3.44,0.05) -1.79* (-3.27,-0.32) 
Age 0.33*** (0.26,0.40) 0.37*** (0.31,0.43) 
Education (reference = degree)   
A-level 1.54** (0.48,2.59) 2.83*** (1.77,3.88) 
GSCE 2.00** (0.54,3.46) 2.04** (0.57,3.52) 
Difficulty walking  
(reference = "not at all")   
Very little 4.78*** (3.61,5.96) 3.05*** (1.91,4.18) 
Somewhat 4.01*** (2.19,5.82) 5.75*** (3.83,7.67) 
Not asked 0.09 (-2.23,2.41) 0.00 (-2.10,2.10) 
Smoking status  
(reference = never)   
Ex-smoker 1.45** (0.44,2.46) 2.35*** (1.39,3.30) 
Current smoker -0.49 (-2.10,1.13) -0.54 (-1.93,0.86) 
Alcohol consumption  
(reference = none)   
Within guidelines -1.04 (-2.29,0.21) 0.21 (-1.33,1.74) 
Moderate (16-35 g/~) -0.05 (-2.18,2.09) 1.84 (-0.05,3.74) 
Heavy (>35g/day) 5.69* (1.21,10.18) 4.49*** (2.34,6.65) 
Mediterranean Diet Score -0.23** (-0.41,-0.06) -0.17* (-0.33,-0.01) 
Study site 
(reference=Cambridge)   
Ely 0.47 (-0.64,1.59) 2.36*** (1.29,3.44) 
Wisbech 0.79 (-0.62,2.20) 2.99*** (1.68,4.30) 
Usual method of travel  
(reference = car)   
Walking -1.44* (-2.65,-0.22) -0.92 (-2.10,0.25) 
Public transport -1.28 (-5.06,2.50) -0.18 (-4.13,3.77) 
Cycling -1.81 (-4.50,0.87) -5.45*** (-7.47,-3.43) 
Occupation type  
(reference = sedentary)   
Standing -1.04* (-2.05,-0.02) -0.47 (-1.78,0.85) 
Manual -0.93 (-2.83,0.98) -2.57*** (-3.66,-1.48) 
Leisure physical activity -0.24*** (-0.35,-0.13) -0.15*** (-0.23,-0.07) 
Significance level: * p<0.05; ** p<0.01; *** p<0.001; co-efficient shown that represent difference in square root of visceral adipose tissue  
(cm3/2); all co-variates included in linear regression model are shown. 
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4.4 Discussion 
 
4.4.1 Summary of findings 
Among those living within five miles of work, people who reported regularly cycling to work had 
reduced body fat and VAT compared to those using the car. Among those living five miles or further 
from work, people who reported regular car-use combined with active travel had reduced body fat 
and VAT compared to those using the car. Using an alternative approach to classifying participants 
who lived five miles or further from work, only participants who reported combining car or public 
transport use with cycling (and not those who reported combining car or public transport use with 
walking) had significantly reduced adiposity. 
 
People who reported walking or cycling as their usual mode of travel also had reduced adiposity 
compared to people who usually used the car. Amongst those who cycled to work, there was an 
inverse association between distance to work and percentage body fat.  
 
4.4.2 Strengths and limitations 
 
4.4.2.1 Cross-sectional 
The study was cross-sectional so provides a very weak basis from which to draw causal inference. 
The observed associations might be attributable to reverse causation, i.e. that adiposity influences 
choice of commute mode. I note that most studies describing the associations between active travel 
and health are cross-sectional,130,230–240 but because the study has several other unique factors it 
makes an important contribution. 
 
4.4.2.2 Classification of active commuting 
Stratifying the sample by distance to work and focusing on patterns of commuting may facilitate 
more meaningful comparisons. Nonetheless the choice of groups was partly limited by data. Public 
transport use was relatively low compared to some parts of the country, such as London. Moreover, 
public transport may be different in other places, in terms of the opportunity to sit (or stand) and the 
extent to which it is combined with car-use or active travel, so one should be cautious about 
generalising the findings to other settings. 
 
Whilst associations for walking as part of commuting were not significant the number of participants 
categorised to one of the walking groups was relatively small, and consequently some of these 
analyses were under-powered. Participants who were categorised as walking also included public 
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transport users, who might undertake very little or no walking, which might have biased some of the 
estimates of walking to zero. I also note that unadjusted estimates of physical activity energy 
expenditure (data not shown) for those participants who reported regularly walking were relatively 
low, lower than those participants who reported only using the car, which might suggest that these 
participants were relatively inactive in other areas of their life as well undertaking a low amount of 
walking as part of travel to work. 
 
With the exception of participants who reported only walking to work or only cycling to work, I do 
not have a good means of reporting the ‘dose’ of active commuting in terms of either distance or 
duration. 
  
4.4.2.3 Detailed characterisation adiposity 
An important strength of this study is the objective measurement of adiposity, including visceral 
adipose tissue. VAT is strongly associated with cardio-metabolic disease, and may be a better 
predictor of health outcomes than other measures of adiposity.149–151  No other study has reported 
the associations between active travel and visceral adiposity, although two studies have reported the 
associations for waist-to-hip ratio which is an indicator of visceral adipose tissue.  
 
Whilst DEXA measurement of visceral adipose tissue is not equivalent to the gold standard measure 
of CT measurement. CT scanning in large epidemiological study is unlikely to be feasible or ethical 
(due to radiation dose). DEXA measurement has been shown to be sufficiently accurate for 
population based studies.259–261  
 
This study has also reported percentage body fat (again measured by DEXA). This is a better measure 
of total adiposity than the measure more usually used, BMI, as it is not affected by fat free mass, 
such as skeletal muscle. However, using body fat measured by DEXA and visceral adipose tissue 
means the findings from this study are not directly comparable with the findings from other studies. 
 
4.4.2.4 Detailed characterisation of diet 
In contrast to other studies,130,232,234–236 this study has characterised diet in detail using a 130-item 
food frequency questionnaire and used a measure of dietary behaviour that reflects the overall 
pattern of dietary consumption, rather than focusing on single elements. This measure has been 
shown to be associated with obesity.263,264 Nonetheless residual confounding by diet is still possible, 
and some potentially important components of dietary behaviour as they relate to active travel (e.g. 
snacking) have not been captured. 
 
125 
 
4.4.2.5 Measurement of physical activity  
This study has made use of two measures of physical activity, first self-reported physical activity 
(assessed using the RPAQ) and secondly objective measurement of physical activity (measured by an 
Acitheart® device).  
 
The former has enabled adjustment not only for active commuting but also usual mode of travel, so 
has effectively allowed consideration of two dimensions of active travel, as well as adjustment for 
other physical activity both at work and in leisure time. Both of these other types of physical activity 
were independently associated with adiposity.  
 
The latter, objective physical activity, potentially offers a better means to capture all physical activity, 
including short bouts of activity (e.g. walking up a flight of stairs) that may not be well captured by a 
questionnaire. A particular strength of using Actiheart® (as opposed to other measures, e.g. 
accelerometer) is that by recording heart rate it can better detect and measure the energy 
expenditure associated with a wider range of activities (e.g. cycling, which is poorly recorded by a hip 
mounted accelerometer).148  
 
Physical activity energy expenditure has to be estimated or inferred. It is not directly observed in the 
way that one may observe height. Estimates of physical activity energy expenditure are based in part 
on the association between heart rate and energy expenditure.267,270 This depends on accurate 
individual-level calibration of the relationship between heart rate and energy expenditure. At lower 
heart rate levels estimates are made based on the accelerometer trace. A large number of inferences 
have to be made in order to estimate physical activity energy expenditure. Nonetheless physical 
activity energy expenditure has been shown to compare favourably to other estimates of physical 
activity energy, such as questionnaire or accelerometer, relative to gold-standard estimates of total 
energy expenditure made using double-labelled water or whole body calorimetry.271,272  
 
The time period of observation of self-reported physical activity and objectively measured physical 
activity was different. The former was reported for the four weeks prior to visiting the clinical 
research facility and the latter was undertaken in the week after visiting the clinical research facility. 
 
4.4.3 Comparison with other studies  
My findings are consistent with other reports, including the analysis of the Commuting and Health in 
Cambridge dataset, that active travel is associated with reduced BMI relative to car-use.130,131,155,230–
240  
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4.4.3.1 Walking 
The findings of stronger associations for cycling than walking also mirror the findings reported in the 
previous chapter and much of the literature (see section 3.4.3). As before these differences may 
reflect some behaviour specific characteristics, i.e. lower intensity of walking relative to cycling or 
tendency for walking to be of shorter duration than cycling. They may also reflect other factors like 
the inclusion of public transport users in some walking groups, who may undertake relatively little 
walking (although the number of such participants was relatively low). 
 
Whilst non-significant, I note a trend for women participants who lived within five miles of work and 
reported car use with occasional walking to have greater adiposity (relative to those only using the 
car). Reverse causation may also contribute, for example being overweight and choosing to walk to 
work in order to lose weight (which might account for the higher adiposity among women living near 
to work and who reported regular car-use with occasional walking). Sex specific associations were 
not explored in the previous chapter as the sample was too small. Nonetheless it remains possible 
that such behaviour could contribute to the observation of non-significant associations between 
walking to work and BMI reported in the previous chapter. 
 
Nonetheless, the study, as with the analysis using Commuting and Health in Cambridge, does provide 
some evidence of the value of walking. Walking as a usual mode of travel was associated with 
reduced adiposity relative to car-use. The associations for walking for men or in combination with 
car-use (men living near to work, women living far from work) were in the expected direction and 
nearly reached the threshold for significance (p<0.05).    
 
4.4.3.2 Public Transport 
Some studies have demonstrated significant associations between public transport use and reduced 
adiposity, although some reported non-significant associations.130,235,238,240 I did not observe any 
significant associations between commuting by public transport and adiposity, although the 
estimated effect sizes were in the expected direction (and the sample relatively small). Moreover 
only 40% of public transport users reported some walking and 27% some cycling. Estimates of effect 
size were close to zero when isolating individuals who did not report combining public transport with 
active travel. Differences in the categorisation of public transport and how much physical activity is 
associated with its use may account for these differences. Other differences in use of public transport 
(e.g. snacking, standing vs sitting) may also contribute. 
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4.4.3.3 Percentage body fat 
Two previous studies have described associations between active commuting and body fat. Both 
studies reported a similar estimated effect size (1.5% reduction for cycling to work and 1.4% for 
active travel, relative to car-use) to those described here, although the categorisation of active 
commuting was different in these other studies.130,235 I am not aware of any studies that have 
described the association between active commuting and VAT. 
 
4.4.3.4 Dose-response 
Previous work has demonstrated a dose-response association, between ‘intensity’ of active travel 
and BMI,130 and duration of active travel and BMI131. My findings show a relationship between 
distance cycled to work and body fat.  
 
4.4.4 Study interpretation  
 
4.4.4.1 Adjustment of physical activity 
Additional adjustment for both other self-reported and physical activity energy expenditure (PAEE) 
attenuated the observed relationship. These findings are consistent with other physical activity being 
a confounder and PAEE being a mediator of the relationship between active commuting and 
adiposity. Adjusting for objective PAEE I only observed partial attenuation, this may be because I had 
not accounted for past PAEE or because there may be other pathways between commuting and 
adiposity (e.g. snacking in cars).  
 
 
4.4.4.2 Participants who live five miles or further from work 
Participants who reported regular car-use combined with active travel had reduced adiposity. Whilst 
this group are likely to have done this in different ways, it seems likely that a minority of commuters 
were doing this by driving to ‘park and ride’ facilities as very few participants reported regularly (i.e. 
usually or always) walking or cycling. Moreover, in contrast to Commuting and Health in Cambridge, 
not everyone in the Fenland Study worked in Cambridge and whilst it may be possible to park on the 
edge of other cities and then cycle or walk into the centre, it is only Cambridge that has specific 
facilities (‘park and ride’ sites) to enable this.  
 
An alternative means for participants to combine cycling and car-use and one that appears better 
supported by the data, is to cycle (the relatively long distance) from home to work occasionally and 
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to drive on other occasions. Walking more than five miles to work is possiblexxi, but seems less likely. 
Another approach is combining public transport with walking or cycling on non-driving days. These 
approaches seem more likely with over half the sample reporting cycling (most of which was 
occasional) and nearly half the sample reporting occasional public transport use. 
 
It is also notable that active travel (either cycling or walking) as the usual mode of non-work travel 
was more commonly associated with reduced adiposity amongst those living five miles or further 
from work than amongst those living within five miles of work. This may be because those who live 
further from work are more predisposed to being obese (see section 3.4.4.3) and/or reflect the lower 
levels of active commuting relative to those living within five miles of work. 
 
4.4.5 Overall interpretation of adiposity studies 
Looking across the two studies (Fenland and Commuting and Health in Cambridge) a stronger case 
for a causal association between active travel and adiposity can be made, than looking at either study 
in isolation. Associations of both active commuting and non-commuting active travel with reduced 
adiposity have been observed. Longitudinal associations were reported in Commuting and Health in 
Cambridge, although these were not significant after conditioning on baseline BMI. Some of the 
deficiencies in that study (self-reported weight, no adjustment for diet, limited adjustment for other 
physical activity) were addressed by the Fenland Study. A dose-response relationship was also 
demonstrated in the Fenland Study, which is one ‘test’ of a causal association.35 
 
A consistent theme across both studies was that stronger associations were observed for cycling, 
although taken together there is some evidence that walking is important (e.g. in Fenland walking as 
usual mode of travel was associated with adiposity and in Commuting and Health in Cambridge the 
pattern of findings for walking to work whilst not significant was suggestive of an association). 
 
The findings across the two studies also underscore the potential for and benefits of incorporating 
active travel into commuting. The exposures across the two studies were different, but in each case I 
tried to identify commuters who were undertaking some active travel, either for whole or part of the 
journey to work, rather than only cycling or walking to work. 
 
The effect size estimates may appear comparatively small from an individual perspective. 
Considering the first study (for which the measures are more readily understandable), a difference in 
                                                          
xxi It is conceivable that some participants might run these distances to work on an infrequent basis. Running was not 
included in the modes of travel in the RPAQ. 
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BMI of 1.2 kg/m2 equates to a difference of 3kg for a person 1.6m or 5 feet 3 inches tall. At a 
population level such differences are important, given an average weight gain of 10kg in the US 
during the thirty years when obesity prevalence among adults has risen from around 10% to over 
35%.245,273 This suggests that increasing active commuting could be an important component of a 
strategy for reducing or preventing obesity.  
 
 
4.4.6 Future Research 
 
4.4.6.1 Active travel and adiposity 
Uncertainty remains concerning the relationship between dose (duration, intensity and frequency) of 
active travel and adiposity. Addressing this is likely to require objective measurement of active travel. 
This will also be important for understanding the different associations observed for walking and 
cycling. 
 
The commuting categories identified using the Fenland dataset have not been formally validated. 
They could be validated using the Commuting and Health in Cambridge dataset by comparing 
answers to the RPAQ with the seven-day retrospective travel record. The commuting question on the 
RPAQ has been used in other large studies, such as European Prospective Investigation into Cancer 
(EPIC) and UK Biobank. Validation may facilitate future work in such studies. 
 
4.4.6.2 Active travel and health in the Fenland Study 
The Fenland Study is longitudinal study (participants are currently being invited for follow-up 
assessment), in due course a longitudinal analysis will be possible. Before then, there are other ways 
that the Fenland analyses could be extending in the short term, notably describing the associations 
of active commuting with other risk factors for cardiovascular disease (e.g. blood pressure, serum 
cholesterol and glycosylated haemoglobin) and well-being (assessed using the Short Form 8 
questionnaire) 
 
Future work should also seek to develop methods to estimate physical activity energy attributable to 
commuting in the Fenland Study. It may be possible to develop existing methods that can estimate 
physical activity energy attributable to commuting using Actiheart®data,212 although these methods 
presently rely on using a seven-day travel record (and this instrument was not used in the Fenland 
Study).  
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4.5 Chapter summary 
 
This chapter has described the associations of active commuting with body fat and visceral adipose 
tissue in the Fenland dataset at baseline.  
 
Participants who reported active commuting (principally cycling to work among participants living 
within five miles of work and car-use combined with active commuting amongst participants living 
five miles or further from work) had reduced adiposity after adjustment for diet, other physical 
activity and other co-variates. There was also some evidence that walking for travel (e.g. walking for 
non-commuting travel) was also associated with reduced adiposity.  
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Part II 
 
Public health modelling: the estimated impact of 
increases in physical activity on need for healthcare 
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5 Modelling introduction and methods 
 
“The sustainability of the NHS now depends on a radical upgrade in 
prevention and public health”.  
NHS Five Year Forward View 
  
133 
 
5.1 Introduction 
 
The preceding chapters have described the associations between active commuting and different 
indices of health. Promoting active travel may be one approach to shift (increase) the distribution of 
physical activity. In this, the second, part of my thesis I consider the effect this might have on need 
for healthcare. Rather than consider indices of health and well-being, as I did in the first part, in this 
part of my thesis I focus on major non-communicable diseases. 
 
It appears relatively common to assume that if physical activity levels increase (or if similar changes 
are made to the distribution of other risk factors for non-communicable disease) that need for and 
consequently demand on health services should fall. However, I am not sure these assumptions have 
properly accounted for increases in life expectancy that may occur, resulting in more time lived at 
older ages when disease incidence is higher. The aim of this second part of my thesis is to begin to 
understand whether increases in survival, due to increases in physical activity, will reduce demand 
for care, principally considering the diseases for which physical activity is protective.  
 
5.1.1 Chapter overview 
This chapter introduces the modelling work. It outlines why I undertook the work and outlines the 
different pathways through which physical activity influences the number of people living with 
disease (an important indicator of healthcare utilisation) (section 5.2.1.). It discusses ambiguity in the 
use of the phrase “burden of disease”, and introduces the concept of ‘need’, as used within the 
public health literature (section 5.2.2). I argue that need is a more appropriate term than “burden of 
disease” or “healthcare utilisation” to describe what I am interested in measuring and reflects what 
can be measured. Whilst no work has directly addressed the question I set out to answer, other work 
has addressed related questions which partially address my research questions. I discuss this 
literature and its relevance to study design (section 5.2.4). I also describe the study aims, including 
research questions, and study scope (section 5.2.5). 
 
The chapter then sets out the modelling methods. It first describes the model structure before 
elaborating in detail about the different parts. It then describes the health outcomes studied (section 
5.3.3), the scenarios modelled (section 5.3.4), sensitivity and uncertainty analyses undertaken 
(including justification) (section 5.3.5), and the sources of data (section 5.3.6). 
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5.2 Background 
 
Investments in interventions to promote physical activity have to compete alongside other spending 
priorities. Practising as a public health physician I have noticed increasing pressure to “justify” 
investment in public health or preventive interventions on the grounds that they may reduce 
demand on the NHS and so reduce healthcare expenditure. This pressure was particularly noticeable 
when I worked in a Primary Care Trust (an organisation with responsibility both for delivering public 
health programmes and commissioning healthcare for its local community) from 2010 to 2012, at 
that time the NHS was seeking to make £20 billion of efficiency savings (16% of its budget) in a four 
year period.274 
 
More recently the Five Year Forward View suggested that the “sustainability of the NHS…depends on 
a radical upgrade in prevention and public health”.275 The apparent implication being that more or 
better prevention initiatives would reduce the burden of disease, reduce need for healthcare and 
reduce demand on health and social care systems. This was a reassertion of a case made over ten 
years earlier in the Wanless report, which described options for ensuring the long-term viability of a 
state funded NHS.276 Public Health England’s recent report, Everybody Active Every Day emphasised 
the costs of physical inactivity to and potential cost saving for the NHS.108  
 
The implicit logic in much of this thinking appears to be that improving the population distribution of 
a risk factor such as physical activity will reduce the incidence rate of disease, thereby resulting in 
fewer incident cases and fewer people living with disease who require care. However, this may 
overlook the importance of increased survival, more people living to an older age at which the 
incidence of many common chronic diseases is higher. 
 
5.2.1 How physical activity affects the number of people living with disease 
Increases in physical activity may affect the number of people living with disease by several 
pathways, not all of which will act to reduce the number of people living with disease (see Figure 
5.1). First a reduction in relative risk, arising from an increase in physical activity, will lead to a 
reduction in the incidence rate of disease. For a fixed number of people at each age, this will result in 
fewer incident cases of diseases and consequently fewer people living with disease. I term this the 
‘incidence effect’. 
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Figure 5.1 How increases in physical activity may affect the number of people living with 
cardiovascular disease  
 
A second opposing effect, is one I term the ‘population ageing effect’ (shown in yellow in Fig 1). If the 
incidence rate of a specific disease (and of chronic disease in general) decreases, the attributable 
mortality will also decrease, resulting in greater life expectancy and more people living to an older 
age. Because the incidence rate of many chronic diseases increases with age,277–279 this will result in 
an increase in the absolute number of incident cases, and therefore also in the number of people 
living with disease. 
 
A third effect may also occur, which I will term the ‘disease survival effect’. Physical activity may 
increase disease-specific survival, for example it is used as a treatment for some diseases, such as 
ischaemic heart disease.53 The average duration of disease survival will increase, resulting in more 
people living with disease. It will also contribute to population ageing. Consequently, when 
considering these later two effects (‘population ageing’ and ‘disease survival’), it is no longer clear 
whether and the extent to which increases in physical activity will be associated with reductions in 
the number of incident cases or the number of people living with disease. 
 
From an individual perspective all three effects are a form of health gain. Respectively they result in 
reduced risk of disease onset, increased life expectancy, increased disease-specific life expectancy 
(and likely an associated reduction in disease severity). However, my interest is in exploring their 
cumulative effect at the population level as it applies to the burden of disease that impacts on health 
and social care. 
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5.2.2 Burden of disease and healthcare utilisation 
The term “burden of disease” may be used in different ways. Sometimes it refers to a comprehensive 
assessment of the health status of a population, including a diverse set of metrics (e.g. life 
expectancy, disability adjusted life years (DALYs), contribution of risk factors to DALYs).280,281 
Sometimes it is used to refer to the quantity of disease in a population, reflecting the literal meaning 
of burden. Used in this way it is commonly linked to demand for healthcare.282  
 
My interest and focus is in the ‘quantity’ definition, with a specific focus on measures of quantity that 
relate to healthcare. I think this is best captured by the concept of ‘need’, as defined within the 
health needs assessmentxxii literature.283–285 
 
5.2.3 Definition of need 
“Need”, within this literature, is defined as a capacity to benefit from healthcare interventions. There 
are different types of need (e.g. felt, expressed, normative).283–285 Normative need is what health 
professionals identify as need, i.e. based on clinically recognised disease states. In contrast expressed 
(or felt need) is what individuals identify as their need for care. Whilst the latter may be a better 
indicator of demand for healthcare, it is the former that aligns with the defined disease states that 
are outcomes of epidemiological studies describing the association between physical activity and 
disease. For this reason I have chosen to focus on normative need for healthcare rather than demand 
(i.e. expressed or felt need) for healthcare. 
 
5.2.3.1 Epidemiological approach to needs assessment 
Furthermore, I draw on the epidemiological approach to a needs assessments, i.e. using 
epidemiological parameters to quantify need for healthcare.284 Some of these indices may be 
relatively crude (e.g. prevalence, incidence, disease-specific mortality), whereas others may be more 
tightly linked to healthcare utilisation (e.g. admissions, procedures, consultations). 
 
I will limit my indices of need for healthcare to incidence and prevalence (or related measures), in 
part reflecting the existing literature on physical activity and health and part because these two 
indices capture the two broad patterns of disease presentation: chronic disease with ongoing 
                                                          
xxii A health needs assessment (HNA) is a systematic approach to identifying met and unmet healthcare needs of a 
population, which can be used to plan the provision of health services 
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presentation over many years and acute (including sub-acute) presentation where significant 
resources are invested at or around the time of diagnosis. 
 
5.2.4 Summary of existing research 
There is limited research which has explored the extent to which risk factor modification or 
preventive interventions can reduce need or demand for health care. 
 
5.2.4.1 Literature on expansion and compression of morbidity 
The question I pose could be reframed as whether increases in physical activity are associated with 
disease events being postponed or reduced (or even increased). These questions have been explored 
before, most often making reference to disease expansion and disease compression. Respectively 
these refer to an increase and a decrease in the mean duration an individual person lives with 
disease or disability.286–288 Diseases compression implies a reduction in disease burden on individuals 
and reduction in the need for healthcare.  
 
Authors have tended to argue that that changes in behavioural risk factors or other preventative 
measures will both postpone the onset of disability and reduce total disability.288 However this 
literature is focused on measures of total disease or disability (i.e. aggregating across all disease 
states), so gives an incomplete description of changes or differences that may happen at the level of 
individual diseases, which might be different. It also overlooks the potential effect of behaviours on 
survival (e.g. physical activity is used to improve survival after a diagnosis of myocardial infarction).53 
Medical treatments, in contrast to prevention, by improving survival and if not curative, may result in 
disease expansion.288  
 
More generally the focus of much of this literature is understanding how patterns of health and 
disease have changed in the past or may change in the future, rather than understanding the 
potential effect of changes in particular risk factors.286,287,289  
 
5.2.4.2 Observational studies 
A few observational studies have reported inverse associations between physical activity and 
healthcare utilisation.152,153,290 However these studies were either cross-sectional or had a short 
period of follow-up. The findings could be explained by reverse causation, poor health status limited 
physical activity. These studies do not adequately account for disease events that have been 
postponed past the period of observation. 
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5.2.4.3 Modelling studies 
Modelling studies138 that model ageing or time may be a more appropriate means to understand the 
effect of increasing longevity than cohort studies. To fully understand the effect of increased 
longevity a long period with complete follow-up until death is needed to capture all disease events 
that are postponed, which may not be practical in a cohort study. However, it is possible to model 
such complete follow-up until death. To date these studies have seldom been used to describe the 
effects of changes in physical activity on need for healthcare.291–296 They have tended to focus on 
single diseases, often cardiovascular disease,292–294 and so may not adequately consider how one 
disease may affect another disease (e.g. changes in dementia incidence may be brought about by 
reduced incidence of and increased survival from cardiovascular disease). They report only a single 
measure of healthcare need, i.e. average years lived with disease or disability, which offers a limited 
perspective on need for healthcare. Time lived with disease may change because the average 
duration of illness changes or because the number of incident events may change, which may have 
implications for need for healthcare (e.g. acute care and chronic disease management). 
 
A popular health impact modelling technique is comparative risk assessment.19,21,125,143,297 This 
approach does not make allowance for changes in life expectancy and so risks overestimating the 
benefits that may accrue in terms of reduction in disease prevalence or incident events. A secondary 
aim of this part of my thesis is to understand the extent to which comparative risk assessment 
models may overestimate the benefits attributable to reductions in physical activity. 
 
5.2.5 Study aims and scope 
The aim of the modelling research is to contribute to a richer understanding of how physical activity 
may affect disease in a population as it relates to health and social care, making allowance for 
changes in longevity. I am primarily interested in diseases for which regular physical activity is 
protective and do not consider in detail diseases whose incidence is independent of physical activity 
(e.g. some cancers) but whose incidence rises with age.  
 
5.2.5.1 Research questions 
My research questions are: 
1) What is the modelled effect of increases in physical activity in a population on changes in 
indices of need for health or social care, considering individual diseases for which physical 
activity is protective, when allowance is made for the effect of physical activity on survival? 
2) How do these estimates compare with estimates that do not make allowance for changes in 
survival? 
3) When allowance is made for increased survival do indices of need still decrease? 
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5.3 Methods 
 
The model consists of two parts: a microsimulation model and a proportional multistate life table 
model. As I stated in Chapter One, I will predominantly refer to the model as a life table model as this 
is the part which describes health impacts. 
 
A schematic overview of the model is show in Figure 5.2. Data inputs are shown in orange, the two 
parts of the model (microsimulation and multistate life table model) are shown in green, and the key 
model outputs are shown in red. The microsimulation model, which describes the effect of changes 
in physical activity on disease risk at the individual level, is used to estimate population impact 
fractions. The estimates of population impact fraction are ‘inputs’ for the proportional multistate life 
table model, and describe the change in incidence or case fatality attributable to changes in physical 
activity. The multistate life table model has two component parts, disease specific life tables and a 
general life table model. The former is used to estimate the prevalence and incidence (rate) of 
disease, and the latter to estimate the number of people alive. By multiplying prevalence and 
incidence rate by the number of people alive, one can estimate the total number of people living 
with disease and the number of incident cases. 
 
Below, I first describe the two parts of the model (microsimulation and life table) in more detail. I 
then describe the outcomes, scenarios modelled, sensitivity and uncertainty analyses and finally data 
sources. 
 
5.3.1 Microsimulation model 
I simulated a population of 8,118 adults based on the Health Survey of England 2012 sample, which is 
representative of the English adult (aged 16 years and over) population in terms of age and sex.298 
Each individual’s physical activity level was related to their disease risk (see Figure 5.3), and could 
change independently. Changes in physical activity for any individual were modelled as movement 
along the physical activity relative risk curve. By summing together these changes for multiple 
individuals, I estimated the mean change for sub-populations (defined by age or sex), expressed as 
population impact fractions. The modelling of the relationship between physical activity and disease 
risk, as well as the calculation of population impact fractions are described in more detail below.  
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Figure 5.2 Schematic outline of model 
 
PIF = population impact fraction 
 
 
5.3.1.1 Modelled relationship between physical activity and disease risk 
Most studies report a curvilinear relationship between physical activity and disease or mortality, 
although different approaches have been used to mathematically describe the relationship between 
physical activity level and disease risk (e.g. log linear, square root transformation).43,44,110,299  
Following the approach used by others,142 I assumed changes in risk of disease to be log linearly 
associated with a power transformation of the physical activity exposure, where the power 
transformation take a value of 0.5 (range 0.25 to 1.0 with a triangular distribution) for all 
relationships, following the range used within the Integrated Transport and Health Impact Modelling 
tool (ITHIM).125  
 
This relationship can be written as follows: 
RR = a(PA dose/b)^t 
Where RR=relative risk, PA dose=physical activity dose measured in marginal MET-hours, t=power transformation, a is the reported relative 
risk from the meta-analysis, b is the physical activity level at which the reported relative risk occurred. 
 
Examples of this relationship are shown in Figure 5.3. Where possible I took estimates of relative risk 
and physical activity level (parameters a and b) from the original ITHIM model.125 Where estimates of 
the these parameters were not given in the work of Woodcock et al,125 I sought estimates from the 
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literature. The search strategy and data extraction technique are explained later in the chapter 
(Section 5.3.6.2). 
 
Figure 5.3 Example relationship between physical activity level and relative risk 
 
In this example, a=0.80, and b=10 marginal MET-hours 
 
5.3.1.2 Calculation of population impact fraction 
Population impact fractions were estimated by a weighted sum of the ratio of the relative risk 
observed under each scenario of interest compared to baseline. First relative risks were calculated 
under the baseline scenario (no change in physical activity) for each individual and then under the 
alternative or counterfactual scenario (an increase in physical activity levels) for each individual.  
 
The population impact fraction was then estimated as:  
 
 
 
Where PIF is the Population Impact Fraction, RRi’ is the relative risk under the counterfactual 
scenario and RRi is the relative risk under the baseline scenario. This is a similar approach to 
estimating a Population Attributable Fraction (PAF).  Although when estimating a PAF the ‘scenario’ 
is eliminating that risk factor.300  
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5.3.2 Proportional multistate life table model 
A proportional multistate life table model was used to estimate the effect of changes in physical 
activity on population health and survival. The technique been adopted by others to model the effect 
of physical activity,292,301 or other risk factors, on health.291,302 
 
5.3.2.1 General description of proportional multistate life table 
The proportional multistate life table was first described by Barendregt et al.303 It consists of two 
parts: a general life table and a set of disease life tables. The general life table very closely resembles 
the life table first described by John Graunt in the 17th Century.304 The table consists of two states: 
dead and alive, with transitions describing the hazard or probability of moving from one state (‘alive’) 
to the other state (‘dead’). This probability is age and sex dependent.  
 
The size of the population alive at the end of the first year of life is thus the starting or birth 
population multiplied by the probability of death in that first year of life. The population alive at the 
end of the second year of life is thus the population alive at the end of the first year of life multiplied 
by the probability of death in the second year of life. These calculations continue through to the 
upper limit of the life table, typically 100 years, above which transition hazards tend not to be 
reported. Thus the general life table describes the survival of a cohort from birth through to death or 
some fixed upper limit.  
 
The disease life tables are similar. It has three states: alive and living without disease; alive and living 
with disease; and dead. Transition hazards (incidence, remission and case fatality) are used to 
describe the probability of moving between states in any given year of life. Within each disease life 
table mortality from all other causes is assumed to be zero. In other words the disease life tables only 
considers mortality that is attributable to the diseases being modelled in that life table. These 
hazards are age and sex dependent. 
 
A similar process is followed to estimate the number of people in each state. The size of the 
population with disease at the end of the first year of life is thus the starting or birth population 
multiplied by the probability of disease incidence in that first year of life. The population with disease 
at the end of the second year of life is thus the population alive at the end of the first year with 
disease less those who died from disease (those alive with disease at the start of that year multiplied 
by case fatality in that year of life) and less those who recovered (those alive with disease at the start 
of the year multiplied by remission in that year).  
143 
 
Assuming independence (i.e. that disease incidence is independent and that causes of death are 
independent), the disease life table provides an unbiased estimate of disease prevalence and 
disease-specific mortality. Prevalence at any age is estimated by the number alive with disease 
divided by the total population alive, and mortality by dividing the number of deaths in that year by 
the population living with disease at the start of that year. 
 
Scenarios are modelled by applying a new set of transition hazards to the disease life tables 
(incidence, remission and case fatality). These changes will lead to a new estimate of the disease-
specific mortality by age and sex. Changes in disease-specific mortality are summed to give an overall 
estimate of the change in mortality. These are added to the mortality hazards in the general life 
table, to calculate a new set of hazards (by age and sex), which describes the survival of the cohort 
under the given scenario.  
 
5.3.2.2 Application of proportional multistate life table model 
I assumed no disease remission or recovery, so that the disease life table only made use of two sets 
of transition hazards (incidence and case fatality). 
 
As others have done,301 I did not allow changes in type 2 diabetes mortality to affect changes in 
overall mortality. This was to prevent a violation of the assumption of independence. Type 2 diabetes 
is a direct cause of ischaemic heart disease and stroke, so its full inclusion in the model (i.e. in a way 
that would affect mortality) would undermine the assumption. It also avoided the risk of double 
counting, as these forms of mortality are already considered within the model.  
  
5.3.2.3 Diseases included in model 
I included diseases if: a) the disease was an important cause of morbidity or mortality; b) disease 
incidence was reduced by physical activity according to consensus; and c) estimates of the relative 
risk could be extracted from published meta-analyses. I defined consensus as being included in the 
physical activity guidelines from three of the following four countries: Australia, Canada, UK and 
USA.41,64,65,88 
 
Diseases included were ischaemic heart disease, stroke, type 2 diabetes, dementia, colon cancer and 
breast cancer. The nature and strength of the evidence base concerning the relationship between 
physical activity and these health outcomes was described in Chapter 1 (section 1.2.3). For all these 
diseases, I assumed that physical activity affected risk of disease incidence. For ischaemic heart 
disease, breast cancer and colon cancer, I additionally assumed that physical activity affected disease 
survival. 
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Depression was not included because the existing meta-analyses described the association between 
physical activity and depression score, rather than incident depression, effectively treating mood as a 
continuous trait.305 The multistate life table model cannot readily handle continuous traits as it is a 
Markov type model with discrete states. The parameters in published meta-analyses could not 
readily be transformed into relative risk of disease incidence (or remission). 
 
I assumed that physical activity did not affect survival from a stroke, dementia or diabetes. For 
stroke, whilst physical activity is recommended after stroke, the nature of the activity has to be 
tailored to the individual and any residual disability, it is advocated primarily as a means to improve 
functional performance and quality of life, and I found no evidence (either observational 
epidemiology or randomised controlled trials) that quantified the relationship between physical 
activity after stroke and mortality due to stroke.306,307 For dementia, I found no studies (either 
observation or randomised controlled trials) that quantified the relationship between physical 
activity after a diagnosis of dementia and subsequent mortality from dementia.  
 
As discussed earlier (see section 5.3.2.2), I have not included a direct effect of physical activity on 
diabetes related survival, because much of the mortality attributable to diabetes occurs through 
ischaemic heart disease and stroke, and modelling diabetes in this way would likely violate the 
underlying assumptions of a proportional multi-state life table model.303  
 
5.3.3 Outcomes 
I chose two primary indices of healthcare need: number of people living with disease and number of 
incident cases.283,284 As discussed in the previous chapter (section 5.2.3.1) epidemiological 
parameters may be used to assess need for healthcare, with different parameters assessing different 
aspects of need.283–285 The former outcome (number with disease) may be an important indicator of 
need for healthcare for diseases that require continuous input throughout life (e.g. type 2 diabetes). 
The latter may be an important indicator of need for diseases that require significant input around 
the time of diagnosis (e.g. cancer). Some diseases may have elements of both (e.g. stroke).  
 
To ensure I recorded disease that was postponed until later life, a cohort was followed from birth to 
death (or 100 years of age). Measuring the two indices (number with disease and incident cases) 
across the life of the cohort gave two outcomes: person-years lived with disease and total incident 
cases.  
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I estimated the person-years lived with disease by summing the product of the age-specific 
prevalence (taken from the disease life table) and the number of people alive at each age (taken 
from the general life table). I estimated total incident cases by summing the product of the age-
specific disease incidence (taken from the disease life table) and the number of people alive at that 
age. I then estimated percentage change under the scenario being studied (relative to baseline) for 
these two outcomes.  
 
To compare these estimates with measures that do not make allowance for increasing life 
expectancy, I used comparative risk assessment (CRA) methods to estimate the change in person-
years with disease, by summing the product of: the age-specific prevalence (at baseline), the number 
of people alive (at baseline) and the population impact fraction.143,300 I then estimated the 
percentage change relative to baseline. I have called this metric ‘person-years with disease 
(unchanged life expectancy)’.  
 
I also estimated the change in life expectancy for each scenario using the general life table (the total 
number of person-years lived during the life of the cohort divided by the total population). 
 
5.3.4 Scenarios 
For all scenarios, I assumed that physical activity only changed for adults (people aged 16 years and 
over). Physical activity levels for children were thus assumed to be unchanged. This reflected the 
microsimulation model which only described the effect of physical activity on disease for people aged 
16 years and over.  
 
I explored two scenarios where the levels of physical activity that adults achieved changed. The 
primary scenario was based on all adults meeting the UK adult physical activity (PA) guidelines, which 
I labelled as “all adults meeting PA guidelines”.63 I assumed this was achieved by walking for 150 
minutes on flat ground at 3mph (equivalent to 3.3 MET; i.e. at relatively low intensity within the 
range of values for intensity that correspond to moderate intensity). The walking scenario was 
chosen as it is likely to be the most feasible way for the population to meet this goal (as outlined in 
the introductory chapter). This ‘dose’ of physical activity is equivalent to 5.75 marginal MET-hours 
per week (see section 5.3.6.1 for full explanation of marginal MET-hours). Those individuals who 
were already undertaking at least this amount did not change their physical activity level, all other 
individuals increased their physical activity level to 5.75 marginal MET-hours. Thus meeting physical 
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activity guidelines was defined as undertaking at least 5.75 marginal MET-hours of physical 
activity.xxiii 
 
The secondary scenario was labelled ‘all adults increase’, in which I assumed that all adults, 
irrespective of their current physical activity level, increased their physical activity by 5.75 marginal 
MET-hours, i.e. the existing distribution of physical activity shifted 5.75 marginal MET-hours to the 
right without changing in shape. I also modelled the effect of everyone increasing by half this amount 
(2.875 marginal MET-hours, equivalent to 75 minutes walking or similar MVPA per week) and 50% 
more than this amount (8.625 marginal MET-hours, equivalent to 225 minutes of walking or other 
MVPA per week). I label these ‘all adults increase PA (150 minutes walking)’, ‘all adults increase PA 
(75 minutes walking)’, and ‘all adults increase PA (225 minutes walking)’ respectively. Whilst other 
changes in physical activity would result in equivalent changes, for simplicity the labels for the 
scenarios reflect change in walking. 
 
5.3.5 Uncertainty and sensitivity analyses 
Uncertainty and sensitivity analyses are often ill-defined and overlap. I use the term ‘uncertainty 
analysis’ to refer to techniques that quantify uncertainty surrounding the model’s parameters and 
structure, and ‘sensitivity analysis’ to refer to techniques that identify which explicit assumptions 
are critical to the model (in terms of having a significant impact on the model outcome).138 
 
I used Monte Carlo analyses (a form of uncertainty analysis) to estimate ‘95% uncertainty intervals’ 
that quantify the effect of parametric uncertainty on point estimates. These are similar to, but are 
different from, 95% confidence intervals. I used tornado plots (as a form of sensitivity analysis) to 
describe the relative importance of different sources of parametric uncertainty on the three 
outcomes. I made changes to the model’s structure to examine the effect of structural uncertainty 
(i.e. the effect of making different assumptions concerning the model’s structure or configuration), 
which could be described as either a sensitivity analysis or an uncertainty analysis. I only undertook 
uncertainty and sensitivity analyses for the primary scenario (‘meeting guidelines’). 
                                                          
xxiii The guidelines are expressed in minutes rather than marginal MET-hours. Undertaking 5.75 marginal MET-hours of 
physical activity may be equivalent to meeting the guidelines for most individuals but is not exactly the same. One hour of 
intense activity (e.g. at 10 METs) would exceed 5.75 marginal MET-hours, but would not meet the recommendation of a 
minimum of 75 minutes or vigorous activity. 
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5.3.5.1 Monte Carlo analyses to estimate uncertainty intervals 
I estimated 95% uncertainty intervals (2.5th to the 97.5th percentile) from 5000 iterations of a Monte 
Carlo analysis. Testing of model convergence (repeatedly running the model with increasing number 
of iterations) showed that 5000 iterations produced stable estimates for the uncertainty intervals.  
 
I modelled uncertainty for three sets of parameters: the power transformation; the association of 
physical activity with relative risk of disease incidence; the association of physical activity with 
relative risk of case fatality. For each iteration a random value was drawn from the described 
distribution for each parameter, i.e. a normal distribution for all parameters except for the power 
transformation was assumed to have a triangular distribution.  
 
5.3.5.2 Tornado Plots 
To test the relative importance of the different sources of parametric uncertainty, tornado plots 
were constructed for the following outcomes: change in person-years lived with disease, change in 
total incident cases and for change in life expectancy. Plots were constructed for each of the six 
diseases.  
 
Tornado plots are a special type of bar chart, where the bars are arranged horizontally and in order 
of size. Typically the largest bar is at the top and the smallest bar at the bottom so that the diagram 
forms a visual ‘tornado’. Tornado plots are a common means to undertake ‘deterministic sensitivity 
analyses’, where the relative importance of variation in different parameters is compared. Used in 
this way each bar represents the range of outcome values expected consistent with the reported or 
described uncertainty for the given input. The inputs whose uncertainty contributes most to 
uncertainty in the outcome will have the largest bars and thus be at the top of the diagram. The 
tornado plot is centred around the mid-point (median) estimate for all parameters.  
 
The 95% confidence interval for parameters were used to describe variation in most parameters, 
except for the power transformation where the 2.5th and 97.5th percentile were taken from the 
(triangular) distribution of values used as inputs to the modelling. 
 
5.3.5.3 Testing Structural Uncertainty 
I examined structural uncertainty by making changes to the model structure (omitting, adding or 
changing parts of the model). These changes, and the rationale for their choice, are summarised in 
Table 5.1.  
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Table 5.1 Structural changes to model 
Name of model variant Description Rationale for change 
Cancer Survival 
(no effect) 
Physical activity does not 
affect cancer case fatality 
An association between physical activity and cancer survival 
was reported in observational studies and could be explained 
by confounding by indication rather than a true effect of 
physical activity on survival. 
No lag No lag was assumed 
between physical activity 
and its effect on disease 
risk 
There is very little published information on the duration of 
lags and I wanted to explore the extent to which lags affected 
the model outcomes. 
Leisure only  Only walking, sport and 
recreational physical 
activity contribute to 
baseline physical activity 
Current epidemiological studies of physical activity and 
disease, predominantly considers either leisure time physical 
activity or walking (and thus excluded domestic, transport 
and occupation activity). Including these other types of 
physical activity results in an overestimate of baseline 
physical activity and consequently an underestimate of the 
effect of increases in physical activity on health.  
Cancer Incidence Physical activity reduces 
the risk of incidence of 
other cancers 
There is good evidence that physical activity affects the 
incidence of other cancers.  
Mortality Physical activity has a direct 
effect on all-cause mortality 
(i.e. on the general life 
table) rather than through 
its effect on each disease 
The effect of physical activity on all-cause mortality may be 
greater than the effect attributed by modelling the effect 
through each disease 
 
Changes to cancer survival were made because I was concerned that the associations were based on 
observational studies of cancer survival and might be influenced by confounding by cancer severity 
(cancer severity being associated with physical activity and survival). Other changes were chosen 
because they would result in a greater population ageing effect (i.e. increased all-cause survival). 
Early work with the model suggested that the estimates of increases in physical activity on changes in 
life expectancy were low compared to other estimates. I made three changes to the model to 
‘enhance’ the effect of physical activity on disease incidence and all-cause survival.  
 
First, I recalculated the baseline levels of physical activity to only include leisure activity (sport, 
recreation and walkingxxiv). This resulted in a lower estimate of baseline levels of physical activity,  
and because the effect of physical activity is greatest amongst the least activexxv, lower baseline 
levels of physical activity would be expected to lead to greater improvements in health. This 
approach may be more appropriate. The studies that estimated the association between physical 
activity and disease risk (see section 5.3.6.2) tended to only consider walking or leisure time physical 
activity. The baseline levels of physical activity in these studies was relatively low compared to the 
                                                          
xxiv The questionnaire did not distinguish between walking for travel and walking for leisure. The definition of leisure physical activity thus 
still includes walking for travel and so may overestimate leisure time physical activity. 
xxv This is represented in the dose-response relationship between physical activity and relative risk. Steep initial decline in risk, followed by 
flattening of the curve, see Figure 5.3. 
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baseline levels of physical activity estimated for the English population in the microsimulation model, 
which including all domains of physical activity (occupation, domestic, travel and leisure). 
 
Second, I assumed that physical activity reduced the incidence of other cancers (lung, prostate and 
pancreatic). Whilst not incorporated into some physical activity guidelines,41,63,65 a recent review 
highlighted new evidence of associations between physical activity and risk of several other 
cancers.69 For three major cancersxxvi (pancreatic, prostate and lung) the evidence of a causal 
association was described as “probable” or “possible”.69 It seems plausible that the effect of physical 
activity on disease is not limited to the six diseases that I initially chose to incorporate into the 
model. The incorporation of these other cancers may be considered a broader test of the extent to 
which including more diseases affects the model outcomes. For lung cancer I assumed that physical 
activity only affected lung cancer attributable to smoking, in keeping with recent findings.308,309 Given 
the attributable fraction for smoking with respect to lung cancer is 80%,310 I assumed the incidence of 
lung cancer that was attributable to smoking was 80% of all reported lung cancer incident cases of 
lung cancer. 
 
Finally, I modelled the effect of physical activity on mortality directly, rather than indirectly through 
its effect on different diseases. I refer to this as the ‘mortality model’. This also resulted in an 
enhanced effect of physical activity on all-cause survival (although not on disease incidence). 
 
5.3.5.4 Mortality Model 
A schematic overview of the mortality model is set out in Figure 5.4. In the mortality model physical 
activity has a direct effect on mortality as modelled in the general life table (shown by the line going 
directly from the green microsimulation box to the general life table box, Figure 5.4), and the 
corresponding links describing the indirect effect of physical activity on mortality through the 
different diseases (i.e. the link between the disease life tables and general life tables is lost). In doing 
this the model violates the principle that changes in all-cause mortality are estimated from the 
summing of change in each disease-specific mortality, described in the original proportional 
multistate life table model.303 However similar models have been described in which physical activity 
affects all-cause mortality and affects disease incidence.292,311   
 
                                                          
xxvi Together with colon and breast cancer, these three cancers are the cancers responsible for the most deaths in the UK.367 
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Figure 5.4 Schematic outline of mortality model 
 
PIF = population impact fraction; Ix = incidence; CFR = Case Fatality Rate 
 
5.3.6 Data 
The model had four principles data inputs: physical activity levels; relationship between physical 
activity and disease; transition hazards (incidence and case fatality) for the disease life tables; 
mortality for the general life table. In all cases I sought data that were representative of the English 
population.  
 
5.3.6.1 Physical activity level 
Physical activity level was defined as the product of duration and intensity of physical activity. 
Estimates of the duration and type of physical activity were taken from the Health Survey for England 
2012.298 Estimates of the intensity of each type of physical activity were taken from the Compendium 
of Physical Activity.213 
 
The Health Survey for England in 2012 included the International Physical Activity Questionnaire 
(IPAQ).312 The questionnaire seeks information on the type, duration, frequency and sometimes 
intensity of all forms of physical activity undertaken in the past four weeks. Weekly duration of each 
activity was estimated by multiplying the weekly frequency by the reported average duration of 
activity.  
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Each activity was assigned a value of intensity or energy expenditure, measured in metabolic 
equivalent of taskxxvii, taken from the Compendium of Physical Activity.213 I included the following 
types of physical activity: occupational (walking, stair climbing, lifting), domestic (housework and 
gardening), travel (walking) and recreational. Where the activity described in the IPAQ did not clearly 
map to an activity in the Compendium of Physical Activities, I identified a set of activities that could 
fit the description of the physical activity recorded in the IPAQ, and took an average (median) value 
of those activities. These values are shown in Table 5.2. I only included physical activity that was 
moderate or vigorous intensity (i.e. ≥ 3 MET). This is because the large empirical evidence base that 
considers moderate-to-vigorous physical activity, which was used to parametrise my model.41,63,65 
 
I then converted these measures of intensity, in MET, to marginal-MET, by subtracting one MET. 
This is an adjustment made by some authors that discounts energy expenditure due to basal 
metabolism (as this level of expenditure would occur independent of physical activity).125 Using 
marginal-MET instead of MET results in low intensity activities undertaken for a long period of time 
‘scoring’ less.  
 
5.3.6.2 Relationship between physical activity and disease 
As described in earlier section of this chapter (section 5.3.1.1), I modelled the relationship between 
physical activity level and relative risk as a log linear relationship with a power transformation. The 
relationship between physical activity level and relative risk was partly defined by estimates of 
relative risk (parameter labelled ‘a’) and the corresponding ‘dose’ of physical activity (parameter 
labelled ‘b’).  
 
The parameters ‘a’ and ‘b’ were extracted from published meta-analyses of cohort studies or 
randomised controlled trials. This data is summarised in Table 5.3. Where possible, I took the 
parameters ‘a’ and ‘b’ from the original Integrated Travel and Health Impact Modelling (ITHIM) tool, 
published in 2009).125 Where this was not possible, I undertook a literature review to identify suitable 
parameters. The theoretical basis for the inclusion of diseases was outlined in section 5.3.2.3. 
 
  
                                                          
xxvii One metabolic equivalent of task (MET) is the amount of oxygen consumed whilst sitting at rest, and is equal to 3.5 ml per kg per 
minute. MET are used a measure of physical activity energy expenditure (or intensity). The energy expenditure of the activity is estimated 
by dividing its energy cost (ml of O2 per kg per minute) by 3.5.266 An activity with an energy expenditure of 3.00 to 6.00 MET is categorised 
as moderate intensity, and an activity with an energy expenditure greater than 6.00 MET is categorised as vigorous.24 
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Table 5.2 Estimates of intensity of different activities 
Activity in IPAQ Assigned Physical 
Activity Intensity 
(MET) 
How assigned value was estimated (numbers refer to code used in 
the Compendium of Physical Activity) 
Occupation   
Occupation, Walking at 
work 
3.5 Median value of the following codes: walking on the job at speeds of 
less than 2mph to 3.5mph (11791, 2.0 MET; 11792, 3.5 MET; 11793, 
4.3 MET), and walking on the job carrying light objects (11795, 3.5 
MET). 
Occupation, Climbing 
stairs/ladders  
6.3 Median value of the following codes: carrying light load upstairs 
(17026, 5.0 MET), stair climbing or climbing a ladder (17130, 8.0 
MET), stair climbing at a slow pace (17133, 4.0 MET), stair climbing 
at a fast pace (17134, 8.8 MET), climbing hills with no load (17033, 
6.3 MET). 
Occupation, Lifting, 
carrying or moving heavy 
loads 
7.5 Median of walking or standing whilst carrying objects weighing from 
25lbs to 100lbs or more (11820, 5.0 MET; 11830, 6.5 MET; 11840, 
7.5 MET; 11850, 8.5 MET), loading and unloading truck (11766, 6.5 
MET), standing and continuously lifting items (11615, 4.5 MET), 
carrying heavy loads (11050, 8.0 MET), moving boxes (11060, 8.0 
MET), and moving or carrying objects of 75lbs or more (11490, 7.5 
MET) 
Domestic   
Heavy housework 3.5 Median of multiple household tasks at light (05025, 2.8 MET), 
moderate (05026, 3.5 MET) and vigorous intensity (05027, 4.3 MET) 
Heavy manual work at 
home (DIY, gardening or 
building work) 
4.15 Median of gardening – general (08245, 3.8 MET), and home repair at 
light (06126, 2.5 MET), moderate (06127, 4.5 MET) and vigorous 
intensity (06128, 6.0 MET). 
Walking at a brisk or fast 
pace (4mph or greater) 
3.9 Median of walking on a flat surface from 2.5mph to 4mph (17170, 
3.0 MET; 17190, 3.5 MET; 17200, 4.3 MET; 17220, 5.0 MET) 
Sport   
Swimming 6.0 Swimming general (18310) 
Cycling 6.8 Bicycling to/from work, self-selected pace (01015) 
Working out (e.g. weight 
training or exercise bike) 
6.0 Median of exercise bike (02010, 7.0 MET), weight lifting (02030, 6.0 
MET), and calisthenics (02020, 3.8 MET) 
Aerobics, keep fit and 
gymnastics 
7.3 Aerobics (03015, 7.3 MET) – assume this is predominantly 
aerobics/keep fit rather than gymnastics 
Dancing 5.0 Ballet, modern, jazz or general dancing (03010) 
Running or jogging 8.4 Median of jogging in general (12020, 7.0 MET) and running at 6mph 
(12050, 9.8 MET) 
Football or rugby 7.65 Median of soccer – competitive (15605, 10.0 MET), soccer – casual 
(15610, 7.0 MET), rugby – competitive (15560, 8.3 MET), and rugby – 
non-competitive (15562, 6.3 MET) 
Badminton or tennis 7.0 Median of tennis – general (15675, 7.3 MET), badminton – social 
(15030, 5.5 MET) and badminton – competitive (15020, 7.0 MET) 
Squash 7.3 Squash general (15652) 
Exercises (e.g. press ups) 8.0 Calisthenics (02020) 
Any other sport 6.0  
Travel   
Walking Dependent on 
speed  
Slow = 2.5 MET (17152) was discounted unless the participant was 
aged over 65 years and reported breathlessness on walking, in which 
case I assumed this was equivalent to achieving moderate intensity 
physical activity; average pace = 3.0 MET (17170); fairly brisk = 3mph 
= moderate pace = 3.3 MET (17190); fast pace = 4.0mph = 5.0 MET 
(17220) 
MET= Metabolic Equivalent of Task; raw values in column three were taken from the compendium of physical activity.213 
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Table 5.3 Summary of parameters characterising the relationship between physical activity 
and risk 
Disease Study  Relative Risk (95% CI) Physical 
activity level 
(marginal 
MET-hours 
per week) 
Standardised 
Relative Risk 
Lag (years) 
Incident Disease      
Breast cancer Monninkhof et al, 
2007313 
0.94 (0.92-0.97) 3.5 0.97 1-30 
Cardiovascular 
disease  
 
Hamer et al, 
2008129 
0.84 (0.79-0.90) 5.4 0.94 1-5  
Colon Cancer Harriss et al, 
200968 
Men: 0.80 (0.67-0.96) 
Women: 0.86 (0.76-0.98) 
Men: 23 
Women: 14 
0.98 
 
 
1-30 
Diabetes Jeon et al, 2006314 0.83 (0.75-0.91) 10 0.94 1-5  
Dementia Hamer et al, 
2009315 
0.72 (0.60-0.86) 24.5 0.95 1-30 
Lung cancer Buffart et al, 
2014309 
0.82 (0.77-0.87) 21 0.97 1-30 
Pancreatic cancer O’Rorke et al, 
2010316 
0.72 (0.52-0.99) 24 0.95 1-30 
Prostate cancer Liu et al, 
2011317 
0.90 (0.84-0.95) 28 0.98 1-30 
Case Fatality      
Breast cancer Schmid et al, 
201467 
0.72 (0.60-0.85) 24 0.94 1-5 
Colon cancer Schmid et al, 
201467 
0.61(0.40-0.92) 11 0.89 1-5 
Ischaemic Heart 
Disease 
 
Heran et al,  
2011 53 
0.87 (0.75-0.99) 6 0.90 1-5  
Standardised relative risk is the relative risk re-calculated for an increase of one marginal MET-hour per week. Estimates of relative risk 
were taken from meta-analyses of cohort studies, with the exception of case fatality from ischaemic heart disease, which was taken from a 
meta-analysis of randomised controlled trials. 
 
These literature reviews are described below. Once suitable studies were identified not only was it 
necessary to extract a measure of relative risk, but also to describe the dose of physical activity at 
which that relative risk occurred. The process of estimating that dose is also described below. 
 
Estimates of relative risk of disease incidence for the main model 
For estimates of the relative risk of incidence for ischaemic heart disease, stroke, type 2 diabetes, 
breast cancer, colon cancer and dementia were taken from ITHIM.125 A systematic review undertaken 
as part of the development of ITHIM had identified and extracted relevant parameters based on 
cohort studies describing the relationship between physical activity and disease incidence.125  
 
Literature search to describe the effect of physical activity on disease survival 
For estimates of other cancers (i.e. prostate cancer, pancreatic cancer and lung cancer), which were 
included only within sensitivity analyses (see section 5.3.5.3), and were not included in ITHIM, I 
undertook a literature review to identify suitable estimates of relative risk.  
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I identified studies that described the effect of physical activity on disease survival using the 
following search terms in Pubmed on 1 April 2015: “systematic review” or “meta-analysis” and 
“physical activity” or “exercise” and “incidence” or “relative risk” and “prostate cancer” or 
“pancreatic cancer” or “lung cancer”. The identified meta-analyses were of cohort studies. 
  
Literature search to describe the effect of physical activity on disease survival 
There were no estimates of case fatality used within ITHIM.125 As it was a comparative risk 
assessment model, it did not explicitly model an effect of physical activity on case fatality. 
Consequently, I undertook a literature search to identify whether physical activity affects disease-
specific survival (after disease onset for ischaemic heart disease, breast cancer and colon cancer), 
and where appropriate extracted the relevant parameters.  
 
I identified studies that described the effect of physical activity on disease survival using the 
following search terms in Pubmed on 1 April 2015: “systematic review” or “meta-analysis” and 
“physical activity” or “exercise” and “survival” or “case fatality” and “colon cancer” (including bowel 
cancer and colo-rectal cancer) or “breast cancer” or “ischaemic heart disease” (including myocardial 
infarction, IHD and cardiovascular disease).  
 
A meta-analysis of randomised controlled trials of physical activity (‘exercise based cardiac 
rehabilitation’) after a diagnosis of ischaemic heart disease was used to describe the relationship 
between physical activity and survival from ischaemic heart disease. Meta-analyses of cohort studies 
were used to describe the relationship between physical activity and survival from breast cancer and 
colon cancer. 
 
Extraction of physical activity dose from identified studies 
None of the meta-analyses identified provided an estimate of the physical activity dose or level that 
pertained to the reported relative risk. Estimates of this dose were made using the approach outlined 
by Woodcock et al.125 Having identified a value for relative risk from a meta-analysis, I then sought to 
identify the largest single study within the meta-analysis. I then sought an estimate of the median 
physical activity level in the highest exposure group (or whichever group corresponds to the relative 
risk value used within the meta-analysis) from this study. Most studies quantified the duration and 
intensity for the relevant group from which an estimate of physical activity level in marginal MET-
hours could be made. If no such estimate could be made, then I reviewed the second largest study.  
 
I used adjusted estimates of relative risk to describe the un-confounded association between 
physical activity and disease risk. A summary of the extracted parameters is presented in Table 5.3, 
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including estimates of the ‘standardised relative risk’. The standardised relative risk recalculates the 
relative risk for an increase in physical activity comparing zero marginal MET-hours per week to one 
marginal MET-hour per week, and thus serves as a means to compare the association between 
physical activity and different disease outcomes across studies that have observed different changes 
in physical activity. In calculating these estimates I assumed a log linear relationship with a 0.5 power 
transformation. 
 
5.3.6.3 Transition Hazards (incidence and case fatality) 
Transition hazards were estimated from routine data sources. A program called DisMod II v1.05 
(World Health Organisation, 2001-09) was used to convert routine epidemiological parameters to 
estimates of incidence and case fatality by one year age bands.318 Remission was assumed to be zero. 
Separate estimates were made for men and women. 
 
I used estimates of epidemiological parameters published in routine or comprehensive datasets 
where possible. No routine data existed for dementia, consequently I took prevalence estimates 
from a recent large UK based prevalence study,278 and estimates of relative mortality from a recent 
UK based study of general practice records.319 The sources of the epidemiological parameters are 
summarised in Table 5.4. 
 
5.3.6.4 Mortality (General Life table) 
I used the interim life table for England for the years 2010-2012320 to parameterise the general life 
table of the model.  
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Table 5.4 Sources of disease parameters used as inputs for DisMod to estimate transition 
hazards for disease models 
Disease First Parameter Second Parameter 
 Parameter  Source  Parameter  Source  
Breast cancer Mortality Mortality Statistics 
2011321 
Incidence  National Cancer Registry 
(2011)279 
Colon Cancer Mortality Mortality Statistics 
2011321 
Incidence  National Cancer Registry 
(2011)279 
Lung cancer Mortality Mortality Statistics 
2011321 
Incidence  National Cancer Registry 
(2011)279 
Pancreatic cancer Mortality Mortality Statistics 
2011321 
Incidence  National Cancer Registry 
(2011)279 
Prostate cancer Mortality Mortality Statistics 
2011321 
Incidence  National Cancer Registry 
(2011)279 
Ischaemic Heart 
Disease 
Mortality Mortality Statistics 
2012322 
Prevalence Health Survey for England 
2012323 
Stroke Mortality Mortality Statistics 
2012322 
Prevalence Health Survey for England 
2012323 
Diabetes Standardised 
mortality rate 
National audit of general 
practice 2011-12; report 
2324 
Prevalence National audit of general 
practice 2011-12; report 
1325 
Dementia Relative risk of 
mortality 
Analysis of primary care 
data319 
Incidence CFAS II study278 
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5.4 Chapter summary 
 
It is common to assume that improvements in the distribution of a risk factor through improvements 
in health will reduce need for healthcare. The implicit assumption in much of this thinking, and 
explicit assumptions (when modelled using comparative assessment or similar approaches) is that 
increases in life expectancy, which also result from the same changes, will not materially affect need 
for healthcare. 
 
This has been little considered and inadequately explored in the existing literature. Observational 
studies are either cross-sectional or short-term and fail to account adequately for reverse causation 
or disease events being postponed. Modelling studies have not considered how changes in disease 
incidence (arising from changes in physical activity) may affect survival and indices of healthcare 
need at the disease-level. 
 
The modelling section of thesis aims to better illustrate or understand how improvements in the 
distribution of physical activity, when making allowance for changes in survival, may affect need of 
healthcare. Whilst predominantly referred to as a life table model the model consists of two parts: a 
micro-simulation model to describe the effects of changes in physical activity on disease risk from 
which population impact fractions are estimated; and a proportional multi-state life table model that 
describes the health impacts of changes in physical activity on six diseases. The former part modelled 
the relationship between physical activity level, using a continuous measure of physical activity 
(which combined intensity and duration).  
 
I have outlined two scenarios (‘all adults meeting PA guidelines’ and ‘all adults increase PA’) and 
described two primary outcomes or indices of healthcare need (person-years lived with disease and 
incident cases). I described a number of approaches to dealing with uncertainty (uncertainty 
intervals, tornado plots and testing of structural assumptions). 
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6 Modelling Results 
 
“Far better an approximate answer to the right question, which is 
often vague, than an exact answer to the wrong question, which can 
always be made precise” 
John Tukey 
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6.1 Chapter outline 
 
This short chapter describes the modelling results. 
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6.2 Results for all adults meeting physical activity guidelines 
 
Under the ‘all adults meeting PA guidelines’ scenario estimated life expectancy increased by 95 days 
(95% uncertainty intervals: 68 to 126 days), or 89 days for men (60 to 123 days) and 101 days for 
women (75-131 days).  
 
Changes in person-years with disease and total incident cases are shown in Figure 6.1. Person-years 
lived with disease decreased for ischaemic heart disease, stroke, type 2 diabetes and dementia, and 
increased for colon cancer (uncertainty intervals not including zero) and breast cancer (uncertainty 
intervals including zero). The decreases observed for ischaemic heart disease and dementia were 
small (with uncertainty intervals that included zero).  
 
Figure 6.1 Effect of meeting physical activity guidelines on the change in indices of 
healthcare need 
 
All adults meeting PA guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours of physical activity 
(equivalent to 150 minutes of walking at 3mph on flat ground (3.3 MET) per week) increase their physical activity to 5.75 marginal MET-
hours, the physical activity level of adults who are doing more than 5.75 marginal MET-hours per week is unchanged; Whisker plots 
indicate 95% uncertainty intervals; LE = life expectancy; IHD = ischaemic heart disease 
Total incident cases decreased for all six diseases, although the 95% uncertainty intervals included 
zero for dementia and colon cancer. Estimates of the decrease in person-years lived with disease 
were considerably smaller than estimates made using comparative risk assessment methods 
(labelled “person-years with disease (unchanged LE)” and shown in yellow, Figure 6.1). The 
differences were particularly marked for IHD, dementia, colon cancer and breast cancer.  
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6.3 Results for all adults increase physical activity 
 
The estimated increases in life expectancy for the ‘all adults increase PA’ scenarios are shown in 
Table 6.1. The increases in life expectancy for ‘all adults increase PA” by 150 and by 225 minutes of 
walking per week were greater than the increase observed for the scenario ‘all adults meeting PA 
guidelines’. The increase in life expectancy for 75 minutes per week walking was similar to the 
increase observed for the ‘all adults meeting PA guidelines’ scenario. 
 
Changes in person-years with disease and total incident cases for the ‘everyone increase’ scenarios 
are shown in Figure 6.2. Broadly, the pattern of results (i.e. comparing the relative changes between 
diseases, and relative changes between indices of healthcare need) was similar across the different  
scenarios. The one noticeable difference between the ‘all adults increase PA’ scenarios and ‘all adults 
meeting PA guidelines’ scenario was the estimate of the change in person-years lived with breast 
cancer (a small decrease for all three scenarios of ‘all adults increase PA’ and a small increase under 
the ‘all adults meeting PA guidelines’ scenario, although for all scenarios the uncertainty interval 
included zero).  
 
Table 6.1 Estimated increase in life expectancy under three 'all adults increase PA' 
scenarios of an increase in physical activity 
 Increase in life expectancy at birth (days) 
Scenario ‘All adults increase PA’ 
(75 mins walking) 
‘All adults increase PA’  
(150 mins walking) 
‘All adults increase PA’  
(225 mins walking) 
Women 96 (71-123) 154 (111-201) 203 (143-274) 
Men 86 (60-117) 138 (93-194) 182 (119-262) 
Combined 91 (66-119) 147 (103-197) 193 (133-267) 
95% uncertainty intervals shown in brackets; the everyone increase scenario assumes that all adults increase their physical activity by the 
same amount, respectively 2.875 marginal MET-hours, 5.75 marginal MET-hours and 8.625 marginal MET-hours; these increases are 
equivalent to an additional 75 minutes, 150 minutes and 225 minutes respectively of walking at 3mph on flat ground (3.3 MET) per week. 
The absolute magnitude of the changes varies between the scenarios. The largest changes were 
observed for the increase of 225 minutes of walking per week, and the smallest changes were 
observed for the increase of 75 minutes of walking per week. 
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Figure 6.2 Effect of all adults increasing physical activity on change in indices of need for 
healthcare 
 
The ‘all adults increase PA’ scenarios assumes that all adults increase their physical activity by the same amount equal to 2.875 marginal 
MET-hours, 5.75 marginal MET-hours and 8.625 marginal MET-hours; these increases are equivalent to an additional 75 minutes, 150 
minutes and 225 minutes respectively of walking at 3mph on flat ground (3.3 MET); Whisker plots indicate 95% uncertainty intervals; LE = 
life expectancy; IHD = ischaemic heart disease. 
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6.4 Change in incidence, prevalence an incident cases by age 
 
I display results by age for only one scenario, ‘all adults increase PA’ by 225 minutes of walking per 
week. The pattern of changes observed was similar for other scenarios. However, the absolute 
changes were greatest for this scenario, and consequently the visual differences between baseline 
and the scenario in the displayed figures are more apparent. 
 
The number of people alive by age is shown in Figure 6.3. It was only at older ages that the baseline 
and ‘all adults increase PA’ curves visibly departed. Incidence and prevalence by age are shown in 
Figure 6.4 and Figure 6.5. Incidence was lower under the scenario of increased physical activity, 
labelled ‘all adults increase PA (225 minutes)’ at all ages for all diseases. Prevalence was lower under 
the scenario of increased physically at all ages for stroke, type 2 diabetes and dementia.  
 
Figure 6.3 Number of people alive by age comparing baseline and the scenario of all adults 
increase PA by 225 minutes walking per week 
 
Baseline scenario = no change in physical activity; the ‘all adults increase PA (225 mins walking) scenario assumes that all adults increase 
their physical activity by the same amount equal to 8.625 marginal MET-hours (equivalent to an additional 225 minutes of walking at 3mph 
on flat ground (3.3 MET) per week). 
However, for the diseases for which physical activity was modelled to have a direct effect on disease 
survival (i.e. colon cancer, breast cancer and ischaemic heart disease), prevalence was higher under 
the scenario of increased physical activity compared to baseline for some age groups. For example, 
the prevalence of colon cancer and ischaemic heart disease under the scenario of increased physical 
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activity was higher relative to baseline at older ages (above 75 years for colon cancer; and above 90 
years for ischaemic heart disease). Differences in prevalence comparing baseline with increased 
physical activity were slight for breast cancer. 
 
The number of incident cases and number of people living with disease by age are shown in Figure 
6.6 and Figure 6.7 respectively. The number of incident cases is the product of the number of people 
alive (Figure 6.3) and incidence (Figure 6.4). Whilst the number of people living with disease by age is 
the product of the number of people alive (Figure 6.3) and prevalence (Figure 6.5). In contrast to 
incidence (shown in Figure 6.4), incident cases peaked and declined with age. Moreover, for some 
diseases (e.g. dementia) the number of incident cases at older ages was greater under the scenario 
of increased physical activity compared with the baseline scenario. 
 
Number of people living with disease peaked with age and then declined, whilst for most diseases 
the prevalence increased with age. At older ages the number of people living with disease (a product 
of prevalence and number of people alive) is similar comparing increased physical activity with 
baseline. In some instances, (e.g. dementia above 90 years of age, breast cancer above 85 years of 
age) the number of people living with disease increased with increased physical activity. 
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Figure 6.4 Disease incidence by age comparing baseline with all adults increasing physical 
activity by the equivalent of additional 225 minutes walking per week 
 
Baseline scenario = no change in physical activity; the all adults increase PA scenario assumes that all adults increase their physical activity 
by the same amount equal to 8.625 marginal MET-hours (equivalent to an additional 225 minutes of walking at 3mph on flat ground (3.3 
MET) per week). 
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Figure 6.5 Disease prevalence by age comparing baseline with all adults increasing physical 
activity by the equivalent of additional 225 minutes walking per week 
 
Baseline scenario = no change in physical activity; the all adults increase PA scenario assumes that all adults increase their physical activity 
by the same amount equal to 8.625 marginal MET-hours (equivalent to an additional 225 minutes of walking at 3mph on flat ground (3.3 
MET) per week). 
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Figure 6.6 Incident cases by age comparing baseline with all adults increasing physical 
activity by the equivalent of additional 225 minutes walking per week 
 
Baseline scenario = no change in physical activity; the all adults increase PA scenario assumes that all adults increase their physical activity 
by the same amount equal to 8.625 marginal MET-hours (equivalent to an additional 225 minutes of walking at 3mph on flat ground (3.3 
MET) per week). 
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Figure 6.7 Number of people living with disease comparing baseline with all adults 
increasing physical activity by the equivalent of additional 225 minutes walking per week 
 
Baseline scenario = no change in physical activity; the all adults increase PA scenario assumes that all adults increase their physical activity 
by the same amount equal to 8.625 marginal MET-hours (equivalent to an additional 225 minutes of walking at 3mph on flat ground (3.3 
MET) per week). 
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6.5 Estimates of mean age of disease onset 
 
Figure 6.6 shows that disease events are postponed (and/or prevented). Estimates of the change 
mean age of disease onset are shown in Table 6.2. Generally, these show that disease onset is 
deferred. However, these estimates are based only on the people who develop disease and it is 
noticeable that some estimates are negative (i.e. earlier age of onset), despite an apparent 
rightwards shift of the related curves (e.g. Figure 6.6). 
 
Table 6.2 Change in mean age of disease onset 
 Change in mean age of onset (days) 
Scenario ‘All adults meeting PA 
guidelines’  
‘All adults increase PA 
(75 mins walking’ 
‘All adults increase 
PA 
(150 mins walking)’  
‘All adults increase 
PA 
(225 mins walking)’ 
IHD -52 (-87 to -18) 5 (-37 to 80) 22 (-37 to 155) 39 (-35 to 224) 
Stroke -40 (-93 to 14) 23 (-32 to 98) 50 (-26 to 178) 76 (-18 to 249) 
Type 2 Diabetes 76 (54 to 100) 79 (55 to 108) 127 (85 to 185) 168 (110 to 254) 
Dementia 39 (3 to 70) 47 (14 to 74) 77 (28 to 126) 102 (40 to 172) 
Breast Cancer 23 (-4 to 51) 39 (18 to 65) 66 (33 to 114) 89 (46 to 158) 
Colon Cancer -39 (-67 to -16) -16 (-43 to 10) -21 (-55 to 21) -24 (-62 to 31) 
All adults meeting PA guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours of physical activity 
(equivalent to 150 minutes of walking at 3mph on flat ground (3.3 MET) per week) increase their physical activity to 5.75 marginal MET-
hours, the physical activity level of adults who are doing more than 5.75 marginal MET-hours per week is unchanged; the all adults increase 
PA scenario assumes that all adults increase their physical activity by the same amount, respectively 2.875 marginal MET-hours, 5.75 
marginal MET-hours and 8.625 marginal MET-hours; these increases are equivalent to an additional 75 minutes, 150 minutes and 225 
minutes respectively of walking at 3mph on flat ground (3.3 MET); IHD = ischaemic heart disease; 95% uncertainty intervals shown in 
brackets; bold type indicates that the uncertainty intervals do not overlap with zero. 
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6.6 Sensitivity analyses 
 
Sensitivity analyses were performed only on the primary scenario (‘all adults meeting PA guidelines’). 
 
6.6.1 Tornado Plots 
The effect of parametric uncertainty on estimates of changes in life expectancy (comparing baseline 
with ‘all adults meeting PA guidelines’ scenario) is shown in Figure 6.8. Uncertainty in estimates of 
the effect of physical activity on case fatality (for both ischaemic heart disease and colon cancer) 
were relatively important, as was uncertainty in the estimates of incidence for dementia and 
ischaemic heart diseases.  
 
The effects of parametric uncertainty on estimates of changes in person-years lived with disease 
(comparing baseline with ‘all adults meeting PA guidelines’ scenario) is shown in Figure 6.9. Of note, 
the range of estimates of the change in person-years lived with ischaemic heart disease crossed zero 
for two parameters (relative risk of ischaemic heart disease/stroke incidence for physical activity, and 
relative risk of case fatality of ischaemic heart disease for physical activity). In other words, an 
increase in the person-years lived with ischaemic heart disease is a possible outcome, given the 
published uncertainty for these parameters. A similar pattern was exhibited for dementia for the 
following parameters, relative risk of dementia incidence, relative risk of ischaemic heart disease 
case fatality and the power transformation describing the log linear relationship between physical 
activity and disease risk. 
 
The effects of parametric uncertainty on estimates of changes in incident cases (comparing baseline 
with ‘all adults meeting PA guidelines’ scenario) is shown in Figure 6.10. 
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Figure 6.8 Tornado plot showing the effect of parametric uncertainty on estimates of 
change in life expectancy (baseline vs 'all adults meeting PA guidelines') 
 
Stroke/IHD = relative risk of stroke incidence and ischaemic heart disease incidence for physical activity; Dementia = relative risk of 
dementia incidence for physical activity; Colon Ca (m) = relative risk of colon cancer incidence amongst men for physical activity; Colon Ca 
(w) = relative risk of colon cancer inci 
dence amongst women for physical activity; Breast Ca = relative risk of breast cancer incidence amongst women for physical activity; 
Diabetes = relative risk of type 2 diabetes incidence for physical activity; IHD CFR = relative risk of mortality amongst people with diagnosed 
IHD for physical activity; Breast Ca CFR = relative risk of mortality amongst women with diagnosed breast cancer for physical activity; Colon 
Ca CFR = relative risk of mortality for people with diagnosed colon cancer for physical activity; Dose response inc = log linear power 
transformation for association between physical activity and disease incidence; Dose response CFR = log linear power transformation for 
association between physical activity and mortality from disease (either IHD, colon cancer or breast cancer); baseline = no change in 
physical activity; ‘All adults meeting PA guidelines’ scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours 
of physical activity (equivalent to 150 minutes of walking at 3mph on flat ground (3.3 MET) per week) increase their physical activity to 5.75 
marginal MET-hours, the physical activity level of adults who are doing more than 5.75 marginal MET-hours per week is unchanged. 
Tornado plots are a special type of bar chart, where the bars are arranged horizontally and in order of bar size, typically with the largest bar 
at the top and the smallest bar at the bottom so that the diagram forms a visual ‘tornado’. Tornado plots are a common means to 
undertake ‘deterministic sensitivity analyses’, where the relative importance of variation in different parameters is compared. Used in this 
way each bar represents the range of outcome values expected consistent with the reported or described uncertainty for the given input. 
The inputs whose uncertainty contributes most to uncertainty in the outcome will have the largest bars and thus be at the top of the 
diagram. The tornado plot is centred around the mid-point (median) estimate for all parameters.  
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Figure 6.9 Tornado plots showing the effect of parametric uncertainty on estimates of 
change in person-years lived with disease (baseline vs ‘all adults meeting PA guidelines’) 
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Figure 6.10 Tornado plots showing the effect of parametric uncertainty on estimates of 
change in incident cases (baseline vs ‘all adults meeting PA guidelines’) 
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Footnote for Figure 6.9 and Figure 6.10 
Stroke/IHD = relative risk of stroke incidence and ischaemic heart disease incidence for physical activity; Dementia = relative risk of 
dementia incidence for physical activity; Colon Ca (m) = relative risk of colon cancer incidence amongst men for physical activity; Colon Ca 
(w) = relative risk of colon cancer incidence amongst women for physical activity; Breast Ca = relative risk of breast cancer incidence 
amongst women for physical activity; Diabetes = relative risk of type 2 diabetes incidence for physical activity; IHD CFR = relative risk of 
mortality amongst people with diagnosed IHD for physical activity; Breast Ca CFR = relative risk of mortality amongst women with 
diagnosed breast cancer for physical activity; Colon Ca CFR = relative risk of mortality for people with diagnosed colon cancer for physical 
activity; Dose response inc = log linear power transformation for association between physical activity and disease incidence; dose 
response CFR = log linear power transformation for association between physical activity and mortality from disease (either IHD, colon 
cancer or breast cancer); baseline = no change in physical activity; ‘All adults meeting PA guidelines’ scenario assumes that all adults who 
are not presently doing 5.75 marginal MET-hours of physical activity (equivalent to 150 minutes of walking at 3mph on flat ground (3.3 
MET) per week) increase their physical activity to 5.75 marginal MET-hours, the physical activity level of adults who are doing more than 
5.75 marginal MET-hours per week is unchanged. Tornado plots are a special type of bar chart, where the bars are arranged horizontally 
and in order of bar size, typically with the largest bar at the top and the smallest bar at the bottom so that the diagram forms a visual 
‘tornado’. Tornado plots are a common means to undertake ‘deterministic sensitivity analyses’, where the relative importance of variation 
in different parameters is compared. Used in this way each bar represents the range of outcome values expected consistent with the 
reported or described uncertainty for the given input. The inputs whose uncertainty contributes most to uncertainty in the outcome will 
have the largest bars and thus be at the top of the diagram. The tornado plot is centred around the mid-point (median) estimate for all 
parameters.  
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6.6.2 Structural Uncertainty 
Results for the five structural variants of the model, together with the original or standard model, are 
summarised in  
Table 6.3. Results for the mortality variant (or mortality model) were noticeably different compared 
to the standard model. These results are therefore discussed separately and presented first. 
 
6.6.2.1 Mortality Model 
Results for the mortality model are show in In general estimates of change shifted towards being 
more positive (i.e. decreases became smaller decreases or became increases; increases became 
larger). The extent of this shift tended to be more marked for change person-years with disease than 
for change in incident cases. It was also particularly marked for dementia, for which estimates of 
change in person-years with dementia and change in incident cases switched from small decreases to 
modest increases (change in incident cases, -0.4% using the standard model vs 3.3% using the 
mortality model; change in person-years, -0.6% vs 2.8%). 
 
6.6.2.2 Other model variants 
With the exception of the mortality variant, broadly the relative pattern of results between indices is 
similar under each variant of the original model (Table 6.3). The relatively large differences in the 
estimate of change in person-years lived with disease using the life table method (that allowed life 
expectancy to change) compared with comparative risk assessment method (that assumed life 
expectancy was unchanged) persisted across all model variants. 
 
Compared to the standard model the first variant, labelled ‘cancer survival (no effect)’, the increase 
in life expectancy was reduced by 11 days. The estimated large increase in person-years lived with 
colon cancer was attenuated when no effect of physical activity on cancer survival was modelled, 
such that uncertainty intervals included zero, and the point estimate for breast cancer changed from 
a small increase to a small decrease (uncertainty intervals including zero). Other measures of change 
in disease burden were very similar, compared to the standard model. 
 
Compared to the standard model the second variant, labelled ‘no lag’, the increase in life expectancy 
was increased by 20 days. Measures of disease burden were principally different for dementia, 
breast cancer and colon cancer, i.e. the diseases for which long lag are assumed in the standard 
model.  
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Compared to the standard model, the third variant, labelled ‘leisure only’, the increase in life 
expectancy was increased by 20 days. Measures of disease burden were noticeably different for all 
diseases. In general measures of the disease burden that were negative became greater (i.e. more 
negative), and measure of disease burden that were positive also become greater. The exception to 
this pattern was breast cancer. The change in person-years lived with breast cancer was 0.8% under 
the standard model and decreased to 0.3% under the ‘leisure only’ variant. 
 
Compared to the standard model, the fourth variant, labelled ‘cancer incidence’, the increase in life 
expectancy was 6 days greater. Under this variant, it was assumed that physical affected the 
incidence of lung cancer, prostate cancer and pancreatic cancer. The change in incident cases of 
these cancers was negative under this variant, whereas it was positive under the standard model. 
The change in person-years lived with lung cancer and pancreatic cancer was negative, where as it 
was positive for prostate cancer. 
 
The fifth variant, the mortality model, was discussed previously (section 6.6.2.1). Compared to the 
other variants it is noticeable that the increase in life expectancy, relative to the standard model was 
much greater, 103 days, whereas the changes were of the order of 5-20 days for the other variants. 
Changes in other measures of disease burden were also large, although not always larger than 
changes observed with other variants.  
 
Figure 6.11 Figure 6.11 and (alongside other findings, including the ‘standard model’) and in Table 
6.3. Increases in life expectancy using the mortality model were approximately twice as great 
compared with the standard model (198 days vs 95 days). The direction of change for some indices of 
need for healthcare was different from that observed with the standard model. In contrast to the 
standard model, change in person-years lived with dementia and change in incident cases of 
dementia were both positive, although the uncertainty intervals included zero. Also in contrast to the 
standard model, there was a small increase in person-years lived with ischaemic heart disease 
(uncertainty interval includes zero). The increase in person-years lived with breast cancer was larger 
than in the standard and the uncertainty intervals no longer included zero. 
 
In general estimates of change shifted towards being more positive (i.e. decreases became smaller 
decreases or became increases; increases became larger). The extent of this shift tended to be more 
marked for change person-years with disease than for change in incident cases. It was also 
particularly marked for dementia, for which estimates of change in person-years with dementia and 
change in incident cases switched from small decreases to modest increases (change in incident 
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cases, -0.4% using the standard model vs 3.3% using the mortality model; change in person-years, -
0.6% vs 2.8%). 
 
6.6.2.3 Other model variants 
With the exception of the mortality variant, broadly the relative pattern of results between indices is 
similar under each variant of the original model (Table 6.3). The relatively large differences in the 
estimate of change in person-years lived with disease using the life table method (that allowed life 
expectancy to change) compared with comparative risk assessment method (that assumed life 
expectancy was unchanged) persisted across all model variants. 
 
Compared to the standard model the first variant, labelled ‘cancer survival (no effect)’, the increase 
in life expectancy was reduced by 11 days. The estimated large increase in person-years lived with 
colon cancer was attenuated when no effect of physical activity on cancer survival was modelled, 
such that uncertainty intervals included zero, and the point estimate for breast cancer changed from 
a small increase to a small decrease (uncertainty intervals including zero). Other measures of change 
in disease burden were very similar, compared to the standard model. 
 
Compared to the standard model the second variant, labelled ‘no lag’, the increase in life expectancy 
was increased by 20 days. Measures of disease burden were principally different for dementia, 
breast cancer and colon cancer, i.e. the diseases for which long lag are assumed in the standard 
model.  
 
Compared to the standard model, the third variant, labelled ‘leisure only’, the increase in life 
expectancy was increased by 20 days. Measures of disease burden were noticeably different for all 
diseases. In general measures of the disease burden that were negative became greater (i.e. more 
negative), and measure of disease burden that were positive also become greater. The exception to 
this pattern was breast cancer. The change in person-years lived with breast cancer was 0.8% under 
the standard model and decreased to 0.3% under the ‘leisure only’ variant. 
 
Compared to the standard model, the fourth variant, labelled ‘cancer incidence’, the increase in life 
expectancy was 6 days greater. Under this variant, it was assumed that physical affected the 
incidence of lung cancer, prostate cancer and pancreatic cancer. The change in incident cases of 
these cancers was negative under this variant, whereas it was positive under the standard model. 
The change in person-years lived with lung cancer and pancreatic cancer was negative, where as it 
was positive for prostate cancer. 
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The fifth variant, the mortality model, was discussed previously (section 6.6.2.1). Compared to the 
other variants it is noticeable that the increase in life expectancy, relative to the standard model was 
much greater, 103 days, whereas the changes were of the order of 5-20 days for the other variants. 
Changes in other measures of disease burden were also large, although not always larger than 
changes observed with other variants.  
 
Figure 6.11 Estimates of change in indices of healthcare need under the 'all adults meeting 
PA guidelines' scenario using the mortality model 
 
All adults meeting PA guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours of physical activity 
(equivalent to 150 minutes of walking at 3mph on flat ground (3.3 MET) per week) increase their physical activity to 5.75 marginal MET-
hours, the physical activity level of adults who are doing more than 5.75 marginal MET-hours per week is unchanged; Whisker plots 
indicate 95% uncertainty intervals; LE = life expectancy; IHD = ischaemic heart disease 
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Table 6.3 Results summary for different ‘structural’ configurations of the model under the 
‘all adults meeting PA guidelines’ scenario 
 Original 
Model 
Model Variant  
Cancer survival 
(no effect) 
No lag Leisure only Cancer incidence Mortality 
Increase in LE (days)       
Women 101 (75-131) 85 (60-115) 126 (92-170) 128 (95-164) 106 (79-138) 211 (160-269) 
Men 89 (61-123) 82 (54-117) 103 (72-141) 115 (82-154)  95 (67-130) 183 (137-237) 
All 95 (69-126) 84 (58-115) 115 (83-153) 115 (83-153) 101 (74-133) 198 (162-236) 
Change in total 
incidence cases (%) 
      
IHD -4.6 (-7.6 to -2.4) -4.7 (-7.7 to -2.5) -4.8 (-8.0 to -2.4) -6.0 (-9.3 to -3.2) -4.5 (-7.6 to -2.3) -3.3 (-6.6 to -0.9) 
Stroke -4.6 (-7.9 to -2.1) -4.7 (-8.1 to -2.2) -4.8 (-8.3 to -2.0) -6.0 (-9.7 to -2.8) -4.5 (-7.8 to -1.9) -3.1 (-6.7 to -0.3) 
Type 2 Diabetes -2.5 (-4.4 to -1.1) -2.6 (-4.4 to -1.1) -2.8 (-4.7 to -1.2) -4.0 (-6.6 to -1.9) -2.5 (-4.3 to -1.1) -2.3 (-4.2 to -0.9) 
Dementia -0.4 (-3.6 to 1.9) -0.7 (-3.9 to 1.6) -2.2 (-7.2 to 1.2) -0.8 (-4.9 to 2.0) -0.2 (-3.4 to 2.1) 3.3 (-0.9 to 6.4) 
Breast Cancer -0.8 (-2.0 to 0.0) -0.8 (-2.1 to 0.0) -1.6 (-3.3 to -0.3) -1.6 (-3.3 to -0.3) -0.7 (-2.0 to 0.1) 0.9 (-1.1 to 2.3) 
Colon Cancer -0.6 (-2.5 to 0.8) -0.7 (-2.5 to 0.7) -1.7 (-4.6 to 0.5) -1.3 (-4.0 to 0.7) -0.5 (-2.4 to 0.9) 0.0 (-1.3 to 0.8) 
Lung Cancer 1.5 (1.1 to 2.0) 1.1 (0.8 to 1.5) 1.9 (1.3 to 2.5) 1.9 (1.4 to 2.5) -0.7 (-1.8 to 0.3) 2.6 (2.1 to 3.1) 
Prostate Cancer 1.3 (0.9 to 1.7) 1.4 (0.9 to 1.9) 1.5 (1.1 to 2.1) 1.6 (1.2 to 2.1) 0.5 (-0.3 to 1.2) 3.1 (2.6 to 3.7) 
Pancreatic Cancer 1.7 (1.2 to 2.2) 1.5 (1.0 to 2.1) 2.1 (1.5 to 2.7) 2.1 (1.6 to 2.8) -2.0 (-8.1 to 1.4) 3.4 (2.8 to 4) 
Change in person-
years with disease 
(%) 
      
IHD -1.2 (-4.2 to 1.4) -1.3 (-4.5 to 1.3) -1.1 (-4.5 to 1.6) -2.5 (-6.1 to 0.7) -1.0 (-4.3 to 1.5) 0.3 (-3.0 to 2.9) 
Stroke -3.1 (-6.0 to -1.1) -3.2 (-6.1 to -1.2) -3.1 (-6.3 to -1.0) -4.7 (-8.1 to -2.0) -3.0 (-5.9 to -1.0) -1.6 (-4.9 to 0.5) 
Type 2 Diabetes -1.5 (-3.2 to -0.2) -1.6 (-3.3 to -0.3) -1.5 (-3.3 to -0.1) -2.8 (-5.2 to -0.8) -1.4 (-3.1 to -0.1) -0.6 (-2.3 to 0.7) 
Dementia -0.6 (-3.7 to 1.6) -0.9 (-4.1 to 1.3) -2.5 (-7.4 to 0.9) -1.3 (-5.5 to 1.6) -0.4 (-3.6 to 1.8) 2.8 (-1.3 to 5.9) 
Breast Cancer 0.8 (-0.50 to 1.7) -0.1 (-1.3 to 0.6) 0.5 (-1.2 to 1.8) 0.3 (-1.5 to 1.8) 0.8 (-0.4 to 1.8) 2.1 (0.7 to 3.2) 
Colon Cancer 4.4 (1.1 to 10.3) 0.3 (-1.4 to 1.6) 4.1 (-0.1 to 10.2) 4.9 (0.4 to 11.4) 4.6 (1.1 to 10.4) 6.8 (3.2 to 12.6) 
Lung Cancer 1.8 (1.3 to 2.4) 1.6 (1.1 to 2.2) 2.2 (1.5 to 3.0) 2.3 (1.7 to 3.0) -0.3 (-1.4 to 0.7) 3.7 (2.8 to 4.7) 
Prostate Cancer 1.9 (1.3 to 2.6) 1.7 (1.2 to 2.5) 2.2 (1.6 to 2.9) 2.4 (1.7 to 3.2) 1.3 (0.5 to 2.2) 3.6 (3.0 to 4.3) 
Pancreatic Cancer 1.5 (1.1 to 2.0) 1.4 (0.9 to 1.9) 1.8 (1.3 to 2.4) 1.9 (1.4 to 2.5) -1.9 (-7.7 to 1.3) 3.1 (2.5 to 3.7) 
Change in person-
years with disease 
(life expectancy 
unchanged) (%) 
      
IHD -5.1 (-8.2 to -2.9) -5.1 (-8.2 to -2.9) -5.1 (-8.2 to -2.9) -6.8 (-10.4 to -4.0) -5.1 (-8.2 to -2.9) -5.1 (-8.2 to -2.9) 
Stroke -5.2 (-8.3 to -2.9) -5.2 (-8.3 to -2.9) -5.2 (-8.3 to -2.9) -6.9 (-10.4 to -4.0) -5.2 (-8.3 to -2.9) -5.2 (-8.3 to -2.9) 
Type 2 Diabetes -3.8 (-6.1 to -1.8) -3.8 (-6.1 to -1.8) -3.8 (-6.1 to -1.8) -5.1 (-8.0 to -2.5) -3.8 (-6.1 to -1.8) -3.8 (-6.1 to -1.8) 
Dementia -4.0 (-7.5 to -1.6) -4.0 (-7.5 to -1.6) -4.0 (-7.5 to -1.6) -5.3 (-9.9 to -2.2) -4.0 (-7.5 to -1.6) -4.0 (-7.5 to -1.6) 
Breast Cancer -2.4 (-4.0 to -1.2) -2.4 (-4.0 to -1.2) -2.4 (-4.0 to -1.2) -3.2 (-5.2 to -1.7) -2.4 (-4.0 to -1.2) -2.4 (-4.0 to -1.2) 
Colon Cancer -2.2 (-4.2 to -0.8) -2.2 (-4.2 to -0.8) -2.2 (-4.2 to -0.8) -3.1 (-5.7 to -1.1) -2.2 (-4.2 to -0.8) -2.2 (-4.2 to -0.8) 
Lung Cancer 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) -2.5 (-3.7 to -1.6) 0 (0 to 0) 
Prostate Cancer 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) -1.0 (-0.4 to -2.0) 0 (0 to 0) 
Pancreatic Cancer 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) -3.9 (-0.5 to -10.0) 0 (0 to 0) 
All adults meeting PA guidelines scenario assumes that all adults who are not presently doing 5.75 marginal MET-hours of physical activity 
(equivalent to 150 minutes of walking per week) increase their physical activity to 5.75 marginal MET-hours, the physical activity level of 
adults who are doing more than 5.75 marginal MET-hours per week is unchanged; IHD = ischaemic heart disease; bold type indicates that 
the uncertainty intervals do not include zero; Outcomes for lung cancer, prostate cancer and pancreatic cancer are included under all 
variants of the model for comparison. Physical activity only affects the incidence of lung cancer, prostate cancer or pancreatic cancer in the 
third model described as ‘PA effects incidence of other cancers’. In all other models physical activity does not affect the incidence of lung 
cancer, prostate cancer or pancreatic cancer. 
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6.7 Chapter summary 
 
This chapter has presented the modelling results for two principle outcomes (change in person-years 
with disease and change in total incident cases), considering six diseases and two scenarios (all adults 
meeting PA guidelines and all adults increase PA). Sensitivity analyses (tornado plots and structural 
changes to the model) have also been presented. A summary of the results is included at the start of 
the next chapter that discusses the results. 
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7 Discussion of findings from the modelling study 
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7.1 Chapter outline 
 
The chapter discusses the modelling results. It begins with a summary of important findings. It then 
considers study limitations, model validity and draws comparisons with other studies, before offering 
an interpretation of the findings (including considering why the pattern of results is different for 
different diseases). Next it considers the implications of the findings for practice and policy. It finishes 
with some suggestions for future research specific to the work presented. Overarching suggestions 
for practice, policy and future research are discussed in the final chapter. 
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7.2 Summary of main findings 
 
Increases in physical activity were associated with improvements in health, namely reduced risk of 
disease onset, prevention or delay in onset of disease, improved disease-specific survival and 
increased life expectancy.  
 
Generally, increases in physical activity were associated with decreases in indices of healthcare need 
for the six diseases considered, for which physical activity is protective. Increases in physical activity 
were associated with decreases in the number of incident cases for the six diseases considered 
(under the scenarios considered), although some of these decreases were small and approached zero 
(e.g. dementia). Increases in physical activity were associated with decreases in the person-years 
lived with diseases for four diseases (ischaemic heart disease, stroke, dementia and type 2 diabetes, 
with uncertainty intervals that included zero for ischaemic heart disease and dementia) and 
increases in the person years lived with colon cancer and breast cancer. In other words, increases in 
physical activity led to an increase in person-years lived with disease for some diseases, decreases for 
some diseases and small changes that were close to zero for others. 
 
Estimates of increases in physical activity on decrease in need, using a life table method which made 
allowance for change in survival, were smaller than similar estimates made using comparative risk 
assessment methods that did not make allowance for changes in survival. For some diseases these 
differences were relatively small (e.g. stroke, type 2 diabetes), but for other diseases these 
differences were relatively large (e.g. dementia) or led to estimates in the opposite direction (e.g. 
colon cancer).   
 
The pattern of findings, comparing the different indices and comparing between diseases, was 
broadly similar under different sensitivity analyses, with the exception of the ‘mortality model’, 
which effectively modelled a much greater effect of physical activity on all-cause survival. Under 
these assumptions estimates of change in indices of healthcare need tended to be pulled in the 
positive direction (i.e. estimates that were negative changed to be less negative or became positive, 
estimates that were positive changed to be more positive). The sensitivity analyses also confirmed 
that the direction of change (i.e. increase or decrease) was uncertain for change parameters that 
were estimated to be close to zero. 
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7.3 Strengths and limitations 
 
7.3.1 Strengths 
The strengths of this study include: the explicit modelling of ageing, modelling the effect of physical 
activity on mortality through a set of diseases, use of different indices to describe need for 
healthcare, long period of follow-up, and making allowance for a lag between physical activity and its 
effect on disease risk. I have also sought to draw explicit comparisons between modelling techniques 
(life table vs comparative risk assessment). 
 
7.3.2 Limitations 
I consider limitations with life table modelling, in the measurement of physical activity in 
epidemiological studies, in the choice of scenarios considered, in the outcome measures (indices of 
healthcare need), that affect the diseases considered (cancer, type 2 diabetes), modelling effects in 
old age, and in assessment of background incidence of disease. 
 
7.3.2.1 Life table model 
The principle limitation of the life table modelling that pertains to this work is the assumption of 
independence (See Chapter Five, section 5.3.2.2).303 A strict interpretation would suggest that the 
independence assumptions are violated. All six diseases share a common cause, physical activity, so 
their incidence is not independent. Moreover, four of the diseases (ischaemic heart disease, stroke, 
type 2 diabetes and dementia) share the same cardio-metabolic risk factors.  
 
The extent to which violation of this assumption can be tolerated is unclear and is not discussed 
more widely in the literature.301–303,326 Other authors have developed similar life table models to the 
one described here.301,302,326 The original paper that described the proportional multi-state life table 
model included an example model with both heart disease and stroke, which shared common risk 
factors so could not strictly be considered independent.303 Cross-sectional data shows that, despite 
sharing common risk factors, the extent to which chronic diseases co-occur above that expected if 
their probabilities of incidence were truly independent may be relatively slight particularly below the 
age of 70 years. For example, observed data suggests the combined prevalence of diabetes and acute 
myocardial infarction is one percentage point higher than suggested by independent probabilities. 
For other disease pairings such as stroke and acute myocardial infarction the excess is less than half a 
percentage point.327  
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The excess risk associated with co-occurrence of risk factors or conditions (e.g. excess risk of cardio-
vascular mortality for an individual with type 2 diabetes and cardiovascular disease) is implicitly 
considered within the model. As the estimates of risk are derived for the English population whose 
underlying risk reflects the distribution, including co-occurrence, of risk factors in the population, 
small deviations from this are unlikely to be important, but larger deviations may be. For example, if 
increases in physical activity resulted in the prevalence of diabetes halving, then estimates for 
cardiovascular case fatality may not be valid as they were estimated on the assumption of a much 
higher prevalence of diabetes (and consequently of cardiovascular disease co-morbid with diabetes) 
in the population. 
 
I have modelled a birth cohort from birth to death. I chose to do this partly for simplicity but also 
partly to consider the full effect of changes in physical activity throughout life. An alternative 
approach would have been to model a cohort representative of the English population through to 
death or for a fixed period of time. This might give a different perspective, as well as consider the 
effect on healthcare need in the short to medium term, which may be a more relevant timeframe for 
decision makers. 
 
7.3.2.2 Measurement of physical activity 
The model depends on quantification of physical activity, both to characterise the simulated 
population and to describe the relationship between physical activity and disease (based on 
epidemiological studies). Physical activity dose was quantified using information from 
questionnaires. However, physical activity questionnaires are subjective, typically biased towards 
recreational and leisure activities, do not adequately account for intra- and inter-participant variation 
in intensity and incompletely measure duration of activity. Existing epidemiological studies have 
tended to treat physical activity as a categorical variable. Translating estimates based on different 
categories or scales to a continuous measure may have introduced error. Further error may be 
introduced by comparing across populations if questions were interpreted differently in different 
settings. Consequently, the quantification of dose of physical activity is likely to be poor. The 
sensitivity and uncertainty analyses have not considered the effect of these error on the outcomes. 
 
7.3.2.3 Assessment of baseline physical activity levels 
I used questionnaire data from the Health Survey for England 2012.98 I chose to include all forms of 
physical activity (i.e. leisure, transport, occupation and domestic) when estimating baseline levels of 
physical activity, in order to consider all physical activity energy expenditure. However, this may have 
led to relatively high estimates of physical activity levels compared to estimates reported in cohort 
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studies (and from which estimates of relative risk were derived). This effectively moved some 
individuals further along the dose-response curve, such that increases in physical activity had less 
effect on disease reduction.  
 
One of the sensitivity analyses (labelled ‘leisure only’ and reported Table  6.3) used different 
estimates of physical activity levels, derived using estimates of leisure-time physical activity reported 
in the Health Survey for England. Under this assumption the effect of physical activity on the 
reported outcomes was greater (most estimates being 10-30% greater), although the overall pattern 
of finding persisted. This scenario may give a more realistic estimate of the effect of increases in 
physical activity as the estimates of physical activity levels are more consistent with the 
measurement of physical activity in the studies that have been used to describe the association 
between physical activity and disease risk. This scenario also serves as an example of how the effect 
of increases in physical activity might be different if background levels of physical activity were lower. 
 
7.3.2.4 Estimating the relationship between physical activity and disease 
Using questionnaires to estimate doses of physical activity will result in measurement error (as 
discussed above, section 7.3.2.3). In addition, other factors may lead to errors in the estimate of the 
relationship between physical activity and disease. First the physical activity level that the relative 
risk corresponded to was estimated from the single largest study contributing to the meta-analysis, 
rather than a weighted average across all studies.  
 
Second following the approach used in the Integrated Health and Transport Impact Model, I assumed 
the relationship between physical activity and relative risk was a log linear relationship with a power 
transformation between 0.25 and 1.0. Whilst this relationship may be broadly consistent with other 
described relationships, it is different from those used in published meta-analyses for mortality43,299 
and for cardiovascular disease.44 The tornado plots suggest the magnitude of the power 
transformation did not have much influence on the observed outcomes, so the modelled relationship 
may equate to a log linear relationship. A recently published meta-analysis for five of the six diseases 
(dementia was not included) broadly suggests that modelling the relationship between physical 
activity and relative risk as log linear was reasonable for colon cancer, breast cancer, ischaemic heart 
disease, type 2 diabetes and stroke.110 
 
At a more fundamental level, there is uncertainty about the true relationship between physical 
activity and health. I have assumed the relationship between physical activity and health outcomes is 
dependent on the product of duration and intensity of activities above a certain energy level (3.0 
MET). However other facets of physical activity may be important: frequency, type of activity, 
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context of activity and associated risk, relative (rather than absolute) intensity, low intensity (<3.0 
MET) and sedentary activity.  
 
Using the product of duration and intensity implies that doubling the time of physical activity is 
equivalent to doubling the intensity. If energy expenditure is what drives the association between 
physical activity and health such a relationship is appropriate. Whilst it seems possible to suggest 
other relationships, such as product of duration and energy square root, I am not aware that any 
have been explicitly tested. 
 
I chose to use marginal MET-hours, rather than MET-hours, because it appeared inappropriate to 
give ‘credit’ for baseline energy consumption. However I note that MET-hours is increasingly being 
used.44,110,299 Using marginal MET-hours effectively gave more weight to high intensity activity over 
lower intensity activity. For example, using MET-hours, an hour at 6.0 MET is 2 times as much 
physical activity as an hour at 3.0 MET, but using marginal MET-hours an hour at 6.0 MET becomes 
an hour at 5.0 marginal MET-hours, and an hour at 3.0 MET and hour at 2.0 marginal MET-hours, 
which is 2.5 times as much physical activity.  
 
7.3.2.5 Scenarios 
I have only explored a small number of scenarios. Whilst the pattern of results for these scenarios 
was similar some small differences in outcomes between the scenarios were noted. I have not 
explored other scenarios (e.g. around increases in physical activity during particular life stages such 
as mid-life), as others have done.311 I have also assumed uniform increases across the population, 
which is unlikely to reflect the effect of real interventions, for which uptake and changes in physical 
activity (both duration and intensity) might be expected to show variability between individuals.  
 
7.3.2.6 Assessment of outcome 
I have considered only some measures of healthcare need. I have not considered severity or co-
morbid illness, nor have I attempted to translate these epidemiological measures of need into 
demand for healthcare (e.g. presentations, referrals, procedures, prescriptions) or better indicators 
of need for social care (e.g. disability). Consideration of disease severity may be particularly 
important for some diseases, such as colon cancer and ischaemic heart disease. For these diseases 
increases in physical activity were associated with improved disease-specific survival, which might 
suggestive the severity of the underlying disease process was also reduced.  
 
I have not considered costs. A full economic appraisal would require decisions to be made about the 
cost perspective (e.g. healthcare costs or societal costs) and consequently whether to include wider 
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costs and benefits (e.g. sickness absence and productivity, pension costs, changes in the size of the 
tax base attributed to a larger population).  
 
Estimates of changes in the mean age of onset only account for those individuals who develop 
disease. If disease is prevented the estimates of age of onset are calculated for two different groups. 
One group consisting of those who develop disease under the baseline scenario and a second those 
who develop disease under the test scenario. The latter group will consist of fewer people because 
cases of disease were prevented, so is not comparable to the former group. As noted in the results, it 
is possible for the mean age of onset to fall when graph representing the number of people living 
with disease by age suggests that disease events are being pushed later into life.  
 
7.3.2.7 Cancer 
I have modelled cancer as a chronic disease, and not explicitly modelled recovery or remission. The 
increase in the person-years lived with colon cancer and breast cancer should thus be treated with 
some caution. Some of these person-years would be lived free of cancer with limited or no need for 
cancer related healthcare, although some of those years for some people will be lived in disability.  
Whilst not the usual metric of cancer burden, cancer prevalence is reported and is based on incident 
disease and does not account for recovery.328 Cancer is increasingly seen as a chronic disease 
because the number of cancer survivors is increasing (around one in two live ten years or longer after 
diagnosis in the UK) and because many are left with residual symptoms and/or disability after 
surgical treatment or treatment with radiotherapy or chemotherapy.329,330  
 
Data on cancer incidence is taken from cancer registries and given the nature of the reporting 
systems should be accurate.279,331 Estimates of incidence are based on “new registrations” of cancer. 
Generally, events of cancer recurrence are coded as such and linked to the initial registration, 
although incident cancers in the same organ in cancer survivors can occur and would be counted as a 
new registration (Personal correspondence with John Broggio, National Cancer Registration and 
Analysis Service, Public Health England). Consequently the estimates of cancer incidence and 
prevalence may be slightly over-estimated. 
 
I was also concerned that the assumption that physical activity affected cancer survival might not be 
realistic. The modelled effect of physical activity on cancer survival came from observational 
studies,67,68 and may be prone to bias. Of particular concern in these studies, studying cohorts of 
patients after a diagnosis of cancer, was confounding by cancer severity. Cancer severity may 
determine how active people are and how likely they are to die of cancer, a form of confounding by 
indication.332 In other words the improved survival reported in observation studies might be 
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attributable to a less aggressive cancer rather than physical activity. This was handled by undertaking 
sensitivity analyses where no survival effect was assumed, which markedly reduced the magnitude of 
the increase in person-years lived with colon cancer and resulted in a small increase in person-years 
lived with breast cancer changing to a small decrease.  
 
7.3.2.8 Type 2 diabetes 
The incidence data and prevalence of type 2 diabetes were inconsistent when entered into DisMod. 
At older ages, either the estimated incidences produced by DisMod were too low compared to those 
reported, or the estimated prevalence at older ages was too high. This discrepancy is most likely due 
to recent changes in the reported incidence of type 2 diabetes, partly reflecting changes in diagnostic 
practice.  
 
The standardised incidence ratio of type 2 diabetes has risen nearly three-fold in the twenty years 
since 1990, because of changes in diagnostic practice and a true increase in the underlying incidence 
of type 2 diabetes.333 The prevalence in published data reflects historical incidence, which was much 
lower than current incidence. However, the prevalence in DisMod reflects the current (relatively 
high) incidence rates, which leads to a high estimate of prevalence. Consequently, the estimates 
from DisMod and published data were discordant. Alternatively, DisMod could be set to 
preferentially track the prevalence, but this could only be achieved by estimating lower incidence 
rates. 
 
If some of the rise in type 2 diabetes incidence is explained by a shift towards earlier diagnosis (or 
identification of undiagnosed type 2 diabetes), the reported incidence rates may be artificially 
inflated for a short period of time, i.e. they would appear higher than the true underlying incidence. 
Reported incidence rates at that level (in the absence of changes in the underlying incidence) would 
not be sustained. Using such rates would lead to an overestimate of the prevalence (i.e. higher than 
the underlying disease epidemiology would allow).  
 
Given this and because prevalence rather than incidence is the more usual measure of healthcare 
need for type 2 diabetes, I chose to bias DisMod towards re-creating the prevalence of type 2 
diabetes, accepting that this resulted in a very low (zero) estimate of incidence at older ages. In 
reality the incidence will be higher than zero, although in contrast to other diseases it does genuinely 
appear to reduce in old age.333 The net effect of these assumptions is to bias the model towards to 
modelling type 2 diabetes as a disease for which physical activity leads to prevention rather than 
delay in its onset, because there are so few cases in old age. The epidemiology of diabetes (i.e. 
marked decline in incidence with age) does suggest that type 2 diabetes may be prevented rather 
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than just be delayed in onset, but the extent to which this happens may be overestimated in the 
model. 
 
Type 2 diabetes was also modelled differently to other diseases. Type 2 diabetes and cardiovascular 
disease are not independent, as diabetes is a risk factor for the development of cardiovascular 
disease.303 As  others have done,301 I did not model changes in diabetes incidence (from the disease 
model) through into changes in mortality in the general model (i.e. changes in the incidence of 
diabetes do not directly result in changes in mortality within the model). This may have 
underestimated the extent to which physical activity could contribute to changes in mortality. 
However, the extent of this underestimation may be small. Much excess mortality from type 2 
diabetes is explained by cardiovascular disease334 so may, in part, be modelled through changes in 
ischaemic heart disease and stroke that arise from changes in physical activity. 
 
I also assumed that physical activity did not affect survival after a diagnosis of type 2 diabetes, and 
did not model remission from type 2 diabetes. Physical activity may have a role in inducing remission, 
amongst some patients.335,336 Modelling different assumptions for these relationships may have 
altered the magnitude of changes observed for type 2 diabetes, and whilst the pattern observed for 
type 2 diabetes may be illustrative of how physical activity may affect a disease, one should be 
cautious about making strong conclusions about the association between changes in physical activity 
and type 2 diabetes specifically. 
 
7.3.2.9 Lags 
The lag between physical activity and development or progression of disease is poorly described, 
particularly for cancer and dementia. If the lag is much shorter than the lag I modelled this will have 
implications for the effect of physical activity on the disease burden. If the lag is shorter the influence 
of physical activity appears to be greater, probably because physical activity declines with age and 
similar absolute increases in physical activity have a greater effect on relative risk (given the nature 
of the dose response curve) at older ages when the absolute risk of disease, and disease burden, is 
greatest. 
 
7.3.2.10 Effect on other diseases 
I have primarily focused on the diseases for which physical activity is protective. The effect of 
increases in physical activity (and resultant increases in life expectancy) on other diseases for which 
physical activity is not protective will be different. The sensitivity analyses highlight this. For example, 
both incident cases and person-years lived with prostate cancer, pancreatic and lung cancer are 
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estimated to increase assuming that physical activity is not associated with incidence of these 
cancers (Chapter 6, Table 6.3). 
 
Generally, for diseases that are not affected by physical activity if incident cases occur in older age 
(and particularly if incidence increases with age), then one would expect that as physical activity 
increases the number of incident cases should increase, because people are living longer. Similarly, 
the person-years with disease should also increase, partly due to more incident cases but also 
because of increased all-cause survival amongst those diagnosed with the disease. However, my 
focus was on considering diseases for which physical activity was protective. 
 
7.3.2.11 Old age 
The results should be treated with caution amongst those aged 80 years and over for several 
reasons. First, there is relatively limited data on disease parameters (incidence and prevalence) 
beyond age 90 years. Second whilst mortality data is complete to 100 years, the coding of deaths in 
older age may be less reliable.337,338 Third, I have assumed that the effect of physical activity on 
disease incidence is similar (on a relative scale) throughout life, although its effect is much less 
studied in older age. Fourth, the increases in physical activity modelled in later life may be less 
achievable, either because of co-morbidities or limited cardiovascular reserve. It is noticeable that 
measures of physical activity intensity for walking are described in terms of absolute parameters, 
relating to walking speed, incline or surface. Whilst such parameters may be unattainable for some 
older people, it is unclear how failure to obtain these levels of intensity affects benefit. I note that 
physiological responses of the body (e.g. fat burning vs glucose metabolism) to activity depend on 
relative intensity rather than absolute intensity.339 Whilst absolute measures of physical activity may 
be less achievable for older people, it seems conceivable that benefits may not wholly be explained 
by absolute intensity of activity. Fifth, co-morbidities are more common in older age, and the effect 
of physical activity on disease risk when there are co-morbidities is not explicitly represented in a 
proportional life-table model. 
 
7.3.2.12 Background incidence of disease 
The model has not accounted for future changes in disease incidence, disease survival or all-cause 
survival. Background incidence of these parameters has effectively been frozen at the values 
currently estimated for England. Historical trends suggest some or all of these parameters are likely 
to change. For example ischaemic heart disease incidence and case fatality have decreased, 340 and 
life expectancy increased over the past fifty years.340,341 However, the extent to which past patterns 
continue in future trends is far from certain. Future changes in risk factors prevalence (e.g. smoking, 
obesity) and treatment will lead to changes in model parameters, such as ischaemic heart disease 
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incidence and case fatality. If the decrease in ischaemic heart disease incidence were to continue the 
effect of physical activity on population ageing might be less, which would affect the life table 
results. 
 
Consequently, I suggest the results should not read as forecasts as to what would happen from 
increases in physical activity in England in the future, but rather one should see the work as an 
exploration of the effect of increases in physical activity on indices of healthcare need (or 
illumination of how increases in physical activity may affect need for healthcare).342  
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7.4 Model validity: comparisons with other estimates 
 
Alongside limitations one should consider the model’s validity, before interpretation of the findings. 
Although it has been suggested that health impact models should be systematically and explicitly 
tested for validity, in practice this does not happen.138 Moreover, I am not aware of any guidance 
about how such testing should take place.  
 
Validation is not straightforward. Comparison with empirical data may be one approach, but often 
health impact models are seeking to estimate the effects of interventions that are not empirically 
observable. Comparisons with other models may appear sensible, but this may result in models 
replicating mistakes and depends on the comparison model being validated. 
 
My working approach, here, is first to compare model outputs (where possible) with empirical data, 
which effectively only validates part of the model. Second, I draw comparisons with other models, 
particularly those which have been validated. 
 
In practice this has meant doing three things. First I have compared model estimates of incidence 
and prevalence with existing epidemiological parameters. Second I have compared estimates of 
changes in life expectancy from the model with other published estimates attributed to changes in 
physical activity. Third I have compared model outputs for changes in population attributable 
fraction (PAF) or population impact fraction (PIF). 
 
7.4.1 Comparisons of incidence and prevalence 
Comparisons of simulated epidemiological parameters (incidence for cancers, prevalence for cardio-
metabolic disease) for the six diseases are shown below (Tables 7.1-7.4). Broadly these estimates 
show good agreement. There are some areas of divergence, e.g. the very high prevalence of 
dementia above age of 90 years (35.0% in observational data vs 28.4% in simulated data; Table 7.4) 
and a relatively shallow decline in type 2 diabetes prevalence at ages above 85 years (Table 7.2). 
These may reflect measurement error (e.g. the 95% confidence for the estimate of dementia 
prevalence was 28.4% to 42.3%) or it may reflect genuine differences in reconciling epidemiological 
parameters when underlying disease parameters are changing (e.g. type 2 diabetes, see section 
7.3.2.8).  
 
The good agreement, whilst reassuring, is expected as the comparison values were used as inputs to 
generate incidence and case fatality estimates by age. Given the primary focus of the work is to 
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explore the effect of changes in physical activity on indices of healthcare need, rather than forecast 
actual healthcare need, discrepancies between observed and simulated estimates are less important.  
 
Table 7.1 Comparison of observational (Health Survey for England) and simulated 
estimates of cardiovascular prevalence  
Observational Data Simulated Data 
 Prevalence (%)  Prevalence (%) 
 Ischaemic Heart Disease Stroke Age 
(years) 
Ischaemic Heart Disease Stroke 
Age band 
(years) 
Male Female Male Female 
 
Male Female Male Female 
45-54 3.6 1.6 1.5 1.3 45 2.4 0.4 1.2 0.4 
     
50 3.8 0.9 1.9 0.8 
55-64 8.6 4.1 4.1 2.4 55 6.1 2.0 2.9 1.5 
     
60 9.2 3.9 4.3 2.6 
65-74 15.1 7.5 7.2 4.4 65 13.3 7.0 6.1 4.2 
     
70 18.1 10.7 8.3 6.1 
75-84 25.2 17.3 10.9 9.4 75 23.0 13.8 10.8 8.0 
     
80 27.2 15.8 13.2 9.4 
85+ 31.6 14.4 16.6 9.5 85 30.4 16.6 15.3 10.3 
 
Table 7.2 Comparison of observational (National Audit of Primary Care) and simulated 
estimates of diabetes prevalence 
Observational Data Simulated Data 
 Prevalence (%)  Prevalence (%) 
Age band (years) Male Female Age Male Female 
30-34 0.6 0.6 30 0.5 0.5 
35-39 1.3 0.8 35 1.0 0.8 
40-44 2.4 1.4 40 2.0 1.2 
45-49 4.2 2.5 45 3.5 2.1 
50-54 6.4 4.0 50 5.5 3.5 
55-59 8.9 5.6 55 7.9 5.0 
60-64 10.7 6.9 60 10.2 6.5 
65-69 13.9 9.2 65 12.5 8.4 
70-74 16.3 11.8 70 15.2 10.8 
75-79 17.5 13.3 75 16.9 12.7 
80-84 16.3 12.5 80 16.9 12.8 
85-89 13.1 10.3 85 15.5 11.5 
90+ 9.4 7.5 90 13.3 9.7 
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Table 7.3 Comparison of observational (cancer registry) and simulated estimates of cancer 
incidence by age 
Observational data Simulated data used within model  
Incidence (per 100,000 population)  Incidence (per 100,000 population) 
Age 
band 
(years) 
Colon cancer 
(females) 
Colon cancer 
(males) 
Breast cancer 
(females) 
Age 
(years) 
Colon cancer 
(females) 
Colon cancer 
(males) 
Breast cancer 
(females) 
40-44 7.5 6.9 119.4 40 10 0 100 
45-49 11.7 12.0 214.5 45 10 10 150 
50-54 21.9 23.1 273.6 50 20 20 210 
55-59 37.6 42.5 270.0 55 40 30 270 
60-64 65.9 91.7 343.9 60 70 60 320 
65-69 95.2 137.0 399.9 65 120 110 360 
70-74 137.2 199.5 330.1 70 160 170 390 
75-79 181 260.8 379.6 75 200 230 400 
80-84 239.1 314.6 409.6 80 220 280 410 
85 and 
over 
245.6 342.9 441.5 85 240 320 420 
 
Table 7.4 Comparison of observational (Cognitive Functioning and Ageing Study II) and 
simulated estimates of dementia prevalence 
Observational data Simulated data  
 
Prevalence (%) 
 
Prevalence (%) 
Age band (years) Male Female Age (years) Male Female 
65-69 1.2 1.8 65 0.9 0.4 
70-74 3 2.5 70 2.1 1.1 
75-79 5.2 6.2 75 4.7 3.3 
80-84 10.6 9.5 80 8.6 8.5 
85-90 12.8 18.1 85 13.1 18.1 
≥ 90 17.1 35.0 90 16.8 28.4 
 
7.4.2 Comparisons of life expectancy estimates 
Table 7.5 compares estimates of the effect of increased physical activity on life expectancy. 
Comparisons should primarily be made with the first section of the table (‘Population based 
scenarios’) as these scenarios describe changes occurring in a population with a range of baseline 
levels of activity (rather than the effect arising from an individual, or a population with a narrow 
range of physical activity levels, changing). 
 
The estimated increase in life expectancy from the standard model is noticeably less than other 
estimates. The estimates from the ‘mortality variant’ are compatible with the other estimates, within 
the limits of error. The other estimates, as with the mortality variant of the model, are made using a 
life table model parameterised with estimates, from observational studies, describing the association 
between physical activity and mortality. The relatively good agreement between the mortality 
variant of the model and the other estimates suggests that the primary model may not be  
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Table 7.5 Comparison of estimates of increase in life expectancy attributable to increases 
in physical activity 
Study Scenario Population Method Estimated increase in 
life expectancy (years) 
Population based scenarios 
Mytton, 2016 
(Thesis) 
Everyone in England meeting physical 
activity guidelines 
England Standard model (multi-state 
life table model: effect of 
physical activity on mortality 
modelled indirectly through 
five diseases) 
0.26 
Mytton, 2016 
(Thesis) 
Everyone in England meeting physical 
activity guidelines 
England Mortality variant of the model: 
i.e. effect of physical activity on 
mortality modelled directly 
0.54 
Baal et al, 
2016311  
Everyone in England, between the 
ages of 40 and 65 years of age, meets 
physical activity recommendations 
England Life table based model, 
physical activity has a direct 
effect on mortality 
0.46 
Ekelund et al, 
2015196 
Everyone in the UK undertook at 
least 20 minutes of brisk walking 
UK Large European cohort study to 
estimate RR of mortality and 
UK life table 
0.70 
Lee et al, 
2012107 
Elimination of physical inactivity 
globally, i.e. everybody meets 
physical activity guidelines (≥ 150 
minutes of MVPA per week) 
World Life table (country specific) 0.68 
Individual based scenarios 
Janssen et al, 
2014343 
An individual becoming “active” (8.33 
MET-hours of leisure time physical 
i.e. 150 minutes of MVPA leisure 
activity per week) relative to inactive 
(no leisure time PA, 0 MET-hours per 
week) 
USA Survey data linked to death 
certification to estimate RR of 
mortality and US life table 
2.4 (for men) and 3.0 
(for women) 
Moore et al, 
2010344 
A physical activity level of 0.1-3.74 
MET-hour per week equivalent to 
brisk walking for up to 75 min per 
week relative to no leisure time 
activity (0 MET-hours per week) 
USA Six US based cohort studies to 
estimate relative risk of death 
and survival curves (i.e. life 
table method)  
1.8 (95% CI: 1.6-2.0) y 
in life expectancy 
Nusselder et 
al, 2008294 
An individual becoming “active” (>33 
MET-hours per day) relative to 
inactive (<30 MET-hours per day) 
Framingham, 
USA 
Life table based model, 
physical activity has a direct 
effect on mortality 
3.5 (for men) and 3.4 
(for women) 
 
adequately describing how physical activity affects mortality (e.g. physical activity may affect other 
diseases that are important causes of mortality or physical activity may have an effect on survival of 
other diseases). I note that the sensitivity analyses suggest that the inclusion of other diseases (e.g. 
assuming physical activity affects risk of lung cancer, prostate cancer and pancreatic cancer) may 
have a relatively small effect on changes in life expectancy, however disease survival effects (e.g. 
demonstrated by the sensitivity analysis that assumed physical activity did not affect breast cancer 
and colon cancer case fatality) may be more important. Model specific issues, notably around co-
morbid illness (see section 7.3.2.1) may also be a factor, but it seems unlikely that they could fully 
explain the observed discrepancy. 
 
Issues with the epidemiological studies may also contribute to the discrepant estimates. It is 
noticeable that estimates of the association between physical activity and mortality tend to be of a 
similar magnitude to estimates of the association between physical activity and cardiovascular 
disease (e.g. 16-30% mortality reduction associated with changing from inactive to moderately 
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active; 17% incidence reduction and 23% mortality reduction in cardiovascular disease associated 
with change from inactive to all adults meeting PA guidelines).44,196 This appears implausible because 
cardiovascular disease only contributes to around a quarter of all deaths in England322 and would 
appear to be the important disease that mediates the relationship between physical activity and 
mortality. The findings may point to issues with the epidemiological studies, e.g. that the 
epidemiological studies overestimate the effect of physical activity on mortality and/or 
underestimate the effect of physical activity on other diseases. 
 
Some other model specific factors may contribute to the lower estimates, but alone are insufficient 
to explain the differences given the marked discrepancy between the standard model and the 
mortality variant. For example, over estimating baseline physical activity levels (by including all forms 
of physical activity) relative to cohort studies, may contribute (section 7.3.2.3) although this issue is 
common to both the standard model and the mortality variant.  
 
It is possible that a combination of these issues (e.g. that physical activity affects the risk of other 
cancers, that physical activity affects survival from other diseases, that baseline physical activity is 
modelled using leisure-time physical activity) might account for the differences between the 
mortality model and the standard model. 
 
7.4.3 Comparison of estimates of population attributable fraction 
Table 7.6 compares estimates of the population attributable fraction. The estimates from Lee et al 
are most relevant as they are UK specific and produced more recently,107 although the relatively high 
estimates for breast, and to a lesser extent colon cancer, should be treated with caution. Lee’s 
estimates of the population attributable fraction are about two to three fold greater for cardio-
metabolic disease, although the reported intervals overlap for ischaemic heart disease. 
 
These differences may be explained by differences in the data sources or how that data was used. Of 
note they may be explained by differences in the definition of baseline physical activity. My study 
had a broad definition of physical activity, including travel, recreational and work-related physical 
activity. This effectively inflated the proportion of the population who were meeting guidelines. The 
Lee study was based on older data where it was more common to use less flexible definitions of  
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Table 7.6 Comparison of population attributable fractions for physical activity and selected 
diseases 
Model Mytton et al (Thesis) Lee et al, 2012 WHO, 2002 
Scenario All adults meet public health 
guidelines (UK) 
All adults meet public 
health guidelines (UK) 
All adults meet public 
health guidelines 
(‘typical’ developed 
country) 
Ischaemic Heart Disease 5.1 (2.9-8.2) 10.5 (4.0-17.3) 22 
Stroke 5.2 (2.9-8.3) - 13 
Type 2 Diabetes 3.8 (1.8-6.1) 13.0 (6.4 to 20.2) 15 
Colon Cancer 2.4 (1.2-4.0) 17.9 (8.5-27.8) 17 
Breast Cancer 2.2 (0.8-4.2) 18.7 (10.5 to 27.1) 11 
 
 
bouts of physical activity (see section 1.3.2) and to define meeting guidelines based principally on 
leisure-time physical activity. This effectively meant the proportion of the population classified as 
inactive may be greater in these other studies, and hence there is more scope for physical activity to 
increase and effect health. The figures, in part, are thus estimating different things, my data refers to 
all adults meeting physical activity guidelines (by undertaking a range of activities) under the 
assumption that a relatively large proportion already are (through doing short bouts of activity and 
non-leisure activity), whereas the Lee figures refer to all adults undertaking at least 150 minutes of 
leisure-time physical activity (i.e. meeting guidelines primarily through undertaking leisure-time 
activity).    
 
They may also reflect differences in the interpretation of ‘all adults meeting PA guidelines’. I took a 
conservative interpretation of ‘all adults meeting PA guidelines’, undertaking 5.75 marginal MET-
hours of physical activity, very close to the minimum threshold for meeting the guidelines (150 
minutes at 3.0 MET, i.e. 5.0 marginal MET-hours). While the MET assumptions used by these authors 
were not explicitly stated,107 I note that other authors when defining ‘meeting guidelines’ assume an 
intensity of 4.5 METs (i.e. 8.75 marginal MET-hours).299 Moreover these authors based their 
estimates on measures of relative risk that used studies that effectively compared inactive people 
with active people. The latter group includes those who both just meet guidelines and also those 
who exceed the guidelines. Thus, the estimates are effectively calculating an attributable fraction 
under the assumption that inactive people adopt the physical activity distribution of active people, 
rather than minimal levels of physical activity.  
 
Given the changes observed under some of the sensitivity analyses (e.g. ‘leisure only’ variant) and 
different scenarios (e.g. increase of 225 minutes per person, equivalent to 8.6 marginal MET-hour 
increase), it seems likely that estimates of the population impact fraction made using my model 
could be comparable with Lee’s estimates, at least for cardio-metabolic disease.  
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However, my estimates and those of Lee’s suggest a different ordering or relative magnitude of 
population attributable fraction for the different diseases. Lee suggests that the effect of physical 
activity on breast and colon cancer is greater than its effect on cardio-metabolic disease. My model 
suggests the opposite.  A recent meta-analysis of the dose response relationship between physical 
activity and different diseases that suggested the effect of physical activity was less on breast and 
colon cancer risk than cardio-metabolic riks,110 consistent with my model. 
 
7.4.4 Implications for interpretation 
Taken together these comparisons suggest that the model is under estimating the effect of physical 
activity on disease. This may relate to structural factors (e.g. not fully capturing all the pathways 
through which physical activity affects mortality) or differences in how the data has been used (e.g. 
modelling relationship between physical activity and disease, including non-leisure related activity in 
the assessment of baseline levels of activity). Differences in the interpretation of the scenario (e.g. 
the dose of physical activity used to simulate ‘all adults meeting PA guidelines’) may also have 
contributed to the appearance that the model is under-estimating the effect of physical activity. It 
warrants further investigation. 
 
As the model is not primarily being used to estimate absolute health benefits, but rather to illustrate 
how physical activity through its effect on longevity may influence indices of healthcare need, 
possible under-estimation attributed to scenarios or data differences is less of a concern. However, a 
failure to model all of the pathways through which physical activity affects mortality (and hence life 
expectancy), as suggested by the differences in life expectancy between the ‘standard’ and 
‘mortality’ models, may be more problematic. Nonetheless the overall findings that increases in 
physical activity may not be associated with decreases in indices of need for some diseases and that 
estimates of change in need are more conservative when making allowance for increased survival is 
likely to be robust. This general pattern of finding was observed for both the standard and mortality 
model. 
 
The ‘mortality’ model suggests that if the ageing effect was greater, then in general estimates of 
change in indices of healthcare need would change (positive changes would be greater, negative 
changes would be smaller or become positive changes). However, such changes could only be 
explained by changes in the underlying disease processes (e.g. greater effect of physical activity on 
disease incidence; physical activity affecting more diseases; or physical activity affecting survival of 
other diseases). These changes would also likely alter other aspects of the model and outcomes from 
the model. For example, if physical activity improved dementia-specific survival, then one might 
expect that physical activity would be associated with an increase in person-years lived with 
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dementia rather than no change or a small decrease. Conversely if the effect of physical activity on 
dementia incidence was greater this would result in larger reductions in incident cases of dementia 
and person-years lived with dementia (although it would still tend to push estimates of person-years 
lived with other diseases in a positive direction). 
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7.5 Comparison with previous work: indices of healthcare need 
 
I am not aware of any work that has sought to do what I have done (either for physical activity or for 
other behavioural risk factors, e.g. smoking). Nevertheless, some aspects of my work can be 
compared to other pieces of work. I have arranged these under four groups of studies: 
 first studies describing the association of changes in physical activity with all-cause disability 
(an indicator of healthcare need);  
 second studies describing the association of changes in physical activity with changes in the 
burden of several diseases;  
 third life table modelling studies describing the association of changes in physical activity 
with changes in the burden of a single disease;  
 and fourth life table modelling studies describing the association between other risk factors 
and change in indices of need.  
 
Most of the modelling studies have used a different set of metrics to the metrics I have presented 
here, and I first discuss the comparability of these other metrics with the metrics I have presented.  
 
7.5.1 Comparing across modelling studies with different metrics 
The modelling studies with which I draw comparisons have estimated the mean number of years an 
individual would live with a particular disease (e.g. estimated years lived with a particular 
disease).291–293 
 
I think changes in years lived with disease are equivalent to changes in person-years lived with 
disease.xxviii Change in mean years lived with disease for the average individual is estimated by 
dividing the total number of person-years lived with disease by the total population (at the start of 
the period of observation). In my study the population size at the start of observation (birth) was 
fixed in all scenarios. Thus increases in the person-years lived with disease will result in an increase in 
the average number of years lived with disease. Similarly decreases in the person-years lived with 
disease will result in a decrease in the average number of years lived with disease. One shortcoming 
of the approach that only reports individual expectation of years lived with disease is that it depends 
both on the likelihood of developing disease and duration of disease. Using only this metric, one 
                                                          
xxviii Whilst the two measures may be equivalent, the implied focus of each is different. One is an expression of the amount 
of disease in a population (and thus need for healthcare) and the other is an indicator of individual expectation of years 
lived with disease. Many of these studies use the terms disease expansion and disease compression (section 5.2.4.1). 
Disease expansion is an absolute increase in the average number of years lived with disease, so is equivalent to an increase 
in the person-years lived with disease. Disease compression is an absolute decrease in the average years lived with disease, 
so is equivalent to a decrease in person years lived with disease. 
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cannot distinguish between changes that result in more people living with disease (i.e. changes in the 
total incident cases) and the same number of people living with disease for a longer duration. The 
complementary indicators of healthcare need that I used (person-years with disease, total incident 
cases) allows these two effects to be distinguished. 
 
7.5.2 Studies of physical activity and disability 
Studies, whether using life table methods294,301 or comparative risk assessment methods,125,141 
conclude that increases in physical activity are associated with a reduction in disability, expressed 
either as years lived with disability or disability-adjusted life years (DALYs).xxix,125,141,294,301 Whilst I have 
not estimated all-cause disability, I note that the general trend (for the diseases considered) was for 
the person-years lived with disease to decrease. 
 
The exception to this trend were colon cancer and breast cancer, although the increase observed for 
breast cancer were small and the burden of disability attributed to these two diseases relative to the 
other diseases is small. In the UK, the burden of disease as measured by Disability Adjusted Life Years 
(DALYs) for other diseases (for which indices of need decreased) was much greater (DALYs for 
ischaemic heart disease: 1,454,000; ischaemic stroke: 392,000; diabetes: 208,000; and Alzheimer’s 
dementia: 387,000; vs DALYS for breast cancer: 295,000 and for colorectal cancer:xxx 325,000).106 
Moreover ischaemic heart disease, stroke, diabetes and Alzheimer’s disease are in the top 25 causes 
of years lived with disability, whereas colon and breast cancer are not.106 The contribution of colon 
and breast cancer to DALYS is predominantly through premature mortality rather than disability (i.e. 
the increases in person-years lived with colon cancer are likely to contribute little to disability). 
 
7.5.3 Studies of physical activity and several individual diseases 
Woodcock et al estimated that an increase in active travel (mean of 7 minutes per day) would reduce 
the disease burden (percentage change in DALYs) using comparative risk assessment modelling by 
7.6% for ischaemic heart disease, 7.0% for stroke, 7.2% for type 2 diabetes, 5.3% for dementia, 2.2% 
for colon cancer and 1.8% for breast cancer.140 The increases in this modelled scenario were largely 
attributable to increased cycling (at a mean of 6.8 MET), which together with walking may equate to 
a mean shift of around four to five marginal MET-hours. This is similar to the scenario ’all adults 
increase PA (150 minutes of walking)’, which modelled an increase of 5.75 marginal MET-hours, so 
                                                          
xxix Disability adjusted life years includes two components, years of life lost (to premature death) and years lived with 
disability, so reflects more than disability.  
xxx Approximately half of colorectal cancer is attributable to colon cancer.279 
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drawing comparisons between the outcome for this scenario and the Woodcock paper appears 
reasonable 
 
As one would expect given parts of the underlying models are similar, when using comparative risk 
assessment estimates, the estimates from my model (estimates of the change in person-years lived 
with disease, unchanged life expectancy) are similar (slightly higher) to those of Woodcock et al.140 
However when comparing with the life table estimates, the results of the two studies no longer look 
similar. This underscores how consideration of changes in survival affects estimates of burden of 
disease and indices of healthcare need. 
 
I am only aware of one published study that has used methods that allow for changes in life 
expectancy and has made estimates of the effect of changes in physical activity on a set of 
diseases.301 However this study did not publish estimates for change at the level of individual 
diseases, instead pooling across diseases and describing changes in estimated DALYs. Consequently, 
no comparisons are possible for changes in individual diseases. 
 
7.5.4 Life table studies of physical activity and single diseases 
Several life table studies have been published that describe the effect of increases in physical on a 
single disease. In these studies, a direct effect of physical activity on mortality is modelled, such that 
these studies make allowance for changes in life expectancy attributable to changes in physical 
activity. 
 
Two similar studies reported that increases in physical activity (during mid-life) were associated with 
small non-significant increases in average years lived with cardiovascular disease.293,294 Their finding 
of a small increase may appear to contrast with my finding of a small decrease for ischaemic heart 
disease (assuming the direction of change for average years lived with disease and person-years lived 
with disease are comparable; see section 7.5.1). Both estimates might be best interpreted as being 
close to zero and have uncertainty intervals that overlap, so could be considered similar. I also note 
that the equivalent estimate for the ‘mortality’ model was a small increase. 
 
A third study, using a similar model, but by a different set of authors, reported that increases in 
physical activity (inactive to low active; inactive to some activity; inactive to meets 
recommendations) was associated with a significant decrease in average years lived with 
dementia.345 However other increases in physical activity (low active to some activity; low activity to 
meeting recommendations; and some activity to meeting recommendations) were associated with 
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very small changes in the average years lived with dementia. The study reported using a conservative 
estimate of the association between physical activity and all-cause mortality, when using estimates 
that modelled a larger effect size it was estimated that dementia related costs increased.xxxi Direct 
comparisons with my work are not possible as I explored scenarios around the population 
distribution of physical activity changing, whereas this paper described scenarios around individuals 
with specified activity levels changing. However broadly this study does provide some evidence that 
increases in physical activity (principally among people who are already active) may not be 
associated with reductions in need for care. 
 
7.5.5 Life table studies of other risk factors 
Life table modelling has also been used to describe the effect of changes in other risk factors on 
years lived with cardiovascular disease.291,292,295 Smoking cessation was associated with an increase in 
the average number of years lived with cardiovascular disease (equivalent to an increase in the 
person-years lived with disease).292 In contrast reductions in body weight were associated with a 
reduction in the average number of years lived with cardiovascular disease.292,295 These findings are 
consistent with my general observation that an ‘improvement’ in a risk factor can be associated with 
either an increase or a decrease in person-years lived with those diseases for which it is a risk factor. 
  
                                                          
xxxi For this sensitivity analysis years lived with dementia were not reported, as healthcare costs were fixed per person-year 
and not discounted, changes in healthcare costs may be a proxy for changes in years lived with dementia.  
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7.6 Interpretation 
 
Whilst it is possible that the model has not captured all of the pathways by which physical activity 
affects life expectancy and may also for other reasons underestimate the effect of changes in 
physical activity on individual diseases, the value of this work is its comparative analysis that draws 
out the differences from additionally modelling the effect of physical activity on survival. This shows 
that when modelling the effect on some diseases, it is important to make allowance for changes in 
survival and that for some diseases increases in physical activity that reduce risk may be associated 
with only small changes in indices of need for healthcare. Whilst other studies have not explicitly 
asked the same question, elements of other work would appear to underscore these findings. 
 
7.6.1 Understanding patterns of change at a disease level 
The effects of physical activity on changes in disease epidemiology show marked variation between 
the different diseases. The patterns of change in the disease epidemiology (indices of healthcare 
need) relate to the three effects I described in Chapter 5 and to the underlying epidemiology of that 
disease.  
 
Type 2 diabetes and stroke show a similar pattern (decrease in incident cases, decrease in person-
years lived with disease, and both these estimates are not too discordant from estimates made using 
comparative risk assessment methods). For these diseases the incidence effect is dominant. This 
reflects a relatively strong effect of physical activity on relative risk of incidence and the absence of a 
disease survival effect (i.e. physical activity does not affect disease case fatality). For type 2 diabetes, 
the fall in incidence rate with age also means that population ageing is less important. 
 
Dementia is different (small decreases in incident cases and person-years lived with disease that are 
close to zero and much less than estimates made using comparative risk assessment methods). The 
incidence of dementia increases sharply with age, such that the population ageing effect is 
important. Whilst a few cases of dementia were prevented, more commonly the onset of dementia 
was postponed. 
 
Ischaemic heart disease is different again (large decrease in incident cases but relatively small 
decrease in person-years lived with disease). The disease survival effect is important, whilst cases of 
disease are prevented those with disease are living longer. For colon and breast cancer the disease 
survival effect is also important. In addition, few cases of colon and breast cancer are prevented, 
which may be attributed to population ageing and a rise in incidence with age and/or a relatively 
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weak effect of physical activity on incidence. For colon cancer the combination of these effects 
meant that increases in physical activity were associated with an increase in person-years with colon 
cancer. 
 
7.6.2 Extrapolation to other risk factors 
Whilst I have only considered physical activity, the conclusions may extend to other risk factors for 
non-communicable diseases. The underlying epidemiological factors (e.g. an increase in incidence 
with age) and the multiple pathways between physical activity and disease (i.e. the three different 
effects outlined in Chapter 5, section 5.2.1) are common to other risk factors and diseases. I also note 
that the literature for other risk factors (considered briefly under section 7.5.5)  appears consistent 
with the idea that changes in risk factor distribution resulting in risk reduction may only be 
associated with small change in indices of need for healthcare. 
 
7.6.3 Mean age of disease onset 
For some diseases, increases in physical activity were associated with decreases in the mean age of 
onset. Whilst this may appear counter-intuitive, particularly given that the curves for incident cases 
and people (Figures 6.6 and 6.7) shifted to the right suggesting later onset, one should remember 
that the estimates reflect the mean age for those who develop disease. Thus it is possible for the 
mean age of onset to decrease, whilst the age of onset is delayed if cases of disease are prevented 
predominantly in those who would have developed the disease at old age (i.e. this group is no longer 
part of the denominator).  
 
Theoretically this also seems possible. One could imagine a scenario in which a disease is caused by a 
combination of genetic and environmental factors. A strong genetic predisposition combined with 
environmental factors results in early onset, and the absence of those environmental factors results 
in onset in mid-life. A weak genetic predisposition only results in disease when combined with 
environmental risk and onset is late in life. Most individuals in the population have a weak genetic 
predisposition. Elimination of the environmental cause will prevent disease amongst those with a 
weak genetic predisposition and shift the age of onset amongst those with a strong genetic 
predisposition to later in life. Thus disease cases will be prevented, disease onset amongst those who 
develop the disease is later, but (because of elimination of cases in old age) the mean age of onset 
could still decrease. 
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7.7 Implications  
 
Broadly my work suggests that changes in life expectancy are important when evaluating or formally 
estimating the effect of changes in physical activity (and likely changes in other non-communicable 
disease risk factors) on indices of need for health or social care. Whilst beneficial changes in the 
distribution of a risk factor will be associated with improvements in health, need for health or social 
care for some diseases may be postponed rather than reduced. For some diseases for which physical 
activity is protective, need for health or social care could increase, although this is unlikely and any 
increases are likely to be small. 
 
7.7.1 Implications for public health practice 
 
7.7.1.1 Expectation that public health interventions will reduce need for health or social care 
My findings suggest that public health officials and policy makers should be more cautious about 
claiming that interventions designed to increase physical activity or reduce other risk factors for non-
communicable disease will lead to large reductions in need for health and social care in the long run. 
Whilst it may be reasonable to expect need to decrease for some diseases, such as type 2 diabetes, 
or to be postponed, in the long run it may not be a reasonable expectation for some diseases, such as 
dementia. Simply extrapolating estimates of risk reduction to reduction in indices of need will lead to 
overly optimistic estimates of the benefits of an intervention on reduction in need. 
 
7.7.1.2 Appropriate language for risk reduction interventions 
“Prevention” is a commonly used word within public health discourse. However, my work shows how 
risk reduction may result in little or no prevention of incident cases of disease, and I suggest that the 
word “prevention” should be used with caution. For some diseases (e.g. type 2 diabetes) prevention 
may be the appropriate term, but when it is not appropriate or it is unclear the phrase “risk 
reduction that may prevent or delay onset” may be more appropriate. This reflects the language in 
some recent publications concerning dementia risk reduction.346,347  
 
7.7.1.3 Expectation that population ageing leads to increased need for health and social care 
It is commonly assumed that an ageing population leads to increased need for health and social care, 
because the incidence of disease increases with age.286,348 There have, for example, been forecasts 
that population ageing will lead to a significant rise in burden of dementia.349,350 Whilst this 
assumption may sometimes be reasonable, my work shows that if changes occur in a risk factor, 
which is a risk factor for both mortality and for disease incidence, then it is possible for the 
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population to age whilst the need for healthcare (at least for some diseases) is relatively unchanged. 
Consistent with this, I note that recent research suggests that the number of people living with 
dementia is largely unchanged in the last 10-20 years, despite population ageing.278,351 
 
7.7.1.4 Estimates of population attributable fraction and physical activity guidelines 
Whilst not the focus of my study, my work suggests that estimates of the population attributable 
fraction for physical activity may be very different if different assumptions are made about either 
habitual (baseline) levels of physical activity (i.e. what physical activity is ‘counted’ as contributing to 
achieving physical activity guidelines) or about the intensity of physical activity undertaken to 
achieve physical activity guidelines. Whilst changing physical activity guidelines (see section 1.3.2) to 
include the incorporation of small bouts of physical activity may be important in recognising the 
value of these small bouts and encouraging more people, particularly less active people, to 
undertake some physical activity, it does result in a higher estimate of the proportion of the 
population who are physically active. This results in a smaller estimate of population attributable 
fraction for physical activity. Similarly, whilst an emphasis on activity at lower intensity (e.g. walking) 
may be an appropriate means to engage the least active in being active, the population health gains 
(measured as a population impact fraction) will be lower (perhaps markedly lower) if only this 
minimum level of activity is achieved and care should be taken in extrapolating the health gains from 
studies that assume greater increases in physical activity (intensity or duration). 
 
The discrepancy between the estimates of the population attributable fraction and changes in indices 
of need for healthcare underscores the importance of remembering that the population attributable 
fraction is estimated under the assumption of all other factors, including mortality, being fixed.352 
Whilst the population attributable fraction may be interpreted as the proportion of disease 
attributable to a given risk factor, it does not necessarily follow that that proportion of disease may 
be eradicated by removal of the risk factor. 
 
7.7.1.5 Use of public health models 
Public health practitioners should consider what type of model has been used and whether it is 
appropriate to address the question being considered. Where disease events may realistically be 
prevented then comparative risk assessment (or similar) models are appropriate, if disease events 
may be postponed and particularly where one wants to consider the implications of interventions for 
need for health or social care, then a form of longitudinal modelling (e.g. life table or 
microsimulation) that makes allowance for changes in life expectancy and delay in events will be 
more appropriate. Modelling work that tries to answer these latter questions but does not use 
appropriate techniques should be treated with caution. 
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7.7.2 Implications for public health modelling 
 
7.7.2.1 Modelling methods 
Much of the work that considers the benefits of physical activity (or costs of physical inactivity) and 
other behaviours uses comparative risk assessment modelling.106,107,141,353 This work suggests that 
researchers should consider using life table models or other tools to make allowance for increased 
life expectancy and the delay in onset of the disease. Whether it is necessary to use more 
complicated tools (e.g. microsimulation or life table models) may depend on the nature of the 
research question. When older age groups are being studied mortality is more important, which may 
suggest methods that account for changes in longevity are more important. It may also depend on 
the disease being studied, estimates of change in indices of healthcare need arising from different 
models were particularly discordant for dementia, but much less so for type 2 diabetes. 
 
The discrepancy between the ‘mortality’ model and standard model warrants further investigation to 
understand the sources of the discrepancy. This is important not only for interpreting results but also 
building future health impact models. The standard model by modelling the known pathways 
through which physical activity is thought to affect health appears more plausible and is more 
internally consistent. For these reasons and for now, it appears the more appropriate model to use. 
 
7.7.2.2 Disability adjusted life years 
Disability Adjusted Life Years (DALYs) have been used extensively with comparative risk assessment 
models, notably the Global Burden of Disease project,106,354 as well as with life table based 
models.301,302 However, comparative risk assessment models assume that the effect of a risk factor 
change is the same on Years of Life Lost (YLL)xxxii and Years Lived with Disability (YLD). My life table 
work suggests this is inappropriate. Disease events can be delayed (which might result in a decrease 
in YLL) whilst the number of years lived with diseases (or YLD) may not change. Using a life table 
based model it is possible to calculate different effects of physical activity on YLL and YLD.301 
Moreover the relative contribution of YLL and YLD to DALYS varies between diseases, which may 
further exacerbate errors caused by assuming that the effect on changes in physical activity on YLD 
and YLL is the same.106 Multistate life table models and microsimulation open the possibility of more 
                                                          
xxxii Years of life lost are estimated relative to life expectancy. They are estimated by summing the different between age of 
death and life expectancy for all deaths that occur before estimated life expectancy. Only premature deaths are counted. 
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realistically reflecting changes in disease onset (and premature mortality) to estimate YLL as well as 
estimating changes in YLD.  
 
7.7.2.3 Appropriate metrics 
There may be a need to develop better metrics and set clear expectations about what metrics should 
be reported, when using life table models (or similar) to capture improvements in health. My simple 
measure of mean age of disease onset did not reflect the delay in disease events when a large 
number of events were prevented (particularly amongst older people). Using a measure of adjusted 
age of onset, adjusting for cases prevented, may be more appropriate.  
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7.8 Chapter summary 
 
This chapter began by summarising the key findings, notably that when allowance is made for 
increases in life expectancy estimates of reduction in need for healthcare are smaller and for some 
diseases are close to zero. Whilst need may decrease for some disease (e.g. type 2 diabetes), for 
other diseases onset of disease may be delayed (e.g. dementia) and the absolute amount of disease 
(measured either in person-years with disease or incident cases) may change very little. Other 
diseases may experience a more mixed pattern, where the period of morbidity is prolonged (e.g. 
colon cancer or ischaemic heart diseases) and the amount of disease may fall for some indices (e.g. 
incident cases) but change little or increase for other (e.g. person-years lived with disease). 
 
 A number of limitations were discussed. Some of these (e.g. measurement of physical activity) may 
affect absolute estimates of effect. Comparisons with empirical data and other models suggest that 
the model may be underestimating the effect of physical activity on health and disease. However, 
the primary contribution of this work is to illustrate the effect of considering increased survival on 
indices of healthcare need, rather than making explicit forecasts about the future or estimates of the 
effect of discrete interventions. 
 
This analysis has principally considered diseases for which physical activity is protective. For other 
age-dependent diseases (e.g. some cancers) indices of need are likely to increase as a result of 
increases in physical activity. Whilst not explicitly explored it is likely that similar patterns may 
emerge for other risk factors. This is important for public health practitioners and policy makers. 
They should be wary of promising or expecting large reductions in need for healthcare as a result of 
investment in risk reduction or preventive interventions. Similarly, when formal estimates, using 
public health modelling techniques, of the health impacts of ‘preventive’ or risk reduction 
interventions are made, consideration should be made of need to make allowance for changes in life 
expectancy that will also result from the intervention.    
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8 Discussion 
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8.1 Chapter Outline 
 
This chapter begins by summarising the key findings from the epidemiological studies (Chapters Two-
Four) and the modelling research (Chapters Five-Seven). It presents an overarching discussion of my 
thesis, focusing around core themes (population approach, complementary methods, and 
measurement of physical activity). It then discusses implications for public health policy and practice 
and outlines future directions for public health and physical activity research, before reflecting on 
how my approach to public health research and practice has changed during the course of the PhD. 
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8.2 Summary of key findings 
 
8.2.1 Associations of active commuting with sickness absence and well-being 
I found that maintenance of cycling to work, relative to maintenance of not cycling to work, was 
associated with reduced sickness absence after adjustment for covariates and baseline sickness 
absence. Looking at the direction, magnitude, consistency and significance of associations across 
both the maintenance and changes analyses, there was some evidence that cycling to work was 
important for both mental and physical well-being, although few of these associations reached the 
recognised threshold of significance (p<0.05). I found no significant associations between walking to 
work and any of the three outcomes, either before or after adjustment for cycling to work.  
 
8.2.2 Associations of active commuting with body mass index 
I found that maintenance of cycling to work was associated with decreased body mass index (BMI) at 
one year follow-up, relative to maintenance of not cycling to work, after adjustment for covariates, 
but this association was markedly attenuated and no longer significant after conditioning on baseline 
BMI. The association for maintenance of walking to work, after adjustment for covariates, was of 
similar magnitude to that estimated for cycling to work (walking: 0.8 kg/m2 vs cycling: 1.1 kg/m2), but 
was marginally non-significant. An increase in weekly time walking to work was associated with a 
decrease in BMI, after adjusting for covariate and restricting to those who did not change home or 
work location. Other changes analyses were non-significant, although the direction of the findings 
was generally in keeping with an inverse association between active commuting and BMI. 
 
8.2.3 Associations of active commuting with adiposity 
Amongst participants living within five miles of work, participants (both men and women) who 
reported regularly cycling to work had decreased adiposity (both visceral adipose tissue and 
percentage body fat) compared to participants who reported always using the car. I also observed a 
dose-response relationship between distance to work and percentage body fat, amongst participants 
who reported only cycling to work. Associations for regular walking were not significant.  
 
Amongst participants living five miles or further from work, participants who reported combining car 
use with active travel, or car/public transport use with cycling had reduced adiposity. There was 
some evidence that walking or cycling, as usual modes of travel, were also associated with decreased 
adiposity. 
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8.2.4 Modelling an increase in physical activity levels and need for healthcare 
A shift increase in physical activity was associated with improvements in the following range of 
health indices: reduced risk of disease onset, improved disease-specific survival and increased life 
expectancy. Generally, increases in physical activity were associated with decreases in indices of 
healthcare need for diseases for which physical activity is protective. Increases in physical activity 
were associated with decreases in the number of incident cases, although some of these decreases 
were small and close to zero (e.g. dementia). Increases in physical activity were associated with 
decreases in the person-years lived with some diseases (e.g. stroke and type 2 diabetes) and 
increases for other diseases (e.g. breast and colon cancer). There were marked differences in 
estimates of healthcare need using life table modelling, compared to comparative risk assessment 
modelling, which did not make allowance for changes in life expectancy. 
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8.3 Themes 
 
There are a number of themes that run through this thesis, which I discuss below. 
 
8.3.1 Population perspective 
Throughout my thesis I have tried to draw a distinction between estimates as they apply to an 
individual and estimates as they apply to populations.  
 
In the early chapters the estimates of effect size (derived from epidemiological studies) were 
typically conceptualised as applying to an ‘average’ individual in the study, comparing somebody who 
commutes actively with somebody who does not commute actively, after holding covariates 
constant. Some of the observed effect sizes may appear relatively small, for example 1 unit for 
physical well-being (PCS-8) compared to suggested thresholds for clinical significance (typically 3 or 
more units).157,184 In Chapter One I suggested that promoting active travel is a population-level 
approach, and so the observed differences, whilst they may be conceptualised as ‘average’ 
individual-level differences, could also be seen as the differences one could expect between a 
population who commute actively and a population who commute by car. Conceived in this way the 
‘small’ difference is more likely to be important.  
 
In order to better contextualise the observed differences, I drew comparisons between populations 
from within the cohort. In Chapter Two, I compared the differences in well-being between 
participants in their 20s and participants in their 50s. In Chapter Three I compared the differences in 
BMI to secular changes in BMI observed in the population of the USA. I also argued in Chapter Two 
(section 2.4.4.1), that ‘acceptable’ effect sizes for individual level interventions targeted at those at 
highest risk are larger than an ‘acceptable’ shift in the population mean for a population-level 
intervention. Thus drawing comparison with clinical thresholds for significance is not appropriate. 
 
Public health modelling often seeks to culminate the estimated effect of multiple, and often small, 
individual changes to estimate population-level impacts.xxxiii,138 Within Part II of my thesis, I tried to 
draw a distinction between, and contrast, the estimated effect of physical activity for a typical 
individual (which was beneficial) and the estimated impact on need for healthcare considered at the 
                                                          
xxxiiiSometime public health modelling may be used to estimate changes expressed at the individual level. These may relate 
to ‘population scenarios’, e.g. mean changes in life expectancy if everybody became more active or ‘individual scenarios’, 
e.g. estimated change in life expectancy for somebody who changes from being inactive to becoming active. 
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population-level (for which ‘benefit’ was less clear-cut). I also drew a distinction between my work, 
which used measures that were explicitly reported at the population-level (e.g. person years with 
disease, incident cases), with previous work that has expressed such measures at the individual-level 
(e.g. mean years lived with disease). 
 
Besides a shift in focus away from individuals towards populations, there are other ways that thesis 
has taken a public health perspective. For example, taking a pragmatic approach to the classification 
of commuting (e.g. Chapter Four), which reflects the limitations imposed on commuting by distance, 
rather than creating biologically ‘pure’ categories of physical activity (i.e. comparing only car use with 
only walking or only cycling). The choice of alternative health indices, sickness absence and well-
being, was motivated in part by a desire to provide evidence that may enable public health 
practitioners (and others) to engage other stakeholders, such as employers, in promoting active 
commuting by creating a broader ‘health case’ for its promotion. I chose to focus on adiposity 
(Chapters Three and Four) because of the strong focus on obesity within public health practice in the 
UK.106,226,227,355 One of the modelling scenarios was based on meeting public health guidelines, and 
the other on increases in walking (an accessible form of physical activity for most of the UK 
population). The modelling part of my thesis also bridged two areas of public health practice, namely 
health improvement and health services public health. 
 
8.3.2 Complementary approaches 
Throughout my thesis I have tried to use complementary approaches to confirm findings or address 
related questions. 
 
8.3.2.1 Epidemiological methods vs modelling methods 
My thesis used two complementary methods for estimating and understanding the health impact of 
physical activity (epidemiological measures of association and health impact modelling). The 
epidemiological studies were used to estimate the association between active commuting and 
indices of health for an individual. The modelling studies were used to estimate changes in health 
(assuming a causal relationship between physical activity and health) or disease at a population-level, 
by culminating evidence from multiple epidemiological studies, and simulating scenarios of increased 
levels of physical activity. 
 
Modelling is underpinned by epidemiology. My epidemiological analyses were not used to directly 
underpin the modelling I undertook. However, the epidemiological work did partially support the 
modelling work. The epidemiological analyses reported in Chapter Three and Four, did provide some 
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evidence linking active travel, and physical activity, via reduced adiposity with diabetes, stroke and 
ischaemic heart disease, which were outcomes in the modelling study.150,356,357 Choosing a different 
set of outcomes for the modelling study, relative to the epidemiological analyses, resulted in my 
thesis, as a whole, covering a broader set of health indices and diseases. 
 
The modelling work also used complementary methods (life table and comparative risk assessment) 
and complementary outcomes (person-years lived with disease, and incident cases). The 
complementary indices of healthcare need are important as single measure is unlikely to capture 
different aspects of healthcare demand, such as acute admissions and routine care. 
 
8.3.2.2 Longitudinal vs cross-sectional methods 
The first part of my thesis used both longitudinal (the Commuting and Health in Cambridge dataset) 
and cross-sectional (the Fenland Study) data. The second part of my thesis used life table modelling, 
which as it explicitly models time could be conceived as longitudinal, and comparative risk 
assessment, which as it does not model time could be conceived as cross-sectional. 
 
I have argued that longitudinal methods tend to be superior. Longitudinal epidemiological studies 
can demonstrate temporality (the risk factor preceding the outcome) or specificity (e.g. linking 
changes in a risk factor with changes in an outcome), both of which may support causal inference.35 
An important strength of the work reported in Chapters Two and Three, relative to previous work, is 
that it used longitudinal data. Similarly, the modelling work demonstrates that explicitly modelling 
time (thus allowing the consideration of survival effects) offers a different, more realistic, perspective 
of the estimated effect of changes in physical activity on need for healthcare, compared to ‘cross-
sectional models’ or comparative risk assessment methods. An important strength of the modelling 
work, compared to previous work, is its ‘longitudinal’ element. 
 
The overall thrust of my thesis represented a movement away from cross-sectional methods towards 
longitudinal methods. The notable exception to this was Chapter Four (cross-sectional analyses using 
the Fenland dataset). Other important strengths of the Fenland Study (large size, detailed 
characterisation of physical activity and dietary behaviour, objective measurement of adiposity) 
justified its use. Similarly, there is still a role for comparative risk assessment modelling. It is easier to 
undertake and there may be circumstances when considering survival effects is less important (e.g. 
when studying younger adults). 
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8.3.2.3 Epidemiological analyses 
The epidemiological analyses also used complementary approaches. In Chapter Two and Chapter 
Three, I used complementary longitudinal approaches (maintenance and change analyses). The 
different analyses addressed slightly different questions. For example, with respect to BMI, the 
maintenance analyses offered a better indication of the long-term difference in BMI attributable to 
active commuting, as many of the commuters are likely to have maintained their commuting 
behaviour for longer than one year. In contrast the change analyses offered an indication of the 
short-term changes in BMI that may occur on starting or stopping active commuting (the average 
change would have occurred half a year before repeat measurement). I also argued that a consistent 
pattern of findings across both maintenance and change analyses (even in the absence of statistical 
association) provided greater evidence of association than observing associations within just one of 
these analyses, as well as strengthening causal inference by demonstrating both temporality and 
specificity. 
 
The conditional analysis also complemented the unconditional analysis. For example, a strong 
association was observed between maintenance of cycling to work and BMI at follow-up, after 
adjustment for co-variates, but not after conditioning on baseline BMI. This suggested that the 
differences observed in the unconditional analysis were largely attributed to differences in BMI at 
baseline between those who maintained cycling to work and those who maintained not cycling to 
work. Whilst such differences may be due to other systematic differences between the groups that 
were not adjusted for, such as diet, they might also be attributed to differences in behaviour prior to 
baseline. Rate of change of BMI, comparing those who cycle and those who do not, may be relatively 
small, such that absolute differences in BMI may only be apparent over a period of years. The 
complementary analyses, using the Fenland dataset more fully considered confounding factors 
(other physical activity, diet). As strong associations between active commuting and adiposity were 
observed after adjustment for confounding, unmeasured dietary or non-travel related physical 
activity confounding appears less likely to be explain the differences in BMI observed in the 
Commuting and Health in Cambridge dataset. 
 
The Fenland analyses also complemented the BMI analyses, undertaken in the Commuting and 
Health in Cambridge dataset, in other ways. They used a different approach to categorisation of 
commuting, included a more socially diverse sample, considered non-commuting travel, and used 
different, more biologically relevant, measures of adiposity. They also tested for a dose-response 
relationship. Across the two studies more robust causal inference was possible (e.g. specificity, dose-
response relationship, consistency, adjustment for a range of confounders) than across either single 
study alone.35 
220 
 
 
8.3.3 Measurement of physical activity 
The importance of accurate measurement of physical activity was another theme. In the early 
chapters I primarily used self-reported measures of physical activity and active commuting. I argued 
that some self-reported measures of active commuting were more accurate than others, such as the 
seven-day travel diaries, which in theory is a more sensitive than other means for capturing any 
active commuting, such as asking about ‘usual’ travel mode for commuting. Better tools for 
measuring the exposure, such as the travel diary, may reduce measurement error and so improve 
power and reduce bias (random measurement error tends to bias results towards the null).147,358  
 
Taking repeated measures is another way to reduce measurement error (e.g. to reduce regression 
dilution).189 By restricting the maintenance analyses to those individuals who maintained commuting 
behaviour (e.g. maintained cycling to work and maintained not cycling to work) I sought to reduce 
the potential misclassification of individuals who started or stopped cycling between baseline and 
follow-up. Had the classification been made only on cycling at baseline (i.e. cycling to work at 
baseline vs not cycling to work at baseline), changing of commute modes between baseline and 
follow-up, would have resulted in two groups who became more alike (effectively ‘regressing to the 
mean’) during the year of follow-up, and biased the result towards the null. Similarly excluding 
movers from change analyses and BMI (Chapter Three), strengthened the association between 
change in walking and change in BMI, such that the association became significantxxxiv. 
 
Objective measurement of physical activity may be another way to reduce measurement error. I 
used objective measurement of physical activity energy expenditure as a co-variate in the adiposity 
analyses (the Fenland Study). The modelling work relied on an understanding of the dose-response 
relationship between physical activity and disease outcomes, and was limited by a lack of objective 
measurement of physical activity. Although not directly shown in the uncertainty analyses, there was 
considerable uncertainty about the actual dose of physical activity in the epidemiological studies 
(measured using questionnaires), and thus of the dose-response relationships between physical 
activity and relative risk used in the model. 
 
                                                          
xxxiv The rationale to exclude movers was that those who moved might be experiencing many other changes that might 
result in a change in BMI (of uncertain direction, i.e. an increase or a decrease), rather than misclassification. However, its 
effect may have been similar as it resulted in a ‘purer’ group of changers and non-changers, whose behaviour was not 
influenced by moving.  
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8.3.3.1 Dose of physical activity 
Different definitions of ‘dose’ of physical activity have been used or implied throughout this thesis, 
although most definitions related to duration and/or intensity. For example, the epidemiological 
analyses defined dose in several ways: time (or change in time) cycling or walking to work, distance 
cycled to work, leisure time physical activity measured in MET-hours and objectively measured 
physical activity energy expenditure. The modelling analyses principally used a product of dose and 
intensity (marginal MET-hours).  
 
Dose is not the only dimension of physical activity that may be important.359 Other dimensions of 
physical activity, such as context, were also discussed in Chapter Two as a possible explanation for 
differences in well-being observed between different walking studies. Chapter Seven discussed issues 
with measuring absolute dose rather than relative dose. Type of physical activity is also relevant for 
some health outcomes, for example weight bearing activity for osteoporosis prevention.79,360 
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8.4 Overall Interpretation 
 
Taken together the epidemiological analyses suggest that active commuting, particularly cycling to 
work, may be valuable for improving well-being, reducing sickness absence and reducing (or 
maintaining) adiposity amongst adults of working age. Given that sickness absence and visceral 
adipose tissue are associated with ‘hard’ outcomes (e.g. mortality and cardio-metabolic disease 
respectively),149,150,175,176 these findings support previous observations of associations between active 
travel and these outcomes.127,129,132 
 
Given the exposures used (stratified by distance in the Fenland analyses, and including any walking or 
cycling in the Commuting and Health in Cambridge dataset analyses) as well as other aspects of the 
findings, such as effect modification by distance for BMI (Chapter Three), a stronger case can be 
made that the inclusion of some active travel, as part of commuting to work, for people who live too 
far to only cycle or walk to work, is beneficial for health. However, it is unclear how much and how 
often active commuting must be undertaken to experience benefit, particularly for those who 
include some walking or cycling as part of a longer commute.  
 
The associations for cycling tended to be stronger, than the associations for walking, across all of the 
outcomes studied. This may be attributed to the low duration of walking to work (relative to cycling, 
and relative to other studies). It may also be attributable to the lower intensity of walking relative to 
cycling. There may also be some Cambridge specific factors, related to socio-economic differences, 
between those cycling to and walking to work. Despite this, across the different analyses there was 
evidence that walking for travel, including walking to work, is valuable for health. 
 
Increases in the levels of physical activity within a population, which could come about from shifts in 
travel behaviour (e.g. away from car-use towards walking and cycling), are likely to be associated 
with improvements in a range of health indices. For some diseases these improvements will result in 
a decrease in healthcare need. However, because of improved survival for some diseases, indices of 
healthcare need may change little or (rarely) increase.  
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8.5 Implications for practice and policy 
I am defining practice as the “carrying out or exercise of a profession,” and policy as “a course or 
principle of action adopted or proposed by an organization or individual”.361 Alternatively the 
practice of public health is what public health professionals do, with much of the professional activity 
taking place at a local level. Government policies, whether intended to effect health or not, are 
predominantly (but not solely) instituted at a national level. 
 
8.5.1.1 Implications for public health practice 
The findings reaffirm the value of active travel, including active commuting, for improving or 
maintaining health amongst adults of working age. This is an important message to communicate to 
individuals when choosing how to commute (or undertake other regular travel). Just as there is a 
recommendation to reduce sedentary time, within public health guidelines,88 there could be an 
explicit recommendation to replace car travel with walking, cycling or public transport, when 
practical.  
 
The findings should also be communicated to those who can influence the determinants of active 
travel (e.g. major employers, transport planners and officials, elected representatives). Of particular 
note, this thesis has strengthened the evidence base associating active commuting with reduced 
sickness absence and improved well-being. Both these outcomes are important to employers and 
may be associated with greater productivity and financial savings. Shifting the distribution of active 
commuting is likely to require changing the underlying environmental determinants of commuting 
behaviour, some of which are under control of employers, such as (car or bicycle) parking, financial 
incentives (to use the car, bicycle or public transport), access routes (by foot, bicycle, car or public 
transport).112,113 
 
My thesis has also strengthened the evidence supporting the inclusion of active commuting within 
long commutes (as opposed to only commuting by foot or bicycle, which is not practical for many 
commuters). This is also an important message to convey to commuters, as some might assume that 
walking or cycling to work is not practical if they live too far from work. However, facilitating this type 
of commuting may require investment in new infrastructure, such as park and ride facilities and 
public transport, or ensuring that urban planning (e.g. the siting of homes and offices) makes best 
use of existing infrastructure.198  
 
Whilst those with long commutes may have relatively more to gain from active commuting, my thesis 
also suggests that other groups, such as those who are obese (Chapter Three) and those who are 
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relatively inactive (implied within the modelling of the dose-response curves, Chapter Five), may also 
have relatively more to gain from active commuting. It might be appropriate to target active travel 
interventions at these groups. 
 
My thesis did suggest that cycling tends to be more beneficial than walking, although the reasons for 
this are not well understood and may relate to intensity, duration or other factors. One implication 
might be to facilitate, encourage and normalise longer walking journeys. Another implication might 
be to make cycling more widely accessible in other parts of the UK.362 Walking and cycling are 
complementary, may fill different travel needs and may appeal to different groups. It is important to 
promote both activities rather than focus on one activity. 
 
The modelling work suggested that public health officials should be more circumspect about 
suggesting that increases in physical activity will reduce need for healthcare in the long run. Whilst 
need may decrease for some diseases, it may not decrease as much as simple calculations may 
suggest and it may not decrease for other diseases. Instead it may be more appropriate to put the 
emphasis on improvements in health and a delay in onset of disability or death. It may be possible to 
‘monetise’ some of the benefits to health by considering wider societal benefits, for example through 
reduced sickness absence, rather than focusing on savings and costs within the healthcare sector.  
 
Similarly, it is common to suggest that physical activity interventions are “preventative”, whilst this 
may be reasonable for some outcomes, like diabetes, it may not be for others, like dementia. If it is 
not clear that prevention will occur, it may be appropriate to use the term “risk reduction, which may 
delay or prevent” onset of disease, reflecting the language used in some recent publications on 
dementia.346,347 A strong case for investment in such interventions can still be made, focusing on 
health benefits.  
 
Similarly, public health practitioners should be cautious in their interpretation and use of findings 
from modelling studies that have not made allowance for the effect of physical activity on survival. 
Some major studies have estimated the burden of disease (measured in disability adjusted life years), 
and consequent costs, attributable to lack of physical activity.106,107,109,354 These models have not 
explicitly modelled changes in survival and consequently have not modelled possible delay in onset 
of disease and associated costs. Their estimates of burden and cost, attributable to lack of physical 
activity, assume that all other factors, including mortality are fixed.352 Thus one should be careful 
about assuming that the relevant increases in physical activity will result in decreases in the burden 
of diseases, principally Years Lived with Disability (YLD), and consequent cost savings, that these 
figures appear to suggest. Some of the cost and some of the burden of disease, that attributable to 
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YLD, will be postponed. Similar caveats are likely to apply to the modelling of the effect of other risk 
factors on non-communicable diseases. 
 
8.5.1.2 Clinical implications 
The estimated association between maintenance of cycling to work and BMI was 1.2 kg/m2. This 
equated to a difference of 3kg for a person of height 1.6m in a cohort with a relatively low 
prevalence of obesity. Whilst there remains uncertainty about the size of the effect, and whether the 
relationship between active travel and adiposity is causal, the reported effect size for active 
commuting is similar to that observed in weight loss interventions (4 to 6kg)xxxv. Given that there are 
good grounds to assume that the relationship is causal and a favourable assessment of benefits 
against risk,142 clinicians may consider recommending active commuting to suitable patients. A 
benefit of adopting active commuting, compared to standard weight loss interventions (which are 
typically offered for a short period), may be long-term maintenance of weight loss, if the behaviour is 
sustained. 
 
8.5.1.3 Implications for government policy 
The implications for policy reflect the implications for practice, i.e. that governments seeking to 
improve health and well-being should encourage, support and facilitate walking and cycling as forms 
of travel, most likely (given limited resources and space constraints) at the expense of car-use. Whilst 
I have not specifically tested the effectiveness of different approaches to promoting active travel, in 
Chapter One I argued that advice alone is unlikely to be sufficient to achieve population ‘shift’. 
Changing the social, environmental and economic determinants of active travel is likely to be 
necessary, and if this is to be done at scale, this requires a significant shift in government policy 
towards walking, cycling and public transport and away from car-use. The need for this is under-
scored by my finding that suggest inclusion of walking or cycling within long commutes (or as part of 
a pattern of commuting) is beneficial. Undertaking this type of commuting is likely to depend on the 
development and maintenance of appropriate infrastructure (i.e. public transport, park and ride 
facilities). 
 
The benefits of physical activity for health are much broader than its effect on obesity,26 as this thesis 
has demonstrated. However, obesity can be an important driver for policy change in the UK, and 
there is a risk that policies to reduce or prevent obesity, primarily or solely, focus on diet and largely 
                                                          
xxxv Trials of weight loss interventions (where most participants are obese) are associated with an initial weight loss of the 
order of four to six kilograms (followed by regain).368–370  
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exclude physical activity including active travel.xxxvi My findings suggests that physical activity, 
particularly active commuting, given the estimated effect sizes and improved causal inference, could 
be a valuable component of any strategy to reduce obesity.  
 
  
                                                          
xxxvi Some commentators dismiss the role of physical activity in preventing obesity.255 The recently released childhood 
obesity action plan did not discuss active travel, and physical activity (sport or physical education) only featured in two of 
the 14 recommendations. 
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8.6 Future research 
 
8.6.1 Measurement of physical activity 
A limitation of both the epidemiological and modelling work has been measurement of physical 
activity.  
 
Future studies of physical activity and health should seek to quantify the dose of physical activity. 
This will facilitate a better description of dose-response relationship between physical activity (and 
active travel) and health, important both for informing public health guidelines (how long? how 
hard? how often?) and developing better public health models. Whilst it is possible to quantify 
physical activity using self-reported questionnaires, this has limitations and consequently objective 
measurement of physical activity should be encouraged. 
 
Much of the discussion on ‘dose’ throughout this thesis has focused on measures of intensity and 
duration. Whilst these dimensions of physical activity are important, future research should also 
measure other dimensions, such as frequency, type of activity and context, as well as evaluating the 
importance of relative intensity (rather than absolute intensity).  
 
A limitation of the modelling work was uncertainty about how to apply findings for a single domain of 
physical activity, such as leisure time physical activity, to a population that is undertaking activity 
across multiple domains. Future work should also consider how to ‘integrate’ measures of physical 
activity across different domains of physical activity.  
 
8.6.1.1 Active travel 
Whilst methods to objectively measure active travel exist,205,206,363 they have not yet been used in a 
large datasets and need further development to enable their use in such studies. Objective 
measurement of active travel may require the retrospective identification of active travel from 
objective records of physical activity (e.g. based on signal pattern, time of activity or supplementary 
Global Positioning System data). This may be possible using the Fenland Study or other studies that 
have measured physical activity objectively, such as UK Biobank. However, studies that have 
measured physical activity objectively are relatively new and the length of follow-up short, so it may 
be several years before their potential can be realised. 
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Another potential direction is to develop methods to measure active travel using mobile phones. 
Mobile phones are ubiquitous and offer the possibility of frequent (or even continuous) data 
collection from large groups of individuals. However mobile phone data may have other limitations, 
such as comparability across multiple devices and generalisability of findings. 
 
Accurate measurement of intensity and duration of walking and cycling, may contribute to a better 
understanding of the different associations for walking and cycling with indices of health. 
 
8.6.2 Development and evaluation of interventions to promote active travel 
Given the strength of the overall evidence suggesting active travel can improve or maintain health 
and well-being, future research should develop and/or evaluate interventions that aim to promote 
active travel. The ‘radical’ population approach to promoting active travel, as well as some of my 
findings suggests that interventions to promote active travel should seek to modify the underlying 
social, economic and physical environmental determinants of active travel. There needs to be more 
empirical evaluation of real interventions, such as the study of the Cambridge guided busway,145 as 
well as health impact assessments of actual or proposed interventions, such as the London cycle hire 
scheme.142 
 
There may also be scope for individually focused interventions. In the previous section on 
implications for practice and policy (section 8.5.1.2, under clinical implications), I suggested that 
clinicians might want to recommend the adoption of active commuting to suitable patients and that 
adopting active travel might support long-term maintenance of weight loss. These approaches may 
be best incorporated into existing interventions to promote physical activity (e.g. exercise on 
prescription) or weight loss maintenance. The acceptability and efficacy of such approaches should 
be tested.  
 
8.6.3 Effect of physical activity on mortality and life expectancy 
The life table modelling has highlighted a discrepancy in estimates of the effect of increases in 
physical activity on changes in life expectancy. Estimates of changes in life expectancy modelled 
through disease pathways are less than when the effect of physical activity on mortality is modelled 
directly. This may relate to issues with the model (e.g. around modelling all the pathways between 
physical activity and mortality) or may be an indication of issues with some of the epidemiological 
studies describing the association of physical activity with disease and mortality. This has not been an 
explicit focus of my work and warrants further exploration. Until this is resolved, I do not think it is 
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possible to make strong inference about the effects of physical activity on life expectancy from multi 
state life table modelling. 
 
Given that epidemiological analyses themselves may appear inconsistent (e.g. recent estimates of 
comparable increases in physical activity were associated with a reduction in mortality of 16-30% and 
a reduction in cardiovascular incidence of 17%; see Chapter 7, section 7.4.2), resoultion may require 
both an exploration of issues with epidemiological studies as well as consideration of the (modelled) 
pathways by which physical activity affects mortality.  
 
8.6.4 Effect of changes in physical activity on healthcare utilisation 
This work only partially answers the question about the extent to which increases in physical activity, 
when considering its effect on survival, affect the disease burden and consequent need for 
healthcare. Future work could estimate the effect of increases in physical activity on all-cause 
disability and on other diseases (including those whose incidence increases with age, but is 
independent of physical activity). It could also explore different scenarios, for example the effect of a 
population with mixed ages (rather than a birth cohort), look over a different time horizon that is 
more prescient for decision makers (e.g. five to 20 years) or restrict the changes in physical activity to 
particular phases of life, such as mid-life.  
 
A full economic appraisal should be undertaken to understand the economic implications. This 
should consider which economic costs or benefits (e.g. the increased tax base from an increased 
population, productivity of a working age population that is healthier, increased pension costs from 
an older population) are in or out of scope. 
 
8.6.5 Use of longitudinal methods for epidemiological analyses 
Future analyses of the association of active travel and health should principally focus on using 
longitudinal data, although many of the existing cohort studies will not have objective measurement 
of active travel. Of note, EPIC-Norfolk (and related EPIC studies) and UK Biobank include the same 
question on mode and frequency of travel to work which I made use of in my analyses reported in 
Chapter Four. This underscores the need to validate the frequency of travel question on the Recent 
Physical Activity Questionnaire. Both EPIC-Norfolk and Biobank have a rich set of health indices 
230 
 
including measures of well-being and objective measures of adiposity, such as BMI, total and regional 
adiposityxxxvii.  
 
Sickness absence is not commonly reported despite being relatively easy to capture with a single 
question. Given its wider importance it should be routinely included within cohort studies. 
 
Appropriate longitudinal methods should be used. Traditional cohort studies test the association 
between an exposure at baseline and an outcome at follow-up. This design, which implicitly assumes 
that the baseline exposure is relatively constant, may be less applicable for active commuting if, as 
was observed in the Commuting and Health in Cambridge dataset, switching to or from active 
commuting is relatively common. Maintenance and change analyses may thus be more appropriate. 
Different approach to data collection, such as using mobile phone data, that could more accurately 
capture the timing of changes in travel patterns or enable collection of data at multiple time-points, 
may facilitate more informative longitudinal analysis. 
 
8.6.6 Development and use of public health modelling methods 
 
8.6.6.1 Appropriate models 
The modelling work suggests that the effect of physical activity on increased survival will, at least in 
some circumstances, affect indices of healthcare need. When undertaking public health modelling 
the extent to which this process may influence the results should be considered, and an appropriate 
choice of public health model should be made. A shift towards greater use of longitudinal models 
within public health modelling may be appropriate. 
 
Much existing work, both of physical activity and other risk factors, makes use of comparative risk 
assessment models. The work I have presented has highlighted the limitation of not considering the 
effect of a risk factor, such as physical activity, on survival. Further work should explore when 
findings from comparative risk assessment models may not be valid, and whether it may be possible 
to make simple adjustments to correct findings under those circumstances. 
 
However my work (the discrepant life expectancy estimates) highlights potential issues with 
multistate life table models, principally that they may not consider all the pathways (and thus the full 
impact) of physical activity on health. Whilst I argue for greater use of these and other longitudinal 
                                                          
xxxvii In the UK Biobank, the cross-sectional associations or active commuting with BMI and percentage body fat have already 
been reported.130  
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models because they make allowance for delay in disease onset, greater use should be accompanied 
by an awareness of the model limitations. It is also important for further comparative modelling, 
between different types of models, to be undertaken in order to better understand differences 
between models and facilitate improvement in modelling methods.   
 
8.6.6.2 Measures of disease 
As an important outcome in longitudinal models is the delay in onset of disease, appropriate metrics 
to report delay may need to be developed (change in mean age of onset in the context of a reduction 
of cases may be misleading). Future work could also explore likely discrepancies in estimates in the 
change in DALYS (Disability Adjusted Life Years), using comparative risk assessment models and 
longitudinal models. 
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8.7 Personal reflections 
 
When I began preparation for this thesis I thought I wanted to identify practical solutions to promote 
active travel that might be applied at the local or national level. I expected to focus a significant part 
of my thesis on the associations between the environment and active travel. This was because I saw 
lack of action in this sphere as a greater challenge for public health practice, than understanding the 
importance of physical activity for population health. I had assumed questions concerning physical 
activity and health were largely answered.  
 
Shifting attention towards describing the associations between physical activity and health was partly 
driven by wanting to connect explicitly with health and disease, reflecting my background in 
medicine. It was also partly because during the process of preparing for and undertaking the PhD, I 
have come to recognise that there is greater uncertainty concerning the associations between 
physical activity (including active travel) and health than I had previously appreciated.  
 
I now think that measurement of physical activity is a critical issue for the field of physical activity 
and public health. Improvements in measurement are necessary to improve public health models 
and refine public health guidelines. Improved measurement may also make it possible to detect, 
small but important, changes associated with real interventions. It may also help to formulate 
solutions by understanding the respective importance of walking for health, and how much is needed 
to improve health and well-being. I also think dose-response questions are important in terms of 
whether a public mandate for widespread environmental change (and restrictions on car use) is 
given. There is still considerable uncertainty for example concerning the effect size associated with 
active travel. If large increases in active travel were only associated with ‘small’ changes in obesity 
prevalence, of the order of one or two percentage points, then such change might not have 
widespread support. However, if the effect was much larger, such as ten percentage points with 
other improvements in other aspects of health and well-being, then such changes might receive 
wider support. 
 
Work that describes the relationship between physical active and health, particularly from a 
population perspective, is important to help people formulate or advocate for solutions. Also work 
identifying, developing and evaluating interventions is necessary to change practice and policy. 
 
Initially the second part of the thesis felt uncomfortable because it was challenging a line of 
argument used within public health practice to advocate for investment in or legislation for public 
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health interventions. It could be seen as undermining, rather than supporting, public health practice, 
particularly advocacy. Initially I justified the work because, I think public health should adhere to high 
standards of evidence and that failure to do so, in the long-run, risks undermining trust in public 
health and public health practice. As the thesis progressed, I came to recognise that a valuable role of 
academia, within society, is critical unbiased analysis. Academic public health should not provide 
evidence to support a particular approach but should offer critical unbiased analysis. 
 
This is one example of a tension between public health advocacy (which involves putting a favourable 
case for health interventions often to audiences who use evidence differently to medical 
researchers) and adherence to evidence. I have seen some academics respond to this challenge by 
simply describing their findings and making no recommendations for policy or practice. I do not think 
this is appropriate, but I do recognise there is a risk of brining bias or prejudice to the analysis and 
interpretation of the results. The approach I have arrived at, during my PhD, is to strive for the 
analysis and interpretation to be impartial and then to frame the implications in terms of what they 
mean for improving health.  
 
Whilst theoretically a population approach to improving health, by shifting the curve, may realise 
large health gains, it remains a theory. From observing other work during the course of my thesis, I 
have come to realise that even apparently modest shifts in behaviour at the population-level (e.g. an 
extra 10 minutes walking per day) are likely to be very hard to achieve in the UK, in part reflecting 
limited political and public support, and in part reflecting the observed effect sizes associated with 
studied interventions. Nonetheless I am sure there will be large changes in health behaviours and 
health, during my career. Some of these changes may be driven by factors outside of public health, 
and indeed outside of government, so called ‘megatrends’,123 for example mobile phones or the use 
of electric cars, which will be important to study and to document. There will still be opportunities 
for academic public health to act as a catalyst for change, but identifying those points of leverage will 
be a challenge and may be as much an art as a science. 
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8.8 Conclusions 
 
Active commuting is associated with improved well-being, reduced sickness absence and reduced 
adiposity amongst adults of working age. Increases in physical activity, because they are associated 
with improved survival, are not necessarily associated with reductions in need for healthcare for 
diseases for which physical activity is protective. When allowance is made for increased survival, 
estimates of reduction in the need for healthcare tend to be smaller and may be negligible. 
 
Active travel should be promoted as a means to improve health. Its importance for health should be 
conveyed to individuals, choosing how to travel, as well as to governments and other stakeholders 
who can influence the determinants of travel.  
 
Shifting the distribution of active travel, and ultimately physical activity, is likely to require facilitating 
and enabling active travel by changing those underlying determinants (e.g. normalising walking and 
cycling, reducing subsidies for car-use, investment in walking and cycling infrastructure). Whilst 
shifting the distribution of physical activity will improve health and reduce the incidence of certain 
disease, policy makers and public health practitioners should be cautious about how such changes 
are extrapolated to changes in need for health, and by implication costs for healthcare, as disease 
events may be postponed rather than prevented. 
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